
<html lang="en"     class="pb-page"  data-request-id="7ad25a8f-a7fe-442c-bcd3-b521120fa87c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2018.61.issue-8;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b01775;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis and Evaluation of Hydrogen Peroxide Sensitive Prodrugs of Methotrexate and Aminopterin for the Treatment of Rheumatoid Arthritis" /></meta><meta name="dc.Creator" content="Jorge  Peiró&#xA;Cadahía" /></meta><meta name="dc.Creator" content="Jon  Bondebjerg" /></meta><meta name="dc.Creator" content="Christian A.  Hansen" /></meta><meta name="dc.Creator" content="Viola  Previtali" /></meta><meta name="dc.Creator" content="Anders E.  Hansen" /></meta><meta name="dc.Creator" content="Thomas L.  Andresen" /></meta><meta name="dc.Creator" content="Mads H.  Clausen" /></meta><meta name="dc.Description" content="A series of novel hydrogen peroxide sensitive prodrugs of methotrexate (MTX) and aminopterin (AMT) were synthesized and evaluated for therapeutic efficacy in mice with collagen induced arthritis (C..." /></meta><meta name="Description" content="A series of novel hydrogen peroxide sensitive prodrugs of methotrexate (MTX) and aminopterin (AMT) were synthesized and evaluated for therapeutic efficacy in mice with collagen induced arthritis (C..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 31, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01775" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01775" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01775" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01775" /></link>
        
    
    

<title>Synthesis and Evaluation of Hydrogen Peroxide Sensitive Prodrugs of Methotrexate and Aminopterin for the Treatment of Rheumatoid Arthritis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01775" /></meta><meta property="og:title" content="Synthesis and Evaluation of Hydrogen Peroxide Sensitive Prodrugs of Methotrexate and Aminopterin for the Treatment of Rheumatoid Arthritis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0008.jpeg" /></meta><meta property="og:description" content="A series of novel hydrogen peroxide sensitive prodrugs of methotrexate (MTX) and aminopterin (AMT) were synthesized and evaluated for therapeutic efficacy in mice with collagen induced arthritis (CIA) as a model of chronic rheumatoid arthritis (RA). The prodrug strategy selected is based on ROS-labile 4-methylphenylboronic acid promoieties linked to the drugs via a carbamate linkage or a direct C–N bond. Activation under pathophysiological concentrations of H2O2 proved to be effective, and prodrug candidates were selected in agreement with relevant in vitro physicochemical and pharmacokinetic assays. Selected candidates showed moderate to good solubility, high chemical and enzymatic stability, and therapeutic efficacy comparable to the parent drugs in the CIA model. Importantly, the prodrugs displayed the expected safer toxicity profile and increased therapeutic window compared to MTX and AMT while maintaining a comparable therapeutic efficacy, which is highly encouraging for future use in RA patients." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01775"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01775">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01775&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01775&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01775&amp;href=/doi/10.1021/acs.jmedchem.7b01775" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3503-3515</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01716" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01795" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Evaluation of Hydrogen Peroxide Sensitive Prodrugs of Methotrexate and Aminopterin for the Treatment of Rheumatoid Arthritis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jorge Peiró Cadahía</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jorge Peiró Cadahía</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Nanomedicine & Theranostics, Department of Chemistry, Technical University of Denmark, Kemitorvet 207, DK-2800 Kongens Lyngby, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jorge++Peir%C3%B3%0ACadah%C3%ADa">Jorge Peiró Cadahía</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jon Bondebjerg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jon Bondebjerg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MC2 Therapeutics, Agern Alle 24-26, 2970 Hørsholm, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jon++Bondebjerg">Jon Bondebjerg</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christian A. Hansen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christian A. Hansen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Capdelta Group Aps, C/O Kavsbjerglund 30, DK-2740 Skovlunde, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christian+A.++Hansen">Christian A. Hansen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Viola Previtali</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Viola Previtali</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Nanomedicine & Theranostics, Department of Chemistry, Technical University of Denmark, Kemitorvet 207, DK-2800 Kongens Lyngby, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Viola++Previtali">Viola Previtali</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anders E. Hansen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anders E. Hansen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Nanomedicine & Theranostics, Department of Micro- and Nanotechnology, Technical University of Denmark, Ørsteds Plads, Building 345, DK-2800 Kongens Lyngby, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anders+E.++Hansen">Anders E. Hansen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thomas L. Andresen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas L. Andresen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Nanomedicine & Theranostics, Department of Micro- and Nanotechnology, Technical University of Denmark, Ørsteds Plads, Building 345, DK-2800 Kongens Lyngby, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+L.++Andresen">Thomas L. Andresen</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Mads H. Clausen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mads H. Clausen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Nanomedicine & Theranostics, Department of Chemistry, Technical University of Denmark, Kemitorvet 207, DK-2800 Kongens Lyngby, Denmark</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +45 45 25 21 31. E-mail: <a href="/cdn-cgi/l/email-protection#066b6e65466d636b6f2862727328626d"><span class="__cf_email__" data-cfemail="c4a9aca784afa1a9adeaa0b0b1eaa0af">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mads+H.++Clausen">Mads H. Clausen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9649-1729" title="Orcid link">http://orcid.org/0000-0001-9649-1729</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01775&amp;href=/doi/10.1021%2Facs.jmedchem.7b01775" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3503–3515</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 31, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 December 2017</li><li><span class="item_label"><b>Published</b> online</span>31 March 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 April 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01775" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01775</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3503%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJorge%2BPeir%25C3%25B3%250ACadah%25C3%25ADa%252C%2BJon%2BBondebjerg%252C%2BChristian%2BA.%2BHansen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D8%26contentID%3Dacs.jmedchem.7b01775%26title%3DSynthesis%2Band%2BEvaluation%2Bof%2BHydrogen%2BPeroxide%2BSensitive%2BProdrugs%2Bof%2BMethotrexate%2Band%2BAminopterin%2Bfor%2Bthe%2BTreatment%2Bof%2BRheumatoid%2BArthritis%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3515%26publicationDate%3DApril%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01775"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2965</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">26</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01775" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Evaluation of Hydrogen Peroxide Sensitive Prodrugs of Methotrexate and Aminopterin for the Treatment of Rheumatoid Arthritis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jorge&quot;,&quot;last_name&quot;:&quot;Peiró\nCadahía&quot;},{&quot;first_name&quot;:&quot;Jon&quot;,&quot;last_name&quot;:&quot;Bondebjerg&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;A. Hansen&quot;},{&quot;first_name&quot;:&quot;Viola&quot;,&quot;last_name&quot;:&quot;Previtali&quot;},{&quot;first_name&quot;:&quot;Anders&quot;,&quot;last_name&quot;:&quot;E. Hansen&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;L. Andresen&quot;},{&quot;first_name&quot;:&quot;Mads&quot;,&quot;last_name&quot;:&quot;H. Clausen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;3503-3515&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01775&quot;},&quot;abstract&quot;:&quot;A series of novel hydrogen peroxide sensitive prodrugs of methotrexate (MTX) and aminopterin (AMT) were synthesized and evaluated for therapeutic efficacy in mice with collagen induced arthritis (CIA) as a model of chronic rheumatoid arthritis (RA). The prodrug strategy selected is based on ROS-labile 4-methylphenylboronic acid promoieties linked to the drugs via a carbamate linkage or a direct C–N bond. Activation under pathophysiological concentrations of H2O2 proved to be effective, and prodrug candidates were selected in agreement with relevant in vitro physicochemical and pharmacokinetic assays. Selected candidates showed moderate to good solubility, high chemical and enzymatic stability, and therapeutic efficacy comparable to the parent drugs in the CIA model. Importantly, the prodrugs displayed the expected safer toxicity profile and increased therapeutic window compared to MTX and AMT while maintaining a comparable therapeutic efficacy, which is highly encouraging for future use in RA patients.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01775&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01775" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01775&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01775" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01775&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01775" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01775&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01775&amp;href=/doi/10.1021/acs.jmedchem.7b01775" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01775" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01775" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01775%26sid%3Dliteratum%253Aachs%26pmid%3D29605999%26genre%3Darticle%26aulast%3DPeir%25C3%25B3%250D%250ACadah%25C3%25ADa%26date%3D2018%26atitle%3DSynthesis%2Band%2BEvaluation%2Bof%2BHydrogen%2BPeroxide%2BSensitive%2BProdrugs%2Bof%2BMethotrexate%2Band%2BAminopterin%2Bfor%2Bthe%2BTreatment%2Bof%2BRheumatoid%2BArthritis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D8%26spage%3D3503%26epage%3D3515%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/jmcmar.2018.61.issue-8/20180426/jmcmar.2018.61.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of novel hydrogen peroxide sensitive prodrugs of methotrexate (MTX) and aminopterin (AMT) were synthesized and evaluated for therapeutic efficacy in mice with collagen induced arthritis (CIA) as a model of chronic rheumatoid arthritis (RA). The prodrug strategy selected is based on ROS-labile 4-methylphenylboronic acid promoieties linked to the drugs via a carbamate linkage or a direct C–N bond. Activation under pathophysiological concentrations of H<sub>2</sub>O<sub>2</sub> proved to be effective, and prodrug candidates were selected in agreement with relevant <i>in vitro</i> physicochemical and pharmacokinetic assays. Selected candidates showed moderate to good solubility, high chemical and enzymatic stability, and therapeutic efficacy comparable to the parent drugs in the CIA model. Importantly, the prodrugs displayed the expected safer toxicity profile and increased therapeutic window compared to MTX and AMT while maintaining a comparable therapeutic efficacy, which is highly encouraging for future use in RA patients.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08746" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08746" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic destructive synovitis and is associated with progressive disability, systemic difficulties, premature death, and socioeconomic costs.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The cause of RA remains unknown, and currently no cure for the disease exists. Several studies have estimated the prevalence of RA to range between 0.5% to 1% of the adult population in developed countries, with a 3 to 1 female to male ratio.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Aminopterin (<b>1</b>, AMT, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), an antifolate drug initially developed for treatment of leukemia, was tested for RA treatment in 1951.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Complex manufacturing,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> unpredictable toxicities,<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6−9)</a> and low therapeutic index<a onclick="showRef(event, 'ref8 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref10">(8,10)</a> led scientists to develop methotrexate (<b>2</b>, MTX, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) as an alternative antifolate for cancer therapy, which later showed antiarthritic properties as a disease modifying antirheumatic drug (DMARD). In 1988, low-dose MTX (LD-MTX, <30 mg in weekly pulses) was approved by the FDA for the treatment of RA and has remained the standard of care since.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> Although efficacious, the mechanisms that govern the anti-inflammatory and immunosuppressive effects of MTX in rheumatic diseases are still not completely understood.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Furthermore, the population of patients that will be responsive to an MTX regimen cannot be reliably predicted before initiating treatment.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Adverse effects and low efficacy of LD-MTX in RA are the predominant reasons for discontinuation of treatment. Side effects are usually mild, self-limiting, and/or preventable, but a subset of patients suffers from severe side-effects. Toxicities including anemia, neutropenia, stomatitis, oral ulcers, lethargy, fatigue, nodulosis, and hepatic and pulmonary fibrosis, as well as renal insufficiency are associated with this drug.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15−18)</a> Additionally, progressive drug tolerance of disease, high patient variability, and pharmacokinetic inadequacies of LD-MTX suggest the need of more efficient and safer RA therapies.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure of aminopterin (AMT, <b>1</b>) and methotrexate (MTX, <b>2</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Prodrugs are chemically modified drugs that have either no or greatly decreased activity compared to the parent drug. Upon administration, prodrugs are activated in the body through chemical and/or enzymatic transformation into the pharmaceutically active moiety.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Approximately 20% of drugs approved since 2000 are prodrugs,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> mostly designed to minimize and/or overcome unacceptable absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of the native drug.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Several prodrugs, drug conjugates, and drug delivery systems for methotrexate have been reported in the literature, but none of them have been approved for clinical use yet.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33">(22−33)</a></div><div class="NLM_p">Reactive oxygen species (ROS), like H<sub>2</sub>O<sub>2</sub>, HO<sup>•</sup>, O<sub>2</sub><sup>–</sup>, produced by phagocytes, and neutrophils,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> have important physiological roles in priming the immune system.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> Increasing evidence from different studies supports the relation between oxidative stress and the pathogenesis of inflammation and rheumatoid arthritis.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> In RA, oxidative stress has been described as an important mechanism in the pathogenesis of destructive proliferative synovitis. Under pathological inflammatory conditions, the extracellular concentration of H<sub>2</sub>O<sub>2</sub>, the most stable ROS, has been determined to be up to a 100-fold higher compared to healthy tissue, reaching concentrations as high as 1.0 mM.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42 ref43 ref44">(39−44)</a> The presence of increased concentrations of H<sub>2</sub>O<sub>2</sub> in the inflammatory environment can serve as the stimulus for prodrug activation in site-selective drug delivery systems. Phenylboronic acids and esters,<a onclick="showRef(event, 'ref45 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47 ref48">(45−48)</a> phenylsulfonate esters,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> thiazolidinones,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a><i>N</i>-(2,5-dihydroxyphenyl)acetamides,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and α-boryl ethers, carbonates, and acetals<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> have been reported as useful structural motifs for hydrogen peroxide activatable prodrugs and imaging, but studies have mainly focused on their applications in oncology.</div><div class="NLM_p last">Here we propose a new approach to RA therapy based on the use of phenylboronic acid-containing prodrugs that are inactive until activated locally in the inflammatory tissue. This mechanism secures that the biological activity is limited to regions of inflammation to facilitate a safer toxicity profile compared to AMT and MTX, and a more effective treatment due to the expected localization and accumulation in the target tissue. We have designed and synthesized a series of MTX and AMT prodrugs that are activated by disease- and tissue-specific factors like H<sub>2</sub>O<sub>2</sub>. Their physicochemical, pharmacokinetic, and drug-like properties have been evaluated in <i>in vitro</i> assays. Additionally, their <i>in vivo</i> efficacy and preliminary toxicity in the murine collagen-induced arthritis model (CIA) was assessed.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67767" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67767" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis of Prodrugs</h3><div class="NLM_p">The pinacolates <b>4b</b> and <b>4c</b> were synthesized from the corresponding 4-hydroxymethylphenyl boronic acids <b>3b</b> and <b>3c</b> via condensation with pinacol (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Subsequently, the chloroformates <b>5a</b>–<b>c</b> were achieved by reaction of <b>3a</b>–<b>c</b> with phosgene. In parallel, the MTX core structure was synthesized starting with bromination of 2,4-diamino-6-(hydroxymethyl)pteridine hydrochloride (<b>6·</b>HCl) and alkylation of 4-methylaminobenzoic acid to form the pteoric acid <b>7</b>, following the procedure described by Kralovej et al.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Amide coupling of <b>7</b> with dimethylglutamate hydrochloride <b>9·</b>HCl, synthesized from glutamic acid <b>8</b>, provided methotrexate dimethylester <b>10</b>. Finally, coupling between <b>10</b> and <b>5a</b>–<b>c</b> formed the desired prodrugs <b>11</b>–<b>13</b> after hydrolysis of the pinacolate with HCl in a mixture of H<sub>2</sub>O/MeCN. The use of DMAP in the coupling step was crucial for the progression of the reaction. Compounds <b>11</b>–<b>13</b> represent a set of MTX prodrugs in which the promoiety is linked to MTX via a carbamate linkage. The promoiety contains different <i>ortho</i>-substituents (H, F, or Me) in order to investigate the effect of modifying the steric and electronic environment around the boronic acid on reactivity toward H<sub>2</sub>O<sub>2</sub>. Furthermore, the carboxylic acids of MTX were also masked as methyl esters.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of MTX Prodrugs <b>11</b>–<b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) pinacol, THF, reflux, 16 h (>94%); (b) COCl<sub>2</sub> (20% in toluene), dioxane, 21 °C, 20 h (>95%); (c) NaOH, H<sub>2</sub>O; (d) PPh<sub>3</sub>Br<sub>2</sub>, DMA, 21 °C, 24 h, then 4-methylaminobenzoic acid, DIPEA, 3 days (77%); (e) PyBOP, Et<sub>3</sub>N, DMF, 21 °C, 30 min, then <b>9·</b>HCl (86%); (f) MeOH, SOCl<sub>2</sub>, 21 °C, 4 days (>95%); (g) <b>5a</b>–<b>c</b>, DIPEA, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 21 °C, 5 h; (h) HCl in H<sub>2</sub>O/MeCN, 21 °C, 16 h (27–32%).</p></p></figure><div class="NLM_p">Efforts aiming for hydrolysis of the methyl esters in <b>11</b>–<b>13</b> using standard conditions based on alkaline hydrolysis with NaOH<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> or LiOH,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> LiI in pyridine,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> or enzymatic hydrolysis using a polymer supported lipase from <i>Candida antarctica</i><a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> were unsuccessful. Therefore, a new synthetic strategy was proposed (see <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of MTX Prodrug <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PMBCl, 1,1,3,3-tetramethylguanidine, CH<sub>2</sub>Cl<sub>2</sub>, 21 °C, 16 h (35%); (b) <b>5a</b>, DIPEA, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 21 °C, 5 h (73%); (c) HCl in H<sub>2</sub>O/MeCN, 21 °C, 20 h (31%); (d) 5% TFA in CH<sub>2</sub>Cl<sub>2,</sub> 21 °C, 30 min (54%).</p></p></figure><div class="NLM_p">Starting from MTX, the synthesis of the corresponding PMB protected intermediate <b>14</b> was achieved. Following the same procedure described for the synthesis of <b>11</b>–<b>13</b>, coupling between <b>5a</b> and <b>14</b> afforded <b>15</b>, which was hydrolyzed to form the corresponding boronic acid <b>16</b>. Lastly, PMB deprotection under acidic conditions afforded the prodrug <b>17</b>.</div><div class="NLM_p">Cbz protection of 4-aminobenzoic acid (<b>18</b>) formed <b>19</b>, and two-step coupling with <b>9</b>·HCl produced <b>20</b>. Hydrogenolysis of <b>20</b> afforded <b>21</b> in high yields, which was subjected to reductive alkylation with 4-formylphenylboronic acid to give <b>22</b>. Alkylation of <b>22</b> with 6-(bromomethyl)-2,4-pteridinediamine hydrobromide (<b>23·</b>HBr) formed the first AMT prodrug <b>24</b>. The concentration of the reaction was critical to obtain a reasonable yield, as previously published by Montgomery et al.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> for similar substrates. The last step consisted of alkaline hydrolysis of <b>24</b> to form the second AMT prodrug <b>25</b>. These compounds represent the proposed set of phenylboronic acid-based AMT prodrugs in which the promoiety is attached to the secondary aniline group, bearing methylester protected (<b>24</b>) or free carboxylic acids (<b>25</b>) (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of AMT Prodrugs <b>24</b> and <b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CbzCl, NaHCO<sub>3</sub>, H<sub>2</sub>O/dioxane, 21 °C, 2 h (89%); (b) SOCl<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 24 h; (c) <b>9·</b>HCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 21 °C, 2 h (>95%); (d) H<sub>2</sub>, Pd/C, MeOH, 21 °C, 12 h; (e) HCl in Et<sub>2</sub>O (>95%); (f) NaBH<sub>4</sub>, MeOH, 21 °C, 24 h (67%); (g) DMA, 55 °C, 3 days (43%); (h) NaOH, H<sub>2</sub>O, 21 °C, 5 min (40%).</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Activation of Prodrugs</h3><div class="NLM_p">For a proof-of-principle of the prodrug strategy, a study on the activation of <b>11</b>–<b>13</b>, <b>17</b>, <b>24</b>, and <b>25</b> under pathophysiological concentrations of H<sub>2</sub>O<sub>2</sub> was performed. The experiment consisted on the incubation of test compounds in a 30% DMSO/PBS mixture at a concentration of 50 μM and H<sub>2</sub>O<sub>2</sub> concentration found in inflammatory tissue (0.5 mM, 10 equiv) at 37 °C. The activation was followed by RP-UPLC-MS (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">Figures S1 and S2</a> for examples on prodrug <b>17</b> and <b>25</b> chromatograms, respectively). Negative controls (no H<sub>2</sub>O<sub>2</sub> addition) were performed in parallel (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">Figure S3</a>). The rationale behind the substitution of a hydrogen atom in the <i>ortho</i>-position of the phenylboronic acid promoiety by a methyl group or a fluorine atom was the reactivity toward oxidative deboronation. Interestingly, prodrugs <b>11</b>–<b>13</b> were activated and released <b>10</b> within less than 3 h (>95% conversion by UPLC-MS); therefore, no effects on the reaction rate by <i>ortho</i>-substituents was observed under the conditions tested (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, left). Furthermore, <b>17</b> was activated within the same time frame, releasing exclusively MTX, with no significant difference compared to <b>11</b>–<b>13</b>. The plot of the formation of prodrug activation products versus time can be found in the SI (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">Figure S4</a>). Moreover, a concentration-dependent release of drug was observed as determined in an activation assay using different concentrations of H<sub>2</sub>O<sub>2</sub> (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">Figure S5</a>).</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Activation of MTX prodrugs <b>11</b>–<b>13</b> and <b>17</b> (left), and AMT-prodrugs <b>24</b> and <b>25</b>, as well as formation and disappearance of intermediates <b>26</b> and <b>27</b> (right). The experiment was carried out at a compound concentration of 50 μM and 0.5 mM H<sub>2</sub>O<sub>2</sub> (10 equiv) in a mixture of 30% DMSO in PBS at 37 °C. Hidden error bars are smaller than symbols.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The activation of AMT prodrugs <b>24</b> and <b>25</b> was also examined. Full consumption of prodrugs was observed in a similar time frame compared to the MTX prodrugs (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, right). AMT prodrugs did not release AMT nor <b>28</b> within the first 2 h of incubation, but instead afforded the corresponding phenol intermediates <b>26</b> and <b>27</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). After 2 h of assay initiation, full disappearance of the prodrugs was observed, and <b>26</b> and <b>27</b> started to slowly release AMT and <b>28</b>, in a H<sub>2</sub>O<sub>2</sub> concentration-independent manner as studied in a separate assay (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">Figure S5</a>). Full formation of products was not observed even after 48 h of incubation. The formation of the relatively stable intermediates <b>26</b> and <b>27</b> could potentially allow them to disperse from the inflammatory environment and exert nonselective drug actions upon AMT release, unlike for the MTX-prodrugs <b>11</b>–<b>13</b> and <b>17</b>, where phenol intermediates were not observed due to the faster self-immolation. This will have to be further evaluated in a future study of the AMT prodrugs.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Activation of AMT Prodrugs <b>24</b> and <b>25</b> with H<sub>2</sub>O<sub>2</sub> To Form the Intermediates <b>26</b> and <b>27</b>, Respectively, Which Slowly Release <b>28</b> and AMT</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Kinetic Solubility</h3><div class="NLM_p">The low solubility of <b>11</b>–<b>13</b> and <b>24</b> in the H<sub>2</sub>O<sub>2</sub> activation assay required the use of high concentrations of DMSO (30%) in PBS. Therefore, the evaluation of the prodrug solubility was prioritized in the development program. Kinetic solubility in PBS was measured at 37 °C, and the results were compared to those determined for the parent drugs, showing low solubility (<10 μg/mL) for the methyl ester prodrugs <b>11</b>–<b>13</b> and <b>24</b>, according to the guidelines for oral administration in humans and animal dosing formulations (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). However, prodrugs <b>17</b> and <b>25</b> showed moderate to good solubility for predicted oral dosing in humans (55 and 48 μg/mL, respectively), although still low for animal dosing applications. The low solubility of <b>11</b>–<b>13</b> and <b>24</b> prompted the decision to select <b>17</b> and <b>25</b> for further <i>in vitro</i> studies.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Kinetic Solubility of <b>11</b>, <b>12</b>, <b>13</b>, <b>17</b>, <b>24</b>, and <b>25</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">kinetic solubility</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">prodrug</th><th class="colsep0 rowsep0" align="center" char="±">μM</th><th class="colsep0 rowsep0" align="center" char="±">μg/mL</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="±">3.0 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">2.0 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char="±">3.1 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">2.1 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char="±">4.6 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">3.1 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char="±">87 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="±">55 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char="±">4.1 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">2.5 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char="±">83 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">48 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>MTX</b></td><td class="colsep0 rowsep0" align="char" char="±">2137 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">970 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AMT</b></td><td class="colsep0 rowsep0" align="char" char="±">>1000 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">>440 ± 0.0</td></tr></tbody></table></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Chemical (pH 7.4), SGF, SIF, Plasma, and Metabolic Stability</h3><div class="NLM_p">The stability of <b>17</b> and <b>25</b> was evaluated in different relevant physiological environments including chemical stability at blood pH 7.4 as well as in simulated gastric fluid (SGF), simulated intestinal fluid (SIF), human and mouse plasma, and liver microsomes. First, the half-lives <i>t</i><sub>1/2</sub> of <b>17</b> and <b>25</b> in PBS (pH 7.4) at 37 °C were determined to be 238 and 577 h, respectively, with stabilities higher than 90% after 24 h in both cases (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">Figure S6</a>). Second, the stability in SGF and SIF was studied and half-lives calculated to be 8 and 770 h in SGF, and 239 and 866 h in SIF for <b>17</b> and <b>25</b>, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">Figure S7</a>). The shorter half-life of <b>17</b> in SGF was found to be pH-dependent rather than a result of enzymatic hydrolysis (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">Figure S7</a>). Third, the stability in human and mouse plasma proved to be high, with 70% and 82% of <b>17</b> and <b>25</b> remaining after 24 h in human plasma, respectively, and 62% and 91% after 8 h in mouse plasma (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">Figure S8</a>). Their half-lives were calculated using first order kinetics, and the results are shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Lastly, the metabolic stability was evaluated by the determination of intrinsic clearance (CL<sub>int</sub>) in human and mouse pooled liver microsomes. Intrinsic clearance of <b>17</b> and <b>25</b> was calculated to be 22 and 1.2 μL/min/mg, respectively, in human microsomes, and 6.4 and 2.6 μL/min/mg in mouse microsomes (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">Figure S9</a>), indicating their high metabolic stability.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Chemical (pH 7.4), SGF, SIF, Plasma, and Metabolic Stabilities of Prodrug Candidates <b>17</b> and <b>25</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">CL<sub>int</sub> (μL/min/mg)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">prodrug</th><th class="colsep0 rowsep0" align="center" char=".">chemical stability (pH 7.4)</th><th class="colsep0 rowsep0" align="center" char=".">SGF stability</th><th class="colsep0 rowsep0" align="center" char=".">SIF stability</th><th class="colsep0 rowsep0" align="center" char=".">human plasma stability</th><th class="colsep0 rowsep0" align="center" char=".">mouse plasma stability</th><th class="colsep0 rowsep0" align="center" char=".">human microsomal stability</th><th class="colsep0 rowsep0" align="center" char=".">mouse microsomal stability</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">238</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">239</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">577</td><td class="colsep0 rowsep0" align="char" char=".">770</td><td class="colsep0 rowsep0" align="char" char=".">866</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Antiarthritic Efficacy and Preliminary Toxicity</h3><div class="NLM_p">The efficacy of the prodrug candidates <b>17</b> and <b>25</b> was evaluated in the collagen type-II induced arthritis (CIA) mouse model. This model has been found to be characterized by oxidative stress<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> and increased concentrations of H<sub>2</sub>O<sub>2</sub> in the joint tissue, paws, and limbs;<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> hence, it represents a good model for the evaluation of the prodrug concept. Prior to the <i>in vivo</i> analysis, the prodrug concept was evaluated <i>in vitro</i> for <b>17</b> and <b>25</b>. To this end, the cell viability inhibition of the prodrugs against two MTX- and AMT-sensitive cancer cell lines, NCI-H460 (lung cancer) and MCF-7 (breast cancer),<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> was tested. The prodrugs showed significantly reduced efficacy in the two cell lines when applied directly to the cells as compared to when they were activated by preincubation with noncytotoxic concentration of H<sub>2</sub>O<sub>2</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">Figures S10–S12</a>). Additionally, the IC<sub>50</sub> values of the preactivated prodrugs <b>17</b> and <b>25</b> showed comparable biological activity to MTX and AMT (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">Figures S13 and S14</a>) in the two selected cancer cell lines. A detailed description of the assays can be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">SI</a>.</div><div class="NLM_p">The <i>in vivo</i> antiarthritic efficacy and preliminary toxicity study was performed using a therapeutic intervention set up in the CIA model, and the parent drugs MTX and AMT were included as treatment controls. Vehicle control (2% DMSO in PBS), MTX (7.0 mg/kg), and equimolar doses of AMT, <b>17</b>, and <b>25</b> were <i>i.p.</i> administered on a daily basis for 2 weeks, starting at onset of disease (day 27 after first immunization). Mean arthritis severity score and average animal body weight were measured three times per week. Reduced incidence of arthritis and reduction of macroscopic arthritis score was observed both for the drugs and prodrugs in comparison to the control group (vehicle) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, left). Additionally, remission of arthritis started to be detected at the end of the study for MTX, <b>17</b>, and <b>25</b>, with no statistically significant difference in efficacy between them. Interestingly, the AMT-group had to be sacrificed at day 33 due to significant toxicity measured as decreased average body weight in the group, while the AMT prodrug <b>25</b> did not show any sign of side-effects (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, right). Progressive weight loss was observed in the MTX-group toward the end of the study but not in the group treated with <b>17</b>. These results indicate the great potential of <b>17</b> and <b>25</b> as prodrugs of MTX and AMT, respectively, showing comparable efficacy in managing arthritis development and control of disease activity, and reducing side-effects compared to the parent drugs.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Suppression of CIA development in DBA/1J mice (left) after treatment with MTX (7 mg/kg) and equimolar amounts of AMT (6.8 mg/kg), <b>17</b> (9.7 mg/kg), and <b>25</b> (8.8 mg/kg) (<i>n</i> = 8 per group). Mice were given the indicated dose of test compound once per day, starting on day 27, and arthritis scoring was performed three times per week. Data represents mean values of arthritic score ± SEM. Statistics were calculated using a one-tailed nonparametric Mann–Whitney. *<i>p</i> < 0.05 and **<i>p</i> < 0.01 between MTX and vehicle and <sup>†</sup><i>p</i> < 0.05 between 17 and vehicle. General health of mice (right) evaluated three times per week as the average body weight in groups of animals (<i>n</i> = 8) tested with vehicle, MTX, AMT, <b>17</b>, and <b>25</b>. Data represents mean values of bodyweight ± SEM; *<i>p</i> < 0.05 between AMT and vehicle. One animal in the vehicle and the <b>25</b> groups were sacrificed pretermination due to high arthritis scores. The AMT group was removed at day 33 due to decline in health. AMT, aminopterin; CIA, collagen induced-arthritis; CII, collagen type-II; MTX, methotrexate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Although no toxicity associated with prodrugs <b>17</b> and <b>25</b> has been observed in the animal assays performed, it is of relevance for future studies of the potential toxicities to also account for the release of quinone methides as the prodrug activation end-product. Their reactivity and toxicity has been linked and reviewed elsewhere,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and prior studies have demonstrated that it is possible to modulate these factors through judicious choice of the substitution pattern on the quinone methides released. Noteworthy, quinone moieties are known in long-term use marketed drugs,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and newly developed ROS-sensitive drug delivery systems, which employ phenyl boronates as the responsive chemical entity, have shown good safety profiles after long-term administration in mice.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this report, we have described the synthesis of new arylboronic acid-based hydrogen peroxide-sensitive prodrugs of MTX and AMT for site-selective delivery of drugs to inflammatory tissues associated with RA with the aim of reducing side effects in MTX and AMT RA therapy. Among the set of prodrugs synthesized, <b>17</b> and <b>25</b> showed moderate to good solubility, high chemical stability, high stability in simulated gastrointestinal fluids, and high plasma and metabolic stabilities both in human and mouse plasma and liver microsomes. Their comparable efficacy and lower toxicity in comparison to parental drugs was identified using a CIA mouse model of RA. Future work will focus on additional <i>in vivo</i> studies to establish optimal dosing and to map toxicity in more detail to hopefully advance these promising prodrugs into clinical evaluations.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62888" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62888" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Considerations</h3><div class="NLM_p last">Unless otherwise stated, commercially available reagents were used without further purification, and all solvents were of HPLC quality. Reactions under nitrogen atmosphere were performed in oven- or flame-dried glassware and anhydrous solvents. Anhydrous CH<sub>2</sub>Cl<sub>2</sub>, CH<sub>3</sub>CN, THF, DMF, and toluene were obtained from Innovative Technology PS-MD-7 PureSolv solvent purification system. All reactions were monitored by thin-layer chromatography (TLC) and/or reversed-phased ultraperformance liquid chromatography mass spectrometry (RP-UPLC-MS). Analytical TLC was conducted on Merck aluminum sheets covered with silica (C60). The plates were either visualized under UV-light or stained by dipping in a developing agent followed by heating. KMnO<sub>4</sub> (3 g in water (300 mL) along with K<sub>2</sub>CO<sub>3</sub> (20 g) and 5% aqueous NaOH (5 mL)) or ninhydrin (3 g in a mixture of <i>n</i>-butanol (200 mL) and AcOH (6 mL)) were used as developing agents. Flash column chromatography was performed using Matrex 60 Å, 35–70 μ silica gel. All new compounds were characterized by IR, <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS (ESI), and melting point (m.p.) when applicable. For recording of <sup>1</sup>H NMR and <sup>13</sup>C NMR, a Bruker Ascend with a Prodigy cryoprobe (operating at 400 MHz for proton and 101 MHz for carbon) was used. Unless otherwise stated, all NMR spectra were recorded at 25 °C. The chemical shifts (δ) are reported in parts per million (ppm) and the coupling constants (<i>J</i>) in Hz. For spectra recorded in CDCl<sub>3</sub>, signal positions were measured relative to the signal for CHCl<sub>3</sub> (7.26 ppm for <sup>1</sup>H NMR and 77.16 ppm for <sup>13</sup>C NMR). For spectra recorded in DMSO-<i>d</i><sub>6</sub>, signal positions were measured relative to the signal for DMSO (δ 2.50 ppm for <sup>1</sup>H NMR and 39.52 ppm for <sup>13</sup>C NMR). For spectra recorded in D<sub>2</sub>O, signal positions were measured relative to the signal for H<sub>2</sub>O (δ 4.79 ppm for <sup>1</sup>H NMR at 25 °C).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The <sup>13</sup>C NMR signal of the <i>ipso</i>-carbon to the boron atom was not observed in any characterized compound, although they were identified by the characteristic HMBC correlation signals. Infrared (IR) spectra were recorded on a Bruker Alpha-P FT-IR (Bruker) instrument. Neat application into the apparatus was used for all compounds. Transmittance units were plotted in the <i>y</i> axis and wavenumber (cm<sup>–1</sup>) on the <i>x</i> axis. Optical rotations were measured on a PerkinElmer Model 241 Polarimeter (cuvette 1.0 mL, 100 mm) using a sodium source lamp (589 nm, 20 °C). Melting points (m.p.) were recorded using a Stuart melting point SMP30 and reported in °C, uncorrected. Analytical RP-UPLC-MS (ESI) analysis was performed on a Waters AQUITY RP-UPLC system equipped with a diode array detector using a Thermo accucore C18 column (<i>d</i> = 2.6 μm, 2.1 × 50 mm; column temp, 50 °C; flow, 0.6 mL/min). Four different methods were used. Method A: eluents A (0.1% HCO<sub>2</sub>H in milli-Q water) and B (0.1% HCO<sub>2</sub>H in CH<sub>3</sub>CN) were used in a linear gradient (5% B to 100% B) in a total run time of 2.6 min. Method B: eluents A (0.1% HCO<sub>2</sub>H in H<sub>2</sub>O) and B (0.1% HCO<sub>2</sub>H in CH<sub>3</sub>CN) were used in a linear gradient (5% B to 100% B) in a total run time of 5.0 min. Method C: eluents A (10 mM NH<sub>4</sub>OAc in milli-Q water) and B (0.1% NH<sub>4</sub>OAc in milli-Q water/MeCN, 90/10, v/v) were used in a linear gradient (5% B to 100% B) in a total run time of 2.6 min. Method D: eluents A (0.1% NH<sub>4</sub>OAc in H<sub>2</sub>O) and B (0.1% NH<sub>4</sub>OAc in CH<sub>3</sub>CN) were used in a linear gradient (5% B to 100% B) in a total run time of 5.0 min. The LC system was coupled to a SQD mass spectrometer operating in both positive and negative electrospray modes. The temperature for all recordings was 20 °C. Analytical LC-HRMS (ESI) analysis was performed on an Agilent 1100 RP-LC system equipped with a diode array detector using a Phenomenex Luna C18 column (<i>d</i> = 3 μm, 2.1 × 50 mm; column temp, 40 °C; flow, 0.4 mL/min). Eluents A (0.1% HCO<sub>2</sub>H in H<sub>2</sub>O) and B (0.1% HCO<sub>2</sub>H in CH<sub>3</sub>CN) were used in a linear gradient (20% B to 100% B) in a total run time of 15 min. The LC system was coupled to a Micromass LCT orthogonal time-of-flight mass spectrometer equipped with a Lock Mass probe operating in positive or negative electrospray mode. Purification of reactions by preparative RP-HPLC was performed on a Waters Alliance reverse-phase HPLC system consisting of a Waters 2545 Binary Gradient Module equipped with either an xBridge BEH C18 OBD Prep Column (130 Å, 5 μm, 30 × 150 mm) or an xBridge Peptide BEH C18 OBD Prep Column (130 Å, 5 μm, 19 mm × 100 mm) both operating at 20 °C and a flow rate of 20 mL/min, a Waters Photodiode Array Detector (detecting at 210–600 nm), a Waters UV Fraction Manager, and a Waters 2767 Sample Manager. Elution was carried out in a reversed-phase gradient fashion combining A1 (0.1% HCO<sub>2</sub>H in milli-Q water) and B1 (0.1% HCO<sub>2</sub>H in CH<sub>3</sub>CN) or A2 (5 mM NH<sub>4</sub>OAc in H<sub>2</sub>O) and B2 (5 mM NH<sub>4</sub>OAc in CH<sub>3</sub>CN): 5% B to 70% B in 10 min, hold for 3.5 min, then 70% B to 100% B in 1.5 min, and hold 3 min. Total run time: 20 min. The purity of the compounds was assessed by RP-UPLC-UV and NMR, and purities ≥95% were considered acceptable for evaluation purposes both in <i>in vitro</i> and <i>in vivo</i> assays.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl Carbonochloridate (<b>4b</b>)</h4><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> General Procedure A</h5><div class="NLM_p last">A suspension of <b>3b</b> (0.9 g, 5.4 mmol) and pinacol (0.7 g, 6.0 mmol) in anhydrous THF (25 mL) was refluxed for 16 h under a N<sub>2</sub> atmosphere. The solids dissolved during the reaction time. Then, the mixture was concentrated <i>in vacuo</i>, and the residue was purified by flash column chromatography on silica gel using a mixture of CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (9/1, v/v) as the eluent to give the title compound <b>4b</b> as a clear oil (1.27 g, 95%), which solidified upon storage in the refrigerator. <i>R</i><sub>f</sub> = 0.84 (silica, CH<sub>2</sub>Cl<sub>2</sub>/EtOAc, 1/1, v/v); m.p., 38.5–41.3 °C. IR (neat, cm<sup>–1</sup>): 3390.6, 2978.1, 2925.3, 2867.7, 1609.0, 1347.1, 335.9. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.76 (d, <i>J</i> = 7.4 Hz, 1H), 7.17–7.09 (m, 2H), 4.67 (s, 2H), 2.54 (s, 3H), 1.34 (s, 12H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 145.5, 143.6, 136.4, 128.3, 123.2, 83.6, 65.4, 25.0, 22.3. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>22</sub>BO<sub>3</sub> [M + Na]<sup>+</sup> 271.1476, found 271.1512.</div></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol (<b>4c</b>)</h4><div class="NLM_p last">Following <i>general procedure A</i> using <b>3c</b> (0.90 g, 5.30 mmol), the title compound <b>4c</b> was afforded as a clear oil (1.26 g, 94%) after purification by flash column chromatography on silica gel using a mixture of CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (9/1, v/v) as the eluent. The oil became a white solid upon storage in the refrigerator. <i>R</i><sub>f</sub> = 0.71 (silica, eluent CH<sub>2</sub>Cl<sub>2</sub>/EtOAc, 1/1, v/v); m.p., 52.5–56.4 °C (Lit.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> 35–38). IR (neat, cm<sup>–1</sup>): 3424.6, 2978.6, 2932.3, 2864.3, 1624.1, 1351.8. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.77–7.67 (m, 1H), 7.12 (d, <i>J</i> = 7.6 Hz, 1H), 7.06 (d, <i>J</i> = 10.1 Hz, 1H), 4.72 (s, 2H), 1.36 (s, 12H).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a><sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.6 (d, <i>J</i> = 251.4 Hz), 147.2 (d, <i>J</i> = 8.0 Hz), 137.2 (d, <i>J</i> = 8.4 Hz), 121.7 (d, <i>J</i> = 2.9 Hz), 113.4 (d, <i>J</i> = 24.7 Hz), 84.0, 64.6, 25.0.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl carbonochloridate (<b>5a</b>)</h4><div id="sec4_2_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> General Procedure B</h5><div class="NLM_p last">A solution of <b>4</b><b>a</b> (2.0 g, 8.54 mmol) in anhydrous dioxane (25 mL) was treated with phosgene (20% in toluene, 22.6 mL, 42.7 mmol), and the reaction was stirred for 20 h under an N<sub>2</sub> atmosphere at 21 °C. The mixture was concentrated <i>in vacuo</i>, redissolved, and concentrated with toluene (2×) to afford the crude title compound <b>5a</b> as a clear oil (2.5 g, >95%). The crude chloroformate was used in subsequent reactions within a few hours after its isolation. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.84 (d, <i>J</i> = 8.1 Hz, 2H), 7.38 (d, <i>J</i> = 8.1 Hz, 2H), 5.31 (s, 2H), 1.35 (s, 12H).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a><sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 150.8, 136.2, 135.4, 128.0, 84.2, 73.4, 25.0.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div></div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl Carbonochloridate (<b>5b</b>)</h4><div class="NLM_p last">Following <i>general procedure B</i> using <b>4b</b> (1.2 g, 4.8 mmol), the title compound <b>5b</b> was afforded as a clear oil (1.5 g, >95%). The crude chloroformate was used in subsequent reactions within a few hours after its isolation. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78 (d, <i>J</i> = 8.0 Hz, 1H), 7.20–7.13 (m, 2H), 5.26 (s, 2H), 2.55 (s, 3H), 1.34 (s, 12H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 150.8, 145.7, 136.5, 135.7, 130.1, 125.0, 83.8, 73.5, 25.0, 22.3.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl Carbonochloridate (<b>5c</b>)</h4><div class="NLM_p last">Following <i>general procedure B</i> using <b>4c</b> (1.2 g, 4.8 mmol), the crude product <b>5c</b> was afforded as a white solid (1.5 g, > 95%). The crude chloroformate was used in subsequent reactions within a few hours after isolation. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.77 (dd, <i>J</i> = 7.5, 6.1 Hz, 1H), 7.15 (dd, <i>J</i> = 7.5, 1.3 Hz, 1H), 7.07 (dd, <i>J</i> = 9.6, 1.1 Hz, 1H), 5.29 (s, 2H), 1.36 (s, 12H).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a><sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.7 (d, <i>J</i> = 251 Hz), 150.8, 138.92 (d, <i>J</i> = 8.3 Hz), 137.6 (d, <i>J</i> = 8.5 Hz), 123.5 (d, <i>J</i> = 3.2 Hz), 115.3 (d, <i>J</i> = 25.4 Hz), 84.3 (s), 72.2 (s), 25.0 (s).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzoic Acid (<b>7</b>)</h4><div class="NLM_p last">2,4-Diamino-6-(hydroxymethyl)pteridine hydrochloride <b>6·</b>HCl (4.4 g, 19 mmol) was dissolved in hot water (150 mL), and after cooling to 21 °C, the solution was neutralized with 1 M aq. NaOH to pH ≈ 7 (ca. 20 mL). The formed precipitates were collected by filtration, washed with water, and dried <i>in vacuo</i> over P<sub>2</sub>O<sub>5</sub> to afford an orange-beige solid corresponding to 2,4-diamino-6-(hydroxymethyl)pteridine. The solid was suspended in anhydrous DMA (25 mL), and triphenylphosphine dibromide (18 g, 43 mmol) was added to the suspension. The turbid and dark mixture was stirred for 24 h under an N<sub>2</sub> atmosphere at 20 °C. Then, 4-aminobenzoic acid (3.0 g, 20 mmol) was added to the reaction and stirred for an additional 3 days. The reaction mixture was poured into 250 mL of 0.33 N NaOH, and the precipitate was filtered off. The filtrate was neutralized with 10% aq. acetic acid (ca. 20 mL), and the precipitate formed upon neutralization was filtered off, washed with water, triturated over MeOH, filtered, and dried <i>in vacuo</i> to afford the title compound <b>7</b> as an orange-beige solid (5.70 g, 91%). m.p., >240 °C (decomp.) (lit.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> 242 °C). IR (neat, cm<sup>–1</sup>): 3378.7, 3279.5, 2233.3, 1663.6, 1598.6, 1288.4, 1186.0.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.15 (br s, 1H), 8.63 (s, 1H), 8.17 (br s, 1H), 7.94 (br s, 1H), 7.73 (d, <i>J</i> = 9.0 Hz, 2H), 7.04 (br s, 2H), 6.83 (d, <i>J</i> = 9.0 Hz, 2H), 4.81 (s, 2H), 3.23 (s, 3H).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a><sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.8, 163.2, 161.1, 152.3, 149.5, 147.8, 131.5, 122.2, 118.1, 111.7, 100.0, 55.2, 39.6.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Dimethyl <span class="smallcaps smallerCapital">l</span>-Glutamate Hydrochloride (<b>9</b>·HCl)</h4><div class="NLM_p last">Thionyl chloride (5.0 mL, 68 mmol) was added dropwise to 50 mL of anhydrous MeOH at 0 °C. The mixture was stirred for 30 min at the same temperature followed by the addition of <span class="smallcaps smallerCapital">l</span>-glutamic acid <b>8</b> (5.0 g, 34 mmol). Then, the reaction was stirred under an N<sub>2</sub> atmosphere for 3 days at 21 °C and concentrated <i>in vacuo</i> to afford the title compound <b>9</b>·HCl as a colorless solid (7.19 g, > 95%). The crude product was used without further purification in the next reactions. m.p., 63.2–64.0 °C (lit.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> 77–79); [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = +25.0 (c 5.0, H<sub>2</sub>O).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> IR (neat, cm<sup>–1</sup>): 2952.45, 2902.73, 2852.33, 1728.67.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a><sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 4.24–4.19 (m, 1H), 3.85 (s, 3H), 3.73 (s, 3H), 2.65 (td, <i>J</i> = 7.3, 2.2 Hz, 2H), 2.37–2.13 (m, 2H).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a><sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 174.8, 170.2, 53.6, 52.4, 52.0, 29.2, 24.7.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Dimethyl (4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzoyl)-<span class="smallcaps smallerCapital">l</span>-glutamate (<b>10</b>)</h4><div class="NLM_p last">To a solution of <b>7</b> (3.0 g, 9.2 mmol) in anhydrous DMF (80 mL) was added Et<sub>3</sub>N (6.4 mL, 46.1 mmol) followed by PyBOP (6.5 g, 12.4 mmol). The mixture was stirred for 30 min under a N<sub>2</sub> atmosphere at 21 °C. Then, <b>9</b>·HCl (2.1 g, 9.9 mmol) was added, and the reaction mixture was stirred for 5 h at the same temperature. Then, the reaction was filtered through a path of Celite, and the filtrate was concentrated <i>in vacuo</i>. Next, the residue was dissolved in a mixture of EtOAc/CHCl<sub>3</sub> (150 mL, 1/1) and poured into 750 mL of Et<sub>2</sub>O at 0 °C under strong stirring. The resultant suspension was filtered off, washed with Et<sub>2</sub>O and cold water, triturated in hot MeOH, and filtered off again. The resultant orange solid was purified by flash column chromatography on silica gel using a mixture of CH<sub>2</sub>Cl<sub>2</sub>/MeOH (92.5/7.5, v/v) as the eluent to give the title compound <b>10</b> as a yellow solid (2.39 g, 54%). <i>R</i><sub>f</sub> = 0.48 (silica, MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 1/9, v/v); m.p., >168.6 (decomp.) (lit.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> 130–134); [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = +2.6 (c 0.5, DMSO). IR (neat, cm<sup>–1</sup>): 3306.96, 3128.91, 2950.99, 2923.52, 1731.36, 1626.09, 1604.36, 1503.14, 1435.41. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.56 (s, 1H), 8.34 (d, <i>J</i> = 7.4 Hz, 1H), 7.77–7.69 (m, 3H), 7.45 (br s, 1H), 6.82 (d, <i>J</i> = 8.8 Hz, 2H), 6.61 (br s, 2H), 4.78 (s, 2H), 4.39 (ddd, <i>J</i> = 9.4, 7.4, 5.6 Hz, 1H), 3.61 (s, 3H), 3.57 (s, 3H), 3.21 (s, 3H), 2.41 (t, <i>J</i> = 7.4 Hz, 2H), 2.17–1.72 (m, 2H).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a><sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.7, 172.6, 166.4, 162.9, 162.7, 155.2, 151.0, 149.2, 145.9, 129.0, 121.4, 120.7, 111.0, 54.9, 51.8, 51.7, 51.4, 38.7, 30.0, 25.8.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>27</sub>N<sub>8</sub>O<sub>5</sub> [M + H]<sup>+</sup> 483.2099, found 483.2119.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>S</i>)-(4-((((2-Amino-6-(((4-((1,5-dimethoxy-1,5-dioxopentan-2-yl)carbamoyl)phenyl)(methyl)amino)methyl)pteridin-4-yl)carbamoyl)oxy)methyl)phenyl)boronic Acid (<b>11</b>)</h4><div id="sec4_2_9_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> General Procedure C</h5><div class="NLM_p last">To a suspension of <b>10</b> (313 mg, 0.68 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added DMAP (417 mg, 3.42 mmol) followed by DIPEA (0.60 mL, 3.42 mmol). The mixture was cooled to 0 °C, and a solution of <b>5a</b> (1.01 g, 3.42 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added dropwise. The reaction was allowed to warm to 21 °C and stirred for 6 h under a N<sub>2</sub> atmosphere. Then, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and washed with 0.1 M aq. HCl (2 × 75 mL), sat. aq. NaHCO<sub>3</sub> (2 × 75 mL), and brine (75 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i> to afford a yellow solid that was purified by reversed-phase preparative HPLC. The CH<sub>3</sub>CN/H<sub>2</sub>O collected fractions containing the pinacolate intermediate were combined into a 250 mL round-bottom flask, and HCl cc. (0.3 mL, pH ≈ 2) was added. The reaction mixture was stirred for 16 h at 21 °C and quenched with sat. aq. NaHCO<sub>3</sub> (ca. 50 mL). After removal of the CH<sub>3</sub>CN under rotatory evaporation the formed precipitate was filtered off, washed with H<sub>2</sub>O, and dried <i>in vacuo</i> to afford the title compound <b>11</b> as a yellow solid (122 mg, 27%). Additional preparative HPLC purification was sometimes needed in specific substrates. m.p., >153.0 °C (decomp.); [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = +4.7 (c 0.32, DMSO). IR (neat, cm<sup>–1</sup>): 3354.4, 3233.1, 2954.7, 1732.5, 1627.5, 1605.2, 1573.9, 1536.9, 1198.5, 1173.2. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.88 (br s, 1H), 8.68 (s, 1H), 8.34 (d, <i>J</i> = 7.5 Hz, 1H), 8.08 (s, 2H), 7.82 (d, <i>J</i> = 7.8 Hz, 2H), 7.72 (d, <i>J</i> = 8.8 Hz, 2H), 7.43 (d, <i>J</i> = 7.8 Hz, 2H), 7.27 (br s, 2H), 6.82 (d, <i>J</i> = 8.8 Hz, 2H), 5.24 (s, 2H), 4.84 (s, 2H), 4.39 (ddd, <i>J</i> = 9.3, 7.5, 5.7 Hz, 1H), 3.60 (s, 3H), 3.56 (s, 3H), 3.20 (s, 3H), 2.40 (t, <i>J</i> = 7.4 Hz, 2H), 2.15–1.90 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.7, 172.6, 166.4, 162.0, 157.8, 155.1, 151.1, 150.7, 150.3, 148.0, 137.7, 134.2, 129.0, 127.0, 120.9, 120.9, 111.1, 66.7, 54.9, 51.8, 51.7, 51.4, 38.9, 30.0, 25.8. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>34</sub>BN<sub>8</sub>O<sub>9</sub> [M + H]<sup>+</sup> 661.2536, found 661.2566.</div></div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>S</i>)-(4-((((2-Amino-6-(((4-((1,5-dimethoxy-1,5-dioxopentan-2-yl)carbamoyl)phenyl)(methyl)amino)methyl)pteridin-4-yl)carbamoyl)oxy)methyl)-2-methylphenyl)boronic Acid (<b>12</b>)</h4><div class="NLM_p last">Following <i>general procedure C</i> using <b>5b</b> (1.45 g, 4.66 mmol), the title compound <b>12</b> was afforded as a yellow solid (179 mg, 22%). m.p., >166.0 °C (decomp.); [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = +4.0 (c 0.7, DMSO). IR (neat, cm<sup>–1</sup>): 3340.8, 3230.2, 2951.6, 1741.8, 1604.5, 1510.3, 1197.7, 1166.6, 1028.4. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.82 (s, 1H), 8.69 (s, 1H), 8.34 (d, <i>J</i> = 7.5 Hz, 1H), 8.02 (s, 2H), 7.72 (d, <i>J</i> = 9.0 Hz, 2H), 7.46 (d, <i>J</i> = 8.0 Hz, 1H), 7.28 (br s, 2H), 7.23–7.16 (m, 2H), 6.83 (d, <i>J</i> = 9.0 Hz, 2H), 5.18 (s, 2H), 4.84 (s, 2H), 4.39 (ddd, <i>J</i> = 9.5, 7.5, 5.4 Hz, 1H), 3.61 (s, 3H), 3.56 (s, 3H), 3.20 (s, 3H), 2.44–2.37 (m, 5H), 2.13–1.88 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.7, 172.6, 166.4, 162.0, 157.8, 155.1, 151.0, 150.7, 150.2, 147.9, 141.4, 136.2, 133.3, 129.0, 128.9, 124.3, 120.9, 120.8, 111.1, 66.7, 54.9, 51.8, 51.7, 51.3, 38.9, 29.9, 25.8, 22.1. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>36</sub>BN<sub>8</sub>O<sub>9</sub> [M + H]<sup>+</sup> 675.2693, found 675.2720.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>S</i>)-(4-((((2-Amino-6-(((4-((1,5-dimethoxy-1,5-dioxopentan-2 yl)carbamoyl)phenyl)(methyl)amino)methyl)pteridin-4-yl)carbamoyl)oxy)methyl)-2-fluorophenyl)boronic Acid (<b>13</b>)</h4><div class="NLM_p last">Following <i>general procedure C</i> using <b>5c</b> (1.30 g, 4.19 mmol), the title compound <b>13</b> was afforded as a yellow solid (237 mg, 34%). m.p., >158.1 °C (decomp.); [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = +4.3 (c 0.6, DMSO). IR (neat, cm<sup>–1</sup>): 3499.4, 3448.3, 3360.5, 3326.1, 3218.7, 2952.9, 1760.0, 1733.0, 1625.6, 1490.3, 1196.3, 1171.6. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.95 (s, 1H), 8.69 (s, 1H), 8.34 (d, <i>J</i> = 7.5 Hz, 1H), 8.22 (s, 2H), 7.72 (d, <i>J</i> = 8.8 Hz, 2H), 7.59 (t, <i>J</i> = 7.0 Hz, 1H), 7.40–7.20 (m, 4H), 6.83 (d, <i>J</i> = 8.9 Hz, 2H), 5.25 (s, 2H), 4.85 (s, 2H), 4.39 (ddd, <i>J</i> = 9.4, 7.5, 5.7 Hz, 1H), 3.61 (s, 3H), 3.56 (s, 3H), 3.20 (s, 3H), 2.41 (t, <i>J</i> = 7.4 Hz, 2H), 2.16–1.86 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.2, 173.04, 166.9, 165.9 (d, <i>J</i> = 244.5 Hz), 162.5, 158.3, 155.6, 151.5, 151.1, 150.7, 148.4, 140.6 (d, <i>J</i> = 8.3 Hz), 136.0(d, <i>J</i> = 9.8 Hz), 129.5, 123.4 (d, <i>J</i> = 2.7 Hz), 121.4, 121.3, 114.5 (d, <i>J</i> = 25.5 Hz), 111.6, 66.2, 55.4, 52.3, 52.2, 51.8, 39.1, 30.4, 26.2. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>33</sub>BFN<sub>8</sub>O<sub>9</sub> [M + H]<sup>+</sup> 679.2442, found 679.2455.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Bis(4-methoxybenzyl) (4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzoyl)-<span class="smallcaps smallerCapital">l</span>-glutamate (<b>14</b>)</h4><div class="NLM_p last">A solution of methotrexate (1.0 g, 2.20 mmol) in anhydrous DMF (50 mL) was treated with 1,1,3,3-tetramethylguanidine (0.55 mL, 4.4 mmol) at 0 °C, and the mixture was stirred for 30 min under an N<sub>2</sub> atmosphere. Then, 4-methoxybenzyl chloride (0.59 mL, 4.4 mmol) was added dropwise, and the mixture was allowed to warm to 21 °C and stirred for 24 h. Next, volatiles were removed <i>in vacuo</i>, and the crude was purified by flash column chromatography on silica gel using a mixture of CH<sub>2</sub>Cl<sub>2</sub>/MeOH (gradient elution from 97/3 to 94/6, v/v) as the eluent to give the title compound <b>14</b> as a yellow solid (915 mg, 60%). <i>R</i><sub>f</sub> = 0.24 (silica, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 95/5, v/v); m.p., 96.5–99.2 °C; [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = +8.0 (c 1.0, DMSO). IR (neat, cm<sup>–1</sup>): 3325.0, 3181.8, 2936.0, 2835.6, 1730.6, 1603.3, 1511.2, 1442.8. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.56 (s, 1H), 8.34 (d, <i>J</i> = 7.5 Hz, 1H), 7.71 (d, <i>J</i> = 8.9 Hz, 2H), 7.65 (br s, 1H), 7.43 (br s, 1H), 7.27 (d, <i>J</i> = 6.9 Hz, 2H), 7.25 (d, <i>J</i> = 6.9 Hz, 2H), 6.90–6.86 (m, 4H), 6.82 (d, <i>J</i> = 8.9 Hz, 2H), 6.60 (br s, 2H), 5.10–4.99 (m, 2H), 4.97 (s, 2H), 4.78 (s, 2H), 4.42 (ddd, <i>J</i> = 9.6, 7.5, 5.4 Hz, 1H), 3.73 (s, 6H), 3.21 (s, 3H), 2.42 (t, <i>J</i> = 7.6 Hz, 2H), 2.13–1.90 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.1, 172.0, 166.5, 162.9, 162.7, 159.1, 155.2, 151.0, 149.2, 145.9, 129.8, 129.7, 129.0, 128.0, 127.9, 121.4, 120.8, 113.8, 111.0, 65.7, 65.3, 55.1, 54.8, 51.9, 38.8, 30.2, 25.8. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>36</sub>H<sub>39</sub>N<sub>8</sub>O<sub>7</sub> [M + H]<sup>+</sup> 695.2936, found 695.2954.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Bis(4-methoxybenzyl) (4-(((2-Amino-4-((((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)oxy)carbonyl)amino)pteridin-6-yl)methyl)(methyl)amino)benzoyl)-<span class="smallcaps smallerCapital">l</span>-glutamate (<b>15</b>)</h4><div class="NLM_p last">To a suspension of <b>15</b> (800 mg, 1.15 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added DMAP (703 mg, 5.76 mmol) followed by DIPEA (1.0 mL, 5.76 mmol). The mixture was cooled to 0 °C, and a solution of <b>5a</b> (1.71 g, 5.76 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added dropwise. The reaction was allowed to warm to 21 °C and stirred for 5 h under a N<sub>2</sub> atmosphere. The mixture was then diluted with CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and washed with 1 M aq. HCl (2 × 75 mL), sat. aq. NaHCO<sub>3</sub> (2 × 75 mL), and brine (75 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. Purification of the residue by reversed-phase preparative HPLC afforded the title compound <b>15</b> as a yellow solid (800 mg, 73%). m.p., >105.0 (decomp.); [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = +8.8 (c 0.42, DMSO). IR (neat, cm<sup>–1</sup>): 3351.5, 3230.0, 2975.5, 2836.5, 1731.3, 1605.6, 1512.6, 1356.9. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) 9.87 (s, 1H), 8.69 (s, 1H), 8.34 (d, <i>J</i> = 7.5 Hz, 1H), 7.72 (d, <i>J</i> = 7.9 Hz, 4H), 7.47 (d, <i>J</i> = 7.9 Hz, 2H), 7.33–7.17 (m, 6H), 6.91–6.85 (m, 4H), 6.82 (d, <i>J</i> = 9.0 Hz, 2H), 5.26 (s, 2H), 5.06–4.98 (m, 2H), 4.96 (s, 2H), 4.84 (s, 2H), 4.43 (ddd, <i>J</i> = 9.5, 7.4, 5.4 Hz, 1H), 3.72 (s, 6H), 3.19 (s, 3H), 2.41 (t, <i>J</i> = 7.4 Hz, 2H), 2.13–1.91 (m, 2H), 1.29 (s, 12H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.1, 172.0, 166.5, 162.0, 159.1 (2C), 157.8, 155.1, 151.1, 150.7, 150.3, 148.0, 139.3, 134.6, 129.8, 129.7, 129.0, 128.0, 127.9, 127.3, 121.0, 120.8, 113.8 (2C), 111.1, 83.7, 66.5, 65.7, 65.3, 55.1 (2C), 54.9, 51.9, 39.5, 30.2, 25.8, 24.7. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>50</sub>H<sub>56</sub>BN<sub>8</sub>O<sub>11</sub> [M + H]<sup>+</sup> 955.4156, found 955.4191.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>S</i>)-(4-((((2-Amino-6-(((4-((1,5-bis((4-methoxybenzyl)oxy)-1,5-dioxopentan-2-yl)carbamoyl)phenyl)(methyl)amino)methyl)pteridin-4-yl)carbamoyl)oxy)methyl)phenyl)boronic Acid (<b>16</b>)</h4><div class="NLM_p last">To a solution of <b>15</b> (0.70 g, 0.73 mmol) in a mixture of CH<sub>3</sub>CN/THF/H<sub>2</sub>O (200 mL, 2/1/1, v/v) was added cc. HCl until pH ≈ 2. The reaction mixture was stirred at 21 °C for 6 h followed by neutralization with sat. aq. NaHCO<sub>3</sub> (approximately 50 mL). After removal of organic solvents <i>in vacuo</i>, the formed precipitate was filtered off, washed with H<sub>2</sub>O, and purified by reversed-phase preparative HPLC to afford the title compound <b>16</b> as a yellow solid (199 mg, 31%). m.p., >147.8 °C; [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = +8.3 (c 0.99, DMSO). IR (neat, cm<sup>–1</sup>): 3362.3, 3230.6, 2954.1, 2836.7, 1732.0, 1628.9, 1605.5, 1512.4, 1198.7, 1170.9. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.10 (br s, 1H), 8.64 (br s, 1H), 8.49 (s, 2H), 8.35 (d, <i>J</i> = 7.5 Hz, 1H), 7.78 (d, <i>J</i> = 7.9 Hz, 2H), 7.71 (d, <i>J</i> = 8.9 Hz, 2H), 7.40 (d, <i>J</i> = 7.9 Hz, 2H), 7.37–7.10 (m, 6H), 6.87 (d, <i>J</i> = 8.7 Hz, 2H), 6.87 (d, <i>J</i> = 8.6 Hz, 2H), 6.82 (d, <i>J</i> = 9.0 Hz, 1H), 5.21 (s, 2H), 5.10–4.98 (m, 2H), 4.96 (s, 2H), 4.83 (s, 2H), 4.42 (ddd, <i>J</i> = 9.6, 7.4, 5.4 Hz, 1H), 3.72 (s, 6H), 3.19 (s, 3H), 2.41 (t, <i>J</i> = 7.6 Hz, 2H), 2.15–1.79 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.2, 172.0, 166.6, 162.1, 159.1 (2C), 157.8, 155.2, 151.1, 150.7, 150.3, 148.0, 132.7, 134.3, 129.9, 129.7, 129.1, 128.0, 127.9, 127.1, 121.0, 120.9, 113.8 (2C), 111.1, 66.7, 65.8, 65.4, 55.1 (2C), 54.9, 51.9, 39.35, 30.2, 25.8. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>44</sub>H<sub>46</sub>BN<sub>8</sub>O<sub>11</sub> [M + H]<sup>+</sup> 873.3374, found 873.3405.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (4-(((2-Amino-4-((((4-boronobenzyl)oxy)carbonyl)amino)pteridin-6-yl)methyl)(methyl)amino)benzoyl)-<span class="smallcaps smallerCapital">l</span>-glutamic Acid (<b>17</b>)</h4><div class="NLM_p last">A solution of <b>16</b> (150 mg, 0.17 mmol) in a mixture of 5% TFA in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (16 mL) was stirred for 25 min under a N<sub>2</sub> atmosphere at 21 °C. The crude mixture was then concentrated <i>in vacuo</i>, and the residue was purified by reversed-phase preparative HPLC to afford the title compound <b>17</b> as an yellow/orange solid (59 mg, 54%). m.p., >200 °C (decomp.); [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = +10.0 (c 0.50, DMSO). IR (neat, cm<sup>–1</sup>): 3336.8, 3203.3, 2929.5, 1728.8, 1604.5, 1505.5, 1199.4, 1171.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.29 (br s, 2H), 9.89 (s, 1H), 8.68 (s, 1H), 8.20 (d, <i>J</i> = 7.8 Hz, 1H), 8.07 (s, 2H), 7.82 (d, <i>J</i> = 7.9 Hz, 2H), 7.73 (d, <i>J</i> = 8.9 Hz, 2H), 7.43 (d, <i>J</i> = 7.9 Hz, 2H), 7.28 (br s, 2H), 6.82 (d, <i>J</i> = 8.9 Hz, 2H), 5.24 (s, 2H), 4.84 (s, 2H), 4.34 (ddd, <i>J</i> = 9.7, 7.8, 5.0 Hz, 1H), 3.19 (s, 3H), 2.31 (t, <i>J</i> = 7.5 Hz, 2H), 2.11–1.99 (m, 1H), 1.99–1.79 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.9, 173.7, 166.3, 162.0, 157.8, 155.1, 151.0, 150.7, 150.3, 148.0, 137.7, 134.2, 129.0, 127.0, 121.3, 120.9, 111.1, 66.7, 54.9, 51.7, 39.0, 30.4, 26.0. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>28</sub>BN<sub>8</sub>O<sub>9</sub> [M-H]<sup>−</sup> 631.2078, found 631.2028.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 4-(((Benzyloxy)carbonyl)amino)benzoic Acid (<b>19</b>)</h4><div class="NLM_p last">To a solution of 4-methylaminobenzoic acid <b>18</b> (4.11 g, 29.9 mmol) and NaHCO<sub>3</sub> (22.6 g, 269 mmol) in a mixture of H<sub>2</sub>O/THF (100 mL, 1/1, v/v) was added benzyl chloroformate (4.26 mL, 29.9 mmol) dropwise at 0 °C. The reaction mixture was stirred for 4 h at 21 °C followed by the addition of 20 mL of water. Then, the mixture was stirred for an additional 16 h followed by acidification with 1 M aq. HCl to pH ≈ 3. Next, the precipitate was filtered off and dried <i>in vacuo</i> to afford <b>19</b> as a white solid (7.2 g, 89%). m.p., 213.0–217.0 °C (lit.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> 217 °C, decomp.). IR (neat, cm<sup>–1</sup>): 3324.4, 2951.7, 2677.4, 2557.2, 1702.1, 1672.4, 1528.6, 1512.8, 1225.8, 1062.6. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.66 (br s, 1H), 10.15 (s, 1H), 7.87 (d, <i>J</i> = 8.7 Hz, 2H), 7.58 (d, <i>J</i> = 8.7 Hz, 2H), 7.51–7.17 (m, 5H), 5.17 (s, 2H).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a><sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.0, 153.2, 143.3, 136.3, 130.5, 128.5, 128.2, 128.2, 124.5, 117.3, 66.1.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Dimethyl (4-(((benzyloxy)carbonyl)amino)benzoyl)-<span class="smallcaps smallerCapital">l</span>-glutamate (<b>20</b>)</h4><div class="NLM_p last">To a suspension of <b>19</b> (2.90 g, 10.7 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> was added 1 drop of DMF followed by thionyl chloride (3.88 mL, 53.4 mmol), and the reaction mixture was refluxed for 24 h under an N<sub>2</sub> atmosphere. Next, all volatiles were removed <i>in vacuo</i> to afford the acyl chloride as a pale yellow solid (3.1 g, >95%), which was added to a stirred mixture of <b>9</b>·HCl (2.40 g, 11.3 mmol) and Et<sub>3</sub>N in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (100 mL), and an additional 2 h stirring was applied under a N<sub>2</sub> atmosphere at 21 °C. The mixture was then diluted with EtOAc (250 mL), washed with 1 M aq. HCl (2 × 150 mL), sat. aq. NaHCO<sub>3</sub> (2 × 150 mL), and brine (200 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i> to afford the title compound <b>20</b> as a white solid (4.3 g, 97%). m.p., 121.7–124.0 °C; [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = −16.2 (c 1.0, MeOH). IR (neat, cm<sup>–1</sup>): 3378.3, 3297.8, 2952.4, 1730.5, 1627.7, 1526.8, 1227.4. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.07 (s, 1H), 8.60 (d, <i>J</i> = 7.4 Hz, 1H), 7.83 (d, <i>J</i> = 8.8 Hz, 2H), 7.55 (d, <i>J</i> = 8.8 Hz, 2H), 7.50–7.26 (m, 5H), 5.18 (s, 2H), 4.44 (ddd, <i>J</i> = 9.5, 7.4, 5.4 Hz, 1H), 3.64 (s, 3H), 3.59 (s, 3H), 2.45 (t, <i>J</i> = 7.5 Hz, 2H), 2.22–1.83 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.7, 172.4, 166.1, 153.2, 142.1, 136.4, 128.5 (2C), 128.2, 128.1, 127.3, 117.2, 66.0, 51.9, 51.9, 51.4, 29.9, 25.7. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>25</sub>N<sub>2</sub>O<sub>7</sub> [M + H]<sup>+</sup> 429.1656, found 429.1676.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Dimethyl (4-aminobenzoyl)-<span class="smallcaps smallerCapital">l</span>-glutamate Hydrochloride (<b>21</b>·HCl)</h4><div class="NLM_p last">A solution of <b>20</b> (2.0 g, 4.8 mmol) in anhydrous MeOH (100 mL) was treated with Pd/C (200 mg, 10% w/w). The mixture was stirred for 12 h under a H<sub>2</sub> atmosphere at 21 °C, then filtered through a path of Celite, concentrated <i>in vacuo</i> over silica gel, and purified by flash column chromatography on silica gel using a mixture of EtOAc/Hep (2/1, v/v) as the eluent to give a clear oil corresponding to the free amine <b>21</b>. Treatment with 2 M HCl in ether afforded the hydrochloride salt <b>21</b>·HCl as a white solid (1.3 g, 95%). <i>R</i><sub>f</sub> = 0.38 (free amine; EtOAc/Hep, 4/1, v/v); m.p., 65.2–70.0 °C; [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = −17.8 (c 1.26, H<sub>2</sub>O). IR (neat, cm<sup>–1</sup>): 3270.9, 2952.3, 2834.2, 2577.2, 1731.4, 1641.3, 1609.8, 1538.9, 1501.4, 1436.4, 1206.7, 1171.7. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.78 (d, <i>J</i> = 8.5 Hz, 2H), 7.33 (d, <i>J</i> = 8.5 Hz, 2H), 4.58 (dd, <i>J</i> = 9.4, 5.2 Hz, 1H), 3.70 (s, 3H), 3.56 (s, 3H), 2.49 (t, <i>J</i> = 7.0 Hz, 2H), 2.35–2.20 (m, 1H), 2.10 (ddt, <i>J</i> = 14.2, 9.4, 6.9 Hz, 1H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 175.8, 173.7, 169.8, 136.8, 131.5, 129.2, 121.9, 53.0, 52.7, 52.3, 30.2, 25.5. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>19</sub>N<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup> 295.1288, found 295.1297.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>S</i>)-(4-(((4-((1,5-Dimethoxy-1,5-dioxopentan-2-yl)carbamoyl)phenyl)amino)methyl)phenyl)boronic Acid (<b>22</b>)</h4><div class="NLM_p last">To a solution of <b>21</b>·HCl (0.80 g, 2.42 mmol) in anhydrous MeOH was added (4-formylphenyl)boronic acid (0.55 g, 3.67 mmol) followed by portion-wise addition of NaBH<sub>3</sub>CN (0.80 g, 12.1 mmol). The reaction mixture was stirred for 12 h under a N<sub>2</sub> atmosphere at 21 °C. Extra (4-formylphenyl)boronic acid (0.55 g, 3.67 mmol) was then added to the stirred mixture followed by an additional 24 h of stirring for completion of the reaction. Next, the crude mixture was concentrated <i>in vacuo</i>, redissolved in EtOAc (150 mL), and washed with sat. aq. NaHCO<sub>3</sub> (2 × 150 mL) and brine (150 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i> to afford a pale yellow solid. Purification by reversed-phase preparative HPLC afforded the title compound <b>22</b> as a white solid (699 mg, 67%). <i>R</i><sub>f</sub> = 0.77 (silica, MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 1/1, v/v); m.p., 84.1–88.2 °C; [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = −16.3 (c 1.04, DMSO). IR (neat, cm<sup>–1</sup>): 3382.1, 2951.9, 1726.9, 1601.9, 1506.4, 1330.4. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.24 (d, <i>J</i> = 7.5 Hz, 1H), 7.98 (s, 2H), 7.73 (d, <i>J</i> = 7.8 Hz, 2H), 7.62 (d, <i>J</i> = 8.6 Hz, 2H), 7.30 (d, <i>J</i> = 7.8 Hz, 2H), 6.84 (t, <i>J</i> = 6.0 Hz, 1H), 6.58 (d, <i>J</i> = 8.6 Hz, 2H), 4.38 (ddd, <i>J</i> = 9.5, 7.5, 5.6 Hz, 1H), 4.33 (d, <i>J</i> = 6.0 Hz, 2H), 3.61 (s, 3H), 3.57 (s, 3H), 2.41 (t, <i>J</i> = 7.4 Hz, 2H), 2.14–2.03 (m, 1H), 2.02–1.86 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.8, 172.7, 166.6, 151.4, 141.6, 134.2, 129.0, 126.2, 120.4, 111.1, 51.8, 51.7, 51.4, 46.0, 30.0, 25.8. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>26</sub>BN<sub>2</sub>O<sub>7</sub> [M + H]<sup>+</sup> 429.1828, found 429.1850.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>S</i>)-(4-((((2,4-Diaminopteridin-6-yl)methyl)(4-((1,5-dimethoxy-1,5-dioxopentan-2-yl)carbamoyl)phenyl)amino)methyl)phenyl)boronic Acid (<b>24</b>)</h4><div class="NLM_p last">A solution of <b>22</b> (461 mg, 1.08 mmol) and 6-(bromomethyl)pteridine-2,4-diamine hydrobromide <b>23</b>·HBr (515 mg, 1.38 mmol) in anhydrous DMA (4.85 mL) was stirred for 3 days under a N<sub>2</sub> atmosphere at 55 °C. Then, Et<sub>3</sub>N (79 μL, 3.21 mmol) was added to the mixture followed by the addition of H<sub>2</sub>O (approximately 30 mL). The orange precipitate was filtered off and purified by reversed-phase preparative HPLC to afford <b>24</b> as a yellow solid (279 mg, 43%). <i>R</i><sub>f</sub> = 0.47 (silica, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 85/15, v/v); m.p., >180 °C (decomp.); [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = +1.75 (c 0.57, DMSO-<i>d</i><sub>6</sub>). IR (neat, cm<sup>–1</sup>): 3485.2, 3327.3, 3169.7, 2952.1, 1727.2, 1625.3, 1602.2, 1201.7. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.64 (s, 1H), 8.31 (d, <i>J</i> = 7.5 Hz, 1H), 7.99 (s, 2H), 7.75 (d, <i>J</i> = 8.0 Hz, 2H), 7.72–7.60 (m, 3H), 7.47 (br s, 1H), 7.23 (d, <i>J</i> = 8.0 Hz, 2H), 6.82 (d, <i>J</i> = 9.1 Hz, 2H), 6.63 (br s, 2H), 4.93 (s, 2H), 4.89 (s, 2H), 4.38 (ddd, <i>J</i> = 9.6, 7.5, 5.3 Hz, 1H), 3.61 (s, 3H), 3.57 (s, 3H), 2.41 (t, <i>J</i> = 7.5 Hz, 2H), 2.17–1.79 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.72, 172.54, 166.38, 162.83, 162.71, 155.18, 150.37, 149.36, 145.92, 140.38, 134.39, 128.93, 125.66, 121.41, 121.10, 111.48, 54.47, 53.98, 51.82, 51.71, 51.35, 29.92, 25.77. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>32</sub>BN<sub>8</sub>O<sub>7</sub> [M + H]<sup>+</sup> 603.2482, found 603.2508.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (4-((4-Boronobenzyl)((2,4-diaminopteridin-6-yl)methyl)amino)benzoyl)-<span class="smallcaps smallerCapital">l</span>-glutamic Acid (<b>25</b>)</h4><div class="NLM_p last">A solution of <b>24</b> (46 mg, 76 μmol) in 1 M aq. NaOH (2 mL) was stirred for 5 min at 21 °C. The crude was directly purified by reversed-phase preparative HPLC to afford the title compound <b>25</b> as a yellow solid (17 mg, 40%). m.p., >245 °C (decomp.); [α]<sub arrange="stagger">D</sub><sup arrange="stagger">20</sup> = +7.8 (c 0.63, DMSO). IR (neat, cm<sup>–1</sup>): 3336.5, 3089.8, 1633.5, 602.7, 1502.8, 1394.2, 1364.9, 1337.0, 1202.5. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.63 (s, 1H), 8.08 (d, <i>J</i> = 7.3 Hz, 1H), 8.01 (s, 2H), 7.73 (d, <i>J</i> = 7.9 Hz, 2H), 7.69–7.55 (m, 3H), 7.46 (br s, 1H), 7.22 (d, <i>J</i> = 7.9 Hz, 2H), 6.81 (d, <i>J</i> = 8.9 Hz, 2H), 6.61 (br s, 2H), 4.91 (s, 2H), 4.88 (s, 2H), 4.32 (ddd, <i>J</i> = 9.7, 7.9, 5.1 Hz, 1H), 2.3 (t, <i>J</i> = 7.5, 2H), 2.02–1.78 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 174.0, 173.7, 166.2, 162.9, 162.7, 155.2, 150.3, 149.4, 145.9, 140.4, 134.4, 128.8, 125.7, 121.5, 121.4, 111.5, 54.4, 54.0, 51.8, 30.6, 26.2. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>28</sub>BN<sub>8</sub>O<sub>7</sub> [M + H]<sup>+</sup> 575.2169, found 575.2187.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Physicochemical and Pharmacokinetic <i>in Vitro</i> Assays</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Activation of Prodrugs under Oxidative Conditions</h4><div class="NLM_p last">To a mixture of DMSO (150 μL) and aq. PBS buffer (650 μL, pH 7.4) in a microcentrifuge tube (1.5 mL) placed in a thermomixer at 37 °C was added a solution of prodrug (50 μL, 1 mM in DMSO) followed by the addition of internal standard solution (diclofenac, 50 μL, 1 mM in DMSO). The assay was initiated by the addition of a solution of H<sub>2</sub>O<sub>2</sub> in PBS (50 μL, 10 mM) followed by vortex mixing. The resulting mixture was incubated at 37 °C in an Eppendorf Thermomixer C (1.5 mL, 1000 rpm), and samples were taken after 5, 15, 30, 60, and 90 min and 2, 3, and 4 h. Analysis of the percentage of remaining compound was performed using RP-UPLC-UV (λ= 306 nm). Further data points were collected for compounds <b>24</b> and <b>25</b>, including 16, 24, and 48 h. A control experiment (no H<sub>2</sub>O<sub>2</sub> addition but PBS) was performed in parallel. Every prodrug activation assay was carried out in triplicates.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Activation of Prodrugs under Different H<sub>2</sub>O<sub>2</sub> Concentrations</h4><div class="NLM_p last">To aq. PBS buffer (750 μL, pH 7.4) was added a solution of prodrug <b>17</b> or <b>25</b> (100 μL, 1 mM in DMSO) followed by the addition of internal standard solution (diclofenac, 100 μL, 1 mM in DMSO). The assay was initiated by the addition of a solution of H<sub>2</sub>O<sub>2</sub> in PBS (50 μL, 10–5–1–0.5–0.25 mM) followed by vortex mixing. The resulting mixture was incubated at 37 °C in an Eppendorf Thermomixer C (1.5 mL, 1000 rpm), and samples were taken after 5, 15, 30, 60, and 90 min and 2, 4, and 24 h (48 h for compound <b>25</b>). Analysis of the percentage of remaining compound was performed using RP-UPLC-UV (λ = 306 nm). A control experiment (no H<sub>2</sub>O<sub>2</sub> addition but PBS) was performed in parallel. Every prodrug activation assay was carried out in triplicates.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Kinetic Solubility</h4><div class="NLM_p last">The kinetic solubility of prodrugs <b>11</b>, <b>12</b>, <b>13</b>, <b>17</b>, <b>24</b>, and <b>25</b> was determined in a 1% DMSO/PBS solution at a concentration of 100 μM. A solution of test compound (10 μL, 10 mM) was added to an microcentrifuge tube containing PBS (990 μL, pH 7.4), and the mixture was incubated at 37 °C for 20 h in an Eppendorf Thermomixer C (1.5 mL, 1000 rpm). After 20 h of incubation, the samples were centrifuged at 5000 rpm (37 °C, 30 min) to pellet insoluble material. Aliquots (250 μL) of the supernatant were diluted in PBS (250 μL), and the concentration of dissolved compound was quantified by RP-UPLC-UV (λ = 306 nm) analysis. Solubility determinations were performed in triplicates.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Chemical Stability pH 7.4</h4><div class="NLM_p last">The chemical stability at pH 7.4 of compounds <b>17</b> and <b>25</b> was assessed using diclofenac as an internal standard. To 490 μL of a prewarmed solution of 20 μM diclofenac in PBS (0.1% DMSO) was added 10 μL of a 1 mM DMSO solution of compounds <b>17</b> and <b>25</b> (in triplicates), and RP-UPLC-UV (λ= 306 nm) analysis was performed after 30 min and 1, 2, 4, 8, 24, and 48 h.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Simulated Gastric and Intestinal Fluid Stability</h4><div class="NLM_p last">Simulated gastric fluid (SGF) was generated by preparing a solution of sodium chloride (0.20 g), concentrated HCl (0.70 mL), and pepsin (Sigma, P-7000, 0.32 g) in deionized water (95 mL) up to 100 mL of final volume. Simulated intestinal fluid (SIF) was generated by preparing a solution of monobasic potassium phosphate (KH<sub>2</sub>PO<sub>4</sub>, 0.68 g), 0.1 N aqueous sodium hydroxide (38 mL), and pancreatin (Sigma, P-1625, 1.0 g) in deionized water up to 100 mL of final volume. The pH of the solution was adjusted to 7.5 by the addition of 1 N aqueous sodium hydroxide.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> To 990 μL of SGF or SIF was added a solution of prodrug <b>17</b> or <b>25</b> (10 μL, 10 mM in DMSO). The resulting mixture was incubated at 37 °C in an Eppendorf Thermomixer C (1.5 mL, 1000 rpm), and samples were taken (90 μL) after 0, 1, 2, 4, and 24 h. Diclofenac (10 μL, 1 mM in DMSO) was added to the taken samples as internal standard. Analysis of the percentage of remaining compound was performed using RP-UPLC-UV (λ = 306 nm). A negative control experiment (no pepsin or pancreatin addition) was performed in parallel. Every assay was carried out in triplicates.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Human and Mouse Plasma Stability</h4><div class="NLM_p last">Two milliliters of lyophilized plasma (Sigma, P9523 for human and P9275 for mouse plasma) were dissolved in 2 mL of milli-Q water. To a microcentrifuge tube containing 240 μL of prewarmed PBS (37 °C) was added 250 μL of plasma. The mixture was shaken at 300 rpm in an Eppendorf Thermomixer C (1.5 mL, 300 rpm) for 10 min before the assay was started. A solution of test compounds <b>17</b> and <b>25</b> in DMSO (1 mM, 10 μL) was added to the prewarmed PBS/plasma mixture to a final concentration of 20 μM. Samples (50 μL) were taken after 30 min and 1, 2, 4, 8, 24, and 48 h and added to 150 μL of ice-cold MeOH containing an internal standard (diclofenac, 10 μM). Procaine and dilizatem were used as positive controls for human and mouse plasma stability, respectively. The half-lives (<i>t</i><sub>1/2</sub>) was determined using GraphPad Prism 6 software and calculated with the slope of the linear region of the plotted logarithm of remaining compound against time, assuming first order kinetics.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Human and Mice Microsomal Stability</h4><div class="NLM_p last">The <i>in vitro</i> microsomal metabolism of compounds <b>17</b> and <b>25</b> was evaluated in isolated liver microsomes (pooled, from CD-1 male mouse and from human male) at a concentration of 10 μM. A solution of liver microsomes (10 mg/mL, 25 μL) was added to a microcentrifuge tube containing 425 μL of PBS at 37 °C in an Eppendorf Thermomixer C (1.5 mL, 1000 rpm), and the mixture was shaken for 10 min before the actual assay was started. Then, a DMSO solution of test compound (5 μL, 1 mM) was added followed by an aq. solution of NADPH (25 μL) for initiation of the experiment. Negative (no NADPH) and positive control experiments (verapamil and diphenhydramine for human and mouse, respectively) were carried out in parallel. Aliquots (50 μL) were removed after 0, 5, 10, 15, 30, 45, and 60 min (additional 120 and 240 min time points for the mice study) and quenched immediately with 50 μL of ice-cold MeCN containing an internal standard (diclofenac 10 μM). Samples were analyzed by RP-UPLC-UV and half-lives calculated plotting the ln[<i>C</i>] versus time, assuming first order kinetics using GraphPad Prism 6.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Cellular Assays</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Materials</h4><div class="NLM_p last">Dulbecco’s phosphate buffer (D-PBS) was purchased from Sigma-Aldrich (D8662, pH 7.4). DMEM (D5976, Sigma-Aldrich) and RPMI (R8758, Sigma-Aldrich) were supplemented with 10% fetal bovine serum (FBS, heat-inactivated, Fisher Scientific), penicillin at 100 units/mL, and streptomycin at 100 mg/mL (all purchased from Sigma-Aldrich). The CellTiter 96  AQueous Non-Radioactive Cell Proliferation Assay was purchased from Promega (MTS, G5421).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Cell Culture</h4><div class="NLM_p last">The human breast cancer MCF-7 (Sigma) and human large cell lung cancer NCIH-460 (ATTC) cell lines were cultured in a humidified, 5% CO<sub>2</sub> atmosphere at 37 °C in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma) or Roswell Park Memorial Institute medium (RPMI) 1640 (Sigma) supplemented with 10% fetal bovine serum (FBS, heat-inactivated, Fisher Scientific) and 1% penicillin/streptomycin. Both cell lines were subcultured every 2–3 days.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Preactivation of Compounds with H<sub>2</sub>O<sub>2</sub></h4><div class="NLM_p last">A 125 μM solution of tested compound was prepared in 1.25 mM H<sub>2</sub>O<sub>2</sub> in DMSO/PBS (1:1), placed in an microcentrifuge tube, and shaken at 21 °C for 24 h at 1000 rpm in an Eppendorf Thermomixer C (1.5 mL). The activation was followed by RP-UPLC-MS (λ = 306 nm) after 0 and 15 min and 1, 4, and 24 h. A negative control consisting of a 125 μM solution of compound in a mixture of DMSO/PBS (1:1) without H<sub>2</sub>O<sub>2</sub> was run in parallel to the activation assay under the same conditions.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Evaluation of Cell Viability</h4><div class="NLM_p">The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium (MTS) assay (Promega Biotech AB, Stockholm, Sweden) was used to determine the in vitro antiproliferative effect of the compounds. This assay is based on the principle that cells have the ability to reduce MTS tetrazolium, while, when dead, they lose this ability. MCF-7 and NCI-H460 cells were cultured in 96-well plates at an initial density of 10<sup>4</sup> cells/well (MCF-7) or 7 × 10<sup>3</sup> cells/well (NCI-H460) in their respective growth medium. After 24 h incubation to allow cell attachment, the medium was removed, and the cells were incubated in the presence or absence of preactivated compounds at different concentrations. After 48 h incubation time, the MTS reagent was added to each well. The cells were further incubated for a period of time between 30 and 60 min at 37 °C until colorimetric reaction was developed within the linear range, and the absorbance of the samples was measured at 490 nm using a 96-well plate spectrophotometer (Victor 3 plate reader with Wallac 1420 Workstation vs 3.0 software).</div><div class="NLM_p last">A control was used for each tested compound, where cells were incubated with DMEM or RPMI containing the equivalent concentration of DMSO (maximum of 0.4% v/v). Each concentration of tested compounds was done in triplicates. The final concentration of H<sub>2</sub>O<sub>2</sub> in each well was always <10 μM (noncytotoxic concentration in MCF-7 and NCI-H460 cell lines, determined with the described assay). The IC<sub>50</sub> values were calculated using GraphPad Prism v6.0 (California, USA) as the concentration of the compounds required to cause 50% response compared to cells exposed to controls using a nonlinear dose–response regression.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Collagen Type-II-Induced Arthritis <i>in Vivo</i> Efficacy and Preliminary Toxicity Assay</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Animals</h4><div class="NLM_p last">DBA/1J mice (male, 8–9 weeks) were obtained from Janvier, France. The mice were maintained in the animal facility at Redoxis, Medicon Village, Lund, Sweden, where they were acclimatized for approximately 1 week before initiation of the experiment. All animal experiments were approved by the local animal ethic committee Malmö/Lund, Sweden, under the license N165-15.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Induction of Disease</h4><div class="NLM_p last">Collagen induced arthritis (CIA) was induced by intradermal immunization with 100 μg of chicken type-II collagen (CII, Chondrex) in Complete Freund’s Adjuvant (CFA, Difco) on day −1 via subcutaneous injection approximately 0.5 cm from the base of the tail. On day 21, a boost injection was administered in the same way with 50 μg of CII. One week after the second immunization, onset of disease started to be observed (day 26).</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Antiarthritic Effect of Test Compounds and Health Evaluation</h4><div class="NLM_p last">Mice were randomly divided in five groups (<i>n</i> = 8 per group): group I (vehicle), group II (<b>MTX</b>, Sigma-Aldrich, 7.0 mg/kg, <i>i.p.</i>), group III (<b>AMT</b>, Enzo Life Sciences, 6.8 mg/kg, <i>i.p.</i>), group IV (<b>17</b>, 9.7 mg/kg, <i>i.p.</i>), and group V (<b>25</b>, 8.8 mg/kg, <i>i.p.</i>). Vehicle or test compound (2% DMSO in PBS, Life Technologies, injection volume = 370 μL) was dosed daily by intraperitoneal injections for 14 days, starting at onset of disease (day 27). Disease was evaluated three times per week in a blinded fashion, starting at day 18 until the end of the experiment (day 40). A macroscopic scoring system of the four limbs ranging from 0 to 15 (1 point per swollen toe, 1 point per swollen foot knuckle, and 5 points for swollen ankle) was used, meaning a maximal score of 60 per mouse. For humane and ethical reasons and restrictions, mice with scores exceeding 45 were euthanized. The general health of mice was evaluated three times per week after disease induction. As an indicator of general health, animal body weight was used.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01775" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64172" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64172" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01775" class="ext-link">10.1021/acs.jmedchem.7b01775</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Hydrogen peroxide prodrug activation, cell viability, chemical, SGF, SIF, plasma, and metabolic stabilities assays, and assigned NMR spectra of synthesized compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf">jm7b01775_si_001.pdf (2.04 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_002.csv">jm7b01775_si_002.csv (2.23 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01775" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mads H. Clausen</span> - <span class="hlFld-Affiliation affiliation">Center
for Nanomedicine & Theranostics, Department of Chemistry, Technical University of Denmark, Kemitorvet 207, DK-2800 Kongens Lyngby, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9649-1729" title="Orcid link">http://orcid.org/0000-0001-9649-1729</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#85e8ede6c5eee0e8ecabe1f1f0abe1ee"><span class="__cf_email__" data-cfemail="274a4f44674c424a4e0943535209434c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jorge Peiró
Cadahía</span> - <span class="hlFld-Affiliation affiliation">Center
for Nanomedicine & Theranostics, Department of Chemistry, Technical University of Denmark, Kemitorvet 207, DK-2800 Kongens Lyngby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jon Bondebjerg</span> - <span class="hlFld-Affiliation affiliation">MC2
Therapeutics, Agern Alle
24-26, 2970 Hørsholm, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian A. Hansen</span> - <span class="hlFld-Affiliation affiliation">Capdelta
Group Aps, C/O Kavsbjerglund
30, DK-2740 Skovlunde, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Viola Previtali</span> - <span class="hlFld-Affiliation affiliation">Center
for Nanomedicine & Theranostics, Department of Chemistry, Technical University of Denmark, Kemitorvet 207, DK-2800 Kongens Lyngby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anders E. Hansen</span> - <span class="hlFld-Affiliation affiliation">Center
for Nanomedicine & Theranostics, Department of Micro- and Nanotechnology, Technical University of Denmark, Ørsteds Plads, Building 345, DK-2800 Kongens Lyngby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas L. Andresen</span> - <span class="hlFld-Affiliation affiliation">Center
for Nanomedicine & Theranostics, Department of Micro- and Nanotechnology, Technical University of Denmark, Ørsteds Plads, Building 345, DK-2800 Kongens Lyngby, Denmark</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.P.C. and V.P. performed experiments. J.P.C., J.B., C.A.H., V.P., A.E.H., T.L.A., and M.H.C. designed the study, analyzed data, and wrote the manuscript. All authors have approved the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d216e4065-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful for financial support from the Independent Research Fund Denmark (grant no. 7017-00026) and the Technical University of Denmark (PoC funding and a Ph.D. scholarship for J.P.C.).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS USED</td></tr><tr><td class="NLM_term">AMT</td><td class="NLM_def"><p class="first last">aminopterin</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">CIA</td><td class="NLM_def"><p class="first last">collagen-induced arthritis</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">DMARD</td><td class="NLM_def"><p class="first last">disease modifying antirheumatic drug</p></td></tr><tr><td class="NLM_term">LD-MTX</td><td class="NLM_def"><p class="first last">low-dose methotrexate</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">RP-UPLC-MS</td><td class="NLM_def"><p class="first last">reversed-phase ultraperformance liquid chromatography</p></td></tr><tr><td class="NLM_term">MTX</td><td class="NLM_def"><p class="first last">methotrexate</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error mean</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77800" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77800" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 75 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koch, A. E.</span></span> <span> </span><span class="NLM_article-title">The Pathogenesis of Rheumatoid Arthritis</span>. <i>Am. J. Orthop. (Belle Mead. NJ).</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=17694191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADC%252BD2srmslagsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=5-8&author=A.+E.+Koch&title=The+Pathogenesis+of+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The pathogenesis of rheumatoid arthritis</span></div><div class="casAuthors">Koch Alisa Erika</div><div class="citationInfo"><span class="NLM_cas:title">American journal of orthopedics (Belle Mead, N.J.)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7 Suppl</span>),
    <span class="NLM_cas:pages">5-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYDabAH3FECgaK-_ZudimnfW6udTcc2ealAHrmfm9SVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srmslagsQ%253D%253D&md5=8a67af25fbeeaed9167ddc7cead1bb38</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DA.%2BE.%26atitle%3DThe%2520Pathogenesis%2520of%2520Rheumatoid%2520Arthritis%26jtitle%3DAm.%2520J.%2520Orthop.%2520%2528Belle%2520Mead.%2520NJ%2529.%26date%3D2007%26volume%3D36%26spage%3D5%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smolen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aletaha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, I. B.</span></span> <span> </span><span class="NLM_article-title">Rheumatoid Arthritis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>388</i></span> (<span class="NLM_issue">10055</span>),  <span class="NLM_fpage">2023</span>– <span class="NLM_lpage">2038</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(16)30173-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2FS0140-6736%2816%2930173-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=27156434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlSmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2016&pages=2023-2038&issue=10055&author=J.+S.+Smolenauthor=D.+Aletahaauthor=I.+B.+McInnes&title=Rheumatoid+Arthritis&doi=10.1016%2FS0140-6736%2816%2930173-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Rheumatoid arthritis</span></div><div class="casAuthors">Smolen, Josef S.; Aletaha, Daniel; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">10055</span>),
    <span class="NLM_cas:pages">2023-2038</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Rheumatoid arthritis is a chronic inflammatory joint disease, which can cause cartilage and bone damage as well as disability.  Early diagnosis is key to optimal therapeutic success, particularly in patients with well-characterized risk factors for poor outcomes such as high disease activity, presence of autoantibodies, and early joint damage.  Treatment algorithms involve measuring disease activity with composite indexes, applying a treatment-to-target strategy, and use of conventional, biol., and new non-biol. disease-modifying antirheumatic drugs.  After the treatment target of stringent remission (or at least low disease activity) is maintained, dose redn. should be attempted.  Although the prospects for most patients are now favorable, many still do not respond to current therapies.  Accordingly, new therapies are urgently required.  In this Seminar, we describe current insights into genetics and etiol., pathophysiol., epidemiol., assessment, therapeutic agents, and treatment strategies together with unmet needs of patients with rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkGMEVL9OqRLVg90H21EOLACvtfcHk0lg4o2HsWPeFBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlSmsbY%253D&md5=01f723daa7e5f0d030f4ab8a2476be30</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2930173-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252930173-8%26sid%3Dliteratum%253Aachs%26aulast%3DSmolen%26aufirst%3DJ.%2BS.%26aulast%3DAletaha%26aufirst%3DD.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DRheumatoid%2520Arthritis%26jtitle%3DLancet%26date%3D2016%26volume%3D388%26issue%3D10055%26spage%3D2023%26epage%3D2038%26doi%3D10.1016%2FS0140-6736%2816%2930173-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gubner, R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Suppression of Tissue Reactivity. I. Comparison of the Effects of Cortisone and Aminopterin</span>. <i>Am. J. Med. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>221</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1097/00000441-195102000-00008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1097%2F00000441-195102000-00008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1951&pages=169-175&issue=2&author=R.+Gubner&title=Therapeutic+Suppression+of+Tissue+Reactivity.+I.+Comparison+of+the+Effects+of+Cortisone+and+Aminopterin&doi=10.1097%2F00000441-195102000-00008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2F00000441-195102000-00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000441-195102000-00008%26sid%3Dliteratum%253Aachs%26aulast%3DGubner%26aufirst%3DR.%26atitle%3DTherapeutic%2520Suppression%2520of%2520Tissue%2520Reactivity.%2520I.%2520Comparison%2520of%2520the%2520Effects%2520of%2520Cortisone%2520and%2520Aminopterin%26jtitle%3DAm.%2520J.%2520Med.%2520Sci.%26date%3D1951%26volume%3D221%26issue%3D2%26spage%3D169%26epage%3D175%26doi%3D10.1097%2F00000441-195102000-00008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gubner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">August, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginsberg, V.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Suppression of Tissue Reactivity. II. Effects of Aminopterin in Rheumatoid Arthritis and Psoriasis</span>. <i>Am. J. Med. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>221</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1097/00000441-195102000-00009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1097%2F00000441-195102000-00009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1951&pages=176-182&issue=2&author=R.+Gubnerauthor=S.+Augustauthor=V.+Ginsberg&title=Therapeutic+Suppression+of+Tissue+Reactivity.+II.+Effects+of+Aminopterin+in+Rheumatoid+Arthritis+and+Psoriasis&doi=10.1097%2F00000441-195102000-00009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1097%2F00000441-195102000-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000441-195102000-00009%26sid%3Dliteratum%253Aachs%26aulast%3DGubner%26aufirst%3DR.%26aulast%3DAugust%26aufirst%3DS.%26aulast%3DGinsberg%26aufirst%3DV.%26atitle%3DTherapeutic%2520Suppression%2520of%2520Tissue%2520Reactivity.%2520II.%2520Effects%2520of%2520Aminopterin%2520in%2520Rheumatoid%2520Arthritis%2520and%2520Psoriasis%26jtitle%3DAm.%2520J.%2520Med.%2520Sci.%26date%3D1951%26volume%3D221%26issue%3D2%26spage%3D176%26epage%3D182%26doi%3D10.1097%2F00000441-195102000-00009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rees, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamlin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibach, H.</span></span> <span> </span><span class="NLM_article-title">Aminopterin for Psoriasis: A Decade’s Observation</span>. <i>Arch. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1001/archderm.1964.01600060010002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1001%2Farchderm.1964.01600060010002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=14206858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADyaF2M%252FhtFagug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1964&pages=544-552&issue=6&author=R.+B.+Reesauthor=J.+H.+Bennettauthor=E.+Hamlinauthor=H.+Maibach&title=Aminopterin+for+Psoriasis%3A+A+Decade%E2%80%99s+Observation&doi=10.1001%2Farchderm.1964.01600060010002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">AMINOPTERIN FOR PSORIASIS. A DECADE'S OBSERVATION</span></div><div class="casAuthors">REES R B; BENNETT J H; HAMLIN E M; MAIBACH H I</div><div class="citationInfo"><span class="NLM_cas:title">Archives of dermatology</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">544-52</span>
        ISSN:<span class="NLM_cas:issn">0003-987X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR_vma9e0Tq7kwlCcfExbvbfW6udTcc2eb8g0XTjCZuCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2M%252FhtFagug%253D%253D&md5=892ea80459c3c6cedf8cc43571732f9f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1001%2Farchderm.1964.01600060010002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchderm.1964.01600060010002%26sid%3Dliteratum%253Aachs%26aulast%3DRees%26aufirst%3DR.%2BB.%26aulast%3DBennett%26aufirst%3DJ.%2BH.%26aulast%3DHamlin%26aufirst%3DE.%26aulast%3DMaibach%26aufirst%3DH.%26atitle%3DAminopterin%2520for%2520Psoriasis%253A%2520A%2520Decade%25E2%2580%2599s%2520Observation%26jtitle%3DArch.%2520Dermatol.%26date%3D1964%26volume%3D90%26issue%3D6%26spage%3D544%26epage%3D552%26doi%3D10.1001%2Farchderm.1964.01600060010002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sacks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenbach, E. B.</span></span> <span> </span><span class="NLM_article-title">The Response of Acute Leukemia to the Administration of the Folic Acid Antagonists, Aminopterin and Amethopterin: Report of 14 Cases</span>. <i>Ann. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">1950</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.7326/0003-4819-32-1-80</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.7326%2F0003-4819-32-1-80" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=15404129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADyaG3c%252FhtlOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1950&pages=80-115&issue=1&author=M.+S.+Sacksauthor=G.+T.+Bradfordauthor=E.+B.+Schoenbach&title=The+Response+of+Acute+Leukemia+to+the+Administration+of+the+Folic+Acid+Antagonists%2C+Aminopterin+and+Amethopterin%3A+Report+of+14+Cases&doi=10.7326%2F0003-4819-32-1-80"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The response of acute leukemia to the administration of the folic acid antagonists, aminopterin and a-methopterin; report of 14 cases</span></div><div class="casAuthors">SACKS M S; BRADFORD G T; SCHOENBACH E B</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">1950</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-115, illust</span>
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwmHczcwXobbmQt-ICR3qNfW6udTcc2eY9Mlw2TBVTbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG3c%252FhtlOlsw%253D%253D&md5=fe3ef0f35ef30079b5a1b5e36bd39d08</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-32-1-80&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-32-1-80%26sid%3Dliteratum%253Aachs%26aulast%3DSacks%26aufirst%3DM.%2BS.%26aulast%3DBradford%26aufirst%3DG.%2BT.%26aulast%3DSchoenbach%26aufirst%3DE.%2BB.%26atitle%3DThe%2520Response%2520of%2520Acute%2520Leukemia%2520to%2520the%2520Administration%2520of%2520the%2520Folic%2520Acid%2520Antagonists%252C%2520Aminopterin%2520and%2520Amethopterin%253A%2520Report%2520of%252014%2520Cases%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D1950%26volume%3D32%26issue%3D1%26spage%3D80%26epage%3D115%26doi%3D10.7326%2F0003-4819-32-1-80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stickney, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagedorn, A. B.</span></span> <span> </span><span class="NLM_article-title">Observations on Acute Leukemia in Children Treated with 4-Aminopteroylglutamic Acid</span>. <i>Pediatrics</i> <span class="NLM_year" style="font-weight: bold;">1950</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1950&pages=52-56&issue=1&author=S.+D.+Millsauthor=J.+M.+Stickneyauthor=A.+B.+Hagedorn&title=Observations+on+Acute+Leukemia+in+Children+Treated+with+4-Aminopteroylglutamic+Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DS.%2BD.%26aulast%3DStickney%26aufirst%3DJ.%2BM.%26aulast%3DHagedorn%26aufirst%3DA.%2BB.%26atitle%3DObservations%2520on%2520Acute%2520Leukemia%2520in%2520Children%2520Treated%2520with%25204-Aminopteroylglutamic%2520Acid%26jtitle%3DPediatrics%26date%3D1950%26volume%3D5%26issue%3D1%26spage%3D52%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawitsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritz, N. D.</span></span> <span> </span><span class="NLM_article-title">Aminopterin (a Folic Acid Antagonist) in the Treatment of Leukemia</span>. <i>Am. J. Clin. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">1949</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1093/ajcp/19.2.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1093%2Fajcp%2F19.2.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=18111375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADyaH1M%252Fht12ksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1949&pages=119-126&issue=2&author=L.+M.+Meyerauthor=H.+Finkauthor=A.+Sawitskyauthor=M.+Rowenauthor=N.+D.+Ritz&title=Aminopterin+%28a+Folic+Acid+Antagonist%29+in+the+Treatment+of+Leukemia&doi=10.1093%2Fajcp%2F19.2.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Aminopterin, a folic acid antagonist, in the treatment of leukemia</span></div><div class="casAuthors">MEYER L M; FINK H</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical pathology</span>
        (<span class="NLM_cas:date">1949</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-26</span>
        ISSN:<span class="NLM_cas:issn">0002-9173</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9Qw9gcJqbe_6BottYdIAWfW6udTcc2eY9Mlw2TBVTbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaH1M%252Fht12ksw%253D%253D&md5=a96498a6469b9eb104edd8d8ebf253d1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fajcp%2F19.2.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcp%252F19.2.119%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DL.%2BM.%26aulast%3DFink%26aufirst%3DH.%26aulast%3DSawitsky%26aufirst%3DA.%26aulast%3DRowen%26aufirst%3DM.%26aulast%3DRitz%26aufirst%3DN.%2BD.%26atitle%3DAminopterin%2520%2528a%2520Folic%2520Acid%2520Antagonist%2529%2520in%2520the%2520Treatment%2520of%2520Leukemia%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D1949%26volume%3D19%26issue%3D2%26spage%3D119%26epage%3D126%26doi%3D10.1093%2Fajcp%2F19.2.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A.</span></span> <span> </span><span class="NLM_article-title">Treatment of Leukemia with Aminopterin</span>. <i>Am. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">452</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1016/0002-9343(51)90290-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2F0002-9343%2851%2990290-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=14819051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADyaG3M%252FkvVKjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1951&pages=452-458&issue=4&author=L.+M.+Meyerauthor=A.+Newman&title=Treatment+of+Leukemia+with+Aminopterin&doi=10.1016%2F0002-9343%2851%2990290-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of leukemia with aminopterin</span></div><div class="casAuthors">MEYER L M; NEWMAN A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of medicine</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">452-8</span>
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6azVgjWImVNhSDZx9hyjKfW6udTcc2eY9Mlw2TBVTbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG3M%252FkvVKjsw%253D%253D&md5=55c092b1f9996d5927aa9894ccb17c33</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0002-9343%2851%2990290-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-9343%252851%252990290-2%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DL.%2BM.%26aulast%3DNewman%26aufirst%3DA.%26atitle%3DTreatment%2520of%2520Leukemia%2520with%2520Aminopterin%26jtitle%3DAm.%2520J.%2520Med.%26date%3D1951%26volume%3D10%26issue%3D4%26spage%3D452%26epage%3D458%26doi%3D10.1016%2F0002-9343%2851%2990290-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venditti, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenhouse, S. W.</span></span> <span> </span><span class="NLM_article-title">A Quantitative Comparison of the Antileukemic Effectiveness of Two Folic Acid Antagonists in Mice</span>. <i>JNCI J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1955</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1657</span>– <span class="NLM_lpage">1664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=14381889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADyaG2MXmtF2itQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1955&pages=1657-1664&issue=6&author=A.+Goldinauthor=J.+M.+Vendittiauthor=S.+R.+Humphreysauthor=D.+Dennisauthor=N.+Mantelauthor=S.+W.+Greenhouse&title=A+Quantitative+Comparison+of+the+Antileukemic+Effectiveness+of+Two+Folic+Acid+Antagonists+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative comparison of the antileukemic effectiveness of two folic acid antagonists in mice</span></div><div class="casAuthors">Goldin, Abraham; Venditti, John M.; Humphreys, Stewart R.; Dennis, Don; Mantel, Nathan; Greenhouse, Samuel W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute (1940-1978)</span>
        (<span class="NLM_cas:date">1955</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1657-64</span>CODEN:
                <span class="NLM_cas:coden">JNCIAM</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">cf. C.A. 48, 12316ah.  Quant. methods, previously developed and applied to the study of host-tumor relations as affected by a specific drug, were utilized to compare the antileukemic effectiveness of aminopterin and amethopterin.  Amethopterin was more effective than aminopterin in the treatment of leukemia L1210.  It produced greater survival times of leukemic mice than did aminopterin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSn3LnAI4j1LVg90H21EOLACvtfcHk0liljEnD7ATVZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2MXmtF2itQ%253D%253D&md5=dd07ba4b58fe69f393e3115c934914b7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoldin%26aufirst%3DA.%26aulast%3DVenditti%26aufirst%3DJ.%2BM.%26aulast%3DHumphreys%26aufirst%3DS.%2BR.%26aulast%3DDennis%26aufirst%3DD.%26aulast%3DMantel%26aufirst%3DN.%26aulast%3DGreenhouse%26aufirst%3DS.%2BW.%26atitle%3DA%2520Quantitative%2520Comparison%2520of%2520the%2520Antileukemic%2520Effectiveness%2520of%2520Two%2520Folic%2520Acid%2520Antagonists%2520in%2520Mice%26jtitle%3DJNCI%2520J.%2520Natl.%2520Cancer%2520Inst.%26date%3D1955%26volume%3D15%26issue%3D6%26spage%3D1657%26epage%3D1664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinblatt, M. E.</span></span> <span> </span><span class="NLM_article-title">Methotrexate in Rheumatoid Arthritis: A Quarter Century of Development</span>. <i>Trans. Am. Clin. Climatol. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=23874006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADC%252BC3sfislanuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2013&pages=16-25&author=M.+E.+Weinblatt&title=Methotrexate+in+Rheumatoid+Arthritis%3A+A+Quarter+Century+of+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Methotrexate in rheumatoid arthritis: a quarter century of development</span></div><div class="casAuthors">Weinblatt Michael E</div><div class="citationInfo"><span class="NLM_cas:title">Transactions of the American Clinical and Climatological Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-25</span>
        ISSN:<span class="NLM_cas:issn">0065-7778</span>.
    </div><div class="casAbstract">Methotrexate (MTX) is now the most popular drug worldwide for the treatment of rheumatoid arthritis.  Low-dose, weekly MTX (10 to 25 mg/wk) used as either monotherapy or in combination with other drugs has a superior efficacy profile as defined in placebo-controlled trials and comparable efficacy to other drugs including anti-TNF therapy.  At 1 year, one third of patients on MTX have no radiographic progression and even greater effects are seen when combined with targeted biological therapies.  MTX is well tolerated; gastrointestinal toxicity is the most common toxicity with rarely bone marrow, lung, or liver toxicity.  MTX therapy has been a major advance in the treatment of rheumatoid arthritis and is now the cornerstone of therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRqArOx8qswLjEwO064Z95rfW6udTcc2eb4neSNWOQEbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfislanuw%253D%253D&md5=2133803c36109fff27f4680d108331d6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26atitle%3DMethotrexate%2520in%2520Rheumatoid%2520Arthritis%253A%2520A%2520Quarter%2520Century%2520of%2520Development%26jtitle%3DTrans.%2520Am.%2520Clin.%2520Climatol.%2520Assoc.%26date%3D2013%26volume%3D124%26spage%3D16%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ćalasan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurlings, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulffraat, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakken, B. J.</span></span> <span> </span><span class="NLM_article-title">Translational Medicine from Bedside to Bench and Back Again: Methotrexate Revisited</span>. <i>Int. J. Clin. Rheumtol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.2217/ijr.13.13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.2217%2Fijr.13.13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=291-306&issue=2&author=M.+B.+%C4%86alasanauthor=R.+M.+Thurlingsauthor=N.+M.+Wulffraatauthor=B.+J.+Prakken&title=Translational+Medicine+from+Bedside+to+Bench+and+Back+Again%3A+Methotrexate+Revisited&doi=10.2217%2Fijr.13.13"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2217%2Fijr.13.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fijr.13.13%26sid%3Dliteratum%253Aachs%26aulast%3D%25C4%2586alasan%26aufirst%3DM.%2BB.%26aulast%3DThurlings%26aufirst%3DR.%2BM.%26aulast%3DWulffraat%26aufirst%3DN.%2BM.%26aulast%3DPrakken%26aufirst%3DB.%2BJ.%26atitle%3DTranslational%2520Medicine%2520from%2520Bedside%2520to%2520Bench%2520and%2520Back%2520Again%253A%2520Methotrexate%2520Revisited%26jtitle%3DInt.%2520J.%2520Clin.%2520Rheumtol.%26date%3D2013%26volume%3D8%26issue%3D2%26spage%3D291%26epage%3D306%26doi%3D10.2217%2Fijr.13.13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cronstein, B. N.</span></span> <span> </span><span class="NLM_article-title">Low-Dose Methotrexate : A Mainstay in the Treatment of Rheumatoid Arthritis</span>. <i>Rev. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1124/pr.57.2.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1124%2Fpr.57.2.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFejtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=163-172&issue=2&author=B.+N.+Cronstein&title=Low-Dose+Methotrexate%E2%80%AF%3A+A+Mainstay+in+the+Treatment+of+Rheumatoid+Arthritis&doi=10.1124%2Fpr.57.2.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Low-dose methotrexate: A mainstay in the treatment of rheumatoid arthritis</span></div><div class="casAuthors">Cronstein, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-172</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Methotrexate administered weekly in low doses is a mainstay in the therapy of rheumatoid arthritis.  Although originally developed as a folate antagonist for the treatment of cancer, its mechanism of action in the therapy of rheumatoid arthritis remains less clear.  Several mechanisms have been proposed including inhibition of T cell proliferation via its effects on purine and pyrimidine metab., inhibition of transmethylation reactions required for the prevention of T cell cytotoxicity, interference with glutathione metab. leading to alterations in recruitment of monocytes and other cells to the inflamed joint, and promotion of the release of the endogenous anti-inflammatory mediator adenosine.  These mechanisms of action and the role of methotrexate in the suppression of rheumatoid arthritis are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAeIg6zcVXbrVg90H21EOLACvtfcHk0liljEnD7ATVZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFejtLw%253D&md5=c6aae603ad4c25f2e2dc4296ecc540c2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fpr.57.2.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.57.2.3%26sid%3Dliteratum%253Aachs%26aulast%3DCronstein%26aufirst%3DB.%2BN.%26atitle%3DLow-Dose%2520Methotrexate%25E2%2580%25AF%253A%2520A%2520Mainstay%2520in%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%26jtitle%3DRev.%2520Pharmacol.%26date%3D2005%26volume%3D57%26issue%3D2%26spage%3D163%26epage%3D172%26doi%3D10.1124%2Fpr.57.2.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonafede, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Princic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, D. J.</span></span> <span> </span><span class="NLM_article-title">Cost of Tumor Necrosis Factor Blockers per Patient with Rheumatoid Arthritis in a Multistate Medicaid Population</span>. <i>Clin. Outcomes Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.2147/CEOR.S61445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.2147%2FCEOR.S61445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=25246804" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=381-388&author=M.+Bonafedeauthor=G.+J.+Josephauthor=N.+Shahauthor=N.+Princicauthor=D.+J.+Harrison&title=Cost+of+Tumor+Necrosis+Factor+Blockers+per+Patient+with+Rheumatoid+Arthritis+in+a+Multistate+Medicaid+Population&doi=10.2147%2FCEOR.S61445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2147%2FCEOR.S61445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCEOR.S61445%26sid%3Dliteratum%253Aachs%26aulast%3DBonafede%26aufirst%3DM.%26aulast%3DJoseph%26aufirst%3DG.%2BJ.%26aulast%3DShah%26aufirst%3DN.%26aulast%3DPrincic%26aufirst%3DN.%26aulast%3DHarrison%26aufirst%3DD.%2BJ.%26atitle%3DCost%2520of%2520Tumor%2520Necrosis%2520Factor%2520Blockers%2520per%2520Patient%2520with%2520Rheumatoid%2520Arthritis%2520in%2520a%2520Multistate%2520Medicaid%2520Population%26jtitle%3DClin.%2520Outcomes%2520Res.%26date%3D2014%26volume%3D6%26spage%3D381%26epage%3D388%26doi%3D10.2147%2FCEOR.S61445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronstein, B. N.</span></span> <span> </span><span class="NLM_article-title">Understanding the Mechanisms of Action of Methotrexate: Implications for the Treatment of Rheumatoid Arthritis</span>. <i>Bull. NYU Hosp. Jt. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=17922664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADC%252BD2sngtVGitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2007&pages=168-173&issue=3&author=H.+Tianauthor=B.+N.+Cronstein&title=Understanding+the+Mechanisms+of+Action+of+Methotrexate%3A+Implications+for+the+Treatment+of+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis</span></div><div class="casAuthors">Tian Henghe; Cronstein Bruce N</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the NYU hospital for joint diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">168-73</span>
        ISSN:<span class="NLM_cas:issn">1936-9719</span>.
    </div><div class="casAbstract">Methotrexate has been widely used for the treatment of rheumatoid arthritis (RA).  The mechanisms of action of methotrexate are complex.  Developed as a folic acid analogue, methotrexate inhibits purine and pyrimidine synthesis, which accounts for its efficacy in the therapy of cancer as well as for some of its toxicities.  Recently, many studies have focused on the adenosine-mediated antiinflammatory effects of methotrexate.  Certain aspects of methotrexate toxicities are also attributed to adenosine release.  A better understanding of the mechanisms of action and toxicities of methotrexate will direct clinicians in their treatment approach and toxicity monitoring.  Toward that objective, the latest developments in the pharmacokinetics, mechanism of action, pharmacogenetics, and toxicity of methotrexate are herein discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKpjpRCjFMtdHxxy173TfNfW6udTcc2eYa2H79RZb96rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sngtVGitQ%253D%253D&md5=b4d433ad29e80faaa489a0dcda426d27</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DH.%26aulast%3DCronstein%26aufirst%3DB.%2BN.%26atitle%3DUnderstanding%2520the%2520Mechanisms%2520of%2520Action%2520of%2520Methotrexate%253A%2520Implications%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%26jtitle%3DBull.%2520NYU%2520Hosp.%2520Jt.%2520Dis.%26date%3D2007%26volume%3D65%26issue%3D3%26spage%3D168%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alarcón, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, W. D.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Methotrexate in Rheumatoid Arthritis. Toxic Effects as the Major Factor in Limiting Long-Term Treatment</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1002/anr.1780320603</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1002%2Fanr.1780320603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=2735960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADyaL1M3os1Klug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=671-676&issue=6&author=G.+S.+Alarc%C3%B3nauthor=I.+C.+Tracyauthor=W.+D.+Blackburn&title=Methotrexate+in+Rheumatoid+Arthritis.+Toxic+Effects+as+the+Major+Factor+in+Limiting+Long-Term+Treatment&doi=10.1002%2Fanr.1780320603"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment</span></div><div class="casAuthors">Alarcon G S; Tracy I C; Blackburn W D Jr</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">671-6</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">In an effort to understand the prognostic features that may influence the probability of a patient's continuing to take methotrexate (MTX) over time, we studied 152 rheumatoid arthritis patients treated with MTX between 1981 and 1986.  The overall probability of continuing to take MTX was 71.2% at 1 year, 55.5% at 3 years, 50% at 5 years, and 49% at 6 years.  By univariate analysis, patients who started MTX therapy later in the study, American blacks, younger patients, those with less severe disease, and those with less frequent or less severe toxic events appeared to have a better probability of continuing the drug therapy.  When these parameters were evaluated by multivariate analysis, only the time when MTX was started and the occurrence of toxic effects independently influenced the probability of continuing MTX.  Thus, by current practice standards, toxic effects emerge as the main reason for MTX discontinuation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBbTXXnkws0ENoizSOkG_FfW6udTcc2eYa2H79RZb96rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M3os1Klug%253D%253D&md5=31fe943931b3ee666b208fb1c58341c8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fanr.1780320603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanr.1780320603%26sid%3Dliteratum%253Aachs%26aulast%3DAlarc%25C3%25B3n%26aufirst%3DG.%2BS.%26aulast%3DTracy%26aufirst%3DI.%2BC.%26aulast%3DBlackburn%26aufirst%3DW.%2BD.%26atitle%3DMethotrexate%2520in%2520Rheumatoid%2520Arthritis.%2520Toxic%2520Effects%2520as%2520the%2520Major%2520Factor%2520in%2520Limiting%2520Long-Term%2520Treatment%26jtitle%3DArthritis%2520Rheum.%26date%3D1989%26volume%3D32%26issue%3D6%26spage%3D671%26epage%3D676%26doi%3D10.1002%2Fanr.1780320603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashkes, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balistreri, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bove, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passo, M. H.</span></span> <span> </span><span class="NLM_article-title">The Long-Term Effect of Methotrexate Therapy on the Liver in Patients with Juvenile Rheumatoid Arthritis</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2226</span>– <span class="NLM_lpage">2234</span>, <span class="refDoi"> DOI: 10.1002/art.1780401218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1002%2Fart.1780401218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=9416861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADyaK1cXltVClsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2226-2234&issue=12&author=P.+J.+Hashkesauthor=W.+F.+Balistreriauthor=K.+E.+Boveauthor=E.+T.+Ballardauthor=M.+H.+Passo&title=The+Long-Term+Effect+of+Methotrexate+Therapy+on+the+Liver+in+Patients+with+Juvenile+Rheumatoid+Arthritis&doi=10.1002%2Fart.1780401218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis</span></div><div class="casAuthors">Hashkes, Philip J.; Balistreri, William F.; Bove, Kevin E.; Ballard, Edgar T.; Passo, Murray H.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2226-2234</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">This work sought to det. if the long-term use of methotrexate (MTX) in juvenile rheumatoid arthritis (JRA) is assocd. with the development of significant liver fibrosis, and to describe the presence of risk factors for liver fibrosis in patients with JRA.  Needle biopsies of the liver were performed on patients with JRA who had received a total cumulative dose of MTX that was either >3000 mg or >4000 mg/1.73 m2 of body surface area.  The presence of risk factors for MTX hepatotoxicity, esp. biochem. abnormalities reflective of liver injury and alc. consumption, were assessed.  Thirteen patients (93%) had biochem. abnormalities while being treated with MTX, but only 5 patients (36%) had ≥1 detn. in which the aspartate or alanine aminotransferase elevation was >3 times the upper limit of normal.  Long-term use of MTX for JRA does not appear to be assocd. with the development of significant liver fibrosis.  Although nearly all patients had minor histol. changes, no significant clin. consequences were apparent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4G2DmdFVNibVg90H21EOLACvtfcHk0liYlNBrk2fOxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltVClsw%253D%253D&md5=561647497ed5a0cfb541a41814915d3e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fart.1780401218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.1780401218%26sid%3Dliteratum%253Aachs%26aulast%3DHashkes%26aufirst%3DP.%2BJ.%26aulast%3DBalistreri%26aufirst%3DW.%2BF.%26aulast%3DBove%26aufirst%3DK.%2BE.%26aulast%3DBallard%26aufirst%3DE.%2BT.%26aulast%3DPasso%26aufirst%3DM.%2BH.%26atitle%3DThe%2520Long-Term%2520Effect%2520of%2520Methotrexate%2520Therapy%2520on%2520the%2520Liver%2520in%2520Patients%2520with%2520Juvenile%2520Rheumatoid%2520Arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D1997%26volume%3D40%26issue%3D12%26spage%3D2226%26epage%3D2234%26doi%3D10.1002%2Fart.1780401218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elashoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorrier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furst, D. E.</span></span> <span> </span><span class="NLM_article-title">Reduction of the Efficacy of Methotrexate by the Use of Folic Acid: Post Hoc Analysis from Two Randomized Controlled Studies</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3030</span>– <span class="NLM_lpage">3038</span>, <span class="refDoi"> DOI: 10.1002/art.21295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1002%2Fart.21295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=16200612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2msrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=3030-3038&issue=10&author=D.+Khannaauthor=G.+S.+Parkauthor=H.+E.+Paulusauthor=K.+M.+Simpsonauthor=D.+Elashoffauthor=S.+B.+Cohenauthor=P.+Emeryauthor=C.+Dorrierauthor=D.+E.+Furst&title=Reduction+of+the+Efficacy+of+Methotrexate+by+the+Use+of+Folic+Acid%3A+Post+Hoc+Analysis+from+Two+Randomized+Controlled+Studies&doi=10.1002%2Fart.21295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies</span></div><div class="casAuthors">Khanna, Dinesh; Park, Grace S.; Paulus, Harold E.; Simpson, Karen M.; Elashoff, David; Cohen, Stanley B.; Emery, Paul; Dorrier, Catharine; Furst, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3030-3038</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. To examine the effect of folic acid on the efficacy of methotrexate (MTX) treatment in rheumatoid arthritis (RA) at 12 mo in 2 phase III randomized controlled trials (RCTs) of leflunomide in which MTX was used as a comparator.  Methods. Analyses were restricted to patients randomized to receive MTX who had rheumatoid factor data.  The US study recruited 482 patients with active RA; 179 received at least 1 dose of MTX, and all were mandated to receive 1 mg of oral folic acid once or twice daily.  The multinational European study recruited 999 patients with active RA; 489 received at least 1 dose of MTX, and oral folic acid was not required, although 50 received folate after developing an adverse event.  Because of similar entry criteria for both studies, the data for patients with available primary outcome data at week 52 were pooled (n = 668), and the patients were grouped by folic acid use (n = 225) and nonuse (n = 443).  To account for the significant between-study differences in the MTX groups, baseline covariates were adjusted using propensity scores so that folic acid users could be matched with nonusers.  This allowed for a comparison of differences in American College of Rheumatol. (ACR) 20% improvement criteria at week 52.  Results. At study entry, non-folic acid users had a significantly lower mean body wt., shorter mean RA duration, and higher mean disease activity (measured by joint counts, patient's and physician's global assessments, and acute-phase reactant levels).  The mean MTX dosage at week 52 was similar in the 2 RCTs.  Using propensity score matching techniques, the proportion of patients achieving an ACR 20% response at week 52 averaged 17% higher in the non-folic acid group than in the folic acid group (range 15-21%).  Similarly, the proportion of patients achieving ACR 50% and ACR 70% responses averaged 14% (range 12-16%) and 12% (range 9-14%) higher, resp., in the non-folic acid group.  Adverse events were reported in 93% of US study patients and 94% of the multinational study patients.  Elevated liver transaminase levels (above the upper limit of normal) were reported in 29% of the US study patients (majority receiving folic acid) and 62% of the multinational study patients (majority not receiving folic acid).  Conclusion. After using propensity scores to adjust for differences in the baseline characteristics of folic acid users and non-folic acid users, 9-21% fewer MTX-treated RA patients taking folic acid had ACR 20%, 50%, or 70% improvement at 52 wk compared with those who did not receive folic acid in the 2 phase III RA clin. trials.  As a post hoc anal., the results of this data anal. should be considered "hypothesis generating" and an impetus for future studies regarding the effects of folic acid on the efficacy of MTX in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEPs1GWs8UY7Vg90H21EOLACvtfcHk0liYlNBrk2fOxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2msrrN&md5=5d4e8bfac44bd3e29995b3498aaf8458</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fart.21295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.21295%26sid%3Dliteratum%253Aachs%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DG.%2BS.%26aulast%3DPaulus%26aufirst%3DH.%2BE.%26aulast%3DSimpson%26aufirst%3DK.%2BM.%26aulast%3DElashoff%26aufirst%3DD.%26aulast%3DCohen%26aufirst%3DS.%2BB.%26aulast%3DEmery%26aufirst%3DP.%26aulast%3DDorrier%26aufirst%3DC.%26aulast%3DFurst%26aufirst%3DD.%2BE.%26atitle%3DReduction%2520of%2520the%2520Efficacy%2520of%2520Methotrexate%2520by%2520the%2520Use%2520of%2520Folic%2520Acid%253A%2520Post%2520Hoc%2520Analysis%2520from%2520Two%2520Randomized%2520Controlled%2520Studies%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26issue%3D10%26spage%3D3030%26epage%3D3038%26doi%3D10.1002%2Fart.21295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rautio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpulainen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimbach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliyai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Järvinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savolainen, J.</span></span> <span> </span><span class="NLM_article-title">Prodrugs: Design and Clinical Applications</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1038/nrd2468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1038%2Fnrd2468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=18219308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFOrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=255-270&author=J.+Rautioauthor=H.+Kumpulainenauthor=T.+Heimbachauthor=R.+Oliyaiauthor=D.+Ohauthor=T.+J%C3%A4rvinenauthor=J.+Savolainen&title=Prodrugs%3A+Design+and+Clinical+Applications&doi=10.1038%2Fnrd2468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs: design and clinical applications</span></div><div class="casAuthors">Rautio, Jarkko; Kumpulainen, Hanna; Heimbach, Tycho; Oliyai, Reza; Oh, Dooman; Jaervinen, Tomi; Savolainen, Jouko</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-270</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Prodrugs are bioreversible derivs. of drug mols. that undergo an enzymic and/or chem. transformation in vivo to release the active parent drug, which can then exert the desired pharmacol. effect.  In both drug discovery and development, prodrugs have become an established tool for improving physicochem., biopharmaceutical or pharmacokinetic properties of pharmacol. active agents.  About 5-7% of drugs approved worldwide can be classified as prodrugs, and the implementation of a prodrug approach in the early stages of drug discovery is a growing trend.  To illustrate the applicability of the prodrug strategy, this article describes the most common functional groups that are amenable to prodrug design, and highlights examples of prodrugs that are either launched or are undergoing human trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxnlEXYMLCVbVg90H21EOLACvtfcHk0li7ewuiPjWFoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFOrs7w%253D&md5=481a088ad2ee4da062779b5b28a33cbb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd2468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2468%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DKumpulainen%26aufirst%3DH.%26aulast%3DHeimbach%26aufirst%3DT.%26aulast%3DOliyai%26aufirst%3DR.%26aulast%3DOh%26aufirst%3DD.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DSavolainen%26aufirst%3DJ.%26atitle%3DProdrugs%253A%2520Design%2520and%2520Clinical%2520Applications%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D255%26epage%3D270%26doi%3D10.1038%2Fnrd2468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huttunen, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raunio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rautio, J.</span></span> <span> </span><span class="NLM_article-title">Prodrugs - from Serendipity to Rational Design</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">771</span>, <span class="refDoi"> DOI: 10.1124/pr.110.003459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1124%2Fpr.110.003459" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=750-771&issue=3&author=K.+M.+Huttunenauthor=H.+Raunioauthor=J.+Rautio&title=Prodrugs+-+from+Serendipity+to+Rational+Design&doi=10.1124%2Fpr.110.003459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.003459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.003459%26sid%3Dliteratum%253Aachs%26aulast%3DHuttunen%26aufirst%3DK.%2BM.%26aulast%3DRaunio%26aufirst%3DH.%26aulast%3DRautio%26aufirst%3DJ.%26atitle%3DProdrugs%2520-%2520from%2520Serendipity%2520to%2520Rational%2520Design%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26issue%3D3%26spage%3D750%26epage%3D771%26doi%3D10.1124%2Fpr.110.003459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zawilska, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojcieszak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, A. B.</span></span> <span> </span><span class="NLM_article-title">Prodrugs: A Challenge for the Drug Development</span>. <i>Pharmacol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/S1734-1140(13)70959-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2FS1734-1140%2813%2970959-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=23563019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amu7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=1-14&author=J.+B.+Zawilskaauthor=J.+Wojcieszakauthor=A.+B.+Olejniczak&title=Prodrugs%3A+A+Challenge+for+the+Drug+Development&doi=10.1016%2FS1734-1140%2813%2970959-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs: a challenge for the drug development</span></div><div class="casAuthors">Zawilska, Jolanta B.; Wojcieszak, Jakub; Olejniczak, Agnieszka B.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">A review.  It is estd. that about 10% of the drugs approved worldwide can be classified as prodrugs.  Prodrugs, which have no or poor biol. activity, are chem. modified versions of a pharmacol. active agent, which must undergo transformation in vivo to release the active drug.  They are designed in order to improve the physicochem., biopharmaceutical and/or pharmacokinetic properties of pharmacol. potent compds.  This article describes the basic functional groups that are amenable to prodrug design, and highlights the major applications of the prodrug strategy, including the ability to improve oral absorption and aq. soly., increase lipophilicity, enhance active transport, as well as achieve site-selective delivery.  Special emphasis is given to the role of the prodrug concept in the design of new anticancer therapies, including antibody-directed enzyme prodrug therapy (ADEPT) and gene-directed enzyme prodrug therapy (GDEPT).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Pl3d6hWiyLVg90H21EOLACvtfcHk0li7ewuiPjWFoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amu7nL&md5=b1c764a7b538c1850839400d76cdd856</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS1734-1140%2813%2970959-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1734-1140%252813%252970959-9%26sid%3Dliteratum%253Aachs%26aulast%3DZawilska%26aufirst%3DJ.%2BB.%26aulast%3DWojcieszak%26aufirst%3DJ.%26aulast%3DOlejniczak%26aufirst%3DA.%2BB.%26atitle%3DProdrugs%253A%2520A%2520Challenge%2520for%2520the%2520Drug%2520Development%26jtitle%3DPharmacol.%2520Rep.%26date%3D2013%26volume%3D65%26spage%3D1%26epage%3D14%26doi%3D10.1016%2FS1734-1140%2813%2970959-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, B.</span></span> <span> </span><span class="NLM_article-title">Methotrexate: A Detailed Review on Drug Delivery and Clinical Aspects</span>. <i>Expert Opin. Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1517/17425247.2012.642362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1517%2F17425247.2012.642362" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=151-169&issue=2&author=Z.+A.+Khanauthor=R.+Tripathiauthor=B.+Mishra&title=Methotrexate%3A+A+Detailed+Review+on+Drug+Delivery+and+Clinical+Aspects&doi=10.1517%2F17425247.2012.642362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F17425247.2012.642362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2012.642362%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DZ.%2BA.%26aulast%3DTripathi%26aufirst%3DR.%26aulast%3DMishra%26aufirst%3DB.%26atitle%3DMethotrexate%253A%2520A%2520Detailed%2520Review%2520on%2520Drug%2520Delivery%2520and%2520Clinical%2520Aspects%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2012%26volume%3D9%26issue%3D2%26spage%3D151%26epage%3D169%26doi%3D10.1517%2F17425247.2012.642362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abolmaali, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamaddon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinarvand, R.</span></span> <span> </span><span class="NLM_article-title">A Review of Therapeutic Challenges and Achievements of Methotrexate Delivery Systems for Treatment of Cancer and Rheumatoid Arthritis</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1115</span>– <span class="NLM_lpage">1130</span>, <span class="refDoi"> DOI: 10.1007/s00280-012-2062-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1007%2Fs00280-012-2062-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=23292116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVemsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2013&pages=1115-1130&issue=5&author=S.+S.+Abolmaaliauthor=A.+M.+Tamaddonauthor=R.+Dinarvand&title=A+Review+of+Therapeutic+Challenges+and+Achievements+of+Methotrexate+Delivery+Systems+for+Treatment+of+Cancer+and+Rheumatoid+Arthritis&doi=10.1007%2Fs00280-012-2062-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis</span></div><div class="casAuthors">Abolmaali, Samira Sadat; Tamaddon, Ali Mohammad; Dinarvand, Rassoul</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1115-1130</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Purpose Methotrexate (MTX) is one of the most widely studied and effective therapeutics agents available to treat many solid tumors, hematol. malignancies, and autoimmune diseases such as rheumatoid arthritis; however, the poor pharmacokinetic and narrow safety margin of the drug limits the therapeutic outcomes of conventional drug delivery systems.  For an improved delivery of MTX, several pathophysiol. features such as angiogenesis, enhanced permeability and retention effects, acidosis, and expression of specific antigens and receptors can be used either as targets or as tools for drug delivery.  Methods There are many novel delivery systems developed to improve the pitfalls of MTX therapy ranged from polymeric conjugates such as human serum albumin, liposomes, microspheres, solid lipid nanoparticles, polymeric nanoparticles, dendrimers, polymeric micelles, in situ forming hydrogels, carrier erythrocyte, and nanotechnol.-based vehicles such as carbon nanotubes, magnetic nanoparticles, and gold nanoparticles.  Some are further modified with targeting ligands for active targeting purposes.  Results Such delivery systems provide prolonged plasma profile, enhanced and specific activity in vitro and in vivo in animal models.  Nevertheless, more complementary studies are needed before they can be applied in human.  Conclusion This review deals with the challenges of conventional systems and achievements of each pharmaceutical class of novel drug delivery vehicle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiKiJt5rFW_rVg90H21EOLACvtfcHk0lht3LXdAL9s6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVemsL4%253D&md5=e371656cf6617af4bd8d2905566e1dcb</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs00280-012-2062-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-012-2062-0%26sid%3Dliteratum%253Aachs%26aulast%3DAbolmaali%26aufirst%3DS.%2BS.%26aulast%3DTamaddon%26aufirst%3DA.%2BM.%26aulast%3DDinarvand%26aufirst%3DR.%26atitle%3DA%2520Review%2520of%2520Therapeutic%2520Challenges%2520and%2520Achievements%2520of%2520Methotrexate%2520Delivery%2520Systems%2520for%2520Treatment%2520of%2520Cancer%2520and%2520Rheumatoid%2520Arthritis%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2013%26volume%3D71%26issue%3D5%26spage%3D1115%26epage%3D1130%26doi%3D10.1007%2Fs00280-012-2062-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wunder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller-Ladner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stelzer, E. H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stehle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pap, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiehn, C.</span></span> <span> </span><span class="NLM_article-title">Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>170</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4793</span>– <span class="NLM_lpage">4801</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.170.9.4793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.4049%2Fjimmunol.170.9.4793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=12707361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtVKntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=4793-4801&issue=9&author=A.+Wunderauthor=U.+M%C3%BCller-Ladnerauthor=E.+H.+K.+Stelzerauthor=J.+Funkauthor=E.+Neumannauthor=G.+Stehleauthor=T.+Papauthor=H.+Sinnauthor=S.+Gayauthor=C.+Fiehn&title=Albumin-Based+Drug+Delivery+as+Novel+Therapeutic+Approach+for+Rheumatoid+Arthritis&doi=10.4049%2Fjimmunol.170.9.4793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritis</span></div><div class="casAuthors">Wunder, Andreas; Mueller-Ladner, Ulf; Stelzer, Ernst H. K.; Funk, Juergen; Neumann, Elena; Stehle, Gerd; Pap, Thomas; Sinn, Hannsjoerg; Gay, Steffen; Fiehn, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4793-4801</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">We reported recently that albumin is a suitable drug carrier for targeted delivery of methotrexate (MTX) to tumors.  Due to pathophysiol. conditions in neoplastic tissue, high amts. of albumin accumulate in tumors and are metabolized by malignant cells.  MTX, covalently coupled to human serum albumin (MTX-HSA) for cancer treatment, is currently being evaluated in phase II clin. trials.  Because synovium of patients with rheumatoid arthritis (RA) shares various features obsd. also in tumors, albumin-based drug targeting of inflamed joints might be an attractive therapeutic approach.  Therefore, the pharmacokinetics of albumin and MTX in a mouse model of arthritis was examd.  Addnl., uptake of albumin by synovial fibroblasts of RA patients and the efficacy of MTX and MTX-HSA in arthritic mice were studied.  The results show that when compared with MTX, significantly higher amts. of albumin accumulate in inflamed paws, and significantly lower amts. of albumin are found in the liver and the kidneys.  The protein is metabolized by human synovial fibroblasts in vitro and in vivo.  MTX-HSA was significantly more effective in suppression of the onset of arthritis in mice than was MTX.  In conclusion, albumin appears to be a suitable drug carrier in RA, most likely due to effects on synovial fibroblasts, which might increase therapeutic efficacy and reduce side effects of MTX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotxpoEkxcv2bVg90H21EOLACvtfcHk0lht3LXdAL9s6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtVKntbY%253D&md5=ee89efe0111a5306c3b4cbb28f62520f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.170.9.4793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.170.9.4793%26sid%3Dliteratum%253Aachs%26aulast%3DWunder%26aufirst%3DA.%26aulast%3DM%25C3%25BCller-Ladner%26aufirst%3DU.%26aulast%3DStelzer%26aufirst%3DE.%2BH.%2BK.%26aulast%3DFunk%26aufirst%3DJ.%26aulast%3DNeumann%26aufirst%3DE.%26aulast%3DStehle%26aufirst%3DG.%26aulast%3DPap%26aufirst%3DT.%26aulast%3DSinn%26aufirst%3DH.%26aulast%3DGay%26aufirst%3DS.%26aulast%3DFiehn%26aufirst%3DC.%26atitle%3DAlbumin-Based%2520Drug%2520Delivery%2520as%2520Novel%2520Therapeutic%2520Approach%2520for%2520Rheumatoid%2520Arthritis%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D170%26issue%3D9%26spage%3D4793%26epage%3D4801%26doi%3D10.4049%2Fjimmunol.170.9.4793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiehn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sass, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller-Ladner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, E.</span></span> <span> </span><span class="NLM_article-title">Targeted Drug Delivery by in Vivo Coupling to Endogenous Albumin: An Albumin-Binding Prodrug of Methotrexate (MTX) Is Better than MTX in the Treatment of Murine Collagen-Induced Arthritis</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1188</span>– <span class="NLM_lpage">1191</span>, <span class="refDoi"> DOI: 10.1136/ard.2007.086843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1136%2Fard.2007.086843" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=18408252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSktbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2008&pages=1188-1191&issue=8&author=C.+Fiehnauthor=F.+Kratzauthor=G.+Sassauthor=U.+M%C3%BCller-Ladnerauthor=E.+Neumann&title=Targeted+Drug+Delivery+by+in+Vivo+Coupling+to+Endogenous+Albumin%3A+An+Albumin-Binding+Prodrug+of+Methotrexate+%28MTX%29+Is+Better+than+MTX+in+the+Treatment+of+Murine+Collagen-Induced+Arthritis&doi=10.1136%2Fard.2007.086843"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis</span></div><div class="casAuthors">Fiehn, C.; Kratz, F.; Sass, G.; Mueller-Ladner, U.; Neumann, E.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1188-1191</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objective: To examine the effect of an albumin-binding prodrug of methotrexate (MTX) in the treatment of murine collagen-induced arthritis (CIA).  Methods: The prodrug AWO54 with the formula EMC-D-Ala-Phe-Lys-Lys-MTX binds selectively to the cysteine-34 position of endogenous albumin, which acts as a macromol. drug carrier for MTX to the site of inflammation.  The CIA model was used to evaluate the anti-arthritic effect of the compd. after i.v. application.  Results: The albumin-bound form of AWO54 was efficiently cleaved by cathepsin B and plasmin, two proteases that are overexpressed in rheumatoid arthritis, and release a MTX lysine deriv.  AWO54 suppressed CIA in a dose-dependent manner and was significantly better than MTX.  To obtain a similar effect only about 20% of the MTX-equiv. dose of AWO54 had to be given.  The efficacy of the drug was tested in two different stages of CIA: while both, MTX and AWO54 inhibited arthritis in an early stage of the disease, in a later stage only AWO54 showed a significant inhibitory effect in comparison with control.  Conclusion: Targeted drug delivery by in vivo coupling of a prodrug of MTX to endogenous albumin is better than MTX in the treatment of CIA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx97X0Qq1abrVg90H21EOLACvtfcHk0lht3LXdAL9s6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSktbjF&md5=5c75070a8209fc1bd72b355d6ccadbea</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1136%2Fard.2007.086843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2007.086843%26sid%3Dliteratum%253Aachs%26aulast%3DFiehn%26aufirst%3DC.%26aulast%3DKratz%26aufirst%3DF.%26aulast%3DSass%26aufirst%3DG.%26aulast%3DM%25C3%25BCller-Ladner%26aufirst%3DU.%26aulast%3DNeumann%26aufirst%3DE.%26atitle%3DTargeted%2520Drug%2520Delivery%2520by%2520in%2520Vivo%2520Coupling%2520to%2520Endogenous%2520Albumin%253A%2520An%2520Albumin-Binding%2520Prodrug%2520of%2520Methotrexate%2520%2528MTX%2529%2520Is%2520Better%2520than%2520MTX%2520in%2520the%2520Treatment%2520of%2520Murine%2520Collagen-Induced%2520Arthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2008%26volume%3D67%26issue%3D8%26spage%3D1188%26epage%3D1191%26doi%3D10.1136%2Fard.2007.086843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Homma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asanuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nohmi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izutani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, R.</span></span> <span> </span><span class="NLM_article-title">Novel Hyaluronic Acid-Methotrexate Conjugates for Osteoarthritis Treatment</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">4647</span>– <span class="NLM_lpage">4656</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.04.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.bmc.2009.04.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=4647-4656&issue=3&author=A.+Hommaauthor=H.+Satoauthor=A.+Okamachiauthor=T.+Emuraauthor=T.+Ishizawaauthor=T.+Katoauthor=T.+Matsuuraauthor=S.+Satoauthor=T.+Tamuraauthor=Y.+Higuchiauthor=T.+Watanabeauthor=H.+Kitamuraauthor=K.+Asanumaauthor=T.+Yamazakiauthor=M.+Ikemiauthor=H.+Kitagawaauthor=T.+Morikawaauthor=H.+Ikeyaauthor=K.+Maedaauthor=K.+Takahashiauthor=K.+Nohmiauthor=N.+Izutaniauthor=M.+Kandaauthor=R.+Suzuki&title=Novel+Hyaluronic+Acid-Methotrexate+Conjugates+for+Osteoarthritis+Treatment&doi=10.1016%2Fj.bmc.2009.04.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.04.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.04.063%26sid%3Dliteratum%253Aachs%26aulast%3DHomma%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DOkamachi%26aufirst%3DA.%26aulast%3DEmura%26aufirst%3DT.%26aulast%3DIshizawa%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DMatsuura%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DH.%26aulast%3DAsanuma%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DIkemi%26aufirst%3DM.%26aulast%3DKitagawa%26aufirst%3DH.%26aulast%3DMorikawa%26aufirst%3DT.%26aulast%3DIkeya%26aufirst%3DH.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DNohmi%26aufirst%3DK.%26aulast%3DIzutani%26aufirst%3DN.%26aulast%3DKanda%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DR.%26atitle%3DNovel%2520Hyaluronic%2520Acid-Methotrexate%2520Conjugates%2520for%2520Osteoarthritis%2520Treatment%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D3%26spage%3D4647%26epage%3D4656%26doi%3D10.1016%2Fj.bmc.2009.04.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saitoh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span> <span> </span><span class="NLM_article-title">Novel Hyaluronic Acid–methotrexate Conjugate Suppresses Joint Inflammation in the Rat Knee: Efficacy and Safety Evaluation in Two Rat Arthritis Models</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1186/s13075-016-0971-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1186%2Fs13075-016-0971-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=26732314" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=1-11&author=T.+Tamuraauthor=Y.+Higuchiauthor=H.+Kitamuraauthor=N.+Muraoauthor=R.+Saitohauthor=T.+Morikawaauthor=H.+Sato&title=Novel+Hyaluronic+Acid%E2%80%93methotrexate+Conjugate+Suppresses+Joint+Inflammation+in+the+Rat+Knee%3A+Efficacy+and+Safety+Evaluation+in+Two+Rat+Arthritis+Models&doi=10.1186%2Fs13075-016-0971-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2Fs13075-016-0971-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13075-016-0971-8%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DH.%26aulast%3DMurao%26aufirst%3DN.%26aulast%3DSaitoh%26aufirst%3DR.%26aulast%3DMorikawa%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DH.%26atitle%3DNovel%2520Hyaluronic%2520Acid%25E2%2580%2593methotrexate%2520Conjugate%2520Suppresses%2520Joint%2520Inflammation%2520in%2520the%2520Rat%2520Knee%253A%2520Efficacy%2520and%2520Safety%2520Evaluation%2520in%2520Two%2520Rat%2520Arthritis%2520Models%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2016%26volume%3D18%26spage%3D1%26epage%3D11%26doi%3D10.1186%2Fs13075-016-0971-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Homma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asanuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nohmi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izutani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Optimization of Hyaluronic Acid-Methotrexate Conjugates to Maximize Benefit in the Treatment of Osteoarthritis</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1075</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.12.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.bmc.2009.12.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=1062-1075&issue=3&author=A.+Hommaauthor=H.+Satoauthor=T.+Tamuraauthor=A.+Okamachiauthor=T.+Emuraauthor=T.+Ishizawaauthor=T.+Katoauthor=T.+Matsuuraauthor=S.+Satoauthor=Y.+Higuchiauthor=T.+Watanabeauthor=H.+Kitamuraauthor=K.+Asanumaauthor=T.+Yamazakiauthor=M.+Ikemiauthor=H.+Kitagawaauthor=T.+Morikawaauthor=H.+Ikeyaauthor=K.+Maedaauthor=K.+Takahashiauthor=K.+Nohmiauthor=N.+Izutaniauthor=M.+Kandaauthor=R.+Suzuki&title=Synthesis+and+Optimization+of+Hyaluronic+Acid-Methotrexate+Conjugates+to+Maximize+Benefit+in+the+Treatment+of+Osteoarthritis&doi=10.1016%2Fj.bmc.2009.12.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.12.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.12.053%26sid%3Dliteratum%253Aachs%26aulast%3DHomma%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DOkamachi%26aufirst%3DA.%26aulast%3DEmura%26aufirst%3DT.%26aulast%3DIshizawa%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DMatsuura%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DHiguchi%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DH.%26aulast%3DAsanuma%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DIkemi%26aufirst%3DM.%26aulast%3DKitagawa%26aufirst%3DH.%26aulast%3DMorikawa%26aufirst%3DT.%26aulast%3DIkeya%26aufirst%3DH.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DNohmi%26aufirst%3DK.%26aulast%3DIzutani%26aufirst%3DN.%26aulast%3DKanda%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520Optimization%2520of%2520Hyaluronic%2520Acid-Methotrexate%2520Conjugates%2520to%2520Maximize%2520Benefit%2520in%2520the%2520Treatment%2520of%2520Osteoarthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26issue%3D3%26spage%3D1062%26epage%3D1075%26doi%3D10.1016%2Fj.bmc.2009.12.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, a S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camilleri, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amos, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B. D.</span></span> <span> </span><span class="NLM_article-title">Differential Effects of Methotrexate and Liposomally Conjugated Methotrexate in Rat Adjuvant-Induced Arthritis</span>. <i>Clin. Exp. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">565</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2249.1995.tb03853.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1111%2Fj.1365-2249.1995.tb03853.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=8536373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADyaK28Xht1GmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1995&pages=560-565&issue=3&author=a+S.+Williamsauthor=J.+P.+Camilleriauthor=N.+Amosauthor=B.+D.+Williams&title=Differential+Effects+of+Methotrexate+and+Liposomally+Conjugated+Methotrexate+in+Rat+Adjuvant-Induced+Arthritis&doi=10.1111%2Fj.1365-2249.1995.tb03853.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritis</span></div><div class="casAuthors">Williams, A. S.; Camilleri, J. P.; Amos, N.; Williams, B. D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">560-5</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">In this study we evaluated the comparative efficacy of free and liposomally conjugated methotrexate on both disease induction and suppression of acute inflammation in rat adjuvant-induced arthritis.  Rats were given either empty liposomes (E-LIPO), free methotrexate (MTX) or the liposomally conjugated methotrexate (MTX-LIPO) at a dose of 100 μg/day for 7 consecutive days by the i.v. route.  When MTX treatment was initiated on the day of arthritis induction the drug suppressed but did not abolish the development of joint inflammation.  Free MTX had no significant anti-inflammatory effect upon an established arthritis when dosing was commenced on day 11 post-adjuvant induction.  Conversely, MTX-LIPO did not affect the progression of the arthritis when dosing was started on day 0, but exerted a significant anti-inflammatory effect on an established arthritis.  MTX-LIPO treatment was significantly less hematotoxic than free MTX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk9iZniAy0uLVg90H21EOLACvtfcHk0lhIsakP7SkW7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xht1GmsL8%253D&md5=dae4bd8eeeccc9f84d22d94c7a4f4cfa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.1995.tb03853.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.1995.tb03853.x%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3Da%2BS.%26aulast%3DCamilleri%26aufirst%3DJ.%2BP.%26aulast%3DAmos%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DB.%2BD.%26atitle%3DDifferential%2520Effects%2520of%2520Methotrexate%2520and%2520Liposomally%2520Conjugated%2520Methotrexate%2520in%2520Rat%2520Adjuvant-Induced%2520Arthritis%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D1995%26volume%3D102%26issue%3D3%26spage%3D560%26epage%3D565%26doi%3D10.1111%2Fj.1365-2249.1995.tb03853.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. K.</span></span> <span> </span><span class="NLM_article-title">Prolonged Blood Circulation of Methotrexate by Modulation of Liposomal Composition</span>. <i>Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1080/107175401317245912</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1080%2F107175401317245912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVeksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=231-237&issue=4&author=M.+S.+Hongauthor=S.+J.+Limauthor=M.+K.+Leeauthor=Y.+B.+Kimauthor=C.+K.+Kim&title=Prolonged+Blood+Circulation+of+Methotrexate+by+Modulation+of+Liposomal+Composition&doi=10.1080%2F107175401317245912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Prolonged blood circulation of methotrexate by modulation of liposomal composition</span></div><div class="casAuthors">Hong, Myo-Sook; Lim, Soo-Jeong; Lee, Mi-Kyung; Kim, Yang Bae; Kim, Chong-Kook</div><div class="citationInfo"><span class="NLM_cas:title">Drug Delivery</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">231-237</span>CODEN:
                <span class="NLM_cas:coden">DDELEB</span>;
        ISSN:<span class="NLM_cas:issn">1071-7544</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis</span>)
        </div><div class="casAbstract">Prolonged circulation by liposomal incorporation has been shown to enhance the therapeutic efficacy of drugs in many cases.  The purpose of this study was to investigate whether the prolonged circulation of methotrexate (MTX) can be achieved by modulating the liposomal compns.  Various compns. of liposomes were prepd. with 2:1 of phosphatidylcholine (PC) and cholesterol (CH) with or without distearoylphosphatidyl-ethanolamine-N-poly(ethyleneglycol) 2000 (DSPE-PEG).  The MTX encapsulation efficiency depended on the type of PC used.  It also appeared to increase by inclusion of DSPE-PEG.  The size of liposomes decreased by the inclusion of DSPE-PEG.  The inclusion of DSPE-PEG lowered the plasma-induced release of MTX from EggPC/CH and DPPC/CH liposomes, suggesting its enhancement effect on the liposomal stability.  After i.v. injection to rats, the pharmacokinetics and biodistribution of MTX were significantly changed by liposomal incorporation and also by the compn. of liposomes.  The total body clearance of MTX incorporated in EggPC/CH, DPPC/CH, EggPC/CH/DSPE-PEG, and DPPC/CH/DSPE-PEG liposomes decreased 4.4-, 14.9-, 24.5-, and 53.1-fold, compared with that of free MTX.  The ratio of MTX concn. in blood to liver and spleen after injection of DPPC/CH, EggPC/CH/DSPE-PEG, and DPPC/CH/DSPE-PEG liposomes was 5.4-, 8.5-, and 13.5-fold higher than that of EggPC/CH liposomes.  Furthermore, the accumulation of MTX in the kidney, one of the organs in which MTX exhibits its toxicity, was significantly lowered by liposomal incorporation, esp. by DSPE-PEG-contg. liposomes.  Taken together, DPPC/CH/DSPE-PEG liposomes most effectively prolonged the blood circulation, and reduced hepatosplenic and kidney uptake of MTX.  DPPC/CH/DSPE-PEG liposomes may have potential as an efficient delivery system for MTX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6jTRxxYDVw7Vg90H21EOLACvtfcHk0lgIQkATtxSNJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVeksrg%253D&md5=6674d3cda9018cc85cb5634344da6ecf</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F107175401317245912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F107175401317245912%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DM.%2BS.%26aulast%3DLim%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DKim%26aufirst%3DY.%2BB.%26aulast%3DKim%26aufirst%3DC.%2BK.%26atitle%3DProlonged%2520Blood%2520Circulation%2520of%2520Methotrexate%2520by%2520Modulation%2520of%2520Liposomal%2520Composition%26jtitle%3DDrug%2520Delivery%26date%3D2001%26volume%3D8%26issue%3D4%26spage%3D231%26epage%3D237%26doi%3D10.1080%2F107175401317245912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risovic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burt, H. M.</span></span> <span> </span><span class="NLM_article-title">Methotrexate Loaded Poly(L-Lactic Acid) Microspheres for Intra-Articular Delivery of Methotrexate to the Joint</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">943</span>– <span class="NLM_lpage">956</span>, <span class="refDoi"> DOI: 10.1002/jps.20031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1002%2Fjps.20031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2004&pages=943-956&issue=4&author=L.+S.+Liangauthor=J.+Jacksonauthor=W.+Minauthor=V.+Risovicauthor=K.+M.+Wasanauthor=H.+M.+Burt&title=Methotrexate+Loaded+Poly%28L-Lactic+Acid%29+Microspheres+for+Intra-Articular+Delivery+of+Methotrexate+to+the+Joint&doi=10.1002%2Fjps.20031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fjps.20031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20031%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DL.%2BS.%26aulast%3DJackson%26aufirst%3DJ.%26aulast%3DMin%26aufirst%3DW.%26aulast%3DRisovic%26aufirst%3DV.%26aulast%3DWasan%26aufirst%3DK.%2BM.%26aulast%3DBurt%26aufirst%3DH.%2BM.%26atitle%3DMethotrexate%2520Loaded%2520Poly%2528L-Lactic%2520Acid%2529%2520Microspheres%2520for%2520Intra-Articular%2520Delivery%2520of%2520Methotrexate%2520to%2520the%2520Joint%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2004%26volume%3D93%26issue%3D4%26spage%3D943%26epage%3D956%26doi%3D10.1002%2Fjps.20031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, G.</span></span> <span> </span><span class="NLM_article-title">Injectable Thermosensitive Hydrogels for Intra-Articular Delivery of Methotrexate</span>. <i>J. Appl. Polym. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">2139</span>– <span class="NLM_lpage">2145</span>, <span class="refDoi"> DOI: 10.1002/app.34332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1002%2Fapp.34332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntlKgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2011&pages=2139-2145&author=B.+Miaoauthor=C.+Songauthor=G.+Ma&title=Injectable+Thermosensitive+Hydrogels+for+Intra-Articular+Delivery+of+Methotrexate&doi=10.1002%2Fapp.34332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Injectable thermosensitive hydrogels for intra-articular delivery of methotrexate</span></div><div class="casAuthors">Miao, Bolong; Song, Cunxian; Ma, Guilei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Polymer Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2139-2145</span>CODEN:
                <span class="NLM_cas:coden">JAPNAB</span>;
        ISSN:<span class="NLM_cas:issn">0021-8995</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Intra-articular drug delivery is the preferred approach for targeting pharmacol. treatment directly at the joints to reduce undesirable side effects assocd. with systemic drug delivery.  In this study, a controlled delivery system of methotrexate (MTX) based on injectable thermosensitive poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) (PCL-PEG-PCL, PEP) hydrogels was developed for the intra-articular drug delivery.  The thermosensitive PEP copolymers were prepd. by ring-opening polymn.  The synthesized PEP copolymers were characterized for their structure, compn., and the sol-to-gel transition.  The in vitro MTX release from the PEP hydrogels was studied.  MTX plasma concn. following intra-articular injection into healthy rats was detd. by HPLC.  Biocompatibility was confirmed by histol. anal. after the intra-articular injection.  The synthesized PEP copolymers aq. solns. formed in situ gel rapidly after the injection.  PEP hydrogels showed the ability to control the release of incorporated MTX.  Following intra-articular injection, the PEP hydrogels decreased the clearance rate of MTX in the joint cavity.  The max. plasma concns. of MTX in rats injected with free MTX were threefold higher than that of the groups injected with MTX hydrogels.  These results suggest that the intra-articular delivery of the PEP hydrogels may be a viable strategy for the controlled release of drugs for treating arthritis diseases. © 2011 Wiley Periodicals, Inc.  J Appl Polym Sci, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhmI8KPlLs5LVg90H21EOLACvtfcHk0lgIQkATtxSNJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntlKgs7s%253D&md5=20bbedd6eac3f7d4096d44dc78c63550</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fapp.34332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fapp.34332%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DB.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DG.%26atitle%3DInjectable%2520Thermosensitive%2520Hydrogels%2520for%2520Intra-Articular%2520Delivery%2520of%2520Methotrexate%26jtitle%3DJ.%2520Appl.%2520Polym.%2520Sci.%26date%3D2011%26volume%3D122%26spage%3D2139%26epage%3D2145%26doi%3D10.1002%2Fapp.34332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kratz, F.</span></span> <span> </span><span class="NLM_article-title">Albumin as a Drug Carrier: Design of Prodrugs, Drug Conjugates and Nanoparticles</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2008.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.jconrel.2008.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=18582981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVensLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2008&pages=171-183&issue=3&author=F.+Kratz&title=Albumin+as+a+Drug+Carrier%3A+Design+of+Prodrugs%2C+Drug+Conjugates+and+Nanoparticles&doi=10.1016%2Fj.jconrel.2008.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles</span></div><div class="casAuthors">Kratz, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-183</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Albumin is playing an increasing role as a drug carrier in the clin. setting.  Principally, three drug delivery technologies can be distinguished: coupling of low-mol. wt. drugs to exogenous or endogenous albumin, conjugation with bioactive proteins and encapsulation of drugs into albumin nanoparticles.  The accumulation of albumin in solid tumors forms the rationale for developing albumin-based drug delivery systems for tumor targeting.  Clin., a methotrexate-albumin conjugate, an albumin-binding prodrug of doxorubicin, i.e. the (6-maleimido)caproylhydrazone deriv. of doxorubicin (DOXO-EMCH), and an albumin paclitaxel nanoparticle (Abraxane) have been evaluated clin.  Abraxane has been approved for treating metastatic breast cancer.  An alternative strategy is to bind a therapeutic peptide or protein covalently or phys. to albumin to enhance its stability and half-life.  This approach has been applied to peptides with antinociceptive, antidiabetes, antitumor or antiviral activity: Levemir, a myristic acid deriv. of insulin that binds to the fatty acid binding sites of circulating albumin, has been approved for the treatment of diabetes.  Furthermore, Albuferon, a fusion protein of albumin and interferon, is currently being assessed in phase III clin. trials for the treatment of hepatitis C and could become an alternative to pegylated interferon.  This review gives an account of the different drug delivery systems which make use of albumin as a drug carrier with a focus on those systems that have reached an advanced stage of preclin. evaluation or that have entered clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPSwOkIFOBr7Vg90H21EOLACvtfcHk0lgIQkATtxSNJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVensLvP&md5=32729be05d7227de8b6a5c8d8d890e38</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2008.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2008.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DKratz%26aufirst%3DF.%26atitle%3DAlbumin%2520as%2520a%2520Drug%2520Carrier%253A%2520Design%2520of%2520Prodrugs%252C%2520Drug%2520Conjugates%2520and%2520Nanoparticles%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2008%26volume%3D132%26issue%3D3%26spage%3D171%26epage%3D183%26doi%3D10.1016%2Fj.jconrel.2008.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mittal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, A. B.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species in Inflammation and Tissue Injury</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1126</span>– <span class="NLM_lpage">1167</span>, <span class="refDoi"> DOI: 10.1089/ars.2012.5149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1089%2Fars.2012.5149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=23991888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXit12qtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1126-1167&issue=7&author=M.+Mittalauthor=M.+R.+Siddiquiauthor=K.+Tranauthor=S.+P.+Reddyauthor=A.+B.+Malik&title=Reactive+Oxygen+Species+in+Inflammation+and+Tissue+Injury&doi=10.1089%2Fars.2012.5149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species in Inflammation and Tissue Injury</span></div><div class="casAuthors">Mittal, Manish; Siddiqui, Mohammad Rizwan; Tran, Khiem; Reddy, Sekhar P.; Malik, Asrar B.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1126-1167</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are key signaling mols. that play an important role in the progression of inflammatory disorders.  An enhanced ROS generation by polymorphonuclear neutrophils (PMNs) at the site of inflammation causes endothelial dysfunction and tissue injury.  The vascular endothelium plays an important role in passage of macromols. and inflammatory cells from the blood to tissue.  Under the inflammatory conditions, oxidative stress produced by PMNs leads to the opening of inter-endothelial junctions and promotes the migration of inflammatory cells across the endothelial barrier.  The migrated inflammatory cells not only help in the clearance of pathogens and foreign particles but also lead to tissue injury.  The current review compiles the past and current research in the area of inflammation with particular emphasis on oxidative stress-mediated signaling mechanisms that are involved in inflammation and tissue injury.  Antioxid. Redox Signal. 20, 1126-1167.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot8O-h45Zi6LVg90H21EOLACvtfcHk0ljfBq-rCt1gPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXit12qtbg%253D&md5=324f08a1e66b88576526690cb6583cf5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.5149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.5149%26sid%3Dliteratum%253Aachs%26aulast%3DMittal%26aufirst%3DM.%26aulast%3DSiddiqui%26aufirst%3DM.%2BR.%26aulast%3DTran%26aufirst%3DK.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMalik%26aufirst%3DA.%2BB.%26atitle%3DReactive%2520Oxygen%2520Species%2520in%2520Inflammation%2520and%2520Tissue%2520Injury%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D20%26issue%3D7%26spage%3D1126%26epage%3D1167%26doi%3D10.1089%2Fars.2012.5149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchon, C. a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Gabalawy, H. S.</span></span> <span> </span><span class="NLM_article-title">Oxidation in Rheumatoid Arthritis</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1186/ar1447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1186%2Far1447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=15535839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADC%252BD2crmtlyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=265-278&author=C.+a.+Hitchonauthor=H.+S.+El-Gabalawy&title=Oxidation+in+Rheumatoid+Arthritis&doi=10.1186%2Far1447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation in rheumatoid arthritis</span></div><div class="casAuthors">Hitchon Carol A; El-Gabalawy Hani S</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis research & therapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">265-78</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxygen metabolism has an important role in the pathogenesis of rheumatoid arthritis.  Reactive oxygen species (ROS) produced in the course of cellular oxidative phosphorylation, and by activated phagocytic cells during oxidative bursts, exceed the physiological buffering capacity and result in oxidative stress.  The excessive production of ROS can damage protein, lipids, nucleic acids, and matrix components.  They also serve as important intracellular signaling molecules that amplify the synovial inflammatory-proliferative response.  Repetitive cycles of hypoxia and reoxygenation associated with changes in synovial perfusion are postulated to activate hypoxia-inducible factor-1alpha and nuclear factor-kappaB, two key transcription factors that are regulated by changes in cellular oxygenation and cytokine stimulation, and that in turn orchestrate the expression of a spectrum of genes critical to the persistence of synovitis.  An understanding of the complex interactions involved in these pathways might allow the development of novel therapeutic strategies for rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnXVVIVHWpuVZoq0fPSOTvfW6udTcc2eYaHBcvWbkGhLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crmtlyhtQ%253D%253D&md5=4cfc31bf2730eb127f7f1cca1d515609</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2Far1447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far1447%26sid%3Dliteratum%253Aachs%26aulast%3DHitchon%26aufirst%3DC.%2Ba.%26aulast%3DEl-Gabalawy%26aufirst%3DH.%2BS.%26atitle%3DOxidation%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2004%26volume%3D6%26spage%3D265%26epage%3D278%26doi%3D10.1186%2Far1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chockley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pase, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieschke, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabher, C.</span></span> <span> </span><span class="NLM_article-title">Hydrogen Peroxide in Inflammation: Messenger, Guide, and Assassin</span>. <i>Adv. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">541471</span>, <span class="refDoi"> DOI: 10.1155/2012/541471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1155%2F2012%2F541471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=22737171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADC%252BC38jltF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=541471&author=C.+Wittmannauthor=P.+Chockleyauthor=S.+K.+Singhauthor=L.+Paseauthor=G.+J.+Lieschkeauthor=C.+Grabher&title=Hydrogen+Peroxide+in+Inflammation%3A+Messenger%2C+Guide%2C+and+Assassin&doi=10.1155%2F2012%2F541471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen peroxide in inflammation: messenger, guide, and assassin</span></div><div class="casAuthors">Wittmann C; Chockley P; Singh S K; Pase L; Lieschke G J; Grabher C</div><div class="citationInfo"><span class="NLM_cas:title">Advances in hematology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">541471</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Starting as a model for developmental genetics, embryology, and organogenesis, the zebrafish has become increasingly popular as a model organism for numerous areas of biology and biomedicine over the last decades.  Within haematology, this includes studies on blood cell development and function and the intricate regulatory mechanisms within vertebrate immunity.  Here, we review recent studies on the immediate mechanisms mounting an inflammatory response by in vivo analyses using the zebrafish.  These recently revealed novel roles of the reactive oxygen species hydrogen peroxide that have changed our view on the initiation of a granulocytic inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXsaLw17-WInO4gDb7JggCfW6udTcc2eYaHBcvWbkGhLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jltF2qtw%253D%253D&md5=98c239957753c47609ab32d7717e9c72</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1155%2F2012%2F541471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F541471%26sid%3Dliteratum%253Aachs%26aulast%3DWittmann%26aufirst%3DC.%26aulast%3DChockley%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DPase%26aufirst%3DL.%26aulast%3DLieschke%26aufirst%3DG.%2BJ.%26aulast%3DGrabher%26aufirst%3DC.%26atitle%3DHydrogen%2520Peroxide%2520in%2520Inflammation%253A%2520Messenger%252C%2520Guide%252C%2520and%2520Assassin%26jtitle%3DAdv.%2520Hematol.%26date%3D2012%26volume%3D2012%26spage%3D541471%26doi%3D10.1155%2F2012%2F541471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalczyk, S.</span></span> <span> </span><span class="NLM_article-title">A Study of Free Radical Chemistry: Their Role and Pathophysiological Significance</span>. <i>Acta Biochim. Pol</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=1-16&issue=1&author=M.+Gutowskiauthor=S.+Kowalczyk&title=A+Study+of+Free+Radical+Chemistry%3A+Their+Role+and+Pathophysiological+Significance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGutowski%26aufirst%3DM.%26aulast%3DKowalczyk%26aufirst%3DS.%26atitle%3DA%2520Study%2520of%2520Free%2520Radical%2520Chemistry%253A%2520Their%2520Role%2520and%2520Pathophysiological%2520Significance%26jtitle%3DActa%2520Biochim.%2520Pol%26date%3D2013%26volume%3D60%26issue%3D1%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wruck, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragoulis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurzynski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandenburg, L.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassenpflug, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitag-Wolf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varoga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pufe, T.</span></span> <span> </span><span class="NLM_article-title">Role of Oxidative Stress in Rheumatoid Arthritis: Insights from the Nrf2-Knockout Mice</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">850</span>, <span class="refDoi"> DOI: 10.1136/ard.2010.132720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1136%2Fard.2010.132720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=21173018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1egsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=844-850&issue=5&author=C.+J.+Wruckauthor=A.+Fragoulisauthor=A.+Gurzynskiauthor=L.-O.+Brandenburgauthor=Y.+W.+Kanauthor=K.+Chanauthor=J.+Hassenpflugauthor=S.+Freitag-Wolfauthor=D.+Varogaauthor=S.+Lipprossauthor=T.+Pufe&title=Role+of+Oxidative+Stress+in+Rheumatoid+Arthritis%3A+Insights+from+the+Nrf2-Knockout+Mice&doi=10.1136%2Fard.2010.132720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice</span></div><div class="casAuthors">Wruck, Christoph Jan; Fragoulis, Athanassios; Gurzynski, Agata; Brandenburg, Lars-Ove; Kan, Yuet Wai; Chan, Kaimin; Hassenpflug, Joachim; Freitag-Wolf, Sandra; Varoga, Deike; Lippross, Sebastian; Pufe, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">844-850</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Increasing evidence suggests that oxidative stress may play a key role in joint destruction due to rheumatoid arthritis (RA).  The aim of this study was to elucidate the role of nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor that maintains the cellular defense against oxidative stress, in RA.  The activation status of Nrf2 was assessed in synovial tissue from patients with RA using immunohistochem.  Antibody-induced arthritis (AIA) was induced in Nrf2-knockout and Nrf2-wild-type control mice.  The severity of cartilage destruction was evaluated using a damage score.  The extent of oxidative stress, the activation state of Nrf2 and the expression level of Nrf2 target genes were analyzed by immunhistol. staining.  The expression of vascular endothelial growth factor (VEGF)-A was examd. on mRNA and protein using the Luminex technique.  A Xenogen imaging system was used to measure Nrf2 activity in an antioxidant response element-luciferase transgenic mouse during AIA.  Results Nrf2 was activated in the joints of arthritic mice and of patients with RA.  Nrf2-knockout mice had more severe cartilage injuries and more oxidative damage, and the expression of Nrf2 target genes was enhanced in Nrf2-wild-type but not in knockout mice during AIA.  Both VEGF-A mRNA and protein expression was upregulated in Nrf2-knockout mice during AIA.  An unexpected finding was the no. of spontaneously fractured bones in Nrf2-knockout mice with AIA.  These results provide strong evidence that oxidative stress is significantly involved in cartilage degrdn. in exptl. arthritis, and indicate that the presence of a functional Nrf2 gene is a major requirement for limiting cartilage destruction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVA53-Yyb-qLVg90H21EOLACvtfcHk0ljvkWY2g-VlXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1egsbk%253D&md5=a68710cc4197ac967802fd1d0631aef2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1136%2Fard.2010.132720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2010.132720%26sid%3Dliteratum%253Aachs%26aulast%3DWruck%26aufirst%3DC.%2BJ.%26aulast%3DFragoulis%26aufirst%3DA.%26aulast%3DGurzynski%26aufirst%3DA.%26aulast%3DBrandenburg%26aufirst%3DL.-O.%26aulast%3DKan%26aufirst%3DY.%2BW.%26aulast%3DChan%26aufirst%3DK.%26aulast%3DHassenpflug%26aufirst%3DJ.%26aulast%3DFreitag-Wolf%26aufirst%3DS.%26aulast%3DVaroga%26aufirst%3DD.%26aulast%3DLippross%26aufirst%3DS.%26aulast%3DPufe%26aufirst%3DT.%26atitle%3DRole%2520of%2520Oxidative%2520Stress%2520in%2520Rheumatoid%2520Arthritis%253A%2520Insights%2520from%2520the%2520Nrf2-Knockout%2520Mice%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2011%26volume%3D70%26issue%3D5%26spage%3D844%26epage%3D850%26doi%3D10.1136%2Fard.2010.132720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinstain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savariar, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsen, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, R. Y.</span></span> <span> </span><span class="NLM_article-title">Vivo Targeting of Hydrogen Peroxide by Activatable Cell- Penetrating Peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1021/ja411547j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja411547j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=874-877&author=R.+Weinstainauthor=E.+N.+Savariarauthor=C.+N.+Felsenauthor=R.+Y.+Tsien&title=Vivo+Targeting+of+Hydrogen+Peroxide+by+Activatable+Cell-+Penetrating+Peptides&doi=10.1021%2Fja411547j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja411547j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja411547j%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstain%26aufirst%3DR.%26aulast%3DSavariar%26aufirst%3DE.%2BN.%26aulast%3DFelsen%26aufirst%3DC.%2BN.%26aulast%3DTsien%26aufirst%3DR.%2BY.%26atitle%3DVivo%2520Targeting%2520of%2520Hydrogen%2520Peroxide%2520by%2520Activatable%2520Cell-%2520Penetrating%2520Peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D874%26epage%3D877%26doi%3D10.1021%2Fja411547j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, S.</span></span> <span> </span><span class="NLM_article-title">Sensitive and Nonenzymatic Measurement of Hydrogen Peroxide in Biological Systems</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1016/S0891-5849(00)00261-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2FS0891-5849%2800%2900261-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=11020662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntVWgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=410-415&issue=5&author=S.+Mueller&title=Sensitive+and+Nonenzymatic+Measurement+of+Hydrogen+Peroxide+in+Biological+Systems&doi=10.1016%2FS0891-5849%2800%2900261-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitive and nonenzymatic measurement of hydrogen peroxide in biological systems</span></div><div class="casAuthors">Mueller, S.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">410-415</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The increasing demand in detecting H2O2 under various exptl. conditions is only partly fulfilled by most conventional peroxidase-based assays.  This article describes a sensitive and nonenzymic H2O2 assay that is based on the chemiluminescence reaction of luminol with hypochlorite.  It allows the detn. of H2O2 down to nanomolar concns.  Actual H2O2 concns. rather than a turnover of H2O2 can be detd. in monolayer cultures, perfusates, suspensions of intact cells, organelles, and crude homogenates.  One of the strengths of this assay is that it may be used to assess fast enzyme kinetics (catalase, glutathione peroxidase, oxidases) at very low H2O2 concns.  Its use together with a glucose oxidase/catalase system appears to be a powerful tool in studying signal functions of H2O2 in various biol. systems on a quant. basis.  Several applications are discussed in detail to demonstrate the tech. requirements and anal. potentials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmnQoMUuXKRrVg90H21EOLACvtfcHk0ljvkWY2g-VlXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntVWgsLs%253D&md5=70e0055f17eefdd6ae26f87b9aa0bca1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2800%2900261-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252800%252900261-6%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DS.%26atitle%3DSensitive%2520and%2520Nonenzymatic%2520Measurement%2520of%2520Hydrogen%2520Peroxide%2520in%2520Biological%2520Systems%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2000%26volume%3D29%26issue%3D5%26spage%3D410%26epage%3D415%26doi%3D10.1016%2FS0891-5849%2800%2900261-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boveris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bustamante, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdez, L.</span></span> <span> </span><span class="NLM_article-title">Measurement of Superoxide Radical and Hydrogen Peroxide Production in Isolated Cells and Subcellular Organelles</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">280</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(02)49342-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2FS0076-6879%2802%2949342-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=11912917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFajtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2002&pages=280-287&author=A.+Boverisauthor=S.+Alvarezauthor=J.+Bustamanteauthor=L.+Valdez&title=Measurement+of+Superoxide+Radical+and+Hydrogen+Peroxide+Production+in+Isolated+Cells+and+Subcellular+Organelles&doi=10.1016%2FS0076-6879%2802%2949342-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of superoxide radical and hydrogen peroxide production in isolated cells and subcellular organelles</span></div><div class="casAuthors">Boveris, Alberto; Alvarez, Silvia; Bustamante, Juanita; Valdez, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">Superoxide Dismutase</span>),
    <span class="NLM_cas:pages">280-287</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review.  The kinetics were investigated of H2O2 release by human mononuclear cells nonstimulated and stimulated by phorbol myristate acetate (PMA) and of H2O2 release from thymocytes.  The superoxide dismutase effect was also studied.  Nonstimulated mononuclear cells reached an equil. with external H2O2 at about 0.25 μM H2O2.  After stimulation by PMA the level was increased to about 0.80 μM H2O2.  The basal situation of thymocytes indicated an intracellular concn. of about 35 nM H2O2, which was increased to about 45 and 75 nM H2O2 after apoptosis stimulation by methylprednisole and thapsigargin, resp.  The addn. of superoxide dismutase to the reaction medium usually had no effect on cells other than the phagocytic cells, which release significant amts. of O2- to the suspending medium.  A review is added on quantitation of O2- and H2O2 prodn. and steady-state concns.  (c) 2002 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq9d_eJWIbG7Vg90H21EOLACvtfcHk0lhCdRO7Um6QbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFajtbk%253D&md5=f0ba3b4fc1260a794b80209a621ba1e2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2802%2949342-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252802%252949342-1%26sid%3Dliteratum%253Aachs%26aulast%3DBoveris%26aufirst%3DA.%26aulast%3DAlvarez%26aufirst%3DS.%26aulast%3DBustamante%26aufirst%3DJ.%26aulast%3DValdez%26aufirst%3DL.%26atitle%3DMeasurement%2520of%2520Superoxide%2520Radical%2520and%2520Hydrogen%2520Peroxide%2520Production%2520in%2520Isolated%2520Cells%2520and%2520Subcellular%2520Organelles%26jtitle%3DMethods%2520Enzymol.%26date%3D2002%26volume%3D349%26spage%3D280%26epage%3D287%26doi%3D10.1016%2FS0076-6879%2802%2949342-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stones, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span> <span> </span><span class="NLM_article-title">Hydrogen Peroxide: A Signalling Messenger</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1089/ars.2006.8.243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1089%2Fars.2006.8.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=16677071" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=243-270&issue=3%E2%80%934&author=J.+R.+Stonesauthor=S.+Yang&title=Hydrogen+Peroxide%3A+A+Signalling+Messenger&doi=10.1089%2Fars.2006.8.243"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1089%2Fars.2006.8.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2006.8.243%26sid%3Dliteratum%253Aachs%26aulast%3DStones%26aufirst%3DJ.%2BR.%26aulast%3DYang%26aufirst%3DS.%26atitle%3DHydrogen%2520Peroxide%253A%2520A%2520Signalling%2520Messenger%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2006%26volume%3D8%26issue%3D3%25E2%2580%25934%26spage%3D243%26epage%3D270%26doi%3D10.1089%2Fars.2006.8.243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Induced and Self-Monitored Intrinsic Apoptosis by Antitumor Theranostic Prodrug: In Vivo Imaging and Precise Cancer Treatment</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">17836</span>– <span class="NLM_lpage">17843</span>, <span class="refDoi"> DOI: 10.1021/ja510421q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja510421q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOjsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=17836-17843&issue=51&author=R.+Kumarauthor=J.+Hanauthor=H.+J.+Limauthor=W.+X.+Renauthor=J.+Y.+Limauthor=J.+H.+Kimauthor=J.+S.+Kim&title=Mitochondrial+Induced+and+Self-Monitored+Intrinsic+Apoptosis+by+Antitumor+Theranostic+Prodrug%3A+In+Vivo+Imaging+and+Precise+Cancer+Treatment&doi=10.1021%2Fja510421q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Induced and Self-Monitored Intrinsic Apoptosis by Antitumor Theranostic Prodrug: In Vivo Imaging and Precise Cancer Treatment</span></div><div class="casAuthors">Kumar, Rajesh; Han, Jiyou; Lim, Hee-Joung; Ren, Wen Xiu; Lim, Ja-Yun; Kim, Jong-Hoon; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">17836-17843</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of apoptosis, the cell death machinery, in tumor cells by organelle-specific delivery of antitumor theranostic agent is the utmost challenge in cancer therapy.  Herein, we developed a highly efficient mitochondria-targeting antitumor theranostic prodrug 7 that contained two mols. of drug 5'-deoxy-5-fluorouridine and an apoptotic marker ethidium for self-monitoring intrinsic (mitochondrial) apoptosis after its activation in tumor cells.  Theranostic 7 was activated by endogenously produced mitochondrial-overexpressed H2O2 and released drug 5'-deoxy-5-fluorouridine and apoptotic marker ethidium to the tumor cells.  The in vitro and in vivo drug release was monitored by observing the fluorescence changes of ethidium.  Theranostic 7 exhibited an enhanced cytotoxicity over com. 5-fluorouracil (an active drug of 5'-deoxy-5-fluorouridine) leading to intrinsic apoptosis monitored by in situ generated ethidium.  Enhanced expression of mitochondria-mediated apoptotic genes (NOXA, PUMA, BID, BAX, and BAK), Cyt C, Caspase-3 and -9, and cell surface death receptors was obsd. after theranostic 7 activation in tumor cells.  In vivo and ex vivo xenografts revealed that theranostic 7 significantly inhibited tumor progression and cured the tumor-bearing mice.  Such organelle-specific theranostic strategies have great potential for the early diagnosis and precise treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxDp1xuNvfLVg90H21EOLACvtfcHk0lhCdRO7Um6QbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOjsL3O&md5=0e80b2f99a1054f9da8570c3ceb84783</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fja510421q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja510421q%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DH.%2BJ.%26aulast%3DRen%26aufirst%3DW.%2BX.%26aulast%3DLim%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DMitochondrial%2520Induced%2520and%2520Self-Monitored%2520Intrinsic%2520Apoptosis%2520by%2520Antitumor%2520Theranostic%2520Prodrug%253A%2520In%2520Vivo%2520Imaging%2520and%2520Precise%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26issue%3D51%26spage%3D17836%26epage%3D17843%26doi%3D10.1021%2Fja510421q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monserrat, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Exploring Hydrogen Peroxide Responsive Thiazolidinone-Based Prodrugs</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">7116</span>– <span class="NLM_lpage">7119</span>, <span class="refDoi"> DOI: 10.1039/C4CC09921D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1039%2FC4CC09921D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=7116-7119&issue=33&author=C.+Perezauthor=J.-P.+Monserratauthor=Y.+Chenauthor=S.+M.+Cohen&title=Exploring+Hydrogen+Peroxide+Responsive+Thiazolidinone-Based+Prodrugs&doi=10.1039%2FC4CC09921D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2FC4CC09921D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CC09921D%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMonserrat%26aufirst%3DJ.-P.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DExploring%2520Hydrogen%2520Peroxide%2520Responsive%2520Thiazolidinone-Based%2520Prodrugs%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26issue%3D33%26spage%3D7116%26epage%3D7119%26doi%3D10.1039%2FC4CC09921D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V.</span></span> <span> </span><span class="NLM_article-title">ROS-Activated Anticancer Prodrugs: A New Strategy for Tumor-Specific Damage</span>. <i>Ther. Delivery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">833</span>, <span class="refDoi"> DOI: 10.4155/tde.12.61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.4155%2Ftde.12.61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=22900465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWjsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=823-833&issue=7&author=X.+Pengauthor=V.+Gandhi&title=ROS-Activated+Anticancer+Prodrugs%3A+A+New+Strategy+for+Tumor-Specific+Damage&doi=10.4155%2Ftde.12.61"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage</span></div><div class="casAuthors">Peng, Xiaohua; Gandhi, Varsha</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Delivery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">823-833</span>CODEN:
                <span class="NLM_cas:coden">TDHEA7</span>;
        ISSN:<span class="NLM_cas:issn">2041-5990</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Targeting tumor cells is an important strategy to improve the selectivity of cancer therapies.  With the advanced studies in cancer biol., we know that cancer cells are usually under increased oxidative stress.  The high level of reactive oxygen species in cancer cells has been exploited for developing novel therapeutic strategies to preferentially kill cancer cells.  Our group, amongst others, have used boronic acids/esters as triggers for developing ROS-activated anticancer prodrugs that target cancer cells.  The selectivity was achieved by combining a specific reaction between boronates and H2O2 with the efficient masking of drug toxicity in the prodrug via boronates.  Prodrugs activated via ferrocene-mediated oxidn. have also been developed to improve the selectivity of anticancer drugs.  We describe how the strategies of ROS-activation can be used for further development of new ROS-targeting prodrugs, eventually leading to novel approaches and/or combined technol. for more efficient and selective treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6WcQA9Z5tObVg90H21EOLACvtfcHk0lhCdRO7Um6QbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWjsrnN&md5=48b7a3af2a98fff0793cbb98a4026c0e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.4155%2Ftde.12.61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ftde.12.61%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DGandhi%26aufirst%3DV.%26atitle%3DROS-Activated%2520Anticancer%2520Prodrugs%253A%2520A%2520New%2520Strategy%2520for%2520Tumor-Specific%2520Damage%26jtitle%3DTher.%2520Delivery%26date%3D2012%26volume%3D3%26issue%3D7%26spage%3D823%26epage%3D833%26doi%3D10.4155%2Ftde.12.61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzenell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jentzsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veldwijk, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1021/jm2014937</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ers7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=924-934&author=H.+Hagenauthor=P.+Marzenellauthor=E.+Jentzschauthor=F.+Wenzauthor=M.+R.+Veldwijkauthor=A.+Mokhir&title=Aminoferrocene-Based+Prodrugs+Activated+by+Reactive+Oxygen+Species&doi=10.1021%2Fjm2014937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species</span></div><div class="casAuthors">Hagen, Helen; Marzenell, Paul; Jentzsch, Elmar; Wenz, Frederik; Veldwijk, Marlon R.; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">924-934</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cancer cells generally generate higher amts. of reactive oxygen species than normal cells.  On the basis of this difference, prodrugs have been developed (e.g., hydroxyferrocifen), which remain inactive in normal cells, but become activated in cancer cells.  In this work we describe novel aminoferrocene-based prodrugs, which, in contrast to hydroxyferrocifen, after activation form not only quinone methides (QMs), but also catalysts (iron or ferrocenium ions).  The released products act in a concerted fashion.  In particular, QMs alkylate glutathione, thereby inhibiting the antioxidative system of the cell, whereas the iron species induce catalytic generation of hydroxyl radicals.  Since the catalysts are formed as products of the activation reaction, it proceeds autocatalytically.  The most potent prodrug described here is toxic toward cancer cells (human promyelocytic leukemia (HL-60), IC50 = 9 μM, and human glioblastoma-astrocytoma (U373), IC50 = 25 μM), but not toxic (up to 100 μM) toward representative nonmalignant cells (fibroblasts).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXZLxLfss0RrVg90H21EOLACvtfcHk0ljJZ8wJQ9OETQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ers7bI&md5=28894e8a8006c8b0ef91455aee76139d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm2014937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014937%26sid%3Dliteratum%253Aachs%26aulast%3DHagen%26aufirst%3DH.%26aulast%3DMarzenell%26aufirst%3DP.%26aulast%3DJentzsch%26aufirst%3DE.%26aulast%3DWenz%26aufirst%3DF.%26aulast%3DVeldwijk%26aufirst%3DM.%2BR.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DAminoferrocene-Based%2520Prodrugs%2520Activated%2520by%2520Reactive%2520Oxygen%2520Species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D924%26epage%3D934%26doi%3D10.1021%2Fjm2014937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">Hydrogen Peroxide Inducible DNA Cross-Linking Agents: Targeted Anticancer Prodrugs</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">19278</span>, <span class="refDoi"> DOI: 10.1021/ja2073824</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja2073824" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyqsLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=19278&author=Y.+Kuangauthor=K.+Balakrishnanauthor=V.+Gandhiauthor=X.+Peng&title=Hydrogen+Peroxide+Inducible+DNA+Cross-Linking+Agents%3A+Targeted+Anticancer+Prodrugs&doi=10.1021%2Fja2073824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen Peroxide Inducible DNA Cross-Linking Agents: Targeted Anticancer Prodrugs</span></div><div class="casAuthors">Kuang, Yunyan; Balakrishnan, Kumudha; Gandhi, Varsha; Peng, Xiaohua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">19278-19281</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The major concern for anticancer chemotherapeutic agents is the host toxicity.  The development of anticancer prodrugs targeting the unique biochem. alterations in cancer cells is an attractive approach to achieve therapeutic activity and selectivity.  We designed and synthesized a new type of nitrogen mustard prodrug that can be activated by high level of reactive oxygen species (ROS) found in cancer cells to release the active chemotherapy agent.  The activation mechanism was detd. by NMR anal.  The activity and selectivity of these prodrugs toward ROS was detd. by measuring DNA interstrand cross-links and/or DNA alkylations.  These compds. showed 60-90% inhibition toward various cancer cells, while normal lymphocytes were not affected.  To the best of our knowledge, this is the first example of H2O2-activated anticancer prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY5EVvl5gaabVg90H21EOLACvtfcHk0ljJZ8wJQ9OETQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyqsLvE&md5=d907a75fa0e9c33185187cdfb85fda29</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fja2073824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja2073824%26sid%3Dliteratum%253Aachs%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DBalakrishnan%26aufirst%3DK.%26aulast%3DGandhi%26aufirst%3DV.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DHydrogen%2520Peroxide%2520Inducible%2520DNA%2520Cross-Linking%2520Agents%253A%2520Targeted%2520Anticancer%2520Prodrugs%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D19278%26doi%3D10.1021%2Fja2073824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species (ROS) Inducible DNA Cross-Linking Agents and Their Effect on Cancer Cells and Normal Lymphocytes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4498</span>– <span class="NLM_lpage">4510</span>, <span class="refDoi"> DOI: 10.1021/jm401349g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401349g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4498-4510&issue=11&author=W.+Chenauthor=K.+Balakrishnanauthor=Y.+Kuangauthor=Y.+Hanauthor=M.+Fuauthor=V.+Gandhiauthor=X.+Peng&title=Reactive+Oxygen+Species+%28ROS%29+Inducible+DNA+Cross-Linking+Agents+and+Their+Effect+on+Cancer+Cells+and+Normal+Lymphocytes&doi=10.1021%2Fjm401349g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm401349g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401349g%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DBalakrishnan%26aufirst%3DK.%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DM.%26aulast%3DGandhi%26aufirst%3DV.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DReactive%2520Oxygen%2520Species%2520%2528ROS%2529%2520Inducible%2520DNA%2520Cross-Linking%2520Agents%2520and%2520Their%2520Effect%2520on%2520Cancer%2520Cells%2520and%2520Normal%2520Lymphocytes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D11%26spage%3D4498%26epage%3D4510%26doi%3D10.1021%2Fjm401349g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major Jourden, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negoescu, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Activation of Sulfonate Ester Based Matrix Metalloproteinase Proinhibitors by Hydrogen Peroxide</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1007/s00775-010-0727-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1007%2Fs00775-010-0727-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=21049301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOhtL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=313-323&issue=2&author=K.+B.+Danielauthor=J.+L.+Major+Jourdenauthor=K.+E.+Negoescuauthor=S.+M.+Cohen&title=Activation+of+Sulfonate+Ester+Based+Matrix+Metalloproteinase+Proinhibitors+by+Hydrogen+Peroxide&doi=10.1007%2Fs00775-010-0727-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of sulfonate ester based matrix metalloproteinase proinhibitors by hydrogen peroxide</span></div><div class="casAuthors">Daniel, Kevin B.; Major Jourden, Jody L.; Negoescu, Kimberly E.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-323</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">This study details the development of matrix metalloproteinase inhibitor prodrugs (proMMPi) that are activated in the presence of reactive-oxygen species (ROS).  Conventional matrix metalloproteinase inhibitors (MMPi) utilize a zinc-binding group (ZBG) that chelates to the catalytic zinc(II) ion of matrix metalloproteinases (MMPs) to inhibit their activity.  To create ROS-sensitive prodrugs, sulfonate esters were used as a protecting group for the ZBG to block their metal binding ability.  Surprisingly, these sulfonate esters were found to be cleaved by H2O2 only when the ZBG contained an N-oxide donor atom moiety.  Sulfonate ester derivs. of full-length MMPi based on these ROS-triggerable systems were synthesized.  It was found that proMMPi with sulfonate ester protecting groups showed relatively high rates of cleavage in the presence of H2O2 to release the active MMPi.  In vitro MMP inhibition studies confirmed a significant increase in inhibitory activity of proMMPi upon addn. of H2O2, demonstrating the use of sulfonate esters to act as cleavable triggers for ROS-activated prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Svnx818k6LVg90H21EOLACvtfcHk0ljJZ8wJQ9OETQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOhtL%252FJ&md5=6ebedb9f348f3cc9828706c5a8c56f78</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2Fs00775-010-0727-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-010-0727-x%26sid%3Dliteratum%253Aachs%26aulast%3DDaniel%26aufirst%3DK.%2BB.%26aulast%3DMajor%2BJourden%26aufirst%3DJ.%2BL.%26aulast%3DNegoescu%26aufirst%3DK.%2BE.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DActivation%2520of%2520Sulfonate%2520Ester%2520Based%2520Matrix%2520Metalloproteinase%2520Proinhibitors%2520by%2520Hydrogen%2520Peroxide%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2011%26volume%3D16%26issue%3D2%26spage%3D313%26epage%3D323%26doi%3D10.1007%2Fs00775-010-0727-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vadukoot, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulsalam, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunderlich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullen, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landero-Figueroa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulloy, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merino, E. J.</span></span> <span> </span><span class="NLM_article-title">Design of a Hydrogen Peroxide-Activatable Agent That Specifically Targets Cancer Cells</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">6885</span>– <span class="NLM_lpage">6892</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.bmc.2014.10.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=6885-6892&issue=24&author=A.+K.+Vadukootauthor=S.+F.+Abdulsalamauthor=M.+Wunderlichauthor=E.+D.+Pullenauthor=J.+Landero-Figueroaauthor=J.+C.+Mulloyauthor=E.+J.+Merino&title=Design+of+a+Hydrogen+Peroxide-Activatable+Agent+That+Specifically+Targets+Cancer+Cells&doi=10.1016%2Fj.bmc.2014.10.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DVadukoot%26aufirst%3DA.%2BK.%26aulast%3DAbdulsalam%26aufirst%3DS.%2BF.%26aulast%3DWunderlich%26aufirst%3DM.%26aulast%3DPullen%26aufirst%3DE.%2BD.%26aulast%3DLandero-Figueroa%26aufirst%3DJ.%26aulast%3DMulloy%26aufirst%3DJ.%2BC.%26aulast%3DMerino%26aufirst%3DE.%2BJ.%26atitle%3DDesign%2520of%2520a%2520Hydrogen%2520Peroxide-Activatable%2520Agent%2520That%2520Specifically%2520Targets%2520Cancer%2520Cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26issue%3D24%26spage%3D6885%26epage%3D6892%26doi%3D10.1016%2Fj.bmc.2014.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deiters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floreancig, P. E.</span></span> <span> </span><span class="NLM_article-title">Alcohol, Aldehyde, and Ketone Liberation and Intracellular Cargo Release through Peroxide-Mediated-Boryl Ether Fragmentation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">13353</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b07890</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b07890" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=13353&author=R.+D.+Hannaauthor=Y.+Naroauthor=A.+Deitersauthor=P.+E.+Floreancig&title=Alcohol%2C+Aldehyde%2C+and+Ketone+Liberation+and+Intracellular+Cargo+Release+through+Peroxide-Mediated-Boryl+Ether+Fragmentation&doi=10.1021%2Fjacs.6b07890"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b07890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b07890%26sid%3Dliteratum%253Aachs%26aulast%3DHanna%26aufirst%3DR.%2BD.%26aulast%3DNaro%26aufirst%3DY.%26aulast%3DDeiters%26aufirst%3DA.%26aulast%3DFloreancig%26aufirst%3DP.%2BE.%26atitle%3DAlcohol%252C%2520Aldehyde%252C%2520and%2520Ketone%2520Liberation%2520and%2520Intracellular%2520Cargo%2520Release%2520through%2520Peroxide-Mediated-Boryl%2520Ether%2520Fragmentation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26spage%3D13353%26doi%3D10.1021%2Fjacs.6b07890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kralovec, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mammen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Methotrexate-Antibody Conjugates by Regiospecific Coupling and Assessment of Drug and Antitumor Activities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2426</span>– <span class="NLM_lpage">2431</span>, <span class="refDoi"> DOI: 10.1021/jm00131a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00131a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=2426-2431&issue=11&author=J.+Kralovecauthor=G.+Spencerauthor=A.+H.+Blairauthor=M.+Mammenauthor=M.+Singhauthor=T.+Ghose&title=Synthesis+of+Methotrexate-Antibody+Conjugates+by+Regiospecific+Coupling+and+Assessment+of+Drug+and+Antitumor+Activities&doi=10.1021%2Fjm00131a003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm00131a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00131a003%26sid%3Dliteratum%253Aachs%26aulast%3DKralovec%26aufirst%3DJ.%26aulast%3DSpencer%26aufirst%3DG.%26aulast%3DBlair%26aufirst%3DA.%2BH.%26aulast%3DMammen%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DGhose%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520Methotrexate-Antibody%2520Conjugates%2520by%2520Regiospecific%2520Coupling%2520and%2520Assessment%2520of%2520Drug%2520and%2520Antitumor%2520Activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26issue%3D11%26spage%3D2426%26epage%3D2431%26doi%3D10.1021%2Fjm00131a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosowsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freisheim, J. H.</span></span> <span> </span><span class="NLM_article-title">Analogues of Methotrexate and Aminopterin with (Gamma)-Methylene and (Gamma)-Cyano Substitution of the Glutamate Side Chain: Synthesis and in Vitro Biological Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1021/jm00105a031</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00105a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=203-208&issue=1&author=A.+Rosowskyauthor=H.+Baderauthor=J.+H.+Freisheim&title=Analogues+of+Methotrexate+and+Aminopterin+with+%28Gamma%29-Methylene+and+%28Gamma%29-Cyano+Substitution+of+the+Glutamate+Side+Chain%3A+Synthesis+and+in+Vitro+Biological+Activity&doi=10.1021%2Fjm00105a031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm00105a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00105a031%26sid%3Dliteratum%253Aachs%26aulast%3DRosowsky%26aufirst%3DA.%26aulast%3DBader%26aufirst%3DH.%26aulast%3DFreisheim%26aufirst%3DJ.%2BH.%26atitle%3DAnalogues%2520of%2520Methotrexate%2520and%2520Aminopterin%2520with%2520%2528Gamma%2529-Methylene%2520and%2520%2528Gamma%2529-Cyano%2520Substitution%2520of%2520the%2520Glutamate%2520Side%2520Chain%253A%2520Synthesis%2520and%2520in%2520Vitro%2520Biological%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26issue%3D1%26spage%3D203%26epage%3D208%26doi%3D10.1021%2Fjm00105a031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peralta-Yahya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornish, V. W.</span></span> <span> </span><span class="NLM_article-title">Optimized Design and Synthesis of Chemical Dimerizer Substrates for Detection of Glycosynthase Activity via Chemical Complementation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6940</span>– <span class="NLM_lpage">6953</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.06.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.bmc.2006.06.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6940-6953&issue=20&author=H.+Taoauthor=P.+Peralta-Yahyaauthor=H.+Linauthor=V.+W.+Cornish&title=Optimized+Design+and+Synthesis+of+Chemical+Dimerizer+Substrates+for+Detection+of+Glycosynthase+Activity+via+Chemical+Complementation&doi=10.1016%2Fj.bmc.2006.06.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.06.034%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DH.%26aulast%3DPeralta-Yahya%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DCornish%26aufirst%3DV.%2BW.%26atitle%3DOptimized%2520Design%2520and%2520Synthesis%2520of%2520Chemical%2520Dimerizer%2520Substrates%2520for%2520Detection%2520of%2520Glycosynthase%2520Activity%2520via%2520Chemical%2520Complementation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26issue%3D20%26spage%3D6940%26epage%3D6953%26doi%3D10.1016%2Fj.bmc.2006.06.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magnus, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, T.</span></span> <span> </span><span class="NLM_article-title">Studies on the Synthesis of the Antitumour Agent CC-1065. Synthesis of the Cyclopropapyrroloindole Portion</span>. <i>J. Chem. Soc., Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>0</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1039/c39840000389</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1039%2Fc39840000389" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=0&publication_year=1984&pages=389-390&author=P.+Magnusauthor=T.+Gallagher&title=Studies+on+the+Synthesis+of+the+Antitumour+Agent+CC-1065.+Synthesis+of+the+Cyclopropapyrroloindole+Portion&doi=10.1039%2Fc39840000389"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2Fc39840000389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39840000389%26sid%3Dliteratum%253Aachs%26aulast%3DMagnus%26aufirst%3DP.%26aulast%3DGallagher%26aufirst%3DT.%26atitle%3DStudies%2520on%2520the%2520Synthesis%2520of%2520the%2520Antitumour%2520Agent%2520CC-1065.%2520Synthesis%2520of%2520the%2520Cyclopropapyrroloindole%2520Portion%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1984%26volume%3D0%26spage%3D389%26epage%3D390%26doi%3D10.1039%2Fc39840000389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adlercreutz, P.</span></span> <span> </span><span class="NLM_article-title">Immobilisation and Application of Lipases in Organic Media</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6406</span>, <span class="refDoi"> DOI: 10.1039/c3cs35446f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1039%2Fc3cs35446f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=23403895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKhtrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=6406&issue=15&author=P.+Adlercreutz&title=Immobilisation+and+Application+of+Lipases+in+Organic+Media&doi=10.1039%2Fc3cs35446f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Immobilization and application of lipases in organic media</span></div><div class="casAuthors">Adlercreutz, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6406-6436</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Different methods of prepg. lipases for use in org. media are critically reviewed.  Solid lipase prepns. can be made by typical immobilization methods such as adsorption, entrapment, covalent coupling or crosslinking.  Immobilization is esp. attractive for lipases because, in addn. to the normal benefits of enzyme immobilization, it can also lead to a considerable increase in catalytic activity, probably caused by conformational changes in the lipase mols.  Activation can be achieved, for example, using hydrophobic support materials or surfactants during the immobilization procedure.  Surfactants can also be used to solubilize lipases in org. media via the formation of hydrophobic ion pairs, surfactant-coated lipase or reversed micelles.  Lipase prepn. methods are discussed with regard to potential lipase inactivation and activation effects, mass transfer limitations, lipase stability and other features important for applications.  The practical applications of lipases in org. media reviewed include ester synthesis, modification of triacylglycerols and phospholipids, fatty acid enrichment, enantiomer resoln., biodiesel prodn. and acylation of carbohydrates and bioactive compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVVlSwzYeI9LVg90H21EOLACvtfcHk0lja1oSL4m9K4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKhtrvN&md5=382e229ffac816d8c0ac718635aed28b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2Fc3cs35446f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cs35446f%26sid%3Dliteratum%253Aachs%26aulast%3DAdlercreutz%26aufirst%3DP.%26atitle%3DImmobilisation%2520and%2520Application%2520of%2520Lipases%2520in%2520Organic%2520Media%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2013%26volume%3D42%26issue%3D15%26spage%3D6406%26doi%3D10.1039%2Fc3cs35446f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temple, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shealy, Y. F.</span></span> <span> </span><span class="NLM_article-title">Analogs of Methotrexate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">862</span>– <span class="NLM_lpage">868</span>, <span class="refDoi"> DOI: 10.1021/jm00193a021</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00193a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1979&pages=862-868&issue=7&author=J.+A.+Montgomeryauthor=J.+R.+Piperauthor=R.+D.+Elliottauthor=C.+Templeauthor=E.+C.+Robertsauthor=Y.+F.+Shealy&title=Analogs+of+Methotrexate&doi=10.1021%2Fjm00193a021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm00193a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00193a021%26sid%3Dliteratum%253Aachs%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26aulast%3DPiper%26aufirst%3DJ.%2BR.%26aulast%3DElliott%26aufirst%3DR.%2BD.%26aulast%3DTemple%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DE.%2BC.%26aulast%3DShealy%26aufirst%3DY.%2BF.%26atitle%3DAnalogs%2520of%2520Methotrexate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1979%26volume%3D22%26issue%3D7%26spage%3D862%26epage%3D868%26doi%3D10.1021%2Fjm00193a021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E.-M.</span></span> <span> </span><span class="NLM_article-title">Oxidative Status of DBA/1J Mice with Type II Collagen-Induced Arthritis</span>. <i>J. Appl. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">472</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1002/jat.1228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1002%2Fjat.1228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=17299831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVGku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=472-481&issue=5&author=E.-M.+Choi&title=Oxidative+Status+of+DBA%2F1J+Mice+with+Type+II+Collagen-Induced+Arthritis&doi=10.1002%2Fjat.1228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative status of DBA/1J mice with type II collagen-induced arthritis</span></div><div class="casAuthors">Choi, Eun-Mi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">472-481</span>CODEN:
                <span class="NLM_cas:coden">JJATDK</span>;
        ISSN:<span class="NLM_cas:issn">0260-437X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The present study was undertaken to compare the oxidant statuses of mice with collagen-induced arthritis (CIA) and those of healthy mice.  For this purpose, serum oxidant products and arthritic profiles were measured in DBA/1J mice with CIA.  In addn., the levels of oxidn. products and the activities of antioxidant enzymes were detd. in liver, heart, spleen, kidney, lung and brain.  The induction of arthritis significantly increased anti-collagen antibody, rheumatoid factor, interleukin (IL)-1β, IL-6, protein carbonyl (PCO), advanced glycation end-products (AGE), malondialdehyde (MDA) and low d. lipoprotein (LDL)-cholesterol levels in serum (P < 0.05).  CIA in DBA/1J mice was assocd. with significantly lower activities of superoxide dismutase, glutathione peroxidase and glutathione reductase in spleen but higher levels of oxidn. products in spleen, kidney and liver than healthy normal mice (P < 0.05).  However, lower concns. of oxidized protein and higher activities of antioxidant enzymes were obsd. in CIA mouse lung and brain than in healthy normal mice.  Dexamethasone treated CIA mice had decreased arthritis-related indexes and showed: reduced PCO and AGE in spleen and brain, and increased PCO and AGE in heart, kidney and lung; increased MDA in heart, spleen, lung and brain; reduced SOD and GR activities in lung and brain; increased GPx activity in spleen and brain; and increased GR activity heart and spleen.  These data suggest that mice with CIA were more susceptible to oxidative damage in the spleen and liver under the chronic inflammatory conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolqRuZydh_l7Vg90H21EOLACvtfcHk0lja1oSL4m9K4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVGku70%253D&md5=c0b01339e1a9f22db502a6c10dd1a29c</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fjat.1228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjat.1228%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DE.-M.%26atitle%3DOxidative%2520Status%2520of%2520DBA%252F1J%2520Mice%2520with%2520Type%2520II%2520Collagen-Induced%2520Arthritis%26jtitle%3DJ.%2520Appl.%2520Toxicol.%26date%3D2007%26volume%3D27%26issue%3D5%26spage%3D472%26epage%3D481%26doi%3D10.1002%2Fjat.1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span> <span> </span><span class="NLM_article-title">Isorhamnetin Attenuates Collagen-Induced Arthritis via Modulating Cytokines and Oxidative Stress in Mice</span>. <i>Int. J. Clin. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">16536</span>– <span class="NLM_lpage">16542</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=26629181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlOmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=16536-16542&issue=9&author=X.+Wangauthor=W.+Zhong&title=Isorhamnetin+Attenuates+Collagen-Induced+Arthritis+via+Modulating+Cytokines+and+Oxidative+Stress+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Isorhamnetin attenuates collagen-induced arthritis via modulating cytokines and oxidative stress in mice</span></div><div class="casAuthors">Wang, Xuewen; Zhong, Wei</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">16536-16542</span>CODEN:
                <span class="NLM_cas:coden">IJCEFA</span>;
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Inflammation and oxidative stress were involved in the development and progression of rheumatoid arthritis (RA).  Isorhamnetin has anti-inflammatory and anti-oxidative activities, but its effects on RA have not been investigated.  In order to observe the possible therapeutic effects of isorhamnetin on RA, we established a collagen-induced arthritis mouse model and treated the animal with isorhamnetin for 3 wk.  Besides, fibroblast-like synoviocytes (FLS) were treated with lipopolysaccharide (LPS) and isorhamnetin.  The severity of arthritis was assessed by arthritis score, joint destruction score and inflammation score.  Levels of cytokines TNF-α, IL-1β, IL-6, IL-17A, IL-17F, IL-10 and IL-35 in the joint tissue homogenate and cell culture medium as well as anti-type II collagen antibody in serum were measured using ELISA.  Contents of H2O2 and malondialdehyde (MDA) in joint tissue homogenate were measured using assay kits.  We found collagen immunization induced significant arthritis in mice and isorhamnetin at the dose of 10 and 20 mg/kg/day could significantly attenuate the collagen-induced arthritis.  Isorhamnetin also modulated the prodn. of cytokines and suppressed the oxidative stress in the mice with collagen-induced arthritis at the dose of 10 and 20 mg/kg/day.  These data suggested that isorhamnetin might be a potential agent for the management of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmStSyNVyW5rVg90H21EOLACvtfcHk0lja1oSL4m9K4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlOmuro%253D&md5=10b7024bbbb56bf6bff01aea703fa312</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DIsorhamnetin%2520Attenuates%2520Collagen-Induced%2520Arthritis%2520via%2520Modulating%2520Cytokines%2520and%2520Oxidative%2520Stress%2520in%2520Mice%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2015%26volume%3D8%26issue%3D9%26spage%3D16536%26epage%3D16542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singla, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, A. K.</span></span> <span> </span><span class="NLM_article-title">Antioxidant Activity and Protective Effect of Suramin against Oxidative Stress in Collagen Induced Arthritis</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2017.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.ejps.2017.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=28189815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlKju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2017&pages=125-139&author=D.+Sahuauthor=S.+Sharmaauthor=R.+K.+Singlaauthor=A.+K.+Panda&title=Antioxidant+Activity+and+Protective+Effect+of+Suramin+against+Oxidative+Stress+in+Collagen+Induced+Arthritis&doi=10.1016%2Fj.ejps.2017.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant activity and protective effect of suramin against oxidative stress in collagen induced arthritis</span></div><div class="casAuthors">Sahu, Debasis; Sharma, Shikha; Singla, Rajeev K.; Panda, Amulya Kumar</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">125-139</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">It is imperative to interrupt the link between arthritis and regulation of oxidative stress with the administration of antioxidants.  Suramin is known for its anti-inflammatory, antineoplastic and antiangiogenic activities implying its possible antioxidant property.  In this study, the antioxidant activity of suramin in cell free system was found to be higher than L-ascorbic acid (L-AA) with respect to its scavenging effect on nitric oxide (NO), hypochlorous acid and hydrogen peroxide radicals.  Besides, suramin was found to be nontoxic to cultured RAW cells even at high concns. along with marked inhibition of NO prodn.  Suramin was found to curb the inflammation assocd. with the collagen induced arthritis (CIA) model.  Administration of suramin significantly reduced the malondialdehyde and protein carbonyl content in joints, liver, kidney and spleen of rats as studied ex vivo.  Furthermore, the increased antioxidant enzymes such as SOD, catalase, GST, GPx and GR activities in the tissues were restored significantly after suramin treatment.  In silico expts. using Vlife MDS4.4-GRIP docking method showed strong affinity of suramin towards erythrocyte catalase followed by glutathione peroxidase thus corroborating with the findings of antioxidant enzyme assays.  Our studies clearly indicate that suramin has remarkable antioxidant potential and can ameliorate arthritis via modulation of oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaUmTHQ_rdmLVg90H21EOLACvtfcHk0liUbYterF--PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlKju7Y%253D&md5=08fa6c6d3d3e9f5a0706f909fc5df058</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2017.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2017.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DSahu%26aufirst%3DD.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DSingla%26aufirst%3DR.%2BK.%26aulast%3DPanda%26aufirst%3DA.%2BK.%26atitle%3DAntioxidant%2520Activity%2520and%2520Protective%2520Effect%2520of%2520Suramin%2520against%2520Oxidative%2520Stress%2520in%2520Collagen%2520Induced%2520Arthritis%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2017%26volume%3D101%26spage%3D125%26epage%3D139%26doi%3D10.1016%2Fj.ejps.2017.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">National
Cancer Institute</span>. <span> </span><span class="NLM_article-title">Cell Miner.
NCI-60 panel of methotrexate
and aminopterin</span>. <a href="https://discover.nci.nih.gov/cellminer/" class="extLink">https://discover.nci.nih.gov/cellminer/</a> (accessed on August 11, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=National%0ACancer+Institute.+Cell+Miner.%0ANCI-60+panel+of+methotrexate%0Aand+aminopterin.+https%3A%2F%2Fdiscover.nci.nih.gov%2Fcellminer%2F+%28accessed+on+August+11%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DCell%2520Miner.%250ANCI-60%2520panel%2520of%2520methotrexate%250Aand%2520aminopterin" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D.</span></span> <span> </span><span class="NLM_article-title">The Metabolism and Toxicity of Quinones, Quinonimines, Quinone Methides, and Quinone-Thioethers</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.2174/1389200023337388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.2174%2F1389200023337388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=12093358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlCqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=425-438&issue=4&author=T.+Monksauthor=D.+Jones&title=The+Metabolism+and+Toxicity+of+Quinones%2C+Quinonimines%2C+Quinone+Methides%2C+and+Quinone-Thioethers&doi=10.2174%2F1389200023337388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers</span></div><div class="casAuthors">Monks, Terrence J.; Jones, Douglas C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">425-438</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Quinones are ubiquitous in nature and constitute an important class of naturally occurring compds. found in plants, fungi and bacteria.  Human exposure to quinones therefore occurs via the diet, but also clin. or via airborne pollutants.  For example, the quinones of polycyclic arom. hydrocarbons are prevalent as environmental contaminants and provide a major source of current human exposure to quinones.  The inevitable human exposure to quinones, and the inherent reactivity of quinones, has stimulated substantial research on the chem. and toxicol. of these compds.  From a toxicol. perspective, quinones possess two principal chem. properties that confer their reactivity in biol. systems.  Quinones are oxidants and electrophiles, and the relative contribution of these properties to quinone toxicity is influenced by chem. structure, in particular substituent effects.  Modification to the quinone nucleus also influences quinone metab.  This review will therefore focus on the differences in structure and metab. of quinones, and how such differences influence quinone toxicol.  Specific examples will be discussed to illustrate the diverse manner by which quinones interact with biol. systems to initiate and propagate a toxic response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcMP5Yen5lN7Vg90H21EOLACvtfcHk0liUbYterF--PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlCqtrY%253D&md5=15000fbf139bf8b4206c503e2baa38ef</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2174%2F1389200023337388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200023337388%26sid%3Dliteratum%253Aachs%26aulast%3DMonks%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DD.%26atitle%3DThe%2520Metabolism%2520and%2520Toxicity%2520of%2520Quinones%252C%2520Quinonimines%252C%2520Quinone%2520Methides%252C%2520and%2520Quinone-Thioethers%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2002%26volume%3D3%26issue%3D4%26spage%3D425%26epage%3D438%26doi%3D10.2174%2F1389200023337388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Non-Proinflammatory and Responsive Nanoplatforms for Targeted Treatment of Atherosclerosis</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2017.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.biomaterials.2017.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=28778000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1OjsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2017&pages=93-108&author=Y.+Douauthor=Y.+Chenauthor=X.+Zhangauthor=X.+Xuauthor=Y.+Chenauthor=J.+Guoauthor=D.+Zhangauthor=R.+Wangauthor=X.+Liauthor=J.+Zhang&title=Non-Proinflammatory+and+Responsive+Nanoplatforms+for+Targeted+Treatment+of+Atherosclerosis&doi=10.1016%2Fj.biomaterials.2017.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis</span></div><div class="casAuthors">Dou, Yin; Chen, Yue; Zhang, Xiangjun; Xu, Xiaoqiu; Chen, Yidan; Guo, Jiawei; Zhang, Dinglin; Wang, Ruibing; Li, Xiaohui; Zhang, Jianxiang</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-108</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Atherosclerosis is the leading cause of many fatal cardiovascular and cerebrovascular diseases.  Whereas nanomedicines are promising for targeted therapy of atherosclerosis, great challenges remain in development of effective, safe, and translational nanotherapies for its treatment.  Herein we hypothesize that non-proinflammatory nanomaterials sensitive to low pH or high reactive oxygen species (ROS) may serve as effective platforms for triggerable delivery of anti-atherosclerotic therapeutics in cellular and tissue microenvironments of inflammation.  To demonstrate this hypothesis, an acid-labile material of acetalated β-cyclodextrin (β-CD) (Ac-bCD) and a ROS-sensitive β-CD material (Ox-bCD) were sep. synthesized by chem. modification of β-CD, which were formed into responsive nanoparticles (NPs).  Ac-bCD NP was rapidly hydrolyzed in mildly acidic buffers, while hydrolysis of Ox-bCD NP was selectively accelerated by H2O2.  Using an anti-atherosclerotic drug rapamycin (RAP), we found stimuli-responsive release of therapeutic mols. from Ac-bCD and Ox-bCD nanotherapies.  Compared with non-responsive poly(lactide-co-glycolide) (PLGA)-based NP, Ac-bCD and Ox-bCD NPs showed negligible inflammatory responses in vitro and in vivo.  By endocytosis in cells and intracellularly releasing cargo mols. in macrophages, responsive nanotherapies effectively inhibited macrophage proliferation and suppressed foam cell formation.  After i.p. delivery in apolipoprotein E-deficient (ApoE-/-) mice, fluorescence imaging showed accumulation of NPs in atherosclerotic plaques.  Flow cytometry anal. indicated that the lymphatic translocation mediated by neutrophils and monocytes/macrophages may contribute to atherosclerosis targeting of i.p. administered NPs, in addn. to targeting via the leaky blood vessels.  Correspondingly, i.p. treatment with different nanotherapies afforded desirable efficacies.  Particularly, both pH and ROS-responsive nanomedicines more remarkably delayed progression of atherosclerosis and significantly enhanced stability of atheromatous lesions, in comparison to non-responsive PLGA nanotherapy.  Furthermore, responsive nanovehicles displayed good safety performance after long-term administration in mice.  Consequently, for the first time our findings demonstrated the therapeutic advantages of nanomedicines responsive to mildly acidic or abnormally high ROS microenvironments for the treatment of atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp8u_VszZM47Vg90H21EOLACvtfcHk0liUbYterF--PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1OjsbbK&md5=eebf0bba12cb71acd781759b02e50fea</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2017.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2017.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DDou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DNon-Proinflammatory%2520and%2520Responsive%2520Nanoplatforms%2520for%2520Targeted%2520Treatment%2520of%2520Atherosclerosis%26jtitle%3DBiomaterials%26date%3D2017%26volume%3D143%26spage%3D93%26epage%3D108%26doi%3D10.1016%2Fj.biomaterials.2017.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotlyar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudelman, A.</span></span> <span> </span><span class="NLM_article-title">NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7512</span>– <span class="NLM_lpage">7515</span>, <span class="refDoi"> DOI: 10.1021/jo971176v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971176v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7512-7515&issue=21&author=H.+E.+Gottliebauthor=V.+Kotlyarauthor=A.+Nudelman&title=NMR+Chemical+Shifts+of+Common+Laboratory+Solvents+as+Trace+Impurities&doi=10.1021%2Fjo971176v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">NMR chemical shifts of common laboratory solvents as trace impurities</span></div><div class="casAuthors">Gottlieb, Hugo E.; Kotlyar, Vadim; Nudelman, Abraham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7512-7515</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 1H (300 MHz) and 13C (75 MHz) NMR chem. shifts for >30 common impurities, such as lab. solvents, stabilizers, greases and water, are reported in 7 deuterated NMR solvents.  The temp. dependence of the chem. shift of the proton residual peak (HDO) in D2O is established for the entire liq. range of this sample.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocnoOemocS9LVg90H21EOLACvtfcHk0liDZIwj2vpt_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D&md5=c297adda99f8c10e9f9b0ab9fe5f55be</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjo971176v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971176v%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DKotlyar%26aufirst%3DV.%26aulast%3DNudelman%26aufirst%3DA.%26atitle%3DNMR%2520Chemical%2520Shifts%2520of%2520Common%2520Laboratory%2520Solvents%2520as%2520Trace%2520Impurities%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26issue%3D21%26spage%3D7512%26epage%3D7515%26doi%3D10.1021%2Fjo971176v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, P. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Boron-Containing Primary Amines</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">12346</span>– <span class="NLM_lpage">12367</span>, <span class="refDoi"> DOI: 10.3390/molecules181012346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.3390%2Fmolecules181012346" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=12346-12367&issue=10&author=S.+H.+Chungauthor=T.+J.+Linauthor=Q.+Y.+Huauthor=C.+H.+Tsaiauthor=P.+S.+Pan&title=Synthesis+of+Boron-Containing+Primary+Amines&doi=10.3390%2Fmolecules181012346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.3390%2Fmolecules181012346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules181012346%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DT.%2BJ.%26aulast%3DHu%26aufirst%3DQ.%2BY.%26aulast%3DTsai%26aufirst%3DC.%2BH.%26aulast%3DPan%26aufirst%3DP.%2BS.%26atitle%3DSynthesis%2520of%2520Boron-Containing%2520Primary%2520Amines%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26issue%3D10%26spage%3D12346%26epage%3D12367%26doi%3D10.3390%2Fmolecules181012346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mosey, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floreancig, P. E.</span></span> <span> </span><span class="NLM_article-title">Versatile Approach to α-Alkoxy Carbamate Synthesis and Stimulus-Responsive Alcohol Release</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">7980</span>– <span class="NLM_lpage">7985</span>, <span class="refDoi"> DOI: 10.1039/c2ob26571k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1039%2Fc2ob26571k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=7980-7985&issue=39&author=R.+A.+Moseyauthor=P.+E.+Floreancig&title=Versatile+Approach+to+%CE%B1-Alkoxy+Carbamate+Synthesis+and+Stimulus-Responsive+Alcohol+Release&doi=10.1039%2Fc2ob26571k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1039%2Fc2ob26571k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob26571k%26sid%3Dliteratum%253Aachs%26aulast%3DMosey%26aufirst%3DR.%2BA.%26aulast%3DFloreancig%26aufirst%3DP.%2BE.%26atitle%3DVersatile%2520Approach%2520to%2520%25CE%25B1-Alkoxy%2520Carbamate%2520Synthesis%2520and%2520Stimulus-Responsive%2520Alcohol%2520Release%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26issue%3D39%26spage%3D7980%26epage%3D7985%26doi%3D10.1039%2Fc2ob26571k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temple, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. A.</span></span> <span> </span><span class="NLM_article-title">Potential Folic Acid Antagonists. IV. Synthetic Approaches to Analogs of Aminopterin and Methotrexate. IV. Preparation of P-{[(2,4-Diamino-6-Pteridinyl)methyl]amino}benzoic Acids</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1680</span>, <span class="refDoi"> DOI: 10.1021/jo00830a093</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00830a093" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1970&pages=1676-1680&issue=5&author=R.+D.+Elliottauthor=C.+Templeauthor=J.+A.+Montgomery&title=Potential+Folic+Acid+Antagonists.+IV.+Synthetic+Approaches+to+Analogs+of+Aminopterin+and+Methotrexate.+IV.+Preparation+of+P-%7B%5B%282%2C4-Diamino-6-Pteridinyl%29methyl%5Damino%7Dbenzoic+Acids&doi=10.1021%2Fjo00830a093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjo00830a093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00830a093%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DR.%2BD.%26aulast%3DTemple%26aufirst%3DC.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26atitle%3DPotential%2520Folic%2520Acid%2520Antagonists.%2520IV.%2520Synthetic%2520Approaches%2520to%2520Analogs%2520of%2520Aminopterin%2520and%2520Methotrexate.%2520IV.%2520Preparation%2520of%2520P-%257B%255B%25282%252C4-Diamino-6-Pteridinyl%2529methyl%255Damino%257Dbenzoic%2520Acids%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1970%26volume%3D35%26issue%3D5%26spage%3D1676%26epage%3D1680%26doi%3D10.1021%2Fjo00830a093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zidar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupnik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovač, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras
Martel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller
Premru, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterlin
Mašič, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikelj, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel 5-Benzylidenerhodanine and 5-Benzylidenethiazolidine-2,4-Dione Inhibitors of MurD Ligase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">6584</span>– <span class="NLM_lpage">6594</span>, <span class="refDoi"> DOI: 10.1021/jm100285g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100285g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6584-6594&issue=18&author=N.+Zidarauthor=T.+Toma%C5%A1i%C4%87author=R.+%C5%A0inkauthor=V.+Rupnikauthor=A.+Kova%C4%8Dauthor=S.+Turkauthor=D.+Patinauthor=D.+Blanotauthor=C.+Contreras%0AMartelauthor=A.+Dessenauthor=M.+M%C3%BCller%0APremruauthor=A.+Zegaauthor=S.+Gobecauthor=L.+Peterlin%0AMa%C5%A1i%C4%8Dauthor=D.+Kikelj&title=Discovery+of+Novel+5-Benzylidenerhodanine+and+5-Benzylidenethiazolidine-2%2C4-Dione+Inhibitors+of+MurD+Ligase&doi=10.1021%2Fjm100285g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm100285g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100285g%26sid%3Dliteratum%253Aachs%26aulast%3DZidar%26aufirst%3DN.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DT.%26aulast%3D%25C5%25A0ink%26aufirst%3DR.%26aulast%3DRupnik%26aufirst%3DV.%26aulast%3DKova%25C4%258D%26aufirst%3DA.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DPatin%26aufirst%3DD.%26aulast%3DBlanot%26aufirst%3DD.%26aulast%3DContreras%2BMartel%26aufirst%3DC.%26aulast%3DDessen%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%2BPremru%26aufirst%3DM.%26aulast%3DZega%26aufirst%3DA.%26aulast%3DGobec%26aufirst%3DS.%26aulast%3DPeterlin%2BMa%25C5%25A1i%25C4%258D%26aufirst%3DL.%26aulast%3DKikelj%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520Novel%25205-Benzylidenerhodanine%2520and%25205-Benzylidenethiazolidine-2%252C4-Dione%2520Inhibitors%2520of%2520MurD%2520Ligase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D18%26spage%3D6584%26epage%3D6594%26doi%3D10.1021%2Fjm100285g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malavašič, Č.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grošelj, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golobič, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezenšek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanovnik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stare, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svete, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Structure of Novel (S)-1,6-Dialkylpiperazine-2,5-Diones and (3S,6S)-1,3,6-Trialkylpiperazine-2,5-Diones</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2011.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.tetasy.2011.03.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=629-640&issue=6&author=%C4%8C.+Malava%C5%A1i%C4%8Dauthor=U.+Gro%C5%A1eljauthor=A.+Golobi%C4%8Dauthor=J.+Bezen%C5%A1ekauthor=B.+Stanovnikauthor=K.+Stareauthor=J.+Waggerauthor=J.+Svete&title=Synthesis+and+Structure+of+Novel+%28S%29-1%2C6-Dialkylpiperazine-2%2C5-Diones+and+%283S%2C6S%29-1%2C3%2C6-Trialkylpiperazine-2%2C5-Diones&doi=10.1016%2Fj.tetasy.2011.03.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2011.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2011.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DMalava%25C5%25A1i%25C4%258D%26aufirst%3D%25C4%258C.%26aulast%3DGro%25C5%25A1elj%26aufirst%3DU.%26aulast%3DGolobi%25C4%258D%26aufirst%3DA.%26aulast%3DBezen%25C5%25A1ek%26aufirst%3DJ.%26aulast%3DStanovnik%26aufirst%3DB.%26aulast%3DStare%26aufirst%3DK.%26aulast%3DWagger%26aufirst%3DJ.%26aulast%3DSvete%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Structure%2520of%2520Novel%2520%2528S%2529-1%252C6-Dialkylpiperazine-2%252C5-Diones%2520and%2520%25283S%252C6S%2529-1%252C3%252C6-Trialkylpiperazine-2%252C5-Diones%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2011%26volume%3D22%26issue%3D6%26spage%3D629%26epage%3D640%26doi%3D10.1016%2Fj.tetasy.2011.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barclay, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantopoulos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrovsky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matisons, J. G.</span></span> <span> </span><span class="NLM_article-title">Chiral Self-Assembly of Designed Amphiphiles: Influences on Aggregate Morphology</span>. <i>Langmuir</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">32</span>),  <span class="NLM_fpage">10001</span>– <span class="NLM_lpage">10010</span>, <span class="refDoi"> DOI: 10.1021/la401987y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/la401987y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2013&pages=10001-10010&issue=32&author=T.+G.+Barclayauthor=K.+Constantopoulosauthor=W.+Zhangauthor=M.+Fujikiauthor=N.+Petrovskyauthor=J.+G.+Matisons&title=Chiral+Self-Assembly+of+Designed+Amphiphiles%3A+Influences+on+Aggregate+Morphology&doi=10.1021%2Fla401987y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fla401987y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fla401987y%26sid%3Dliteratum%253Aachs%26aulast%3DBarclay%26aufirst%3DT.%2BG.%26aulast%3DConstantopoulos%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DFujiki%26aufirst%3DM.%26aulast%3DPetrovsky%26aufirst%3DN.%26aulast%3DMatisons%26aufirst%3DJ.%2BG.%26atitle%3DChiral%2520Self-Assembly%2520of%2520Designed%2520Amphiphiles%253A%2520Influences%2520on%2520Aggregate%2520Morphology%26jtitle%3DLangmuir%26date%3D2013%26volume%3D29%26issue%3D32%26spage%3D10001%26epage%3D10010%26doi%3D10.1021%2Fla401987y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riebeseel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biedermann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Löser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breiter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanselmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mülhaupt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratz, F.</span></span> <span> </span><span class="NLM_article-title">Polyethylene Glycol Conjugates of Methotrexate Varying in Their Molecular Weight from MW 750 to MW 40000: Synthesis, Characterization, and Structure–Activity Relationships in Vitro and in Vivo</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">773</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1021/bc010098m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc010098m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1Krs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=773-785&issue=4&author=K.+Riebeseelauthor=E.+Biedermannauthor=R.+L%C3%B6serauthor=N.+Breiterauthor=R.+Hanselmannauthor=R.+M%C3%BClhauptauthor=C.+Ungerauthor=F.+Kratz&title=Polyethylene+Glycol+Conjugates+of+Methotrexate+Varying+in+Their+Molecular+Weight+from+MW+750+to+MW+40000%3A+Synthesis%2C+Characterization%2C+and+Structure%E2%80%93Activity+Relationships+in+Vitro+and+in+Vivo&doi=10.1021%2Fbc010098m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Polyethylene Glycol Conjugates of Methotrexate Varying in Their Molecular Weight from MW 750 to MW 40000: Synthesis, Characterization, and Structure-Activity Relationships in Vitro and in Vivo</span></div><div class="casAuthors">Riebeseel, Katja; Biedermann, Elfi; Loeser, Roland; Breiter, Norbert; Hanselmann, Ralf; Muelhaupt, Rolf; Unger, Clemens; Kratz, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">773-785</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Poly(ethylene glycol)s (PEGs) are potential drug carriers for improving the therapeutic index of anticancer agents.  In this study, the anticancer drug methotrexate (MTX) was activated with N,N'-dicyclohexylcarbodiimide (DCC) and coupled to amino group bearing PEGs of MW 750, 2000, 5000, 10,000, 20,000, and 40,000.  First, the activation process of MTX with DCC in the presence and absence of N-hydroxysuccinimide was analyzed by HPLC.  Preincubation of methotrexate with DCC alone at 0° was favorable with respect to the amt. of activated species and the formation of byproducts.  MTX-PEG conjugates were synthesized according to this procedure, isolated through size-exclusion chromatog., and characterized by anal. HPLC, MALDI-TOF spectrometry, and gel permeation chromatog.  In a cell-free assay, all of the drug polymer conjugates inhibited the target enzyme of MTX, dihydrofolate reductase (DHFR), to a similar extent, but were not as active as free MTX.  Addnl., incubation of the MTX-PEG 40,000 conjugate for 6 days at 37° in phosphate buffered saline (pH 7.4), in cell-conditioned medium, or in human serum revealed no significant release of methotrexate.  These results, taken together, indicate that release of MTX from polymer conjugates is not necessary for an effective interaction with the active site of dihydrofolate reductase.  Evaluation of the in vitro cytotoxicity of the MTX-PEG conjugates in 2 adherent and 3 suspension human tumor cell lines revealed that the IC50 values of the tested compds. increased with the size of the drug-polymer conjugates.  The most effective compd. tested in these assays was the free drug MTX itself (IC50 value ranging from ∼0.01 to 0.05 μM), while the IC50 values of the polymer conjugates were higher (IC50 value for MTX-PEG750, 2000 and 5000: 0.6-3 μM; for MTX-PEG 10,000 and 20,000: 2-7 μM; and for MTX-PEG 40,000: >6 μM).  Subsequently, MTX-PEG 5000, MTX-PEG 20,000, and MTX-PEG 40,000 were evaluated in a human mesothelioma MSTO-211H xenograft model, and their antitumor effects were compared with free methotrexate and the albumin conjugate MTX-HSA, a conjugate that is currently in phase II clin. trials.  In contrast to the in vitro results, the high mol. wt. MTX-PEG conjugates exhibited the highest in vivo antitumor activity: at a dose of 40 and 80 mg/kg MTX-PEG 5000 was less active than MTX at its optimal dose of 100 mg/kg; MTX-PEG 20,000 at a dose of 40 mg/kg showed antitumor efficacy comparable to MTX, but MTX-PEG 40,000 at a dose of 20 mg/kg was superior to MTX and demonstrated antitumor activity of the same order as MTX-HSA (20 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzrr8MsDP_f7Vg90H21EOLACvtfcHk0lgfVxn78JVFZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1Krs7w%253D&md5=f0dbed23f7655e8ad3a3e731bc4ab585</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fbc010098m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc010098m%26sid%3Dliteratum%253Aachs%26aulast%3DRiebeseel%26aufirst%3DK.%26aulast%3DBiedermann%26aufirst%3DE.%26aulast%3DL%25C3%25B6ser%26aufirst%3DR.%26aulast%3DBreiter%26aufirst%3DN.%26aulast%3DHanselmann%26aufirst%3DR.%26aulast%3DM%25C3%25BClhaupt%26aufirst%3DR.%26aulast%3DUnger%26aufirst%3DC.%26aulast%3DKratz%26aufirst%3DF.%26atitle%3DPolyethylene%2520Glycol%2520Conjugates%2520of%2520Methotrexate%2520Varying%2520in%2520Their%2520Molecular%2520Weight%2520from%2520MW%2520750%2520to%2520MW%252040000%253A%2520Synthesis%252C%2520Characterization%252C%2520and%2520Structure%25E2%2580%2593Activity%2520Relationships%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DBioconjugate%2520Chem.%26date%3D2002%26volume%3D13%26issue%3D4%26spage%3D773%26epage%3D785%26doi%3D10.1021%2Fbc010098m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S.-C.</span></span> <span> </span><span class="NLM_article-title">J. Para-[N-Bis-(2-Chloroethyl)]-Aminobenzoylglutamic Acid</span>. <i>J. Med. Pharm. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1021/jm01236a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm01236a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1962&pages=33-41&issue=1&author=S.-C.+Fu&title=J.+Para-%5BN-Bis-%282-Chloroethyl%29%5D-Aminobenzoylglutamic+Acid&doi=10.1021%2Fjm01236a004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm01236a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm01236a004%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DS.-C.%26atitle%3DJ.%2520Para-%255BN-Bis-%25282-Chloroethyl%2529%255D-Aminobenzoylglutamic%2520Acid%26jtitle%3DJ.%2520Med.%2520Pharm.%2520Chem.%26date%3D1962%26volume%3D5%26issue%3D1%26spage%3D33%26epage%3D41%26doi%3D10.1021%2Fjm01236a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vernall, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briddon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellam, B.</span></span> <span> </span><span class="NLM_article-title">Highly Potent and Selective Fluorescent Antagonists of the Human Adenosine A3 Receptor Based on the 1,2,4-Triazolo[4,3-A]quinoxalin-1-One Scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1771</span>– <span class="NLM_lpage">1782</span>, <span class="refDoi"> DOI: 10.1021/jm201722y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201722y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1771-1782&issue=4&author=A.+J.+Vernallauthor=L.+A.+Stoddartauthor=S.+J.+Briddonauthor=S.+J.+Hillauthor=B.+Kellam&title=Highly+Potent+and+Selective+Fluorescent+Antagonists+of+the+Human+Adenosine+A3+Receptor+Based+on+the+1%2C2%2C4-Triazolo%5B4%2C3-A%5Dquinoxalin-1-One+Scaffold&doi=10.1021%2Fjm201722y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm201722y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201722y%26sid%3Dliteratum%253Aachs%26aulast%3DVernall%26aufirst%3DA.%2BJ.%26aulast%3DStoddart%26aufirst%3DL.%2BA.%26aulast%3DBriddon%26aufirst%3DS.%2BJ.%26aulast%3DHill%26aufirst%3DS.%2BJ.%26aulast%3DKellam%26aufirst%3DB.%26atitle%3DHighly%2520Potent%2520and%2520Selective%2520Fluorescent%2520Antagonists%2520of%2520the%2520Human%2520Adenosine%2520A3%2520Receptor%2520Based%2520on%2520the%25201%252C2%252C4-Triazolo%255B4%252C3-A%255Dquinoxalin-1-One%2520Scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D4%26spage%3D1771%26epage%3D1782%26doi%3D10.1021%2Fjm201722y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lellouche, J. P.</span>; <span class="NLM_string-name">Naddaka, M.</span>; <span class="NLM_string-name">Peled, A.</span>; <span class="NLM_string-name">Mondal, E.</span></span> <span> </span><span class="NLM_article-title">Surface-Modified Polymer Films</span>. <span class="NLM_patent">U.S. Patent 20110306722 A1</span>, December 15, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+P.+Lellouche&author=M.+Naddaka&author=A.+Peled&author=E.+Mondal&title=Surface-Modified+Polymer+Films"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLellouche%26aufirst%3DJ.%2BP.%26atitle%3DSurface-Modified%2520Polymer%2520Films%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuellar, R. A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazar, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suryanarayanan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurvich, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georg, G. I.</span></span> <span> </span><span class="NLM_article-title">Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9334</span>– <span class="NLM_lpage">9344</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01329</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01329" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9334-9344&issue=23&author=S.+Patilauthor=L.+G.+Lisauthor=R.+J.+Schumacherauthor=B.+J.+Norrisauthor=M.+L.+Morganauthor=R.+A.+D.+Cuellarauthor=B.+R.+Blazarauthor=R.+Suryanarayananauthor=V.+J.+Gurvichauthor=G.+I.+Georg&title=Phosphonooxymethyl+Prodrug+of+Triptolide%3A+Synthesis%2C+Physicochemical+Characterization%2C+and+Efficacy+in+Human+Colon+Adenocarcinoma+and+Ovarian+Cancer+Xenografts&doi=10.1021%2Facs.jmedchem.5b01329"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01329%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%26aulast%3DLis%26aufirst%3DL.%2BG.%26aulast%3DSchumacher%26aufirst%3DR.%2BJ.%26aulast%3DNorris%26aufirst%3DB.%2BJ.%26aulast%3DMorgan%26aufirst%3DM.%2BL.%26aulast%3DCuellar%26aufirst%3DR.%2BA.%2BD.%26aulast%3DBlazar%26aufirst%3DB.%2BR.%26aulast%3DSuryanarayanan%26aufirst%3DR.%26aulast%3DGurvich%26aufirst%3DV.%2BJ.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26atitle%3DPhosphonooxymethyl%2520Prodrug%2520of%2520Triptolide%253A%2520Synthesis%252C%2520Physicochemical%2520Characterization%252C%2520and%2520Efficacy%2520in%2520Human%2520Colon%2520Adenocarcinoma%2520and%2520Ovarian%2520Cancer%2520Xenografts%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D23%26spage%3D9334%26epage%3D9344%26doi%3D10.1021%2Facs.jmedchem.5b01329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 26 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">De-Chao Yang, Shuai Wang, Xiao-Lu Weng, Hong-Xia Zhang, Jian-Yong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Zhonghui Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Singlet Oxygen-Responsive Polymeric Nanomedicine for Light-Controlled Drug Release and Image-Guided Photodynamic–Chemo Combination Therapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2021,</strong> <em>13 </em>
                                    (29)
                                     , 33905-33914. <a href="https://doi.org/10.1021/acsami.1c09044" title="DOI URL">https://doi.org/10.1021/acsami.1c09044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.1c09044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.1c09044%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DSinglet%252BOxygen-Responsive%252BPolymeric%252BNanomedicine%252Bfor%252BLight-Controlled%252BDrug%252BRelease%252Band%252BImage-Guided%252BPhotodynamic%2525E2%252580%252593Chemo%252BCombination%252BTherapy%26aulast%3DYang%26aufirst%3DDe-Chao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D16052021%26date%3D07072021%26date%3D17072021%26volume%3D13%26issue%3D29%26spage%3D33905%26epage%3D33914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Pengfei Wang, Qijie Gong, Jiabao Hu, Xiang Li, <span class="NLM_string-name hlFld-ContribAuthor">Xiaojin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 298-325. <a href="https://doi.org/10.1021/acs.jmedchem.0c01704" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01704%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DReactive%252BOxygen%252BSpecies%252B%252528ROS%252529-Responsive%252BProdrugs%25252C%252BProbes%25252C%252Band%252BTheranostic%252BProdrugs%25253A%252BApplications%252Bin%252Bthe%252BROS-Related%252BDiseases%26aulast%3DWang%26aufirst%3DPengfei%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D28092020%26date%3D23122020%26volume%3D64%26issue%3D1%26spage%3D298%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qichao Bao, Liangying Zhang, Nan Wang, Brian Gabet, Weikang Yang, Xingyang Gao, Qidong You, <span class="NLM_string-name hlFld-ContribAuthor">Zhengyu Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrogen Peroxide Inducible JAK3 Covalent Inhibitor: Prodrug for the Treatment of RA with Enhanced Safety Profile. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (11)
                                     , 2182-2189. <a href="https://doi.org/10.1021/acsmedchemlett.0c00323" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00323%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHydrogen%252BPeroxide%252BInducible%252BJAK3%252BCovalent%252BInhibitor%25253A%252BProdrug%252Bfor%252Bthe%252BTreatment%252Bof%252BRA%252Bwith%252BEnhanced%252BSafety%252BProfile%26aulast%3DBao%26aufirst%3DQichao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11062020%26date%3D01102020%26date%3D05102020%26volume%3D11%26issue%3D11%26spage%3D2182%26epage%3D2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jonathan E. Palmer, Breanna M. Brietske, Tyler C. Bate, Erik A. Blackwood, Manasa Garg, Christopher C. Glembotski, <span class="NLM_string-name hlFld-ContribAuthor">Christina B. Cooley</span>. </span><span class="cited-content_cbyCitation_article-title">Reactive Oxygen Species (ROS)-Activatable Prodrug for Selective Activation of ATF6 after Ischemia/Reperfusion Injury. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 292-297. <a href="https://doi.org/10.1021/acsmedchemlett.9b00299" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00299%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DReactive%252BOxygen%252BSpecies%252B%252528ROS%252529-Activatable%252BProdrug%252Bfor%252BSelective%252BActivation%252Bof%252BATF6%252Bafter%252BIschemia%25252FReperfusion%252BInjury%26aulast%3DPalmer%26aufirst%3DJonathan%2BE.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02072019%26date%3D06112019%26date%3D08112019%26date%3D06112019%26volume%3D11%26issue%3D3%26spage%3D292%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yong Ai, Obinna N. Obianom, Meredith Kuser, Yue Li, Yan Shu, <span class="NLM_string-name hlFld-ContribAuthor">Fengtian Xue</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced Tumor Selectivity of 5-Fluorouracil Using a Reactive Oxygen Species-Activated Prodrug Approach. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 127-131. <a href="https://doi.org/10.1021/acsmedchemlett.8b00539" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00539</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00539%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEnhanced%252BTumor%252BSelectivity%252Bof%252B5-Fluorouracil%252BUsing%252Ba%252BReactive%252BOxygen%252BSpecies-Activated%252BProdrug%252BApproach%26aulast%3DAi%26aufirst%3DYong%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D07112018%26date%3D03122018%26date%3D06122018%26date%3D03122018%26volume%3D10%26issue%3D1%26spage%3D127%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Naibo Feng, Modi Yang, Xiangru Feng, Yinan Wang, Fei Chang, <span class="NLM_string-name hlFld-ContribAuthor">Jianxun Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Reduction-Responsive Polypeptide Nanogel for Intracellular Drug Delivery in Relieving Collagen-Induced Arthritis. </span><span class="cited-content_cbyCitation_journal-name">ACS Biomaterials Science & Engineering</span><span> <strong>2018,</strong> <em>4 </em>
                                    (12)
                                     , 4154-4162. <a href="https://doi.org/10.1021/acsbiomaterials.8b00738" title="DOI URL">https://doi.org/10.1021/acsbiomaterials.8b00738</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsbiomaterials.8b00738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsbiomaterials.8b00738%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Biomaterials%2520Science%2520%2526%2520Engineering%26atitle%3DReduction-Responsive%252BPolypeptide%252BNanogel%252Bfor%252BIntracellular%252BDrug%252BDelivery%252Bin%252BRelieving%252BCollagen-Induced%252BArthritis%26aulast%3DFeng%26aufirst%3DNaibo%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30062018%26date%3D01102018%26date%3D17102018%26date%3D01102018%26volume%3D4%26issue%3D12%26spage%3D4154%26epage%3D4162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eun Sook  Lee</span>, <span class="hlFld-ContribAuthor ">Jae Hoon  Sul</span>, <span class="hlFld-ContribAuthor ">Jung Min  Shin</span>, <span class="hlFld-ContribAuthor ">Sol  Shin</span>, <span class="hlFld-ContribAuthor ">Jae Ah  Lee</span>, <span class="hlFld-ContribAuthor ">Hark Kyun  Kim</span>, <span class="hlFld-ContribAuthor ">Yongeun  Cho</span>, <span class="hlFld-ContribAuthor ">Hyewon  Ko</span>, <span class="hlFld-ContribAuthor ">Soyoung  Son</span>, <span class="hlFld-ContribAuthor ">Jeongmi  Lee</span>, <span class="hlFld-ContribAuthor ">Sunyoung  Park</span>, <span class="hlFld-ContribAuthor ">Dong-Gyu  Jo</span>, <span class="hlFld-ContribAuthor ">Jae Hyung  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Reactive oxygen species-responsive dendritic cell-derived exosomes for rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">Acta Biomaterialia</span><span> <strong>2021,</strong> <em>128 </em>, 462-473. <a href="https://doi.org/10.1016/j.actbio.2021.04.026" title="DOI URL">https://doi.org/10.1016/j.actbio.2021.04.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.actbio.2021.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.actbio.2021.04.026%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Biomaterialia%26atitle%3DReactive%252Boxygen%252Bspecies-responsive%252Bdendritic%252Bcell-derived%252Bexosomes%252Bfor%252Brheumatoid%252Barthritis%26aulast%3DLee%26aufirst%3DEun%2BSook%26date%3D2021%26volume%3D128%26spage%3D462%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yufei  Xue</span>, <span class="hlFld-ContribAuthor ">Hua  Bai</span>, <span class="hlFld-ContribAuthor ">Bo  Peng</span>, <span class="hlFld-ContribAuthor ">Bin  Fang</span>, <span class="hlFld-ContribAuthor ">Jonathan  Baell</span>, <span class="hlFld-ContribAuthor ">Lin  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Nicolas Hans  Voelcker</span>. </span><span class="cited-content_cbyCitation_article-title">Stimulus-cleavable chemistry in the field of controlled drug delivery. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>50 </em>
                                    (8)
                                     , 4872-4931. <a href="https://doi.org/10.1039/D0CS01061H" title="DOI URL">https://doi.org/10.1039/D0CS01061H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS01061H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS01061H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DStimulus-cleavable%252Bchemistry%252Bin%252Bthe%252Bfield%252Bof%252Bcontrolled%252Bdrug%252Bdelivery%26aulast%3DXue%26aufirst%3DYufei%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D8%26spage%3D4872%26epage%3D4931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shu  Song</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in the medicinal chemistry of single boron atom-containing compounds. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>73 </em><a href="https://doi.org/10.1016/j.apsb.2021.01.010" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.01.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.01.010%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DRecent%252Bdevelopments%252Bin%252Bthe%252Bmedicinal%252Bchemistry%252Bof%252Bsingle%252Bboron%252Batom-containing%252Bcompounds%26aulast%3DSong%26aufirst%3DShu%26date%3D2021%26volume%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Bibi</span>, <span class="hlFld-ContribAuthor ">Naveeda Akhter  Qureshi</span>, <span class="hlFld-ContribAuthor ">Abdul  Sadiq</span>, <span class="hlFld-ContribAuthor ">Umar  Farooq</span>, <span class="hlFld-ContribAuthor ">Abbas  Hassan</span>, <span class="hlFld-ContribAuthor ">Nargis  Shaheen</span>, <span class="hlFld-ContribAuthor ">Irfa  Asghar</span>, <span class="hlFld-ContribAuthor ">Duaa  Umer</span>, <span class="hlFld-ContribAuthor ">Azmat  Ullah</span>, <span class="hlFld-ContribAuthor ">Farhan A.  Khan</span>, <span class="hlFld-ContribAuthor ">Muhammad  Salman</span>, <span class="hlFld-ContribAuthor ">Ahtaram  Bibi</span>, <span class="hlFld-ContribAuthor ">Umer  Rashid</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the ability of dihydropyrimidine-5-carboxamide and 5-benzyl-2,4-diaminopyrimidine-based analogues for the selective inhibition of L. major dihydrofolate reductase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112986. <a href="https://doi.org/10.1016/j.ejmech.2020.112986" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112986</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112986%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploring%252Bthe%252Bability%252Bof%252Bdihydropyrimidine-5-carboxamide%252Band%252B5-benzyl-2%25252C4-diaminopyrimidine-based%252Banalogues%252Bfor%252Bthe%252Bselective%252Binhibition%252Bof%252BL.%2525C2%2525A0major%252Bdihydrofolate%252Breductase%26aulast%3DBibi%26aufirst%3DMaria%26date%3D2021%26volume%3D210%26spage%3D112986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peifeng  Su</span>, <span class="hlFld-ContribAuthor ">Hongxin  Wu</span>, <span class="hlFld-ContribAuthor ">Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Hongxiang  Lei</span>, <span class="hlFld-ContribAuthor ">Shiyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuanghu  Wang</span>, <span class="hlFld-ContribAuthor ">Yingjia  Li</span>, <span class="hlFld-ContribAuthor ">Yingfeng  Tu</span>, <span class="hlFld-ContribAuthor ">Fei  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Biodegradable Catalase‐Modified Micelles as Ultrasound Contrast Agents for Inflammation Detection. </span><span class="cited-content_cbyCitation_journal-name">Particle & Particle Systems Characterization</span><span> <strong>2020,</strong> <em>37 </em>
                                    (10)
                                     , 2000193. <a href="https://doi.org/10.1002/ppsc.202000193" title="DOI URL">https://doi.org/10.1002/ppsc.202000193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ppsc.202000193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fppsc.202000193%26sid%3Dliteratum%253Aachs%26jtitle%3DParticle%2520%2526%2520Particle%2520Systems%2520Characterization%26atitle%3DBiodegradable%252BCatalase%2525E2%252580%252590Modified%252BMicelles%252Bas%252BUltrasound%252BContrast%252BAgents%252Bfor%252BInflammation%252BDetection%26aulast%3DSu%26aufirst%3DPeifeng%26date%3D2020%26date%3D2020%26volume%3D37%26issue%3D10%26spage%3D2000193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gengqi  Liu</span>, <span class="hlFld-ContribAuthor ">Jonathan F.  Lovell</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yumiao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (17)
                                     , 6380. <a href="https://doi.org/10.3390/ijms21176380" title="DOI URL">https://doi.org/10.3390/ijms21176380</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21176380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21176380%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DStimulus-Responsive%252BNanomedicines%252Bfor%252BDisease%252BDiagnosis%252Band%252BTreatment%26aulast%3DLiu%26aufirst%3DGengqi%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D17%26spage%3D6380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariana Pereira  Silva</span>, <span class="hlFld-ContribAuthor ">Lucília  Saraiva</span>, <span class="hlFld-ContribAuthor ">Madalena  Pinto</span>, <span class="hlFld-ContribAuthor ">Maria Emília  Sousa</span>. </span><span class="cited-content_cbyCitation_article-title">Boronic Acids and Their Derivatives in Medicinal Chemistry: Synthesis and Biological Applications. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (18)
                                     , 4323. <a href="https://doi.org/10.3390/molecules25184323" title="DOI URL">https://doi.org/10.3390/molecules25184323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25184323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25184323%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBoronic%252BAcids%252Band%252BTheir%252BDerivatives%252Bin%252BMedicinal%252BChemistry%25253A%252BSynthesis%252Band%252BBiological%252BApplications%26aulast%3DSilva%26aufirst%3DMariana%2BPereira%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D18%26spage%3D4323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengchen  Lu</span>, <span class="hlFld-ContribAuthor ">Xian  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions. </span><span class="cited-content_cbyCitation_journal-name">Redox Biology</span><span> <strong>2020,</strong> <em>34 </em>, 101565. <a href="https://doi.org/10.1016/j.redox.2020.101565" title="DOI URL">https://doi.org/10.1016/j.redox.2020.101565</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.redox.2020.101565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.redox.2020.101565%26sid%3Dliteratum%253Aachs%26jtitle%3DRedox%2520Biology%26atitle%3DA%252Bhydrogen%252Bperoxide%252Bresponsive%252Bprodrug%252Bof%252BKeap1-Nrf2%252Binhibitor%252Bfor%252Bimproving%252Boral%252Babsorption%252Band%252Bselective%252Bactivation%252Bin%252Binflammatory%252Bconditions%26aulast%3DLu%26aufirst%3DMengchen%26date%3D2020%26volume%3D34%26spage%3D101565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenzhen  Pan</span>, <span class="hlFld-ContribAuthor ">Chengbai  Dai</span>, <span class="hlFld-ContribAuthor ">Yang  Li</span>, <span class="hlFld-ContribAuthor ">Yiming  Yin</span>, <span class="hlFld-ContribAuthor ">Ling  Gong</span>, <span class="hlFld-ContribAuthor ">Jeremiah Ong'achwa  Machuki</span>, <span class="hlFld-ContribAuthor ">Yun  Yang</span>, <span class="hlFld-ContribAuthor ">Shang  Qiu</span>, <span class="hlFld-ContribAuthor ">Kaijin  Guo</span>, <span class="hlFld-ContribAuthor ">Fenglei  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">PRP-chitosan thermoresponsive hydrogel combined with black phosphorus nanosheets as injectable biomaterial for biotherapy and phototherapy treatment of rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">Biomaterials</span><span> <strong>2020,</strong> <em>239 </em>, 119851. <a href="https://doi.org/10.1016/j.biomaterials.2020.119851" title="DOI URL">https://doi.org/10.1016/j.biomaterials.2020.119851</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biomaterials.2020.119851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biomaterials.2020.119851%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomaterials%26atitle%3DPRP-chitosan%252Bthermoresponsive%252Bhydrogel%252Bcombined%252Bwith%252Bblack%252Bphosphorus%252Bnanosheets%252Bas%252Binjectable%252Bbiomaterial%252Bfor%252Bbiotherapy%252Band%252Bphototherapy%252Btreatment%252Bof%252Brheumatoid%252Barthritis%26aulast%3DPan%26aufirst%3DWenzhen%26date%3D2020%26volume%3D239%26spage%3D119851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bjoern  Bielec</span>, <span class="hlFld-ContribAuthor ">Isabella  Poetsch</span>, <span class="hlFld-ContribAuthor ">Esra  Ahmed</span>, <span class="hlFld-ContribAuthor ">Petra  Heffeter</span>, <span class="hlFld-ContribAuthor ">Bernhard K.  Keppler</span>, <span class="hlFld-ContribAuthor ">Christian R.  Kowol</span>. </span><span class="cited-content_cbyCitation_article-title">Reactive Oxygen Species (ROS)-Sensitive Prodrugs of the Tyrosine Kinase Inhibitor Crizotinib. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (5)
                                     , 1149. <a href="https://doi.org/10.3390/molecules25051149" title="DOI URL">https://doi.org/10.3390/molecules25051149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25051149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25051149%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DReactive%252BOxygen%252BSpecies%252B%252528ROS%252529-Sensitive%252BProdrugs%252Bof%252Bthe%252BTyrosine%252BKinase%252BInhibitor%252BCrizotinib%26aulast%3DBielec%26aufirst%3DBjoern%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D5%26spage%3D1149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amna  Riaz</span>, <span class="hlFld-ContribAuthor ">Maliha  Ghaffar</span>, <span class="hlFld-ContribAuthor ">Hina  Salahuddin</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacogenomics of Methotrexate-Induced Toxicity in Children. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 401-412. <a href="https://doi.org/10.1007/978-981-15-1067-0_17" title="DOI URL">https://doi.org/10.1007/978-981-15-1067-0_17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-15-1067-0_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-15-1067-0_17%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacogenomics%252Bof%252BMethotrexate-Induced%252BToxicity%252Bin%252BChildren%26aulast%3DRiaz%26aufirst%3DAmna%26date%3D2020%26date%3D2020%26spage%3D401%26epage%3D412%26pub%3DSpringer%2520Singapore%26atitle%3D%252527Essentials%252Bof%252BCancer%252BGenomic%25252C%252BComputational%252BApproaches%252Band%252BPrecision%252BMedicine%26aulast%3DMasood%26aufirst%3DNosheen%26date%3D2020%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Viola  Previtali</span>, <span class="hlFld-ContribAuthor ">Katarina  Petrovic</span>, <span class="hlFld-ContribAuthor ">Jorge  Peiró Cadahía</span>, <span class="hlFld-ContribAuthor ">Nikolaj Sten  Troelsen</span>, <span class="hlFld-ContribAuthor ">Mads H.  Clausen</span>. </span><span class="cited-content_cbyCitation_article-title">Auxiliary in vitro and in vivo biological evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (2)
                                     , 115247. <a href="https://doi.org/10.1016/j.bmc.2019.115247" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115247%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAuxiliary%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bbiological%252Bevaluation%252Bof%252Bhydrogen%252Bperoxide%252Bsensitive%252Bprodrugs%252Bof%252Bmethotrexate%252Band%252Baminopterin%252Bfor%252Bthe%252Btreatment%252Bof%252Brheumatoid%252Barthritis%26aulast%3DPrevitali%26aufirst%3DViola%26date%3D2020%26volume%3D28%26issue%3D2%26spage%3D115247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiawen  Zhu</span>, <span class="hlFld-ContribAuthor ">Jingting  Chen</span>, <span class="hlFld-ContribAuthor ">Dongmei  Song</span>, <span class="hlFld-ContribAuthor ">Wenda  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianpeng  Guo</span>, <span class="hlFld-ContribAuthor ">Guiping  Cai</span>, <span class="hlFld-ContribAuthor ">Yuhao  Ren</span>, <span class="hlFld-ContribAuthor ">Chengying  Wan</span>, <span class="hlFld-ContribAuthor ">Lingyi  Kong</span>, <span class="hlFld-ContribAuthor ">Wenying  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Real-time monitoring of etoposide prodrug activated by hydrogen peroxide with improved safety. </span><span class="cited-content_cbyCitation_journal-name">Journal of Materials Chemistry B</span><span> <strong>2019,</strong> <em>7 </em>
                                    (47)
                                     , 7548-7557. <a href="https://doi.org/10.1039/C9TB02041A" title="DOI URL">https://doi.org/10.1039/C9TB02041A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9TB02041A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9TB02041A%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Materials%2520Chemistry%2520B%26atitle%3DReal-time%252Bmonitoring%252Bof%252Betoposide%252Bprodrug%252Bactivated%252Bby%252Bhydrogen%252Bperoxide%252Bwith%252Bimproved%252Bsafety%26aulast%3DZhu%26aufirst%3DJiawen%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D47%26spage%3D7548%26epage%3D7557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles  Skarbek</span>, <span class="hlFld-ContribAuthor ">Silvia  Serra</span>, <span class="hlFld-ContribAuthor ">Hichem  Maslah</span>, <span class="hlFld-ContribAuthor ">Estelle  Rascol</span>, <span class="hlFld-ContribAuthor ">Raphaël  Labruère</span>. </span><span class="cited-content_cbyCitation_article-title">Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>91 </em>, 103158. <a href="https://doi.org/10.1016/j.bioorg.2019.103158" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103158</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103158%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DArylboronate%252Bprodrugs%252Bof%252Bdoxorubicin%252Bas%252Bpromising%252Bchemotherapy%252Bfor%252Bpancreatic%252Bcancer%26aulast%3DSkarbek%26aufirst%3DCharles%26date%3D2019%26volume%3D91%26spage%3D103158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Constantinos G.  Neochoritis</span>, <span class="hlFld-ContribAuthor ">Tryfon  Zarganes-Tzitzikas</span>, <span class="hlFld-ContribAuthor ">Michaela  Novotná</span>, <span class="hlFld-ContribAuthor ">Tatiana  Mitríková</span>, <span class="hlFld-ContribAuthor ">Zefeng  Wang</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kurpiewska</span>, <span class="hlFld-ContribAuthor ">Justyna  Kalinowska-Tłuścik</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">Isocyanide-Based Multicomponent Reactions of Free Phenylboronic Acids. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (35)
                                     , 6132-6137. <a href="https://doi.org/10.1002/ejoc.201901187" title="DOI URL">https://doi.org/10.1002/ejoc.201901187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901187%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIsocyanide-Based%252BMulticomponent%252BReactions%252Bof%252BFree%252BPhenylboronic%252BAcids%26aulast%3DNeochoritis%26aufirst%3DConstantinos%2BG.%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D35%26spage%3D6132%26epage%3D6137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jorge  Peiró Cadahía</span>, <span class="hlFld-ContribAuthor ">Viola  Previtali</span>, <span class="hlFld-ContribAuthor ">Nikolaj S.  Troelsen</span>, <span class="hlFld-ContribAuthor ">Mads H.  Clausen</span>. </span><span class="cited-content_cbyCitation_article-title">Prodrug strategies for targeted therapy triggered by reactive oxygen species. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 1531-1549. <a href="https://doi.org/10.1039/C9MD00169G" title="DOI URL">https://doi.org/10.1039/C9MD00169G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00169G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00169G%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DProdrug%252Bstrategies%252Bfor%252Btargeted%252Btherapy%252Btriggered%252Bby%252Breactive%252Boxygen%252Bspecies%26aulast%3DPeir%25C3%25B3%2BCadah%25C3%25ADa%26aufirst%3DJorge%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D9%26spage%3D1531%26epage%3D1549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincent Kam Wai  Wong</span>, <span class="hlFld-ContribAuthor ">Congling  Qiu</span>, <span class="hlFld-ContribAuthor ">Su‐Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Betty Yuen Kwan  Law</span>, <span class="hlFld-ContribAuthor ">Wu  Zeng</span>, <span class="hlFld-ContribAuthor ">Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Francesco  Michelangeli</span>, <span class="hlFld-ContribAuthor ">Ivo Ricardo De Seabra Rodrigues  Dias</span>, <span class="hlFld-ContribAuthor ">Yuan Qing  Qu</span>, <span class="hlFld-ContribAuthor ">Tsz Wai  Chan</span>, <span class="hlFld-ContribAuthor ">Yu  Han</span>, <span class="hlFld-ContribAuthor ">Ni  Zhang</span>, <span class="hlFld-ContribAuthor ">Simon Wing Fai  Mok</span>, <span class="hlFld-ContribAuthor ">Xi  Chen</span>, <span class="hlFld-ContribAuthor ">Lu  Yu</span>, <span class="hlFld-ContribAuthor ">Hudan  Pan</span>, <span class="hlFld-ContribAuthor ">Sami  Hamdoun</span>, <span class="hlFld-ContribAuthor ">Thomas  Efferth</span>, <span class="hlFld-ContribAuthor ">Wen Jing  Yu</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Yuesheng  Xie</span>, <span class="hlFld-ContribAuthor ">Riqiang  Luo</span>, <span class="hlFld-ContribAuthor ">Quan  Jiang</span>, <span class="hlFld-ContribAuthor ">Liang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Ca
              2+
              signalling plays a role in celastrol‐mediated suppression of synovial fibroblasts of rheumatoid arthritis patients and experimental arthritis in rats. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2019,</strong> <em>176 </em>
                                    (16)
                                     , 2922-2944. <a href="https://doi.org/10.1111/bph.14718" title="DOI URL">https://doi.org/10.1111/bph.14718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14718%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DCa%252B2%25252B%252Bsignalling%252Bplays%252Ba%252Brole%252Bin%252Bcelastrol%2525E2%252580%252590mediated%252Bsuppression%252Bof%252Bsynovial%252Bfibroblasts%252Bof%252Brheumatoid%252Barthritis%252Bpatients%252Band%252Bexperimental%252Barthritis%252Bin%252Brats%26aulast%3DWong%26aufirst%3DVincent%2BKam%2BWai%26date%3D2019%26date%3D2019%26volume%3D176%26issue%3D16%26spage%3D2922%26epage%3D2944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai‐Cheng  Yan</span>, <span class="hlFld-ContribAuthor ">Adam C.  Sedgwick</span>, <span class="hlFld-ContribAuthor ">Yi  Zang</span>, <span class="hlFld-ContribAuthor ">Guo‐Rong  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao‐Peng  He</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Juyoung  Yoon</span>, <span class="hlFld-ContribAuthor ">Tony D.  James</span>. </span><span class="cited-content_cbyCitation_article-title">Sensors, Imaging Agents, and Theranostics to Help Understand and Treat Reactive Oxygen Species Related Diseases. </span><span class="cited-content_cbyCitation_journal-name">Small Methods</span><span> <strong>2019,</strong> <em>3 </em>
                                    (7)
                                     , 1900013. <a href="https://doi.org/10.1002/smtd.201900013" title="DOI URL">https://doi.org/10.1002/smtd.201900013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/smtd.201900013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fsmtd.201900013%26sid%3Dliteratum%253Aachs%26jtitle%3DSmall%2520Methods%26atitle%3DSensors%25252C%252BImaging%252BAgents%25252C%252Band%252BTheranostics%252Bto%252BHelp%252BUnderstand%252Band%252BTreat%252BReactive%252BOxygen%252BSpecies%252BRelated%252BDiseases%26aulast%3DYan%26aufirst%3DKai%25E2%2580%2590Cheng%26date%3D2019%26date%3D2019%26volume%3D3%26issue%3D7%26spage%3D1900013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolaj S.  Andersen</span>, <span class="hlFld-ContribAuthor ">Jorge  Peiró Cadahía</span>, <span class="hlFld-ContribAuthor ">Viola  Previtali</span>, <span class="hlFld-ContribAuthor ">Jon  Bondebjerg</span>, <span class="hlFld-ContribAuthor ">Christian A.  Hansen</span>, <span class="hlFld-ContribAuthor ">Anders E.  Hansen</span>, <span class="hlFld-ContribAuthor ">Thomas L.  Andresen</span>, <span class="hlFld-ContribAuthor ">Mads H.  Clausen</span>. </span><span class="cited-content_cbyCitation_article-title">Methotrexate prodrugs sensitive to reactive oxygen species for the improved treatment of rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>156 </em>, 738-746. <a href="https://doi.org/10.1016/j.ejmech.2018.07.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMethotrexate%252Bprodrugs%252Bsensitive%252Bto%252Breactive%252Boxygen%252Bspecies%252Bfor%252Bthe%252Bimproved%252Btreatment%252Bof%252Brheumatoid%252Barthritis%26aulast%3DAndersen%26aufirst%3DNikolaj%2BS.%26date%3D2018%26volume%3D156%26spage%3D738%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arduino  Mangoni</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Simona  Collina</span>, <span class="hlFld-ContribAuthor ">Jean  Vanden Eynde</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>, <span class="hlFld-ContribAuthor ">Rafik  Karaman</span>, <span class="hlFld-ContribAuthor ">Carlo  Siciliano</span>, <span class="hlFld-ContribAuthor ">Maria  De Sousa</span>, <span class="hlFld-ContribAuthor ">Katalin  Prokai-Tatrai</span>, <span class="hlFld-ContribAuthor ">Jarkko  Rautio</span>, <span class="hlFld-ContribAuthor ">Catherine  Guillou</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>, <span class="hlFld-ContribAuthor ">Stefania  Galdiero</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Luigi  Agrofoglio</span>, <span class="hlFld-ContribAuthor ">Jean-Marc  Sabatier</span>, <span class="hlFld-ContribAuthor ">Christopher  Hulme</span>, <span class="hlFld-ContribAuthor ">George  Kokotos</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Paula  Gomes</span>. </span><span class="cited-content_cbyCitation_article-title">Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-3. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (7)
                                     , 1596. <a href="https://doi.org/10.3390/molecules23071596" title="DOI URL">https://doi.org/10.3390/molecules23071596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23071596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23071596%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBreakthroughs%252Bin%252BMedicinal%252BChemistry%25253A%252BNew%252BTargets%252Band%252BMechanisms%25252C%252BNew%252BDrugs%25252C%252BNew%252BHopes-3%26aulast%3DMangoni%26aufirst%3DArduino%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D7%26spage%3D1596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure of aminopterin (AMT, <b>1</b>) and methotrexate (MTX, <b>2</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of MTX Prodrugs <b>11</b>–<b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) pinacol, THF, reflux, 16 h (>94%); (b) COCl<sub>2</sub> (20% in toluene), dioxane, 21 °C, 20 h (>95%); (c) NaOH, H<sub>2</sub>O; (d) PPh<sub>3</sub>Br<sub>2</sub>, DMA, 21 °C, 24 h, then 4-methylaminobenzoic acid, DIPEA, 3 days (77%); (e) PyBOP, Et<sub>3</sub>N, DMF, 21 °C, 30 min, then <b>9·</b>HCl (86%); (f) MeOH, SOCl<sub>2</sub>, 21 °C, 4 days (>95%); (g) <b>5a</b>–<b>c</b>, DIPEA, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 21 °C, 5 h; (h) HCl in H<sub>2</sub>O/MeCN, 21 °C, 16 h (27–32%).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of MTX Prodrug <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PMBCl, 1,1,3,3-tetramethylguanidine, CH<sub>2</sub>Cl<sub>2</sub>, 21 °C, 16 h (35%); (b) <b>5a</b>, DIPEA, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 21 °C, 5 h (73%); (c) HCl in H<sub>2</sub>O/MeCN, 21 °C, 20 h (31%); (d) 5% TFA in CH<sub>2</sub>Cl<sub>2,</sub> 21 °C, 30 min (54%).</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of AMT Prodrugs <b>24</b> and <b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CbzCl, NaHCO<sub>3</sub>, H<sub>2</sub>O/dioxane, 21 °C, 2 h (89%); (b) SOCl<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 24 h; (c) <b>9·</b>HCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 21 °C, 2 h (>95%); (d) H<sub>2</sub>, Pd/C, MeOH, 21 °C, 12 h; (e) HCl in Et<sub>2</sub>O (>95%); (f) NaBH<sub>4</sub>, MeOH, 21 °C, 24 h (67%); (g) DMA, 55 °C, 3 days (43%); (h) NaOH, H<sub>2</sub>O, 21 °C, 5 min (40%).</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Activation of MTX prodrugs <b>11</b>–<b>13</b> and <b>17</b> (left), and AMT-prodrugs <b>24</b> and <b>25</b>, as well as formation and disappearance of intermediates <b>26</b> and <b>27</b> (right). The experiment was carried out at a compound concentration of 50 μM and 0.5 mM H<sub>2</sub>O<sub>2</sub> (10 equiv) in a mixture of 30% DMSO in PBS at 37 °C. Hidden error bars are smaller than symbols.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Activation of AMT Prodrugs <b>24</b> and <b>25</b> with H<sub>2</sub>O<sub>2</sub> To Form the Intermediates <b>26</b> and <b>27</b>, Respectively, Which Slowly Release <b>28</b> and AMT</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/medium/jm-2017-01775a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Suppression of CIA development in DBA/1J mice (left) after treatment with MTX (7 mg/kg) and equimolar amounts of AMT (6.8 mg/kg), <b>17</b> (9.7 mg/kg), and <b>25</b> (8.8 mg/kg) (<i>n</i> = 8 per group). Mice were given the indicated dose of test compound once per day, starting on day 27, and arthritis scoring was performed three times per week. Data represents mean values of arthritic score ± SEM. Statistics were calculated using a one-tailed nonparametric Mann–Whitney. *<i>p</i> < 0.05 and **<i>p</i> < 0.01 between MTX and vehicle and <sup>†</sup><i>p</i> < 0.05 between 17 and vehicle. General health of mice (right) evaluated three times per week as the average body weight in groups of animals (<i>n</i> = 8) tested with vehicle, MTX, AMT, <b>17</b>, and <b>25</b>. Data represents mean values of bodyweight ± SEM; *<i>p</i> < 0.05 between AMT and vehicle. One animal in the vehicle and the <b>25</b> groups were sacrificed pretermination due to high arthritis scores. The AMT group was removed at day 33 due to decline in health. AMT, aminopterin; CIA, collagen induced-arthritis; CII, collagen type-II; MTX, methotrexate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01775/20180420/images/large/jm-2017-01775a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01775&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i64">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 75 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koch, A. E.</span></span> <span> </span><span class="NLM_article-title">The Pathogenesis of Rheumatoid Arthritis</span>. <i>Am. J. Orthop. (Belle Mead. NJ).</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=17694191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADC%252BD2srmslagsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=5-8&author=A.+E.+Koch&title=The+Pathogenesis+of+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The pathogenesis of rheumatoid arthritis</span></div><div class="casAuthors">Koch Alisa Erika</div><div class="citationInfo"><span class="NLM_cas:title">American journal of orthopedics (Belle Mead, N.J.)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7 Suppl</span>),
    <span class="NLM_cas:pages">5-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYDabAH3FECgaK-_ZudimnfW6udTcc2eZBAgs4253_C7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srmslagsQ%253D%253D&md5=8a67af25fbeeaed9167ddc7cead1bb38</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DA.%2BE.%26atitle%3DThe%2520Pathogenesis%2520of%2520Rheumatoid%2520Arthritis%26jtitle%3DAm.%2520J.%2520Orthop.%2520%2528Belle%2520Mead.%2520NJ%2529.%26date%3D2007%26volume%3D36%26spage%3D5%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smolen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aletaha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, I. B.</span></span> <span> </span><span class="NLM_article-title">Rheumatoid Arthritis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>388</i></span> (<span class="NLM_issue">10055</span>),  <span class="NLM_fpage">2023</span>– <span class="NLM_lpage">2038</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(16)30173-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2FS0140-6736%2816%2930173-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=27156434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlSmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2016&pages=2023-2038&issue=10055&author=J.+S.+Smolenauthor=D.+Aletahaauthor=I.+B.+McInnes&title=Rheumatoid+Arthritis&doi=10.1016%2FS0140-6736%2816%2930173-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Rheumatoid arthritis</span></div><div class="casAuthors">Smolen, Josef S.; Aletaha, Daniel; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">10055</span>),
    <span class="NLM_cas:pages">2023-2038</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Rheumatoid arthritis is a chronic inflammatory joint disease, which can cause cartilage and bone damage as well as disability.  Early diagnosis is key to optimal therapeutic success, particularly in patients with well-characterized risk factors for poor outcomes such as high disease activity, presence of autoantibodies, and early joint damage.  Treatment algorithms involve measuring disease activity with composite indexes, applying a treatment-to-target strategy, and use of conventional, biol., and new non-biol. disease-modifying antirheumatic drugs.  After the treatment target of stringent remission (or at least low disease activity) is maintained, dose redn. should be attempted.  Although the prospects for most patients are now favorable, many still do not respond to current therapies.  Accordingly, new therapies are urgently required.  In this Seminar, we describe current insights into genetics and etiol., pathophysiol., epidemiol., assessment, therapeutic agents, and treatment strategies together with unmet needs of patients with rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkGMEVL9OqRLVg90H21EOLACvtfcHk0lj75SlvdPCLow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlSmsbY%253D&md5=01f723daa7e5f0d030f4ab8a2476be30</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2930173-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252930173-8%26sid%3Dliteratum%253Aachs%26aulast%3DSmolen%26aufirst%3DJ.%2BS.%26aulast%3DAletaha%26aufirst%3DD.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DRheumatoid%2520Arthritis%26jtitle%3DLancet%26date%3D2016%26volume%3D388%26issue%3D10055%26spage%3D2023%26epage%3D2038%26doi%3D10.1016%2FS0140-6736%2816%2930173-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gubner, R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Suppression of Tissue Reactivity. I. Comparison of the Effects of Cortisone and Aminopterin</span>. <i>Am. J. Med. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>221</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1097/00000441-195102000-00008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1097%2F00000441-195102000-00008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1951&pages=169-175&issue=2&author=R.+Gubner&title=Therapeutic+Suppression+of+Tissue+Reactivity.+I.+Comparison+of+the+Effects+of+Cortisone+and+Aminopterin&doi=10.1097%2F00000441-195102000-00008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2F00000441-195102000-00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000441-195102000-00008%26sid%3Dliteratum%253Aachs%26aulast%3DGubner%26aufirst%3DR.%26atitle%3DTherapeutic%2520Suppression%2520of%2520Tissue%2520Reactivity.%2520I.%2520Comparison%2520of%2520the%2520Effects%2520of%2520Cortisone%2520and%2520Aminopterin%26jtitle%3DAm.%2520J.%2520Med.%2520Sci.%26date%3D1951%26volume%3D221%26issue%3D2%26spage%3D169%26epage%3D175%26doi%3D10.1097%2F00000441-195102000-00008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gubner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">August, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginsberg, V.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Suppression of Tissue Reactivity. II. Effects of Aminopterin in Rheumatoid Arthritis and Psoriasis</span>. <i>Am. J. Med. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>221</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1097/00000441-195102000-00009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1097%2F00000441-195102000-00009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1951&pages=176-182&issue=2&author=R.+Gubnerauthor=S.+Augustauthor=V.+Ginsberg&title=Therapeutic+Suppression+of+Tissue+Reactivity.+II.+Effects+of+Aminopterin+in+Rheumatoid+Arthritis+and+Psoriasis&doi=10.1097%2F00000441-195102000-00009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1097%2F00000441-195102000-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000441-195102000-00009%26sid%3Dliteratum%253Aachs%26aulast%3DGubner%26aufirst%3DR.%26aulast%3DAugust%26aufirst%3DS.%26aulast%3DGinsberg%26aufirst%3DV.%26atitle%3DTherapeutic%2520Suppression%2520of%2520Tissue%2520Reactivity.%2520II.%2520Effects%2520of%2520Aminopterin%2520in%2520Rheumatoid%2520Arthritis%2520and%2520Psoriasis%26jtitle%3DAm.%2520J.%2520Med.%2520Sci.%26date%3D1951%26volume%3D221%26issue%3D2%26spage%3D176%26epage%3D182%26doi%3D10.1097%2F00000441-195102000-00009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rees, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamlin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibach, H.</span></span> <span> </span><span class="NLM_article-title">Aminopterin for Psoriasis: A Decade’s Observation</span>. <i>Arch. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1001/archderm.1964.01600060010002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1001%2Farchderm.1964.01600060010002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=14206858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADyaF2M%252FhtFagug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1964&pages=544-552&issue=6&author=R.+B.+Reesauthor=J.+H.+Bennettauthor=E.+Hamlinauthor=H.+Maibach&title=Aminopterin+for+Psoriasis%3A+A+Decade%E2%80%99s+Observation&doi=10.1001%2Farchderm.1964.01600060010002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">AMINOPTERIN FOR PSORIASIS. A DECADE'S OBSERVATION</span></div><div class="casAuthors">REES R B; BENNETT J H; HAMLIN E M; MAIBACH H I</div><div class="citationInfo"><span class="NLM_cas:title">Archives of dermatology</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">544-52</span>
        ISSN:<span class="NLM_cas:issn">0003-987X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR_vma9e0Tq7kwlCcfExbvbfW6udTcc2eaRLEN0ZeFHY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2M%252FhtFagug%253D%253D&md5=892ea80459c3c6cedf8cc43571732f9f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1001%2Farchderm.1964.01600060010002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchderm.1964.01600060010002%26sid%3Dliteratum%253Aachs%26aulast%3DRees%26aufirst%3DR.%2BB.%26aulast%3DBennett%26aufirst%3DJ.%2BH.%26aulast%3DHamlin%26aufirst%3DE.%26aulast%3DMaibach%26aufirst%3DH.%26atitle%3DAminopterin%2520for%2520Psoriasis%253A%2520A%2520Decade%25E2%2580%2599s%2520Observation%26jtitle%3DArch.%2520Dermatol.%26date%3D1964%26volume%3D90%26issue%3D6%26spage%3D544%26epage%3D552%26doi%3D10.1001%2Farchderm.1964.01600060010002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sacks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenbach, E. B.</span></span> <span> </span><span class="NLM_article-title">The Response of Acute Leukemia to the Administration of the Folic Acid Antagonists, Aminopterin and Amethopterin: Report of 14 Cases</span>. <i>Ann. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">1950</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.7326/0003-4819-32-1-80</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.7326%2F0003-4819-32-1-80" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=15404129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADyaG3c%252FhtlOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1950&pages=80-115&issue=1&author=M.+S.+Sacksauthor=G.+T.+Bradfordauthor=E.+B.+Schoenbach&title=The+Response+of+Acute+Leukemia+to+the+Administration+of+the+Folic+Acid+Antagonists%2C+Aminopterin+and+Amethopterin%3A+Report+of+14+Cases&doi=10.7326%2F0003-4819-32-1-80"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The response of acute leukemia to the administration of the folic acid antagonists, aminopterin and a-methopterin; report of 14 cases</span></div><div class="casAuthors">SACKS M S; BRADFORD G T; SCHOENBACH E B</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">1950</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-115, illust</span>
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwmHczcwXobbmQt-ICR3qNfW6udTcc2eZNMz1j4CcQurntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG3c%252FhtlOlsw%253D%253D&md5=fe3ef0f35ef30079b5a1b5e36bd39d08</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-32-1-80&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-32-1-80%26sid%3Dliteratum%253Aachs%26aulast%3DSacks%26aufirst%3DM.%2BS.%26aulast%3DBradford%26aufirst%3DG.%2BT.%26aulast%3DSchoenbach%26aufirst%3DE.%2BB.%26atitle%3DThe%2520Response%2520of%2520Acute%2520Leukemia%2520to%2520the%2520Administration%2520of%2520the%2520Folic%2520Acid%2520Antagonists%252C%2520Aminopterin%2520and%2520Amethopterin%253A%2520Report%2520of%252014%2520Cases%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D1950%26volume%3D32%26issue%3D1%26spage%3D80%26epage%3D115%26doi%3D10.7326%2F0003-4819-32-1-80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stickney, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagedorn, A. B.</span></span> <span> </span><span class="NLM_article-title">Observations on Acute Leukemia in Children Treated with 4-Aminopteroylglutamic Acid</span>. <i>Pediatrics</i> <span class="NLM_year" style="font-weight: bold;">1950</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1950&pages=52-56&issue=1&author=S.+D.+Millsauthor=J.+M.+Stickneyauthor=A.+B.+Hagedorn&title=Observations+on+Acute+Leukemia+in+Children+Treated+with+4-Aminopteroylglutamic+Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DS.%2BD.%26aulast%3DStickney%26aufirst%3DJ.%2BM.%26aulast%3DHagedorn%26aufirst%3DA.%2BB.%26atitle%3DObservations%2520on%2520Acute%2520Leukemia%2520in%2520Children%2520Treated%2520with%25204-Aminopteroylglutamic%2520Acid%26jtitle%3DPediatrics%26date%3D1950%26volume%3D5%26issue%3D1%26spage%3D52%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawitsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritz, N. D.</span></span> <span> </span><span class="NLM_article-title">Aminopterin (a Folic Acid Antagonist) in the Treatment of Leukemia</span>. <i>Am. J. Clin. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">1949</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1093/ajcp/19.2.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1093%2Fajcp%2F19.2.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=18111375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADyaH1M%252Fht12ksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1949&pages=119-126&issue=2&author=L.+M.+Meyerauthor=H.+Finkauthor=A.+Sawitskyauthor=M.+Rowenauthor=N.+D.+Ritz&title=Aminopterin+%28a+Folic+Acid+Antagonist%29+in+the+Treatment+of+Leukemia&doi=10.1093%2Fajcp%2F19.2.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Aminopterin, a folic acid antagonist, in the treatment of leukemia</span></div><div class="casAuthors">MEYER L M; FINK H</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical pathology</span>
        (<span class="NLM_cas:date">1949</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-26</span>
        ISSN:<span class="NLM_cas:issn">0002-9173</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9Qw9gcJqbe_6BottYdIAWfW6udTcc2eZNMz1j4CcQurntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaH1M%252Fht12ksw%253D%253D&md5=a96498a6469b9eb104edd8d8ebf253d1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fajcp%2F19.2.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcp%252F19.2.119%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DL.%2BM.%26aulast%3DFink%26aufirst%3DH.%26aulast%3DSawitsky%26aufirst%3DA.%26aulast%3DRowen%26aufirst%3DM.%26aulast%3DRitz%26aufirst%3DN.%2BD.%26atitle%3DAminopterin%2520%2528a%2520Folic%2520Acid%2520Antagonist%2529%2520in%2520the%2520Treatment%2520of%2520Leukemia%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D1949%26volume%3D19%26issue%3D2%26spage%3D119%26epage%3D126%26doi%3D10.1093%2Fajcp%2F19.2.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, A.</span></span> <span> </span><span class="NLM_article-title">Treatment of Leukemia with Aminopterin</span>. <i>Am. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">452</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1016/0002-9343(51)90290-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2F0002-9343%2851%2990290-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=14819051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADyaG3M%252FkvVKjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1951&pages=452-458&issue=4&author=L.+M.+Meyerauthor=A.+Newman&title=Treatment+of+Leukemia+with+Aminopterin&doi=10.1016%2F0002-9343%2851%2990290-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of leukemia with aminopterin</span></div><div class="casAuthors">MEYER L M; NEWMAN A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of medicine</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">452-8</span>
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6azVgjWImVNhSDZx9hyjKfW6udTcc2eZNMz1j4CcQurntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG3M%252FkvVKjsw%253D%253D&md5=55c092b1f9996d5927aa9894ccb17c33</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0002-9343%2851%2990290-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-9343%252851%252990290-2%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DL.%2BM.%26aulast%3DNewman%26aufirst%3DA.%26atitle%3DTreatment%2520of%2520Leukemia%2520with%2520Aminopterin%26jtitle%3DAm.%2520J.%2520Med.%26date%3D1951%26volume%3D10%26issue%3D4%26spage%3D452%26epage%3D458%26doi%3D10.1016%2F0002-9343%2851%2990290-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venditti, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenhouse, S. W.</span></span> <span> </span><span class="NLM_article-title">A Quantitative Comparison of the Antileukemic Effectiveness of Two Folic Acid Antagonists in Mice</span>. <i>JNCI J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1955</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1657</span>– <span class="NLM_lpage">1664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=14381889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADyaG2MXmtF2itQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1955&pages=1657-1664&issue=6&author=A.+Goldinauthor=J.+M.+Vendittiauthor=S.+R.+Humphreysauthor=D.+Dennisauthor=N.+Mantelauthor=S.+W.+Greenhouse&title=A+Quantitative+Comparison+of+the+Antileukemic+Effectiveness+of+Two+Folic+Acid+Antagonists+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative comparison of the antileukemic effectiveness of two folic acid antagonists in mice</span></div><div class="casAuthors">Goldin, Abraham; Venditti, John M.; Humphreys, Stewart R.; Dennis, Don; Mantel, Nathan; Greenhouse, Samuel W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute (1940-1978)</span>
        (<span class="NLM_cas:date">1955</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1657-64</span>CODEN:
                <span class="NLM_cas:coden">JNCIAM</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">cf. C.A. 48, 12316ah.  Quant. methods, previously developed and applied to the study of host-tumor relations as affected by a specific drug, were utilized to compare the antileukemic effectiveness of aminopterin and amethopterin.  Amethopterin was more effective than aminopterin in the treatment of leukemia L1210.  It produced greater survival times of leukemic mice than did aminopterin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSn3LnAI4j1LVg90H21EOLACvtfcHk0liwXiLCLZgzVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2MXmtF2itQ%253D%253D&md5=dd07ba4b58fe69f393e3115c934914b7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoldin%26aufirst%3DA.%26aulast%3DVenditti%26aufirst%3DJ.%2BM.%26aulast%3DHumphreys%26aufirst%3DS.%2BR.%26aulast%3DDennis%26aufirst%3DD.%26aulast%3DMantel%26aufirst%3DN.%26aulast%3DGreenhouse%26aufirst%3DS.%2BW.%26atitle%3DA%2520Quantitative%2520Comparison%2520of%2520the%2520Antileukemic%2520Effectiveness%2520of%2520Two%2520Folic%2520Acid%2520Antagonists%2520in%2520Mice%26jtitle%3DJNCI%2520J.%2520Natl.%2520Cancer%2520Inst.%26date%3D1955%26volume%3D15%26issue%3D6%26spage%3D1657%26epage%3D1664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinblatt, M. E.</span></span> <span> </span><span class="NLM_article-title">Methotrexate in Rheumatoid Arthritis: A Quarter Century of Development</span>. <i>Trans. Am. Clin. Climatol. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=23874006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADC%252BC3sfislanuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2013&pages=16-25&author=M.+E.+Weinblatt&title=Methotrexate+in+Rheumatoid+Arthritis%3A+A+Quarter+Century+of+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Methotrexate in rheumatoid arthritis: a quarter century of development</span></div><div class="casAuthors">Weinblatt Michael E</div><div class="citationInfo"><span class="NLM_cas:title">Transactions of the American Clinical and Climatological Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-25</span>
        ISSN:<span class="NLM_cas:issn">0065-7778</span>.
    </div><div class="casAbstract">Methotrexate (MTX) is now the most popular drug worldwide for the treatment of rheumatoid arthritis.  Low-dose, weekly MTX (10 to 25 mg/wk) used as either monotherapy or in combination with other drugs has a superior efficacy profile as defined in placebo-controlled trials and comparable efficacy to other drugs including anti-TNF therapy.  At 1 year, one third of patients on MTX have no radiographic progression and even greater effects are seen when combined with targeted biological therapies.  MTX is well tolerated; gastrointestinal toxicity is the most common toxicity with rarely bone marrow, lung, or liver toxicity.  MTX therapy has been a major advance in the treatment of rheumatoid arthritis and is now the cornerstone of therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRqArOx8qswLjEwO064Z95rfW6udTcc2eZRpudAMYy-xLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfislanuw%253D%253D&md5=2133803c36109fff27f4680d108331d6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26atitle%3DMethotrexate%2520in%2520Rheumatoid%2520Arthritis%253A%2520A%2520Quarter%2520Century%2520of%2520Development%26jtitle%3DTrans.%2520Am.%2520Clin.%2520Climatol.%2520Assoc.%26date%3D2013%26volume%3D124%26spage%3D16%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ćalasan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurlings, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulffraat, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakken, B. J.</span></span> <span> </span><span class="NLM_article-title">Translational Medicine from Bedside to Bench and Back Again: Methotrexate Revisited</span>. <i>Int. J. Clin. Rheumtol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.2217/ijr.13.13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.2217%2Fijr.13.13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=291-306&issue=2&author=M.+B.+%C4%86alasanauthor=R.+M.+Thurlingsauthor=N.+M.+Wulffraatauthor=B.+J.+Prakken&title=Translational+Medicine+from+Bedside+to+Bench+and+Back+Again%3A+Methotrexate+Revisited&doi=10.2217%2Fijr.13.13"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2217%2Fijr.13.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fijr.13.13%26sid%3Dliteratum%253Aachs%26aulast%3D%25C4%2586alasan%26aufirst%3DM.%2BB.%26aulast%3DThurlings%26aufirst%3DR.%2BM.%26aulast%3DWulffraat%26aufirst%3DN.%2BM.%26aulast%3DPrakken%26aufirst%3DB.%2BJ.%26atitle%3DTranslational%2520Medicine%2520from%2520Bedside%2520to%2520Bench%2520and%2520Back%2520Again%253A%2520Methotrexate%2520Revisited%26jtitle%3DInt.%2520J.%2520Clin.%2520Rheumtol.%26date%3D2013%26volume%3D8%26issue%3D2%26spage%3D291%26epage%3D306%26doi%3D10.2217%2Fijr.13.13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cronstein, B. N.</span></span> <span> </span><span class="NLM_article-title">Low-Dose Methotrexate : A Mainstay in the Treatment of Rheumatoid Arthritis</span>. <i>Rev. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1124/pr.57.2.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1124%2Fpr.57.2.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFejtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=163-172&issue=2&author=B.+N.+Cronstein&title=Low-Dose+Methotrexate%E2%80%AF%3A+A+Mainstay+in+the+Treatment+of+Rheumatoid+Arthritis&doi=10.1124%2Fpr.57.2.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Low-dose methotrexate: A mainstay in the treatment of rheumatoid arthritis</span></div><div class="casAuthors">Cronstein, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-172</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Methotrexate administered weekly in low doses is a mainstay in the therapy of rheumatoid arthritis.  Although originally developed as a folate antagonist for the treatment of cancer, its mechanism of action in the therapy of rheumatoid arthritis remains less clear.  Several mechanisms have been proposed including inhibition of T cell proliferation via its effects on purine and pyrimidine metab., inhibition of transmethylation reactions required for the prevention of T cell cytotoxicity, interference with glutathione metab. leading to alterations in recruitment of monocytes and other cells to the inflamed joint, and promotion of the release of the endogenous anti-inflammatory mediator adenosine.  These mechanisms of action and the role of methotrexate in the suppression of rheumatoid arthritis are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAeIg6zcVXbrVg90H21EOLACvtfcHk0lhAezS4fRjISA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFejtLw%253D&md5=c6aae603ad4c25f2e2dc4296ecc540c2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fpr.57.2.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.57.2.3%26sid%3Dliteratum%253Aachs%26aulast%3DCronstein%26aufirst%3DB.%2BN.%26atitle%3DLow-Dose%2520Methotrexate%25E2%2580%25AF%253A%2520A%2520Mainstay%2520in%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%26jtitle%3DRev.%2520Pharmacol.%26date%3D2005%26volume%3D57%26issue%3D2%26spage%3D163%26epage%3D172%26doi%3D10.1124%2Fpr.57.2.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonafede, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Princic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, D. J.</span></span> <span> </span><span class="NLM_article-title">Cost of Tumor Necrosis Factor Blockers per Patient with Rheumatoid Arthritis in a Multistate Medicaid Population</span>. <i>Clin. Outcomes Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.2147/CEOR.S61445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.2147%2FCEOR.S61445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=25246804" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=381-388&author=M.+Bonafedeauthor=G.+J.+Josephauthor=N.+Shahauthor=N.+Princicauthor=D.+J.+Harrison&title=Cost+of+Tumor+Necrosis+Factor+Blockers+per+Patient+with+Rheumatoid+Arthritis+in+a+Multistate+Medicaid+Population&doi=10.2147%2FCEOR.S61445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2147%2FCEOR.S61445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCEOR.S61445%26sid%3Dliteratum%253Aachs%26aulast%3DBonafede%26aufirst%3DM.%26aulast%3DJoseph%26aufirst%3DG.%2BJ.%26aulast%3DShah%26aufirst%3DN.%26aulast%3DPrincic%26aufirst%3DN.%26aulast%3DHarrison%26aufirst%3DD.%2BJ.%26atitle%3DCost%2520of%2520Tumor%2520Necrosis%2520Factor%2520Blockers%2520per%2520Patient%2520with%2520Rheumatoid%2520Arthritis%2520in%2520a%2520Multistate%2520Medicaid%2520Population%26jtitle%3DClin.%2520Outcomes%2520Res.%26date%3D2014%26volume%3D6%26spage%3D381%26epage%3D388%26doi%3D10.2147%2FCEOR.S61445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronstein, B. N.</span></span> <span> </span><span class="NLM_article-title">Understanding the Mechanisms of Action of Methotrexate: Implications for the Treatment of Rheumatoid Arthritis</span>. <i>Bull. NYU Hosp. Jt. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=17922664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADC%252BD2sngtVGitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2007&pages=168-173&issue=3&author=H.+Tianauthor=B.+N.+Cronstein&title=Understanding+the+Mechanisms+of+Action+of+Methotrexate%3A+Implications+for+the+Treatment+of+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis</span></div><div class="casAuthors">Tian Henghe; Cronstein Bruce N</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the NYU hospital for joint diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">168-73</span>
        ISSN:<span class="NLM_cas:issn">1936-9719</span>.
    </div><div class="casAbstract">Methotrexate has been widely used for the treatment of rheumatoid arthritis (RA).  The mechanisms of action of methotrexate are complex.  Developed as a folic acid analogue, methotrexate inhibits purine and pyrimidine synthesis, which accounts for its efficacy in the therapy of cancer as well as for some of its toxicities.  Recently, many studies have focused on the adenosine-mediated antiinflammatory effects of methotrexate.  Certain aspects of methotrexate toxicities are also attributed to adenosine release.  A better understanding of the mechanisms of action and toxicities of methotrexate will direct clinicians in their treatment approach and toxicity monitoring.  Toward that objective, the latest developments in the pharmacokinetics, mechanism of action, pharmacogenetics, and toxicity of methotrexate are herein discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKpjpRCjFMtdHxxy173TfNfW6udTcc2eaJr-XQ7RV8Ubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sngtVGitQ%253D%253D&md5=b4d433ad29e80faaa489a0dcda426d27</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DH.%26aulast%3DCronstein%26aufirst%3DB.%2BN.%26atitle%3DUnderstanding%2520the%2520Mechanisms%2520of%2520Action%2520of%2520Methotrexate%253A%2520Implications%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%26jtitle%3DBull.%2520NYU%2520Hosp.%2520Jt.%2520Dis.%26date%3D2007%26volume%3D65%26issue%3D3%26spage%3D168%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alarcón, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, W. D.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Methotrexate in Rheumatoid Arthritis. Toxic Effects as the Major Factor in Limiting Long-Term Treatment</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1002/anr.1780320603</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1002%2Fanr.1780320603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=2735960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADyaL1M3os1Klug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=671-676&issue=6&author=G.+S.+Alarc%C3%B3nauthor=I.+C.+Tracyauthor=W.+D.+Blackburn&title=Methotrexate+in+Rheumatoid+Arthritis.+Toxic+Effects+as+the+Major+Factor+in+Limiting+Long-Term+Treatment&doi=10.1002%2Fanr.1780320603"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment</span></div><div class="casAuthors">Alarcon G S; Tracy I C; Blackburn W D Jr</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">671-6</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">In an effort to understand the prognostic features that may influence the probability of a patient's continuing to take methotrexate (MTX) over time, we studied 152 rheumatoid arthritis patients treated with MTX between 1981 and 1986.  The overall probability of continuing to take MTX was 71.2% at 1 year, 55.5% at 3 years, 50% at 5 years, and 49% at 6 years.  By univariate analysis, patients who started MTX therapy later in the study, American blacks, younger patients, those with less severe disease, and those with less frequent or less severe toxic events appeared to have a better probability of continuing the drug therapy.  When these parameters were evaluated by multivariate analysis, only the time when MTX was started and the occurrence of toxic effects independently influenced the probability of continuing MTX.  Thus, by current practice standards, toxic effects emerge as the main reason for MTX discontinuation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBbTXXnkws0ENoizSOkG_FfW6udTcc2eZXcqgkNqCc0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M3os1Klug%253D%253D&md5=31fe943931b3ee666b208fb1c58341c8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fanr.1780320603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanr.1780320603%26sid%3Dliteratum%253Aachs%26aulast%3DAlarc%25C3%25B3n%26aufirst%3DG.%2BS.%26aulast%3DTracy%26aufirst%3DI.%2BC.%26aulast%3DBlackburn%26aufirst%3DW.%2BD.%26atitle%3DMethotrexate%2520in%2520Rheumatoid%2520Arthritis.%2520Toxic%2520Effects%2520as%2520the%2520Major%2520Factor%2520in%2520Limiting%2520Long-Term%2520Treatment%26jtitle%3DArthritis%2520Rheum.%26date%3D1989%26volume%3D32%26issue%3D6%26spage%3D671%26epage%3D676%26doi%3D10.1002%2Fanr.1780320603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashkes, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balistreri, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bove, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passo, M. H.</span></span> <span> </span><span class="NLM_article-title">The Long-Term Effect of Methotrexate Therapy on the Liver in Patients with Juvenile Rheumatoid Arthritis</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2226</span>– <span class="NLM_lpage">2234</span>, <span class="refDoi"> DOI: 10.1002/art.1780401218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1002%2Fart.1780401218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=9416861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADyaK1cXltVClsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2226-2234&issue=12&author=P.+J.+Hashkesauthor=W.+F.+Balistreriauthor=K.+E.+Boveauthor=E.+T.+Ballardauthor=M.+H.+Passo&title=The+Long-Term+Effect+of+Methotrexate+Therapy+on+the+Liver+in+Patients+with+Juvenile+Rheumatoid+Arthritis&doi=10.1002%2Fart.1780401218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis</span></div><div class="casAuthors">Hashkes, Philip J.; Balistreri, William F.; Bove, Kevin E.; Ballard, Edgar T.; Passo, Murray H.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2226-2234</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">This work sought to det. if the long-term use of methotrexate (MTX) in juvenile rheumatoid arthritis (JRA) is assocd. with the development of significant liver fibrosis, and to describe the presence of risk factors for liver fibrosis in patients with JRA.  Needle biopsies of the liver were performed on patients with JRA who had received a total cumulative dose of MTX that was either >3000 mg or >4000 mg/1.73 m2 of body surface area.  The presence of risk factors for MTX hepatotoxicity, esp. biochem. abnormalities reflective of liver injury and alc. consumption, were assessed.  Thirteen patients (93%) had biochem. abnormalities while being treated with MTX, but only 5 patients (36%) had ≥1 detn. in which the aspartate or alanine aminotransferase elevation was >3 times the upper limit of normal.  Long-term use of MTX for JRA does not appear to be assocd. with the development of significant liver fibrosis.  Although nearly all patients had minor histol. changes, no significant clin. consequences were apparent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4G2DmdFVNibVg90H21EOLACvtfcHk0li_NITAax2U7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltVClsw%253D%253D&md5=561647497ed5a0cfb541a41814915d3e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fart.1780401218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.1780401218%26sid%3Dliteratum%253Aachs%26aulast%3DHashkes%26aufirst%3DP.%2BJ.%26aulast%3DBalistreri%26aufirst%3DW.%2BF.%26aulast%3DBove%26aufirst%3DK.%2BE.%26aulast%3DBallard%26aufirst%3DE.%2BT.%26aulast%3DPasso%26aufirst%3DM.%2BH.%26atitle%3DThe%2520Long-Term%2520Effect%2520of%2520Methotrexate%2520Therapy%2520on%2520the%2520Liver%2520in%2520Patients%2520with%2520Juvenile%2520Rheumatoid%2520Arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D1997%26volume%3D40%26issue%3D12%26spage%3D2226%26epage%3D2234%26doi%3D10.1002%2Fart.1780401218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elashoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorrier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furst, D. E.</span></span> <span> </span><span class="NLM_article-title">Reduction of the Efficacy of Methotrexate by the Use of Folic Acid: Post Hoc Analysis from Two Randomized Controlled Studies</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3030</span>– <span class="NLM_lpage">3038</span>, <span class="refDoi"> DOI: 10.1002/art.21295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1002%2Fart.21295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=16200612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2msrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=3030-3038&issue=10&author=D.+Khannaauthor=G.+S.+Parkauthor=H.+E.+Paulusauthor=K.+M.+Simpsonauthor=D.+Elashoffauthor=S.+B.+Cohenauthor=P.+Emeryauthor=C.+Dorrierauthor=D.+E.+Furst&title=Reduction+of+the+Efficacy+of+Methotrexate+by+the+Use+of+Folic+Acid%3A+Post+Hoc+Analysis+from+Two+Randomized+Controlled+Studies&doi=10.1002%2Fart.21295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies</span></div><div class="casAuthors">Khanna, Dinesh; Park, Grace S.; Paulus, Harold E.; Simpson, Karen M.; Elashoff, David; Cohen, Stanley B.; Emery, Paul; Dorrier, Catharine; Furst, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3030-3038</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. To examine the effect of folic acid on the efficacy of methotrexate (MTX) treatment in rheumatoid arthritis (RA) at 12 mo in 2 phase III randomized controlled trials (RCTs) of leflunomide in which MTX was used as a comparator.  Methods. Analyses were restricted to patients randomized to receive MTX who had rheumatoid factor data.  The US study recruited 482 patients with active RA; 179 received at least 1 dose of MTX, and all were mandated to receive 1 mg of oral folic acid once or twice daily.  The multinational European study recruited 999 patients with active RA; 489 received at least 1 dose of MTX, and oral folic acid was not required, although 50 received folate after developing an adverse event.  Because of similar entry criteria for both studies, the data for patients with available primary outcome data at week 52 were pooled (n = 668), and the patients were grouped by folic acid use (n = 225) and nonuse (n = 443).  To account for the significant between-study differences in the MTX groups, baseline covariates were adjusted using propensity scores so that folic acid users could be matched with nonusers.  This allowed for a comparison of differences in American College of Rheumatol. (ACR) 20% improvement criteria at week 52.  Results. At study entry, non-folic acid users had a significantly lower mean body wt., shorter mean RA duration, and higher mean disease activity (measured by joint counts, patient's and physician's global assessments, and acute-phase reactant levels).  The mean MTX dosage at week 52 was similar in the 2 RCTs.  Using propensity score matching techniques, the proportion of patients achieving an ACR 20% response at week 52 averaged 17% higher in the non-folic acid group than in the folic acid group (range 15-21%).  Similarly, the proportion of patients achieving ACR 50% and ACR 70% responses averaged 14% (range 12-16%) and 12% (range 9-14%) higher, resp., in the non-folic acid group.  Adverse events were reported in 93% of US study patients and 94% of the multinational study patients.  Elevated liver transaminase levels (above the upper limit of normal) were reported in 29% of the US study patients (majority receiving folic acid) and 62% of the multinational study patients (majority not receiving folic acid).  Conclusion. After using propensity scores to adjust for differences in the baseline characteristics of folic acid users and non-folic acid users, 9-21% fewer MTX-treated RA patients taking folic acid had ACR 20%, 50%, or 70% improvement at 52 wk compared with those who did not receive folic acid in the 2 phase III RA clin. trials.  As a post hoc anal., the results of this data anal. should be considered "hypothesis generating" and an impetus for future studies regarding the effects of folic acid on the efficacy of MTX in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEPs1GWs8UY7Vg90H21EOLACvtfcHk0li_NITAax2U7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2msrrN&md5=5d4e8bfac44bd3e29995b3498aaf8458</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fart.21295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.21295%26sid%3Dliteratum%253Aachs%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DG.%2BS.%26aulast%3DPaulus%26aufirst%3DH.%2BE.%26aulast%3DSimpson%26aufirst%3DK.%2BM.%26aulast%3DElashoff%26aufirst%3DD.%26aulast%3DCohen%26aufirst%3DS.%2BB.%26aulast%3DEmery%26aufirst%3DP.%26aulast%3DDorrier%26aufirst%3DC.%26aulast%3DFurst%26aufirst%3DD.%2BE.%26atitle%3DReduction%2520of%2520the%2520Efficacy%2520of%2520Methotrexate%2520by%2520the%2520Use%2520of%2520Folic%2520Acid%253A%2520Post%2520Hoc%2520Analysis%2520from%2520Two%2520Randomized%2520Controlled%2520Studies%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26issue%3D10%26spage%3D3030%26epage%3D3038%26doi%3D10.1002%2Fart.21295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rautio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpulainen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimbach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliyai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Järvinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savolainen, J.</span></span> <span> </span><span class="NLM_article-title">Prodrugs: Design and Clinical Applications</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1038/nrd2468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1038%2Fnrd2468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=18219308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFOrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=255-270&author=J.+Rautioauthor=H.+Kumpulainenauthor=T.+Heimbachauthor=R.+Oliyaiauthor=D.+Ohauthor=T.+J%C3%A4rvinenauthor=J.+Savolainen&title=Prodrugs%3A+Design+and+Clinical+Applications&doi=10.1038%2Fnrd2468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs: design and clinical applications</span></div><div class="casAuthors">Rautio, Jarkko; Kumpulainen, Hanna; Heimbach, Tycho; Oliyai, Reza; Oh, Dooman; Jaervinen, Tomi; Savolainen, Jouko</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-270</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Prodrugs are bioreversible derivs. of drug mols. that undergo an enzymic and/or chem. transformation in vivo to release the active parent drug, which can then exert the desired pharmacol. effect.  In both drug discovery and development, prodrugs have become an established tool for improving physicochem., biopharmaceutical or pharmacokinetic properties of pharmacol. active agents.  About 5-7% of drugs approved worldwide can be classified as prodrugs, and the implementation of a prodrug approach in the early stages of drug discovery is a growing trend.  To illustrate the applicability of the prodrug strategy, this article describes the most common functional groups that are amenable to prodrug design, and highlights examples of prodrugs that are either launched or are undergoing human trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxnlEXYMLCVbVg90H21EOLACvtfcHk0liax9BqeRsAuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFOrs7w%253D&md5=481a088ad2ee4da062779b5b28a33cbb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd2468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2468%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DKumpulainen%26aufirst%3DH.%26aulast%3DHeimbach%26aufirst%3DT.%26aulast%3DOliyai%26aufirst%3DR.%26aulast%3DOh%26aufirst%3DD.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DSavolainen%26aufirst%3DJ.%26atitle%3DProdrugs%253A%2520Design%2520and%2520Clinical%2520Applications%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D255%26epage%3D270%26doi%3D10.1038%2Fnrd2468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huttunen, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raunio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rautio, J.</span></span> <span> </span><span class="NLM_article-title">Prodrugs - from Serendipity to Rational Design</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">771</span>, <span class="refDoi"> DOI: 10.1124/pr.110.003459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1124%2Fpr.110.003459" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=750-771&issue=3&author=K.+M.+Huttunenauthor=H.+Raunioauthor=J.+Rautio&title=Prodrugs+-+from+Serendipity+to+Rational+Design&doi=10.1124%2Fpr.110.003459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.003459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.003459%26sid%3Dliteratum%253Aachs%26aulast%3DHuttunen%26aufirst%3DK.%2BM.%26aulast%3DRaunio%26aufirst%3DH.%26aulast%3DRautio%26aufirst%3DJ.%26atitle%3DProdrugs%2520-%2520from%2520Serendipity%2520to%2520Rational%2520Design%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26issue%3D3%26spage%3D750%26epage%3D771%26doi%3D10.1124%2Fpr.110.003459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zawilska, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojcieszak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, A. B.</span></span> <span> </span><span class="NLM_article-title">Prodrugs: A Challenge for the Drug Development</span>. <i>Pharmacol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/S1734-1140(13)70959-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2FS1734-1140%2813%2970959-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=23563019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amu7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=1-14&author=J.+B.+Zawilskaauthor=J.+Wojcieszakauthor=A.+B.+Olejniczak&title=Prodrugs%3A+A+Challenge+for+the+Drug+Development&doi=10.1016%2FS1734-1140%2813%2970959-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs: a challenge for the drug development</span></div><div class="casAuthors">Zawilska, Jolanta B.; Wojcieszak, Jakub; Olejniczak, Agnieszka B.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">A review.  It is estd. that about 10% of the drugs approved worldwide can be classified as prodrugs.  Prodrugs, which have no or poor biol. activity, are chem. modified versions of a pharmacol. active agent, which must undergo transformation in vivo to release the active drug.  They are designed in order to improve the physicochem., biopharmaceutical and/or pharmacokinetic properties of pharmacol. potent compds.  This article describes the basic functional groups that are amenable to prodrug design, and highlights the major applications of the prodrug strategy, including the ability to improve oral absorption and aq. soly., increase lipophilicity, enhance active transport, as well as achieve site-selective delivery.  Special emphasis is given to the role of the prodrug concept in the design of new anticancer therapies, including antibody-directed enzyme prodrug therapy (ADEPT) and gene-directed enzyme prodrug therapy (GDEPT).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Pl3d6hWiyLVg90H21EOLACvtfcHk0liax9BqeRsAuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amu7nL&md5=b1c764a7b538c1850839400d76cdd856</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS1734-1140%2813%2970959-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1734-1140%252813%252970959-9%26sid%3Dliteratum%253Aachs%26aulast%3DZawilska%26aufirst%3DJ.%2BB.%26aulast%3DWojcieszak%26aufirst%3DJ.%26aulast%3DOlejniczak%26aufirst%3DA.%2BB.%26atitle%3DProdrugs%253A%2520A%2520Challenge%2520for%2520the%2520Drug%2520Development%26jtitle%3DPharmacol.%2520Rep.%26date%3D2013%26volume%3D65%26spage%3D1%26epage%3D14%26doi%3D10.1016%2FS1734-1140%2813%2970959-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, B.</span></span> <span> </span><span class="NLM_article-title">Methotrexate: A Detailed Review on Drug Delivery and Clinical Aspects</span>. <i>Expert Opin. Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1517/17425247.2012.642362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1517%2F17425247.2012.642362" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=151-169&issue=2&author=Z.+A.+Khanauthor=R.+Tripathiauthor=B.+Mishra&title=Methotrexate%3A+A+Detailed+Review+on+Drug+Delivery+and+Clinical+Aspects&doi=10.1517%2F17425247.2012.642362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F17425247.2012.642362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2012.642362%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DZ.%2BA.%26aulast%3DTripathi%26aufirst%3DR.%26aulast%3DMishra%26aufirst%3DB.%26atitle%3DMethotrexate%253A%2520A%2520Detailed%2520Review%2520on%2520Drug%2520Delivery%2520and%2520Clinical%2520Aspects%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2012%26volume%3D9%26issue%3D2%26spage%3D151%26epage%3D169%26doi%3D10.1517%2F17425247.2012.642362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abolmaali, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamaddon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinarvand, R.</span></span> <span> </span><span class="NLM_article-title">A Review of Therapeutic Challenges and Achievements of Methotrexate Delivery Systems for Treatment of Cancer and Rheumatoid Arthritis</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1115</span>– <span class="NLM_lpage">1130</span>, <span class="refDoi"> DOI: 10.1007/s00280-012-2062-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1007%2Fs00280-012-2062-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=23292116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVemsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2013&pages=1115-1130&issue=5&author=S.+S.+Abolmaaliauthor=A.+M.+Tamaddonauthor=R.+Dinarvand&title=A+Review+of+Therapeutic+Challenges+and+Achievements+of+Methotrexate+Delivery+Systems+for+Treatment+of+Cancer+and+Rheumatoid+Arthritis&doi=10.1007%2Fs00280-012-2062-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis</span></div><div class="casAuthors">Abolmaali, Samira Sadat; Tamaddon, Ali Mohammad; Dinarvand, Rassoul</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1115-1130</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Purpose Methotrexate (MTX) is one of the most widely studied and effective therapeutics agents available to treat many solid tumors, hematol. malignancies, and autoimmune diseases such as rheumatoid arthritis; however, the poor pharmacokinetic and narrow safety margin of the drug limits the therapeutic outcomes of conventional drug delivery systems.  For an improved delivery of MTX, several pathophysiol. features such as angiogenesis, enhanced permeability and retention effects, acidosis, and expression of specific antigens and receptors can be used either as targets or as tools for drug delivery.  Methods There are many novel delivery systems developed to improve the pitfalls of MTX therapy ranged from polymeric conjugates such as human serum albumin, liposomes, microspheres, solid lipid nanoparticles, polymeric nanoparticles, dendrimers, polymeric micelles, in situ forming hydrogels, carrier erythrocyte, and nanotechnol.-based vehicles such as carbon nanotubes, magnetic nanoparticles, and gold nanoparticles.  Some are further modified with targeting ligands for active targeting purposes.  Results Such delivery systems provide prolonged plasma profile, enhanced and specific activity in vitro and in vivo in animal models.  Nevertheless, more complementary studies are needed before they can be applied in human.  Conclusion This review deals with the challenges of conventional systems and achievements of each pharmaceutical class of novel drug delivery vehicle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiKiJt5rFW_rVg90H21EOLACvtfcHk0lgKBeeS9SI4zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVemsL4%253D&md5=e371656cf6617af4bd8d2905566e1dcb</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs00280-012-2062-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-012-2062-0%26sid%3Dliteratum%253Aachs%26aulast%3DAbolmaali%26aufirst%3DS.%2BS.%26aulast%3DTamaddon%26aufirst%3DA.%2BM.%26aulast%3DDinarvand%26aufirst%3DR.%26atitle%3DA%2520Review%2520of%2520Therapeutic%2520Challenges%2520and%2520Achievements%2520of%2520Methotrexate%2520Delivery%2520Systems%2520for%2520Treatment%2520of%2520Cancer%2520and%2520Rheumatoid%2520Arthritis%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2013%26volume%3D71%26issue%3D5%26spage%3D1115%26epage%3D1130%26doi%3D10.1007%2Fs00280-012-2062-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wunder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller-Ladner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stelzer, E. H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stehle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pap, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiehn, C.</span></span> <span> </span><span class="NLM_article-title">Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>170</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4793</span>– <span class="NLM_lpage">4801</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.170.9.4793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.4049%2Fjimmunol.170.9.4793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=12707361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtVKntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=4793-4801&issue=9&author=A.+Wunderauthor=U.+M%C3%BCller-Ladnerauthor=E.+H.+K.+Stelzerauthor=J.+Funkauthor=E.+Neumannauthor=G.+Stehleauthor=T.+Papauthor=H.+Sinnauthor=S.+Gayauthor=C.+Fiehn&title=Albumin-Based+Drug+Delivery+as+Novel+Therapeutic+Approach+for+Rheumatoid+Arthritis&doi=10.4049%2Fjimmunol.170.9.4793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritis</span></div><div class="casAuthors">Wunder, Andreas; Mueller-Ladner, Ulf; Stelzer, Ernst H. K.; Funk, Juergen; Neumann, Elena; Stehle, Gerd; Pap, Thomas; Sinn, Hannsjoerg; Gay, Steffen; Fiehn, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4793-4801</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">We reported recently that albumin is a suitable drug carrier for targeted delivery of methotrexate (MTX) to tumors.  Due to pathophysiol. conditions in neoplastic tissue, high amts. of albumin accumulate in tumors and are metabolized by malignant cells.  MTX, covalently coupled to human serum albumin (MTX-HSA) for cancer treatment, is currently being evaluated in phase II clin. trials.  Because synovium of patients with rheumatoid arthritis (RA) shares various features obsd. also in tumors, albumin-based drug targeting of inflamed joints might be an attractive therapeutic approach.  Therefore, the pharmacokinetics of albumin and MTX in a mouse model of arthritis was examd.  Addnl., uptake of albumin by synovial fibroblasts of RA patients and the efficacy of MTX and MTX-HSA in arthritic mice were studied.  The results show that when compared with MTX, significantly higher amts. of albumin accumulate in inflamed paws, and significantly lower amts. of albumin are found in the liver and the kidneys.  The protein is metabolized by human synovial fibroblasts in vitro and in vivo.  MTX-HSA was significantly more effective in suppression of the onset of arthritis in mice than was MTX.  In conclusion, albumin appears to be a suitable drug carrier in RA, most likely due to effects on synovial fibroblasts, which might increase therapeutic efficacy and reduce side effects of MTX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotxpoEkxcv2bVg90H21EOLACvtfcHk0lgKBeeS9SI4zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtVKntbY%253D&md5=ee89efe0111a5306c3b4cbb28f62520f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.170.9.4793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.170.9.4793%26sid%3Dliteratum%253Aachs%26aulast%3DWunder%26aufirst%3DA.%26aulast%3DM%25C3%25BCller-Ladner%26aufirst%3DU.%26aulast%3DStelzer%26aufirst%3DE.%2BH.%2BK.%26aulast%3DFunk%26aufirst%3DJ.%26aulast%3DNeumann%26aufirst%3DE.%26aulast%3DStehle%26aufirst%3DG.%26aulast%3DPap%26aufirst%3DT.%26aulast%3DSinn%26aufirst%3DH.%26aulast%3DGay%26aufirst%3DS.%26aulast%3DFiehn%26aufirst%3DC.%26atitle%3DAlbumin-Based%2520Drug%2520Delivery%2520as%2520Novel%2520Therapeutic%2520Approach%2520for%2520Rheumatoid%2520Arthritis%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D170%26issue%3D9%26spage%3D4793%26epage%3D4801%26doi%3D10.4049%2Fjimmunol.170.9.4793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiehn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sass, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller-Ladner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, E.</span></span> <span> </span><span class="NLM_article-title">Targeted Drug Delivery by in Vivo Coupling to Endogenous Albumin: An Albumin-Binding Prodrug of Methotrexate (MTX) Is Better than MTX in the Treatment of Murine Collagen-Induced Arthritis</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1188</span>– <span class="NLM_lpage">1191</span>, <span class="refDoi"> DOI: 10.1136/ard.2007.086843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1136%2Fard.2007.086843" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=18408252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSktbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2008&pages=1188-1191&issue=8&author=C.+Fiehnauthor=F.+Kratzauthor=G.+Sassauthor=U.+M%C3%BCller-Ladnerauthor=E.+Neumann&title=Targeted+Drug+Delivery+by+in+Vivo+Coupling+to+Endogenous+Albumin%3A+An+Albumin-Binding+Prodrug+of+Methotrexate+%28MTX%29+Is+Better+than+MTX+in+the+Treatment+of+Murine+Collagen-Induced+Arthritis&doi=10.1136%2Fard.2007.086843"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis</span></div><div class="casAuthors">Fiehn, C.; Kratz, F.; Sass, G.; Mueller-Ladner, U.; Neumann, E.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1188-1191</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objective: To examine the effect of an albumin-binding prodrug of methotrexate (MTX) in the treatment of murine collagen-induced arthritis (CIA).  Methods: The prodrug AWO54 with the formula EMC-D-Ala-Phe-Lys-Lys-MTX binds selectively to the cysteine-34 position of endogenous albumin, which acts as a macromol. drug carrier for MTX to the site of inflammation.  The CIA model was used to evaluate the anti-arthritic effect of the compd. after i.v. application.  Results: The albumin-bound form of AWO54 was efficiently cleaved by cathepsin B and plasmin, two proteases that are overexpressed in rheumatoid arthritis, and release a MTX lysine deriv.  AWO54 suppressed CIA in a dose-dependent manner and was significantly better than MTX.  To obtain a similar effect only about 20% of the MTX-equiv. dose of AWO54 had to be given.  The efficacy of the drug was tested in two different stages of CIA: while both, MTX and AWO54 inhibited arthritis in an early stage of the disease, in a later stage only AWO54 showed a significant inhibitory effect in comparison with control.  Conclusion: Targeted drug delivery by in vivo coupling of a prodrug of MTX to endogenous albumin is better than MTX in the treatment of CIA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx97X0Qq1abrVg90H21EOLACvtfcHk0lgKBeeS9SI4zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSktbjF&md5=5c75070a8209fc1bd72b355d6ccadbea</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1136%2Fard.2007.086843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2007.086843%26sid%3Dliteratum%253Aachs%26aulast%3DFiehn%26aufirst%3DC.%26aulast%3DKratz%26aufirst%3DF.%26aulast%3DSass%26aufirst%3DG.%26aulast%3DM%25C3%25BCller-Ladner%26aufirst%3DU.%26aulast%3DNeumann%26aufirst%3DE.%26atitle%3DTargeted%2520Drug%2520Delivery%2520by%2520in%2520Vivo%2520Coupling%2520to%2520Endogenous%2520Albumin%253A%2520An%2520Albumin-Binding%2520Prodrug%2520of%2520Methotrexate%2520%2528MTX%2529%2520Is%2520Better%2520than%2520MTX%2520in%2520the%2520Treatment%2520of%2520Murine%2520Collagen-Induced%2520Arthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2008%26volume%3D67%26issue%3D8%26spage%3D1188%26epage%3D1191%26doi%3D10.1136%2Fard.2007.086843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Homma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asanuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nohmi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izutani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, R.</span></span> <span> </span><span class="NLM_article-title">Novel Hyaluronic Acid-Methotrexate Conjugates for Osteoarthritis Treatment</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">4647</span>– <span class="NLM_lpage">4656</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.04.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.bmc.2009.04.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=4647-4656&issue=3&author=A.+Hommaauthor=H.+Satoauthor=A.+Okamachiauthor=T.+Emuraauthor=T.+Ishizawaauthor=T.+Katoauthor=T.+Matsuuraauthor=S.+Satoauthor=T.+Tamuraauthor=Y.+Higuchiauthor=T.+Watanabeauthor=H.+Kitamuraauthor=K.+Asanumaauthor=T.+Yamazakiauthor=M.+Ikemiauthor=H.+Kitagawaauthor=T.+Morikawaauthor=H.+Ikeyaauthor=K.+Maedaauthor=K.+Takahashiauthor=K.+Nohmiauthor=N.+Izutaniauthor=M.+Kandaauthor=R.+Suzuki&title=Novel+Hyaluronic+Acid-Methotrexate+Conjugates+for+Osteoarthritis+Treatment&doi=10.1016%2Fj.bmc.2009.04.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.04.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.04.063%26sid%3Dliteratum%253Aachs%26aulast%3DHomma%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DOkamachi%26aufirst%3DA.%26aulast%3DEmura%26aufirst%3DT.%26aulast%3DIshizawa%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DMatsuura%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DH.%26aulast%3DAsanuma%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DIkemi%26aufirst%3DM.%26aulast%3DKitagawa%26aufirst%3DH.%26aulast%3DMorikawa%26aufirst%3DT.%26aulast%3DIkeya%26aufirst%3DH.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DNohmi%26aufirst%3DK.%26aulast%3DIzutani%26aufirst%3DN.%26aulast%3DKanda%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DR.%26atitle%3DNovel%2520Hyaluronic%2520Acid-Methotrexate%2520Conjugates%2520for%2520Osteoarthritis%2520Treatment%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D3%26spage%3D4647%26epage%3D4656%26doi%3D10.1016%2Fj.bmc.2009.04.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saitoh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span> <span> </span><span class="NLM_article-title">Novel Hyaluronic Acid–methotrexate Conjugate Suppresses Joint Inflammation in the Rat Knee: Efficacy and Safety Evaluation in Two Rat Arthritis Models</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1186/s13075-016-0971-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1186%2Fs13075-016-0971-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=26732314" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=1-11&author=T.+Tamuraauthor=Y.+Higuchiauthor=H.+Kitamuraauthor=N.+Muraoauthor=R.+Saitohauthor=T.+Morikawaauthor=H.+Sato&title=Novel+Hyaluronic+Acid%E2%80%93methotrexate+Conjugate+Suppresses+Joint+Inflammation+in+the+Rat+Knee%3A+Efficacy+and+Safety+Evaluation+in+Two+Rat+Arthritis+Models&doi=10.1186%2Fs13075-016-0971-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2Fs13075-016-0971-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13075-016-0971-8%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DH.%26aulast%3DMurao%26aufirst%3DN.%26aulast%3DSaitoh%26aufirst%3DR.%26aulast%3DMorikawa%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DH.%26atitle%3DNovel%2520Hyaluronic%2520Acid%25E2%2580%2593methotrexate%2520Conjugate%2520Suppresses%2520Joint%2520Inflammation%2520in%2520the%2520Rat%2520Knee%253A%2520Efficacy%2520and%2520Safety%2520Evaluation%2520in%2520Two%2520Rat%2520Arthritis%2520Models%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2016%26volume%3D18%26spage%3D1%26epage%3D11%26doi%3D10.1186%2Fs13075-016-0971-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Homma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asanuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nohmi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izutani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Optimization of Hyaluronic Acid-Methotrexate Conjugates to Maximize Benefit in the Treatment of Osteoarthritis</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1075</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.12.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.bmc.2009.12.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=1062-1075&issue=3&author=A.+Hommaauthor=H.+Satoauthor=T.+Tamuraauthor=A.+Okamachiauthor=T.+Emuraauthor=T.+Ishizawaauthor=T.+Katoauthor=T.+Matsuuraauthor=S.+Satoauthor=Y.+Higuchiauthor=T.+Watanabeauthor=H.+Kitamuraauthor=K.+Asanumaauthor=T.+Yamazakiauthor=M.+Ikemiauthor=H.+Kitagawaauthor=T.+Morikawaauthor=H.+Ikeyaauthor=K.+Maedaauthor=K.+Takahashiauthor=K.+Nohmiauthor=N.+Izutaniauthor=M.+Kandaauthor=R.+Suzuki&title=Synthesis+and+Optimization+of+Hyaluronic+Acid-Methotrexate+Conjugates+to+Maximize+Benefit+in+the+Treatment+of+Osteoarthritis&doi=10.1016%2Fj.bmc.2009.12.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.12.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.12.053%26sid%3Dliteratum%253Aachs%26aulast%3DHomma%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DOkamachi%26aufirst%3DA.%26aulast%3DEmura%26aufirst%3DT.%26aulast%3DIshizawa%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DMatsuura%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DHiguchi%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DH.%26aulast%3DAsanuma%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DIkemi%26aufirst%3DM.%26aulast%3DKitagawa%26aufirst%3DH.%26aulast%3DMorikawa%26aufirst%3DT.%26aulast%3DIkeya%26aufirst%3DH.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DNohmi%26aufirst%3DK.%26aulast%3DIzutani%26aufirst%3DN.%26aulast%3DKanda%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520Optimization%2520of%2520Hyaluronic%2520Acid-Methotrexate%2520Conjugates%2520to%2520Maximize%2520Benefit%2520in%2520the%2520Treatment%2520of%2520Osteoarthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26issue%3D3%26spage%3D1062%26epage%3D1075%26doi%3D10.1016%2Fj.bmc.2009.12.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, a S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camilleri, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amos, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B. D.</span></span> <span> </span><span class="NLM_article-title">Differential Effects of Methotrexate and Liposomally Conjugated Methotrexate in Rat Adjuvant-Induced Arthritis</span>. <i>Clin. Exp. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">565</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2249.1995.tb03853.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1111%2Fj.1365-2249.1995.tb03853.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=8536373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADyaK28Xht1GmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1995&pages=560-565&issue=3&author=a+S.+Williamsauthor=J.+P.+Camilleriauthor=N.+Amosauthor=B.+D.+Williams&title=Differential+Effects+of+Methotrexate+and+Liposomally+Conjugated+Methotrexate+in+Rat+Adjuvant-Induced+Arthritis&doi=10.1111%2Fj.1365-2249.1995.tb03853.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritis</span></div><div class="casAuthors">Williams, A. S.; Camilleri, J. P.; Amos, N.; Williams, B. D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">560-5</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">In this study we evaluated the comparative efficacy of free and liposomally conjugated methotrexate on both disease induction and suppression of acute inflammation in rat adjuvant-induced arthritis.  Rats were given either empty liposomes (E-LIPO), free methotrexate (MTX) or the liposomally conjugated methotrexate (MTX-LIPO) at a dose of 100 μg/day for 7 consecutive days by the i.v. route.  When MTX treatment was initiated on the day of arthritis induction the drug suppressed but did not abolish the development of joint inflammation.  Free MTX had no significant anti-inflammatory effect upon an established arthritis when dosing was commenced on day 11 post-adjuvant induction.  Conversely, MTX-LIPO did not affect the progression of the arthritis when dosing was started on day 0, but exerted a significant anti-inflammatory effect on an established arthritis.  MTX-LIPO treatment was significantly less hematotoxic than free MTX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk9iZniAy0uLVg90H21EOLACvtfcHk0lixUOuBypmrEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xht1GmsL8%253D&md5=dae4bd8eeeccc9f84d22d94c7a4f4cfa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.1995.tb03853.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.1995.tb03853.x%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3Da%2BS.%26aulast%3DCamilleri%26aufirst%3DJ.%2BP.%26aulast%3DAmos%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DB.%2BD.%26atitle%3DDifferential%2520Effects%2520of%2520Methotrexate%2520and%2520Liposomally%2520Conjugated%2520Methotrexate%2520in%2520Rat%2520Adjuvant-Induced%2520Arthritis%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D1995%26volume%3D102%26issue%3D3%26spage%3D560%26epage%3D565%26doi%3D10.1111%2Fj.1365-2249.1995.tb03853.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. K.</span></span> <span> </span><span class="NLM_article-title">Prolonged Blood Circulation of Methotrexate by Modulation of Liposomal Composition</span>. <i>Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1080/107175401317245912</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1080%2F107175401317245912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVeksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=231-237&issue=4&author=M.+S.+Hongauthor=S.+J.+Limauthor=M.+K.+Leeauthor=Y.+B.+Kimauthor=C.+K.+Kim&title=Prolonged+Blood+Circulation+of+Methotrexate+by+Modulation+of+Liposomal+Composition&doi=10.1080%2F107175401317245912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Prolonged blood circulation of methotrexate by modulation of liposomal composition</span></div><div class="casAuthors">Hong, Myo-Sook; Lim, Soo-Jeong; Lee, Mi-Kyung; Kim, Yang Bae; Kim, Chong-Kook</div><div class="citationInfo"><span class="NLM_cas:title">Drug Delivery</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">231-237</span>CODEN:
                <span class="NLM_cas:coden">DDELEB</span>;
        ISSN:<span class="NLM_cas:issn">1071-7544</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis</span>)
        </div><div class="casAbstract">Prolonged circulation by liposomal incorporation has been shown to enhance the therapeutic efficacy of drugs in many cases.  The purpose of this study was to investigate whether the prolonged circulation of methotrexate (MTX) can be achieved by modulating the liposomal compns.  Various compns. of liposomes were prepd. with 2:1 of phosphatidylcholine (PC) and cholesterol (CH) with or without distearoylphosphatidyl-ethanolamine-N-poly(ethyleneglycol) 2000 (DSPE-PEG).  The MTX encapsulation efficiency depended on the type of PC used.  It also appeared to increase by inclusion of DSPE-PEG.  The size of liposomes decreased by the inclusion of DSPE-PEG.  The inclusion of DSPE-PEG lowered the plasma-induced release of MTX from EggPC/CH and DPPC/CH liposomes, suggesting its enhancement effect on the liposomal stability.  After i.v. injection to rats, the pharmacokinetics and biodistribution of MTX were significantly changed by liposomal incorporation and also by the compn. of liposomes.  The total body clearance of MTX incorporated in EggPC/CH, DPPC/CH, EggPC/CH/DSPE-PEG, and DPPC/CH/DSPE-PEG liposomes decreased 4.4-, 14.9-, 24.5-, and 53.1-fold, compared with that of free MTX.  The ratio of MTX concn. in blood to liver and spleen after injection of DPPC/CH, EggPC/CH/DSPE-PEG, and DPPC/CH/DSPE-PEG liposomes was 5.4-, 8.5-, and 13.5-fold higher than that of EggPC/CH liposomes.  Furthermore, the accumulation of MTX in the kidney, one of the organs in which MTX exhibits its toxicity, was significantly lowered by liposomal incorporation, esp. by DSPE-PEG-contg. liposomes.  Taken together, DPPC/CH/DSPE-PEG liposomes most effectively prolonged the blood circulation, and reduced hepatosplenic and kidney uptake of MTX.  DPPC/CH/DSPE-PEG liposomes may have potential as an efficient delivery system for MTX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6jTRxxYDVw7Vg90H21EOLACvtfcHk0lgFzrArYh1bNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVeksrg%253D&md5=6674d3cda9018cc85cb5634344da6ecf</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F107175401317245912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F107175401317245912%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DM.%2BS.%26aulast%3DLim%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DKim%26aufirst%3DY.%2BB.%26aulast%3DKim%26aufirst%3DC.%2BK.%26atitle%3DProlonged%2520Blood%2520Circulation%2520of%2520Methotrexate%2520by%2520Modulation%2520of%2520Liposomal%2520Composition%26jtitle%3DDrug%2520Delivery%26date%3D2001%26volume%3D8%26issue%3D4%26spage%3D231%26epage%3D237%26doi%3D10.1080%2F107175401317245912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risovic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burt, H. M.</span></span> <span> </span><span class="NLM_article-title">Methotrexate Loaded Poly(L-Lactic Acid) Microspheres for Intra-Articular Delivery of Methotrexate to the Joint</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">943</span>– <span class="NLM_lpage">956</span>, <span class="refDoi"> DOI: 10.1002/jps.20031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1002%2Fjps.20031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2004&pages=943-956&issue=4&author=L.+S.+Liangauthor=J.+Jacksonauthor=W.+Minauthor=V.+Risovicauthor=K.+M.+Wasanauthor=H.+M.+Burt&title=Methotrexate+Loaded+Poly%28L-Lactic+Acid%29+Microspheres+for+Intra-Articular+Delivery+of+Methotrexate+to+the+Joint&doi=10.1002%2Fjps.20031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fjps.20031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20031%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DL.%2BS.%26aulast%3DJackson%26aufirst%3DJ.%26aulast%3DMin%26aufirst%3DW.%26aulast%3DRisovic%26aufirst%3DV.%26aulast%3DWasan%26aufirst%3DK.%2BM.%26aulast%3DBurt%26aufirst%3DH.%2BM.%26atitle%3DMethotrexate%2520Loaded%2520Poly%2528L-Lactic%2520Acid%2529%2520Microspheres%2520for%2520Intra-Articular%2520Delivery%2520of%2520Methotrexate%2520to%2520the%2520Joint%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2004%26volume%3D93%26issue%3D4%26spage%3D943%26epage%3D956%26doi%3D10.1002%2Fjps.20031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, G.</span></span> <span> </span><span class="NLM_article-title">Injectable Thermosensitive Hydrogels for Intra-Articular Delivery of Methotrexate</span>. <i>J. Appl. Polym. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">2139</span>– <span class="NLM_lpage">2145</span>, <span class="refDoi"> DOI: 10.1002/app.34332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1002%2Fapp.34332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntlKgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2011&pages=2139-2145&author=B.+Miaoauthor=C.+Songauthor=G.+Ma&title=Injectable+Thermosensitive+Hydrogels+for+Intra-Articular+Delivery+of+Methotrexate&doi=10.1002%2Fapp.34332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Injectable thermosensitive hydrogels for intra-articular delivery of methotrexate</span></div><div class="casAuthors">Miao, Bolong; Song, Cunxian; Ma, Guilei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Polymer Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2139-2145</span>CODEN:
                <span class="NLM_cas:coden">JAPNAB</span>;
        ISSN:<span class="NLM_cas:issn">0021-8995</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Intra-articular drug delivery is the preferred approach for targeting pharmacol. treatment directly at the joints to reduce undesirable side effects assocd. with systemic drug delivery.  In this study, a controlled delivery system of methotrexate (MTX) based on injectable thermosensitive poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) (PCL-PEG-PCL, PEP) hydrogels was developed for the intra-articular drug delivery.  The thermosensitive PEP copolymers were prepd. by ring-opening polymn.  The synthesized PEP copolymers were characterized for their structure, compn., and the sol-to-gel transition.  The in vitro MTX release from the PEP hydrogels was studied.  MTX plasma concn. following intra-articular injection into healthy rats was detd. by HPLC.  Biocompatibility was confirmed by histol. anal. after the intra-articular injection.  The synthesized PEP copolymers aq. solns. formed in situ gel rapidly after the injection.  PEP hydrogels showed the ability to control the release of incorporated MTX.  Following intra-articular injection, the PEP hydrogels decreased the clearance rate of MTX in the joint cavity.  The max. plasma concns. of MTX in rats injected with free MTX were threefold higher than that of the groups injected with MTX hydrogels.  These results suggest that the intra-articular delivery of the PEP hydrogels may be a viable strategy for the controlled release of drugs for treating arthritis diseases. © 2011 Wiley Periodicals, Inc.  J Appl Polym Sci, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhmI8KPlLs5LVg90H21EOLACvtfcHk0lgFzrArYh1bNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntlKgs7s%253D&md5=20bbedd6eac3f7d4096d44dc78c63550</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fapp.34332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fapp.34332%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DB.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DG.%26atitle%3DInjectable%2520Thermosensitive%2520Hydrogels%2520for%2520Intra-Articular%2520Delivery%2520of%2520Methotrexate%26jtitle%3DJ.%2520Appl.%2520Polym.%2520Sci.%26date%3D2011%26volume%3D122%26spage%3D2139%26epage%3D2145%26doi%3D10.1002%2Fapp.34332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kratz, F.</span></span> <span> </span><span class="NLM_article-title">Albumin as a Drug Carrier: Design of Prodrugs, Drug Conjugates and Nanoparticles</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2008.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.jconrel.2008.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=18582981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVensLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2008&pages=171-183&issue=3&author=F.+Kratz&title=Albumin+as+a+Drug+Carrier%3A+Design+of+Prodrugs%2C+Drug+Conjugates+and+Nanoparticles&doi=10.1016%2Fj.jconrel.2008.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles</span></div><div class="casAuthors">Kratz, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-183</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Albumin is playing an increasing role as a drug carrier in the clin. setting.  Principally, three drug delivery technologies can be distinguished: coupling of low-mol. wt. drugs to exogenous or endogenous albumin, conjugation with bioactive proteins and encapsulation of drugs into albumin nanoparticles.  The accumulation of albumin in solid tumors forms the rationale for developing albumin-based drug delivery systems for tumor targeting.  Clin., a methotrexate-albumin conjugate, an albumin-binding prodrug of doxorubicin, i.e. the (6-maleimido)caproylhydrazone deriv. of doxorubicin (DOXO-EMCH), and an albumin paclitaxel nanoparticle (Abraxane) have been evaluated clin.  Abraxane has been approved for treating metastatic breast cancer.  An alternative strategy is to bind a therapeutic peptide or protein covalently or phys. to albumin to enhance its stability and half-life.  This approach has been applied to peptides with antinociceptive, antidiabetes, antitumor or antiviral activity: Levemir, a myristic acid deriv. of insulin that binds to the fatty acid binding sites of circulating albumin, has been approved for the treatment of diabetes.  Furthermore, Albuferon, a fusion protein of albumin and interferon, is currently being assessed in phase III clin. trials for the treatment of hepatitis C and could become an alternative to pegylated interferon.  This review gives an account of the different drug delivery systems which make use of albumin as a drug carrier with a focus on those systems that have reached an advanced stage of preclin. evaluation or that have entered clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPSwOkIFOBr7Vg90H21EOLACvtfcHk0lgFzrArYh1bNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVensLvP&md5=32729be05d7227de8b6a5c8d8d890e38</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2008.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2008.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DKratz%26aufirst%3DF.%26atitle%3DAlbumin%2520as%2520a%2520Drug%2520Carrier%253A%2520Design%2520of%2520Prodrugs%252C%2520Drug%2520Conjugates%2520and%2520Nanoparticles%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2008%26volume%3D132%26issue%3D3%26spage%3D171%26epage%3D183%26doi%3D10.1016%2Fj.jconrel.2008.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mittal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, A. B.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species in Inflammation and Tissue Injury</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1126</span>– <span class="NLM_lpage">1167</span>, <span class="refDoi"> DOI: 10.1089/ars.2012.5149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1089%2Fars.2012.5149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=23991888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXit12qtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1126-1167&issue=7&author=M.+Mittalauthor=M.+R.+Siddiquiauthor=K.+Tranauthor=S.+P.+Reddyauthor=A.+B.+Malik&title=Reactive+Oxygen+Species+in+Inflammation+and+Tissue+Injury&doi=10.1089%2Fars.2012.5149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species in Inflammation and Tissue Injury</span></div><div class="casAuthors">Mittal, Manish; Siddiqui, Mohammad Rizwan; Tran, Khiem; Reddy, Sekhar P.; Malik, Asrar B.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1126-1167</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are key signaling mols. that play an important role in the progression of inflammatory disorders.  An enhanced ROS generation by polymorphonuclear neutrophils (PMNs) at the site of inflammation causes endothelial dysfunction and tissue injury.  The vascular endothelium plays an important role in passage of macromols. and inflammatory cells from the blood to tissue.  Under the inflammatory conditions, oxidative stress produced by PMNs leads to the opening of inter-endothelial junctions and promotes the migration of inflammatory cells across the endothelial barrier.  The migrated inflammatory cells not only help in the clearance of pathogens and foreign particles but also lead to tissue injury.  The current review compiles the past and current research in the area of inflammation with particular emphasis on oxidative stress-mediated signaling mechanisms that are involved in inflammation and tissue injury.  Antioxid. Redox Signal. 20, 1126-1167.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot8O-h45Zi6LVg90H21EOLACvtfcHk0li9V8rhd_S-sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXit12qtbg%253D&md5=324f08a1e66b88576526690cb6583cf5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.5149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.5149%26sid%3Dliteratum%253Aachs%26aulast%3DMittal%26aufirst%3DM.%26aulast%3DSiddiqui%26aufirst%3DM.%2BR.%26aulast%3DTran%26aufirst%3DK.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMalik%26aufirst%3DA.%2BB.%26atitle%3DReactive%2520Oxygen%2520Species%2520in%2520Inflammation%2520and%2520Tissue%2520Injury%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D20%26issue%3D7%26spage%3D1126%26epage%3D1167%26doi%3D10.1089%2Fars.2012.5149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchon, C. a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Gabalawy, H. S.</span></span> <span> </span><span class="NLM_article-title">Oxidation in Rheumatoid Arthritis</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1186/ar1447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1186%2Far1447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=15535839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADC%252BD2crmtlyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=265-278&author=C.+a.+Hitchonauthor=H.+S.+El-Gabalawy&title=Oxidation+in+Rheumatoid+Arthritis&doi=10.1186%2Far1447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation in rheumatoid arthritis</span></div><div class="casAuthors">Hitchon Carol A; El-Gabalawy Hani S</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis research & therapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">265-78</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxygen metabolism has an important role in the pathogenesis of rheumatoid arthritis.  Reactive oxygen species (ROS) produced in the course of cellular oxidative phosphorylation, and by activated phagocytic cells during oxidative bursts, exceed the physiological buffering capacity and result in oxidative stress.  The excessive production of ROS can damage protein, lipids, nucleic acids, and matrix components.  They also serve as important intracellular signaling molecules that amplify the synovial inflammatory-proliferative response.  Repetitive cycles of hypoxia and reoxygenation associated with changes in synovial perfusion are postulated to activate hypoxia-inducible factor-1alpha and nuclear factor-kappaB, two key transcription factors that are regulated by changes in cellular oxygenation and cytokine stimulation, and that in turn orchestrate the expression of a spectrum of genes critical to the persistence of synovitis.  An understanding of the complex interactions involved in these pathways might allow the development of novel therapeutic strategies for rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnXVVIVHWpuVZoq0fPSOTvfW6udTcc2eYMBbM8u-pkT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crmtlyhtQ%253D%253D&md5=4cfc31bf2730eb127f7f1cca1d515609</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2Far1447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far1447%26sid%3Dliteratum%253Aachs%26aulast%3DHitchon%26aufirst%3DC.%2Ba.%26aulast%3DEl-Gabalawy%26aufirst%3DH.%2BS.%26atitle%3DOxidation%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2004%26volume%3D6%26spage%3D265%26epage%3D278%26doi%3D10.1186%2Far1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chockley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pase, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieschke, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabher, C.</span></span> <span> </span><span class="NLM_article-title">Hydrogen Peroxide in Inflammation: Messenger, Guide, and Assassin</span>. <i>Adv. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">541471</span>, <span class="refDoi"> DOI: 10.1155/2012/541471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1155%2F2012%2F541471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=22737171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A280%3ADC%252BC38jltF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=541471&author=C.+Wittmannauthor=P.+Chockleyauthor=S.+K.+Singhauthor=L.+Paseauthor=G.+J.+Lieschkeauthor=C.+Grabher&title=Hydrogen+Peroxide+in+Inflammation%3A+Messenger%2C+Guide%2C+and+Assassin&doi=10.1155%2F2012%2F541471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen peroxide in inflammation: messenger, guide, and assassin</span></div><div class="casAuthors">Wittmann C; Chockley P; Singh S K; Pase L; Lieschke G J; Grabher C</div><div class="citationInfo"><span class="NLM_cas:title">Advances in hematology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">541471</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Starting as a model for developmental genetics, embryology, and organogenesis, the zebrafish has become increasingly popular as a model organism for numerous areas of biology and biomedicine over the last decades.  Within haematology, this includes studies on blood cell development and function and the intricate regulatory mechanisms within vertebrate immunity.  Here, we review recent studies on the immediate mechanisms mounting an inflammatory response by in vivo analyses using the zebrafish.  These recently revealed novel roles of the reactive oxygen species hydrogen peroxide that have changed our view on the initiation of a granulocytic inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXsaLw17-WInO4gDb7JggCfW6udTcc2eYMBbM8u-pkT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jltF2qtw%253D%253D&md5=98c239957753c47609ab32d7717e9c72</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1155%2F2012%2F541471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F541471%26sid%3Dliteratum%253Aachs%26aulast%3DWittmann%26aufirst%3DC.%26aulast%3DChockley%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DPase%26aufirst%3DL.%26aulast%3DLieschke%26aufirst%3DG.%2BJ.%26aulast%3DGrabher%26aufirst%3DC.%26atitle%3DHydrogen%2520Peroxide%2520in%2520Inflammation%253A%2520Messenger%252C%2520Guide%252C%2520and%2520Assassin%26jtitle%3DAdv.%2520Hematol.%26date%3D2012%26volume%3D2012%26spage%3D541471%26doi%3D10.1155%2F2012%2F541471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalczyk, S.</span></span> <span> </span><span class="NLM_article-title">A Study of Free Radical Chemistry: Their Role and Pathophysiological Significance</span>. <i>Acta Biochim. Pol</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=1-16&issue=1&author=M.+Gutowskiauthor=S.+Kowalczyk&title=A+Study+of+Free+Radical+Chemistry%3A+Their+Role+and+Pathophysiological+Significance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGutowski%26aufirst%3DM.%26aulast%3DKowalczyk%26aufirst%3DS.%26atitle%3DA%2520Study%2520of%2520Free%2520Radical%2520Chemistry%253A%2520Their%2520Role%2520and%2520Pathophysiological%2520Significance%26jtitle%3DActa%2520Biochim.%2520Pol%26date%3D2013%26volume%3D60%26issue%3D1%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wruck, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragoulis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurzynski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandenburg, L.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassenpflug, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitag-Wolf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varoga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pufe, T.</span></span> <span> </span><span class="NLM_article-title">Role of Oxidative Stress in Rheumatoid Arthritis: Insights from the Nrf2-Knockout Mice</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">850</span>, <span class="refDoi"> DOI: 10.1136/ard.2010.132720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1136%2Fard.2010.132720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=21173018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1egsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=844-850&issue=5&author=C.+J.+Wruckauthor=A.+Fragoulisauthor=A.+Gurzynskiauthor=L.-O.+Brandenburgauthor=Y.+W.+Kanauthor=K.+Chanauthor=J.+Hassenpflugauthor=S.+Freitag-Wolfauthor=D.+Varogaauthor=S.+Lipprossauthor=T.+Pufe&title=Role+of+Oxidative+Stress+in+Rheumatoid+Arthritis%3A+Insights+from+the+Nrf2-Knockout+Mice&doi=10.1136%2Fard.2010.132720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice</span></div><div class="casAuthors">Wruck, Christoph Jan; Fragoulis, Athanassios; Gurzynski, Agata; Brandenburg, Lars-Ove; Kan, Yuet Wai; Chan, Kaimin; Hassenpflug, Joachim; Freitag-Wolf, Sandra; Varoga, Deike; Lippross, Sebastian; Pufe, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">844-850</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Increasing evidence suggests that oxidative stress may play a key role in joint destruction due to rheumatoid arthritis (RA).  The aim of this study was to elucidate the role of nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor that maintains the cellular defense against oxidative stress, in RA.  The activation status of Nrf2 was assessed in synovial tissue from patients with RA using immunohistochem.  Antibody-induced arthritis (AIA) was induced in Nrf2-knockout and Nrf2-wild-type control mice.  The severity of cartilage destruction was evaluated using a damage score.  The extent of oxidative stress, the activation state of Nrf2 and the expression level of Nrf2 target genes were analyzed by immunhistol. staining.  The expression of vascular endothelial growth factor (VEGF)-A was examd. on mRNA and protein using the Luminex technique.  A Xenogen imaging system was used to measure Nrf2 activity in an antioxidant response element-luciferase transgenic mouse during AIA.  Results Nrf2 was activated in the joints of arthritic mice and of patients with RA.  Nrf2-knockout mice had more severe cartilage injuries and more oxidative damage, and the expression of Nrf2 target genes was enhanced in Nrf2-wild-type but not in knockout mice during AIA.  Both VEGF-A mRNA and protein expression was upregulated in Nrf2-knockout mice during AIA.  An unexpected finding was the no. of spontaneously fractured bones in Nrf2-knockout mice with AIA.  These results provide strong evidence that oxidative stress is significantly involved in cartilage degrdn. in exptl. arthritis, and indicate that the presence of a functional Nrf2 gene is a major requirement for limiting cartilage destruction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVA53-Yyb-qLVg90H21EOLACvtfcHk0lipEhWWeje3AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1egsbk%253D&md5=a68710cc4197ac967802fd1d0631aef2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1136%2Fard.2010.132720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2010.132720%26sid%3Dliteratum%253Aachs%26aulast%3DWruck%26aufirst%3DC.%2BJ.%26aulast%3DFragoulis%26aufirst%3DA.%26aulast%3DGurzynski%26aufirst%3DA.%26aulast%3DBrandenburg%26aufirst%3DL.-O.%26aulast%3DKan%26aufirst%3DY.%2BW.%26aulast%3DChan%26aufirst%3DK.%26aulast%3DHassenpflug%26aufirst%3DJ.%26aulast%3DFreitag-Wolf%26aufirst%3DS.%26aulast%3DVaroga%26aufirst%3DD.%26aulast%3DLippross%26aufirst%3DS.%26aulast%3DPufe%26aufirst%3DT.%26atitle%3DRole%2520of%2520Oxidative%2520Stress%2520in%2520Rheumatoid%2520Arthritis%253A%2520Insights%2520from%2520the%2520Nrf2-Knockout%2520Mice%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2011%26volume%3D70%26issue%3D5%26spage%3D844%26epage%3D850%26doi%3D10.1136%2Fard.2010.132720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinstain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savariar, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsen, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, R. Y.</span></span> <span> </span><span class="NLM_article-title">Vivo Targeting of Hydrogen Peroxide by Activatable Cell- Penetrating Peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1021/ja411547j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja411547j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=874-877&author=R.+Weinstainauthor=E.+N.+Savariarauthor=C.+N.+Felsenauthor=R.+Y.+Tsien&title=Vivo+Targeting+of+Hydrogen+Peroxide+by+Activatable+Cell-+Penetrating+Peptides&doi=10.1021%2Fja411547j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja411547j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja411547j%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstain%26aufirst%3DR.%26aulast%3DSavariar%26aufirst%3DE.%2BN.%26aulast%3DFelsen%26aufirst%3DC.%2BN.%26aulast%3DTsien%26aufirst%3DR.%2BY.%26atitle%3DVivo%2520Targeting%2520of%2520Hydrogen%2520Peroxide%2520by%2520Activatable%2520Cell-%2520Penetrating%2520Peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D874%26epage%3D877%26doi%3D10.1021%2Fja411547j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, S.</span></span> <span> </span><span class="NLM_article-title">Sensitive and Nonenzymatic Measurement of Hydrogen Peroxide in Biological Systems</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1016/S0891-5849(00)00261-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2FS0891-5849%2800%2900261-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=11020662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntVWgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=410-415&issue=5&author=S.+Mueller&title=Sensitive+and+Nonenzymatic+Measurement+of+Hydrogen+Peroxide+in+Biological+Systems&doi=10.1016%2FS0891-5849%2800%2900261-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitive and nonenzymatic measurement of hydrogen peroxide in biological systems</span></div><div class="casAuthors">Mueller, S.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">410-415</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The increasing demand in detecting H2O2 under various exptl. conditions is only partly fulfilled by most conventional peroxidase-based assays.  This article describes a sensitive and nonenzymic H2O2 assay that is based on the chemiluminescence reaction of luminol with hypochlorite.  It allows the detn. of H2O2 down to nanomolar concns.  Actual H2O2 concns. rather than a turnover of H2O2 can be detd. in monolayer cultures, perfusates, suspensions of intact cells, organelles, and crude homogenates.  One of the strengths of this assay is that it may be used to assess fast enzyme kinetics (catalase, glutathione peroxidase, oxidases) at very low H2O2 concns.  Its use together with a glucose oxidase/catalase system appears to be a powerful tool in studying signal functions of H2O2 in various biol. systems on a quant. basis.  Several applications are discussed in detail to demonstrate the tech. requirements and anal. potentials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmnQoMUuXKRrVg90H21EOLACvtfcHk0lipEhWWeje3AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntVWgsLs%253D&md5=70e0055f17eefdd6ae26f87b9aa0bca1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2800%2900261-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252800%252900261-6%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DS.%26atitle%3DSensitive%2520and%2520Nonenzymatic%2520Measurement%2520of%2520Hydrogen%2520Peroxide%2520in%2520Biological%2520Systems%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2000%26volume%3D29%26issue%3D5%26spage%3D410%26epage%3D415%26doi%3D10.1016%2FS0891-5849%2800%2900261-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boveris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bustamante, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdez, L.</span></span> <span> </span><span class="NLM_article-title">Measurement of Superoxide Radical and Hydrogen Peroxide Production in Isolated Cells and Subcellular Organelles</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">280</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(02)49342-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2FS0076-6879%2802%2949342-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=11912917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFajtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2002&pages=280-287&author=A.+Boverisauthor=S.+Alvarezauthor=J.+Bustamanteauthor=L.+Valdez&title=Measurement+of+Superoxide+Radical+and+Hydrogen+Peroxide+Production+in+Isolated+Cells+and+Subcellular+Organelles&doi=10.1016%2FS0076-6879%2802%2949342-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of superoxide radical and hydrogen peroxide production in isolated cells and subcellular organelles</span></div><div class="casAuthors">Boveris, Alberto; Alvarez, Silvia; Bustamante, Juanita; Valdez, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">Superoxide Dismutase</span>),
    <span class="NLM_cas:pages">280-287</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review.  The kinetics were investigated of H2O2 release by human mononuclear cells nonstimulated and stimulated by phorbol myristate acetate (PMA) and of H2O2 release from thymocytes.  The superoxide dismutase effect was also studied.  Nonstimulated mononuclear cells reached an equil. with external H2O2 at about 0.25 μM H2O2.  After stimulation by PMA the level was increased to about 0.80 μM H2O2.  The basal situation of thymocytes indicated an intracellular concn. of about 35 nM H2O2, which was increased to about 45 and 75 nM H2O2 after apoptosis stimulation by methylprednisole and thapsigargin, resp.  The addn. of superoxide dismutase to the reaction medium usually had no effect on cells other than the phagocytic cells, which release significant amts. of O2- to the suspending medium.  A review is added on quantitation of O2- and H2O2 prodn. and steady-state concns.  (c) 2002 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq9d_eJWIbG7Vg90H21EOLACvtfcHk0lipEhWWeje3AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFajtbk%253D&md5=f0ba3b4fc1260a794b80209a621ba1e2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2802%2949342-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252802%252949342-1%26sid%3Dliteratum%253Aachs%26aulast%3DBoveris%26aufirst%3DA.%26aulast%3DAlvarez%26aufirst%3DS.%26aulast%3DBustamante%26aufirst%3DJ.%26aulast%3DValdez%26aufirst%3DL.%26atitle%3DMeasurement%2520of%2520Superoxide%2520Radical%2520and%2520Hydrogen%2520Peroxide%2520Production%2520in%2520Isolated%2520Cells%2520and%2520Subcellular%2520Organelles%26jtitle%3DMethods%2520Enzymol.%26date%3D2002%26volume%3D349%26spage%3D280%26epage%3D287%26doi%3D10.1016%2FS0076-6879%2802%2949342-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stones, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span> <span> </span><span class="NLM_article-title">Hydrogen Peroxide: A Signalling Messenger</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1089/ars.2006.8.243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1089%2Fars.2006.8.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=16677071" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=243-270&issue=3%E2%80%934&author=J.+R.+Stonesauthor=S.+Yang&title=Hydrogen+Peroxide%3A+A+Signalling+Messenger&doi=10.1089%2Fars.2006.8.243"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1089%2Fars.2006.8.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2006.8.243%26sid%3Dliteratum%253Aachs%26aulast%3DStones%26aufirst%3DJ.%2BR.%26aulast%3DYang%26aufirst%3DS.%26atitle%3DHydrogen%2520Peroxide%253A%2520A%2520Signalling%2520Messenger%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2006%26volume%3D8%26issue%3D3%25E2%2580%25934%26spage%3D243%26epage%3D270%26doi%3D10.1089%2Fars.2006.8.243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Induced and Self-Monitored Intrinsic Apoptosis by Antitumor Theranostic Prodrug: In Vivo Imaging and Precise Cancer Treatment</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">17836</span>– <span class="NLM_lpage">17843</span>, <span class="refDoi"> DOI: 10.1021/ja510421q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja510421q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOjsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=17836-17843&issue=51&author=R.+Kumarauthor=J.+Hanauthor=H.+J.+Limauthor=W.+X.+Renauthor=J.+Y.+Limauthor=J.+H.+Kimauthor=J.+S.+Kim&title=Mitochondrial+Induced+and+Self-Monitored+Intrinsic+Apoptosis+by+Antitumor+Theranostic+Prodrug%3A+In+Vivo+Imaging+and+Precise+Cancer+Treatment&doi=10.1021%2Fja510421q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Induced and Self-Monitored Intrinsic Apoptosis by Antitumor Theranostic Prodrug: In Vivo Imaging and Precise Cancer Treatment</span></div><div class="casAuthors">Kumar, Rajesh; Han, Jiyou; Lim, Hee-Joung; Ren, Wen Xiu; Lim, Ja-Yun; Kim, Jong-Hoon; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">17836-17843</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of apoptosis, the cell death machinery, in tumor cells by organelle-specific delivery of antitumor theranostic agent is the utmost challenge in cancer therapy.  Herein, we developed a highly efficient mitochondria-targeting antitumor theranostic prodrug 7 that contained two mols. of drug 5'-deoxy-5-fluorouridine and an apoptotic marker ethidium for self-monitoring intrinsic (mitochondrial) apoptosis after its activation in tumor cells.  Theranostic 7 was activated by endogenously produced mitochondrial-overexpressed H2O2 and released drug 5'-deoxy-5-fluorouridine and apoptotic marker ethidium to the tumor cells.  The in vitro and in vivo drug release was monitored by observing the fluorescence changes of ethidium.  Theranostic 7 exhibited an enhanced cytotoxicity over com. 5-fluorouracil (an active drug of 5'-deoxy-5-fluorouridine) leading to intrinsic apoptosis monitored by in situ generated ethidium.  Enhanced expression of mitochondria-mediated apoptotic genes (NOXA, PUMA, BID, BAX, and BAK), Cyt C, Caspase-3 and -9, and cell surface death receptors was obsd. after theranostic 7 activation in tumor cells.  In vivo and ex vivo xenografts revealed that theranostic 7 significantly inhibited tumor progression and cured the tumor-bearing mice.  Such organelle-specific theranostic strategies have great potential for the early diagnosis and precise treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxDp1xuNvfLVg90H21EOLACvtfcHk0li7CnLvZYCCWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOjsL3O&md5=0e80b2f99a1054f9da8570c3ceb84783</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fja510421q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja510421q%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DH.%2BJ.%26aulast%3DRen%26aufirst%3DW.%2BX.%26aulast%3DLim%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DMitochondrial%2520Induced%2520and%2520Self-Monitored%2520Intrinsic%2520Apoptosis%2520by%2520Antitumor%2520Theranostic%2520Prodrug%253A%2520In%2520Vivo%2520Imaging%2520and%2520Precise%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26issue%3D51%26spage%3D17836%26epage%3D17843%26doi%3D10.1021%2Fja510421q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monserrat, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Exploring Hydrogen Peroxide Responsive Thiazolidinone-Based Prodrugs</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">7116</span>– <span class="NLM_lpage">7119</span>, <span class="refDoi"> DOI: 10.1039/C4CC09921D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1039%2FC4CC09921D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=7116-7119&issue=33&author=C.+Perezauthor=J.-P.+Monserratauthor=Y.+Chenauthor=S.+M.+Cohen&title=Exploring+Hydrogen+Peroxide+Responsive+Thiazolidinone-Based+Prodrugs&doi=10.1039%2FC4CC09921D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2FC4CC09921D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CC09921D%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMonserrat%26aufirst%3DJ.-P.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DExploring%2520Hydrogen%2520Peroxide%2520Responsive%2520Thiazolidinone-Based%2520Prodrugs%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26issue%3D33%26spage%3D7116%26epage%3D7119%26doi%3D10.1039%2FC4CC09921D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V.</span></span> <span> </span><span class="NLM_article-title">ROS-Activated Anticancer Prodrugs: A New Strategy for Tumor-Specific Damage</span>. <i>Ther. Delivery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">833</span>, <span class="refDoi"> DOI: 10.4155/tde.12.61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.4155%2Ftde.12.61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=22900465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWjsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=823-833&issue=7&author=X.+Pengauthor=V.+Gandhi&title=ROS-Activated+Anticancer+Prodrugs%3A+A+New+Strategy+for+Tumor-Specific+Damage&doi=10.4155%2Ftde.12.61"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage</span></div><div class="casAuthors">Peng, Xiaohua; Gandhi, Varsha</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Delivery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">823-833</span>CODEN:
                <span class="NLM_cas:coden">TDHEA7</span>;
        ISSN:<span class="NLM_cas:issn">2041-5990</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Targeting tumor cells is an important strategy to improve the selectivity of cancer therapies.  With the advanced studies in cancer biol., we know that cancer cells are usually under increased oxidative stress.  The high level of reactive oxygen species in cancer cells has been exploited for developing novel therapeutic strategies to preferentially kill cancer cells.  Our group, amongst others, have used boronic acids/esters as triggers for developing ROS-activated anticancer prodrugs that target cancer cells.  The selectivity was achieved by combining a specific reaction between boronates and H2O2 with the efficient masking of drug toxicity in the prodrug via boronates.  Prodrugs activated via ferrocene-mediated oxidn. have also been developed to improve the selectivity of anticancer drugs.  We describe how the strategies of ROS-activation can be used for further development of new ROS-targeting prodrugs, eventually leading to novel approaches and/or combined technol. for more efficient and selective treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6WcQA9Z5tObVg90H21EOLACvtfcHk0li7CnLvZYCCWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWjsrnN&md5=48b7a3af2a98fff0793cbb98a4026c0e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.4155%2Ftde.12.61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ftde.12.61%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DGandhi%26aufirst%3DV.%26atitle%3DROS-Activated%2520Anticancer%2520Prodrugs%253A%2520A%2520New%2520Strategy%2520for%2520Tumor-Specific%2520Damage%26jtitle%3DTher.%2520Delivery%26date%3D2012%26volume%3D3%26issue%3D7%26spage%3D823%26epage%3D833%26doi%3D10.4155%2Ftde.12.61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzenell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jentzsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veldwijk, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1021/jm2014937</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ers7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=924-934&author=H.+Hagenauthor=P.+Marzenellauthor=E.+Jentzschauthor=F.+Wenzauthor=M.+R.+Veldwijkauthor=A.+Mokhir&title=Aminoferrocene-Based+Prodrugs+Activated+by+Reactive+Oxygen+Species&doi=10.1021%2Fjm2014937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species</span></div><div class="casAuthors">Hagen, Helen; Marzenell, Paul; Jentzsch, Elmar; Wenz, Frederik; Veldwijk, Marlon R.; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">924-934</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cancer cells generally generate higher amts. of reactive oxygen species than normal cells.  On the basis of this difference, prodrugs have been developed (e.g., hydroxyferrocifen), which remain inactive in normal cells, but become activated in cancer cells.  In this work we describe novel aminoferrocene-based prodrugs, which, in contrast to hydroxyferrocifen, after activation form not only quinone methides (QMs), but also catalysts (iron or ferrocenium ions).  The released products act in a concerted fashion.  In particular, QMs alkylate glutathione, thereby inhibiting the antioxidative system of the cell, whereas the iron species induce catalytic generation of hydroxyl radicals.  Since the catalysts are formed as products of the activation reaction, it proceeds autocatalytically.  The most potent prodrug described here is toxic toward cancer cells (human promyelocytic leukemia (HL-60), IC50 = 9 μM, and human glioblastoma-astrocytoma (U373), IC50 = 25 μM), but not toxic (up to 100 μM) toward representative nonmalignant cells (fibroblasts).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXZLxLfss0RrVg90H21EOLACvtfcHk0lhJ_BcXaHdpWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ers7bI&md5=28894e8a8006c8b0ef91455aee76139d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm2014937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014937%26sid%3Dliteratum%253Aachs%26aulast%3DHagen%26aufirst%3DH.%26aulast%3DMarzenell%26aufirst%3DP.%26aulast%3DJentzsch%26aufirst%3DE.%26aulast%3DWenz%26aufirst%3DF.%26aulast%3DVeldwijk%26aufirst%3DM.%2BR.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DAminoferrocene-Based%2520Prodrugs%2520Activated%2520by%2520Reactive%2520Oxygen%2520Species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D924%26epage%3D934%26doi%3D10.1021%2Fjm2014937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">Hydrogen Peroxide Inducible DNA Cross-Linking Agents: Targeted Anticancer Prodrugs</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">19278</span>, <span class="refDoi"> DOI: 10.1021/ja2073824</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja2073824" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyqsLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=19278&author=Y.+Kuangauthor=K.+Balakrishnanauthor=V.+Gandhiauthor=X.+Peng&title=Hydrogen+Peroxide+Inducible+DNA+Cross-Linking+Agents%3A+Targeted+Anticancer+Prodrugs&doi=10.1021%2Fja2073824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen Peroxide Inducible DNA Cross-Linking Agents: Targeted Anticancer Prodrugs</span></div><div class="casAuthors">Kuang, Yunyan; Balakrishnan, Kumudha; Gandhi, Varsha; Peng, Xiaohua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">19278-19281</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The major concern for anticancer chemotherapeutic agents is the host toxicity.  The development of anticancer prodrugs targeting the unique biochem. alterations in cancer cells is an attractive approach to achieve therapeutic activity and selectivity.  We designed and synthesized a new type of nitrogen mustard prodrug that can be activated by high level of reactive oxygen species (ROS) found in cancer cells to release the active chemotherapy agent.  The activation mechanism was detd. by NMR anal.  The activity and selectivity of these prodrugs toward ROS was detd. by measuring DNA interstrand cross-links and/or DNA alkylations.  These compds. showed 60-90% inhibition toward various cancer cells, while normal lymphocytes were not affected.  To the best of our knowledge, this is the first example of H2O2-activated anticancer prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY5EVvl5gaabVg90H21EOLACvtfcHk0lhJ_BcXaHdpWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyqsLvE&md5=d907a75fa0e9c33185187cdfb85fda29</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fja2073824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja2073824%26sid%3Dliteratum%253Aachs%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DBalakrishnan%26aufirst%3DK.%26aulast%3DGandhi%26aufirst%3DV.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DHydrogen%2520Peroxide%2520Inducible%2520DNA%2520Cross-Linking%2520Agents%253A%2520Targeted%2520Anticancer%2520Prodrugs%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D19278%26doi%3D10.1021%2Fja2073824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">Reactive Oxygen Species (ROS) Inducible DNA Cross-Linking Agents and Their Effect on Cancer Cells and Normal Lymphocytes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4498</span>– <span class="NLM_lpage">4510</span>, <span class="refDoi"> DOI: 10.1021/jm401349g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401349g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4498-4510&issue=11&author=W.+Chenauthor=K.+Balakrishnanauthor=Y.+Kuangauthor=Y.+Hanauthor=M.+Fuauthor=V.+Gandhiauthor=X.+Peng&title=Reactive+Oxygen+Species+%28ROS%29+Inducible+DNA+Cross-Linking+Agents+and+Their+Effect+on+Cancer+Cells+and+Normal+Lymphocytes&doi=10.1021%2Fjm401349g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm401349g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401349g%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DBalakrishnan%26aufirst%3DK.%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DM.%26aulast%3DGandhi%26aufirst%3DV.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DReactive%2520Oxygen%2520Species%2520%2528ROS%2529%2520Inducible%2520DNA%2520Cross-Linking%2520Agents%2520and%2520Their%2520Effect%2520on%2520Cancer%2520Cells%2520and%2520Normal%2520Lymphocytes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D11%26spage%3D4498%26epage%3D4510%26doi%3D10.1021%2Fjm401349g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major Jourden, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negoescu, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Activation of Sulfonate Ester Based Matrix Metalloproteinase Proinhibitors by Hydrogen Peroxide</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1007/s00775-010-0727-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1007%2Fs00775-010-0727-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=21049301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOhtL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=313-323&issue=2&author=K.+B.+Danielauthor=J.+L.+Major+Jourdenauthor=K.+E.+Negoescuauthor=S.+M.+Cohen&title=Activation+of+Sulfonate+Ester+Based+Matrix+Metalloproteinase+Proinhibitors+by+Hydrogen+Peroxide&doi=10.1007%2Fs00775-010-0727-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of sulfonate ester based matrix metalloproteinase proinhibitors by hydrogen peroxide</span></div><div class="casAuthors">Daniel, Kevin B.; Major Jourden, Jody L.; Negoescu, Kimberly E.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-323</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">This study details the development of matrix metalloproteinase inhibitor prodrugs (proMMPi) that are activated in the presence of reactive-oxygen species (ROS).  Conventional matrix metalloproteinase inhibitors (MMPi) utilize a zinc-binding group (ZBG) that chelates to the catalytic zinc(II) ion of matrix metalloproteinases (MMPs) to inhibit their activity.  To create ROS-sensitive prodrugs, sulfonate esters were used as a protecting group for the ZBG to block their metal binding ability.  Surprisingly, these sulfonate esters were found to be cleaved by H2O2 only when the ZBG contained an N-oxide donor atom moiety.  Sulfonate ester derivs. of full-length MMPi based on these ROS-triggerable systems were synthesized.  It was found that proMMPi with sulfonate ester protecting groups showed relatively high rates of cleavage in the presence of H2O2 to release the active MMPi.  In vitro MMP inhibition studies confirmed a significant increase in inhibitory activity of proMMPi upon addn. of H2O2, demonstrating the use of sulfonate esters to act as cleavable triggers for ROS-activated prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Svnx818k6LVg90H21EOLACvtfcHk0lhJ_BcXaHdpWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOhtL%252FJ&md5=6ebedb9f348f3cc9828706c5a8c56f78</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2Fs00775-010-0727-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-010-0727-x%26sid%3Dliteratum%253Aachs%26aulast%3DDaniel%26aufirst%3DK.%2BB.%26aulast%3DMajor%2BJourden%26aufirst%3DJ.%2BL.%26aulast%3DNegoescu%26aufirst%3DK.%2BE.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DActivation%2520of%2520Sulfonate%2520Ester%2520Based%2520Matrix%2520Metalloproteinase%2520Proinhibitors%2520by%2520Hydrogen%2520Peroxide%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2011%26volume%3D16%26issue%3D2%26spage%3D313%26epage%3D323%26doi%3D10.1007%2Fs00775-010-0727-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vadukoot, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulsalam, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunderlich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullen, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landero-Figueroa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulloy, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merino, E. J.</span></span> <span> </span><span class="NLM_article-title">Design of a Hydrogen Peroxide-Activatable Agent That Specifically Targets Cancer Cells</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">6885</span>– <span class="NLM_lpage">6892</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.bmc.2014.10.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=6885-6892&issue=24&author=A.+K.+Vadukootauthor=S.+F.+Abdulsalamauthor=M.+Wunderlichauthor=E.+D.+Pullenauthor=J.+Landero-Figueroaauthor=J.+C.+Mulloyauthor=E.+J.+Merino&title=Design+of+a+Hydrogen+Peroxide-Activatable+Agent+That+Specifically+Targets+Cancer+Cells&doi=10.1016%2Fj.bmc.2014.10.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DVadukoot%26aufirst%3DA.%2BK.%26aulast%3DAbdulsalam%26aufirst%3DS.%2BF.%26aulast%3DWunderlich%26aufirst%3DM.%26aulast%3DPullen%26aufirst%3DE.%2BD.%26aulast%3DLandero-Figueroa%26aufirst%3DJ.%26aulast%3DMulloy%26aufirst%3DJ.%2BC.%26aulast%3DMerino%26aufirst%3DE.%2BJ.%26atitle%3DDesign%2520of%2520a%2520Hydrogen%2520Peroxide-Activatable%2520Agent%2520That%2520Specifically%2520Targets%2520Cancer%2520Cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26issue%3D24%26spage%3D6885%26epage%3D6892%26doi%3D10.1016%2Fj.bmc.2014.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deiters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floreancig, P. E.</span></span> <span> </span><span class="NLM_article-title">Alcohol, Aldehyde, and Ketone Liberation and Intracellular Cargo Release through Peroxide-Mediated-Boryl Ether Fragmentation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">13353</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b07890</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b07890" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=13353&author=R.+D.+Hannaauthor=Y.+Naroauthor=A.+Deitersauthor=P.+E.+Floreancig&title=Alcohol%2C+Aldehyde%2C+and+Ketone+Liberation+and+Intracellular+Cargo+Release+through+Peroxide-Mediated-Boryl+Ether+Fragmentation&doi=10.1021%2Fjacs.6b07890"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b07890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b07890%26sid%3Dliteratum%253Aachs%26aulast%3DHanna%26aufirst%3DR.%2BD.%26aulast%3DNaro%26aufirst%3DY.%26aulast%3DDeiters%26aufirst%3DA.%26aulast%3DFloreancig%26aufirst%3DP.%2BE.%26atitle%3DAlcohol%252C%2520Aldehyde%252C%2520and%2520Ketone%2520Liberation%2520and%2520Intracellular%2520Cargo%2520Release%2520through%2520Peroxide-Mediated-Boryl%2520Ether%2520Fragmentation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26spage%3D13353%26doi%3D10.1021%2Fjacs.6b07890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kralovec, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mammen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Methotrexate-Antibody Conjugates by Regiospecific Coupling and Assessment of Drug and Antitumor Activities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2426</span>– <span class="NLM_lpage">2431</span>, <span class="refDoi"> DOI: 10.1021/jm00131a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00131a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=2426-2431&issue=11&author=J.+Kralovecauthor=G.+Spencerauthor=A.+H.+Blairauthor=M.+Mammenauthor=M.+Singhauthor=T.+Ghose&title=Synthesis+of+Methotrexate-Antibody+Conjugates+by+Regiospecific+Coupling+and+Assessment+of+Drug+and+Antitumor+Activities&doi=10.1021%2Fjm00131a003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm00131a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00131a003%26sid%3Dliteratum%253Aachs%26aulast%3DKralovec%26aufirst%3DJ.%26aulast%3DSpencer%26aufirst%3DG.%26aulast%3DBlair%26aufirst%3DA.%2BH.%26aulast%3DMammen%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DGhose%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520Methotrexate-Antibody%2520Conjugates%2520by%2520Regiospecific%2520Coupling%2520and%2520Assessment%2520of%2520Drug%2520and%2520Antitumor%2520Activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26issue%3D11%26spage%3D2426%26epage%3D2431%26doi%3D10.1021%2Fjm00131a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosowsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freisheim, J. H.</span></span> <span> </span><span class="NLM_article-title">Analogues of Methotrexate and Aminopterin with (Gamma)-Methylene and (Gamma)-Cyano Substitution of the Glutamate Side Chain: Synthesis and in Vitro Biological Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1021/jm00105a031</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00105a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=203-208&issue=1&author=A.+Rosowskyauthor=H.+Baderauthor=J.+H.+Freisheim&title=Analogues+of+Methotrexate+and+Aminopterin+with+%28Gamma%29-Methylene+and+%28Gamma%29-Cyano+Substitution+of+the+Glutamate+Side+Chain%3A+Synthesis+and+in+Vitro+Biological+Activity&doi=10.1021%2Fjm00105a031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm00105a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00105a031%26sid%3Dliteratum%253Aachs%26aulast%3DRosowsky%26aufirst%3DA.%26aulast%3DBader%26aufirst%3DH.%26aulast%3DFreisheim%26aufirst%3DJ.%2BH.%26atitle%3DAnalogues%2520of%2520Methotrexate%2520and%2520Aminopterin%2520with%2520%2528Gamma%2529-Methylene%2520and%2520%2528Gamma%2529-Cyano%2520Substitution%2520of%2520the%2520Glutamate%2520Side%2520Chain%253A%2520Synthesis%2520and%2520in%2520Vitro%2520Biological%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26issue%3D1%26spage%3D203%26epage%3D208%26doi%3D10.1021%2Fjm00105a031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peralta-Yahya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornish, V. W.</span></span> <span> </span><span class="NLM_article-title">Optimized Design and Synthesis of Chemical Dimerizer Substrates for Detection of Glycosynthase Activity via Chemical Complementation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6940</span>– <span class="NLM_lpage">6953</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.06.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.bmc.2006.06.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6940-6953&issue=20&author=H.+Taoauthor=P.+Peralta-Yahyaauthor=H.+Linauthor=V.+W.+Cornish&title=Optimized+Design+and+Synthesis+of+Chemical+Dimerizer+Substrates+for+Detection+of+Glycosynthase+Activity+via+Chemical+Complementation&doi=10.1016%2Fj.bmc.2006.06.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.06.034%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DH.%26aulast%3DPeralta-Yahya%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DCornish%26aufirst%3DV.%2BW.%26atitle%3DOptimized%2520Design%2520and%2520Synthesis%2520of%2520Chemical%2520Dimerizer%2520Substrates%2520for%2520Detection%2520of%2520Glycosynthase%2520Activity%2520via%2520Chemical%2520Complementation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26issue%3D20%26spage%3D6940%26epage%3D6953%26doi%3D10.1016%2Fj.bmc.2006.06.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magnus, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, T.</span></span> <span> </span><span class="NLM_article-title">Studies on the Synthesis of the Antitumour Agent CC-1065. Synthesis of the Cyclopropapyrroloindole Portion</span>. <i>J. Chem. Soc., Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>0</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1039/c39840000389</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1039%2Fc39840000389" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=0&publication_year=1984&pages=389-390&author=P.+Magnusauthor=T.+Gallagher&title=Studies+on+the+Synthesis+of+the+Antitumour+Agent+CC-1065.+Synthesis+of+the+Cyclopropapyrroloindole+Portion&doi=10.1039%2Fc39840000389"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2Fc39840000389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39840000389%26sid%3Dliteratum%253Aachs%26aulast%3DMagnus%26aufirst%3DP.%26aulast%3DGallagher%26aufirst%3DT.%26atitle%3DStudies%2520on%2520the%2520Synthesis%2520of%2520the%2520Antitumour%2520Agent%2520CC-1065.%2520Synthesis%2520of%2520the%2520Cyclopropapyrroloindole%2520Portion%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1984%26volume%3D0%26spage%3D389%26epage%3D390%26doi%3D10.1039%2Fc39840000389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adlercreutz, P.</span></span> <span> </span><span class="NLM_article-title">Immobilisation and Application of Lipases in Organic Media</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6406</span>, <span class="refDoi"> DOI: 10.1039/c3cs35446f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1039%2Fc3cs35446f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=23403895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKhtrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=6406&issue=15&author=P.+Adlercreutz&title=Immobilisation+and+Application+of+Lipases+in+Organic+Media&doi=10.1039%2Fc3cs35446f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Immobilization and application of lipases in organic media</span></div><div class="casAuthors">Adlercreutz, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6406-6436</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Different methods of prepg. lipases for use in org. media are critically reviewed.  Solid lipase prepns. can be made by typical immobilization methods such as adsorption, entrapment, covalent coupling or crosslinking.  Immobilization is esp. attractive for lipases because, in addn. to the normal benefits of enzyme immobilization, it can also lead to a considerable increase in catalytic activity, probably caused by conformational changes in the lipase mols.  Activation can be achieved, for example, using hydrophobic support materials or surfactants during the immobilization procedure.  Surfactants can also be used to solubilize lipases in org. media via the formation of hydrophobic ion pairs, surfactant-coated lipase or reversed micelles.  Lipase prepn. methods are discussed with regard to potential lipase inactivation and activation effects, mass transfer limitations, lipase stability and other features important for applications.  The practical applications of lipases in org. media reviewed include ester synthesis, modification of triacylglycerols and phospholipids, fatty acid enrichment, enantiomer resoln., biodiesel prodn. and acylation of carbohydrates and bioactive compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVVlSwzYeI9LVg90H21EOLACvtfcHk0lg51DFeZTuHQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKhtrvN&md5=382e229ffac816d8c0ac718635aed28b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2Fc3cs35446f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cs35446f%26sid%3Dliteratum%253Aachs%26aulast%3DAdlercreutz%26aufirst%3DP.%26atitle%3DImmobilisation%2520and%2520Application%2520of%2520Lipases%2520in%2520Organic%2520Media%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2013%26volume%3D42%26issue%3D15%26spage%3D6406%26doi%3D10.1039%2Fc3cs35446f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temple, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shealy, Y. F.</span></span> <span> </span><span class="NLM_article-title">Analogs of Methotrexate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">862</span>– <span class="NLM_lpage">868</span>, <span class="refDoi"> DOI: 10.1021/jm00193a021</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00193a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1979&pages=862-868&issue=7&author=J.+A.+Montgomeryauthor=J.+R.+Piperauthor=R.+D.+Elliottauthor=C.+Templeauthor=E.+C.+Robertsauthor=Y.+F.+Shealy&title=Analogs+of+Methotrexate&doi=10.1021%2Fjm00193a021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm00193a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00193a021%26sid%3Dliteratum%253Aachs%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26aulast%3DPiper%26aufirst%3DJ.%2BR.%26aulast%3DElliott%26aufirst%3DR.%2BD.%26aulast%3DTemple%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DE.%2BC.%26aulast%3DShealy%26aufirst%3DY.%2BF.%26atitle%3DAnalogs%2520of%2520Methotrexate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1979%26volume%3D22%26issue%3D7%26spage%3D862%26epage%3D868%26doi%3D10.1021%2Fjm00193a021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E.-M.</span></span> <span> </span><span class="NLM_article-title">Oxidative Status of DBA/1J Mice with Type II Collagen-Induced Arthritis</span>. <i>J. Appl. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">472</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1002/jat.1228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1002%2Fjat.1228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=17299831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVGku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=472-481&issue=5&author=E.-M.+Choi&title=Oxidative+Status+of+DBA%2F1J+Mice+with+Type+II+Collagen-Induced+Arthritis&doi=10.1002%2Fjat.1228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative status of DBA/1J mice with type II collagen-induced arthritis</span></div><div class="casAuthors">Choi, Eun-Mi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">472-481</span>CODEN:
                <span class="NLM_cas:coden">JJATDK</span>;
        ISSN:<span class="NLM_cas:issn">0260-437X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The present study was undertaken to compare the oxidant statuses of mice with collagen-induced arthritis (CIA) and those of healthy mice.  For this purpose, serum oxidant products and arthritic profiles were measured in DBA/1J mice with CIA.  In addn., the levels of oxidn. products and the activities of antioxidant enzymes were detd. in liver, heart, spleen, kidney, lung and brain.  The induction of arthritis significantly increased anti-collagen antibody, rheumatoid factor, interleukin (IL)-1β, IL-6, protein carbonyl (PCO), advanced glycation end-products (AGE), malondialdehyde (MDA) and low d. lipoprotein (LDL)-cholesterol levels in serum (P < 0.05).  CIA in DBA/1J mice was assocd. with significantly lower activities of superoxide dismutase, glutathione peroxidase and glutathione reductase in spleen but higher levels of oxidn. products in spleen, kidney and liver than healthy normal mice (P < 0.05).  However, lower concns. of oxidized protein and higher activities of antioxidant enzymes were obsd. in CIA mouse lung and brain than in healthy normal mice.  Dexamethasone treated CIA mice had decreased arthritis-related indexes and showed: reduced PCO and AGE in spleen and brain, and increased PCO and AGE in heart, kidney and lung; increased MDA in heart, spleen, lung and brain; reduced SOD and GR activities in lung and brain; increased GPx activity in spleen and brain; and increased GR activity heart and spleen.  These data suggest that mice with CIA were more susceptible to oxidative damage in the spleen and liver under the chronic inflammatory conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolqRuZydh_l7Vg90H21EOLACvtfcHk0lhKG7Tw-g1uwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVGku70%253D&md5=c0b01339e1a9f22db502a6c10dd1a29c</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fjat.1228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjat.1228%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DE.-M.%26atitle%3DOxidative%2520Status%2520of%2520DBA%252F1J%2520Mice%2520with%2520Type%2520II%2520Collagen-Induced%2520Arthritis%26jtitle%3DJ.%2520Appl.%2520Toxicol.%26date%3D2007%26volume%3D27%26issue%3D5%26spage%3D472%26epage%3D481%26doi%3D10.1002%2Fjat.1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span> <span> </span><span class="NLM_article-title">Isorhamnetin Attenuates Collagen-Induced Arthritis via Modulating Cytokines and Oxidative Stress in Mice</span>. <i>Int. J. Clin. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">16536</span>– <span class="NLM_lpage">16542</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=26629181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlOmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=16536-16542&issue=9&author=X.+Wangauthor=W.+Zhong&title=Isorhamnetin+Attenuates+Collagen-Induced+Arthritis+via+Modulating+Cytokines+and+Oxidative+Stress+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Isorhamnetin attenuates collagen-induced arthritis via modulating cytokines and oxidative stress in mice</span></div><div class="casAuthors">Wang, Xuewen; Zhong, Wei</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">16536-16542</span>CODEN:
                <span class="NLM_cas:coden">IJCEFA</span>;
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Inflammation and oxidative stress were involved in the development and progression of rheumatoid arthritis (RA).  Isorhamnetin has anti-inflammatory and anti-oxidative activities, but its effects on RA have not been investigated.  In order to observe the possible therapeutic effects of isorhamnetin on RA, we established a collagen-induced arthritis mouse model and treated the animal with isorhamnetin for 3 wk.  Besides, fibroblast-like synoviocytes (FLS) were treated with lipopolysaccharide (LPS) and isorhamnetin.  The severity of arthritis was assessed by arthritis score, joint destruction score and inflammation score.  Levels of cytokines TNF-α, IL-1β, IL-6, IL-17A, IL-17F, IL-10 and IL-35 in the joint tissue homogenate and cell culture medium as well as anti-type II collagen antibody in serum were measured using ELISA.  Contents of H2O2 and malondialdehyde (MDA) in joint tissue homogenate were measured using assay kits.  We found collagen immunization induced significant arthritis in mice and isorhamnetin at the dose of 10 and 20 mg/kg/day could significantly attenuate the collagen-induced arthritis.  Isorhamnetin also modulated the prodn. of cytokines and suppressed the oxidative stress in the mice with collagen-induced arthritis at the dose of 10 and 20 mg/kg/day.  These data suggested that isorhamnetin might be a potential agent for the management of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmStSyNVyW5rVg90H21EOLACvtfcHk0lhKG7Tw-g1uwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlOmuro%253D&md5=10b7024bbbb56bf6bff01aea703fa312</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DIsorhamnetin%2520Attenuates%2520Collagen-Induced%2520Arthritis%2520via%2520Modulating%2520Cytokines%2520and%2520Oxidative%2520Stress%2520in%2520Mice%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2015%26volume%3D8%26issue%3D9%26spage%3D16536%26epage%3D16542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singla, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, A. K.</span></span> <span> </span><span class="NLM_article-title">Antioxidant Activity and Protective Effect of Suramin against Oxidative Stress in Collagen Induced Arthritis</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2017.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.ejps.2017.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=28189815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlKju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2017&pages=125-139&author=D.+Sahuauthor=S.+Sharmaauthor=R.+K.+Singlaauthor=A.+K.+Panda&title=Antioxidant+Activity+and+Protective+Effect+of+Suramin+against+Oxidative+Stress+in+Collagen+Induced+Arthritis&doi=10.1016%2Fj.ejps.2017.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant activity and protective effect of suramin against oxidative stress in collagen induced arthritis</span></div><div class="casAuthors">Sahu, Debasis; Sharma, Shikha; Singla, Rajeev K.; Panda, Amulya Kumar</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">125-139</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">It is imperative to interrupt the link between arthritis and regulation of oxidative stress with the administration of antioxidants.  Suramin is known for its anti-inflammatory, antineoplastic and antiangiogenic activities implying its possible antioxidant property.  In this study, the antioxidant activity of suramin in cell free system was found to be higher than L-ascorbic acid (L-AA) with respect to its scavenging effect on nitric oxide (NO), hypochlorous acid and hydrogen peroxide radicals.  Besides, suramin was found to be nontoxic to cultured RAW cells even at high concns. along with marked inhibition of NO prodn.  Suramin was found to curb the inflammation assocd. with the collagen induced arthritis (CIA) model.  Administration of suramin significantly reduced the malondialdehyde and protein carbonyl content in joints, liver, kidney and spleen of rats as studied ex vivo.  Furthermore, the increased antioxidant enzymes such as SOD, catalase, GST, GPx and GR activities in the tissues were restored significantly after suramin treatment.  In silico expts. using Vlife MDS4.4-GRIP docking method showed strong affinity of suramin towards erythrocyte catalase followed by glutathione peroxidase thus corroborating with the findings of antioxidant enzyme assays.  Our studies clearly indicate that suramin has remarkable antioxidant potential and can ameliorate arthritis via modulation of oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaUmTHQ_rdmLVg90H21EOLACvtfcHk0lhKG7Tw-g1uwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlKju7Y%253D&md5=08fa6c6d3d3e9f5a0706f909fc5df058</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2017.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2017.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DSahu%26aufirst%3DD.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DSingla%26aufirst%3DR.%2BK.%26aulast%3DPanda%26aufirst%3DA.%2BK.%26atitle%3DAntioxidant%2520Activity%2520and%2520Protective%2520Effect%2520of%2520Suramin%2520against%2520Oxidative%2520Stress%2520in%2520Collagen%2520Induced%2520Arthritis%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2017%26volume%3D101%26spage%3D125%26epage%3D139%26doi%3D10.1016%2Fj.ejps.2017.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">National
Cancer Institute</span>. <span> </span><span class="NLM_article-title">Cell Miner.
NCI-60 panel of methotrexate
and aminopterin</span>. <a href="https://discover.nci.nih.gov/cellminer/" class="extLink">https://discover.nci.nih.gov/cellminer/</a> (accessed on August 11, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=National%0ACancer+Institute.+Cell+Miner.%0ANCI-60+panel+of+methotrexate%0Aand+aminopterin.+https%3A%2F%2Fdiscover.nci.nih.gov%2Fcellminer%2F+%28accessed+on+August+11%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DCell%2520Miner.%250ANCI-60%2520panel%2520of%2520methotrexate%250Aand%2520aminopterin" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D.</span></span> <span> </span><span class="NLM_article-title">The Metabolism and Toxicity of Quinones, Quinonimines, Quinone Methides, and Quinone-Thioethers</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.2174/1389200023337388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.2174%2F1389200023337388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=12093358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlCqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=425-438&issue=4&author=T.+Monksauthor=D.+Jones&title=The+Metabolism+and+Toxicity+of+Quinones%2C+Quinonimines%2C+Quinone+Methides%2C+and+Quinone-Thioethers&doi=10.2174%2F1389200023337388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers</span></div><div class="casAuthors">Monks, Terrence J.; Jones, Douglas C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">425-438</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Quinones are ubiquitous in nature and constitute an important class of naturally occurring compds. found in plants, fungi and bacteria.  Human exposure to quinones therefore occurs via the diet, but also clin. or via airborne pollutants.  For example, the quinones of polycyclic arom. hydrocarbons are prevalent as environmental contaminants and provide a major source of current human exposure to quinones.  The inevitable human exposure to quinones, and the inherent reactivity of quinones, has stimulated substantial research on the chem. and toxicol. of these compds.  From a toxicol. perspective, quinones possess two principal chem. properties that confer their reactivity in biol. systems.  Quinones are oxidants and electrophiles, and the relative contribution of these properties to quinone toxicity is influenced by chem. structure, in particular substituent effects.  Modification to the quinone nucleus also influences quinone metab.  This review will therefore focus on the differences in structure and metab. of quinones, and how such differences influence quinone toxicol.  Specific examples will be discussed to illustrate the diverse manner by which quinones interact with biol. systems to initiate and propagate a toxic response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcMP5Yen5lN7Vg90H21EOLACvtfcHk0ljO2rNeqLJqww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlCqtrY%253D&md5=15000fbf139bf8b4206c503e2baa38ef</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2174%2F1389200023337388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200023337388%26sid%3Dliteratum%253Aachs%26aulast%3DMonks%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DD.%26atitle%3DThe%2520Metabolism%2520and%2520Toxicity%2520of%2520Quinones%252C%2520Quinonimines%252C%2520Quinone%2520Methides%252C%2520and%2520Quinone-Thioethers%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2002%26volume%3D3%26issue%3D4%26spage%3D425%26epage%3D438%26doi%3D10.2174%2F1389200023337388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Non-Proinflammatory and Responsive Nanoplatforms for Targeted Treatment of Atherosclerosis</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2017.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.biomaterials.2017.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=28778000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1OjsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2017&pages=93-108&author=Y.+Douauthor=Y.+Chenauthor=X.+Zhangauthor=X.+Xuauthor=Y.+Chenauthor=J.+Guoauthor=D.+Zhangauthor=R.+Wangauthor=X.+Liauthor=J.+Zhang&title=Non-Proinflammatory+and+Responsive+Nanoplatforms+for+Targeted+Treatment+of+Atherosclerosis&doi=10.1016%2Fj.biomaterials.2017.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis</span></div><div class="casAuthors">Dou, Yin; Chen, Yue; Zhang, Xiangjun; Xu, Xiaoqiu; Chen, Yidan; Guo, Jiawei; Zhang, Dinglin; Wang, Ruibing; Li, Xiaohui; Zhang, Jianxiang</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-108</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Atherosclerosis is the leading cause of many fatal cardiovascular and cerebrovascular diseases.  Whereas nanomedicines are promising for targeted therapy of atherosclerosis, great challenges remain in development of effective, safe, and translational nanotherapies for its treatment.  Herein we hypothesize that non-proinflammatory nanomaterials sensitive to low pH or high reactive oxygen species (ROS) may serve as effective platforms for triggerable delivery of anti-atherosclerotic therapeutics in cellular and tissue microenvironments of inflammation.  To demonstrate this hypothesis, an acid-labile material of acetalated β-cyclodextrin (β-CD) (Ac-bCD) and a ROS-sensitive β-CD material (Ox-bCD) were sep. synthesized by chem. modification of β-CD, which were formed into responsive nanoparticles (NPs).  Ac-bCD NP was rapidly hydrolyzed in mildly acidic buffers, while hydrolysis of Ox-bCD NP was selectively accelerated by H2O2.  Using an anti-atherosclerotic drug rapamycin (RAP), we found stimuli-responsive release of therapeutic mols. from Ac-bCD and Ox-bCD nanotherapies.  Compared with non-responsive poly(lactide-co-glycolide) (PLGA)-based NP, Ac-bCD and Ox-bCD NPs showed negligible inflammatory responses in vitro and in vivo.  By endocytosis in cells and intracellularly releasing cargo mols. in macrophages, responsive nanotherapies effectively inhibited macrophage proliferation and suppressed foam cell formation.  After i.p. delivery in apolipoprotein E-deficient (ApoE-/-) mice, fluorescence imaging showed accumulation of NPs in atherosclerotic plaques.  Flow cytometry anal. indicated that the lymphatic translocation mediated by neutrophils and monocytes/macrophages may contribute to atherosclerosis targeting of i.p. administered NPs, in addn. to targeting via the leaky blood vessels.  Correspondingly, i.p. treatment with different nanotherapies afforded desirable efficacies.  Particularly, both pH and ROS-responsive nanomedicines more remarkably delayed progression of atherosclerosis and significantly enhanced stability of atheromatous lesions, in comparison to non-responsive PLGA nanotherapy.  Furthermore, responsive nanovehicles displayed good safety performance after long-term administration in mice.  Consequently, for the first time our findings demonstrated the therapeutic advantages of nanomedicines responsive to mildly acidic or abnormally high ROS microenvironments for the treatment of atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp8u_VszZM47Vg90H21EOLACvtfcHk0ljO2rNeqLJqww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1OjsbbK&md5=eebf0bba12cb71acd781759b02e50fea</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2017.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2017.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DDou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DNon-Proinflammatory%2520and%2520Responsive%2520Nanoplatforms%2520for%2520Targeted%2520Treatment%2520of%2520Atherosclerosis%26jtitle%3DBiomaterials%26date%3D2017%26volume%3D143%26spage%3D93%26epage%3D108%26doi%3D10.1016%2Fj.biomaterials.2017.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotlyar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudelman, A.</span></span> <span> </span><span class="NLM_article-title">NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7512</span>– <span class="NLM_lpage">7515</span>, <span class="refDoi"> DOI: 10.1021/jo971176v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971176v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7512-7515&issue=21&author=H.+E.+Gottliebauthor=V.+Kotlyarauthor=A.+Nudelman&title=NMR+Chemical+Shifts+of+Common+Laboratory+Solvents+as+Trace+Impurities&doi=10.1021%2Fjo971176v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">NMR chemical shifts of common laboratory solvents as trace impurities</span></div><div class="casAuthors">Gottlieb, Hugo E.; Kotlyar, Vadim; Nudelman, Abraham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7512-7515</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 1H (300 MHz) and 13C (75 MHz) NMR chem. shifts for >30 common impurities, such as lab. solvents, stabilizers, greases and water, are reported in 7 deuterated NMR solvents.  The temp. dependence of the chem. shift of the proton residual peak (HDO) in D2O is established for the entire liq. range of this sample.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocnoOemocS9LVg90H21EOLACvtfcHk0ljO2rNeqLJqww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D&md5=c297adda99f8c10e9f9b0ab9fe5f55be</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjo971176v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971176v%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DKotlyar%26aufirst%3DV.%26aulast%3DNudelman%26aufirst%3DA.%26atitle%3DNMR%2520Chemical%2520Shifts%2520of%2520Common%2520Laboratory%2520Solvents%2520as%2520Trace%2520Impurities%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26issue%3D21%26spage%3D7512%26epage%3D7515%26doi%3D10.1021%2Fjo971176v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, P. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Boron-Containing Primary Amines</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">12346</span>– <span class="NLM_lpage">12367</span>, <span class="refDoi"> DOI: 10.3390/molecules181012346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.3390%2Fmolecules181012346" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=12346-12367&issue=10&author=S.+H.+Chungauthor=T.+J.+Linauthor=Q.+Y.+Huauthor=C.+H.+Tsaiauthor=P.+S.+Pan&title=Synthesis+of+Boron-Containing+Primary+Amines&doi=10.3390%2Fmolecules181012346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.3390%2Fmolecules181012346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules181012346%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DT.%2BJ.%26aulast%3DHu%26aufirst%3DQ.%2BY.%26aulast%3DTsai%26aufirst%3DC.%2BH.%26aulast%3DPan%26aufirst%3DP.%2BS.%26atitle%3DSynthesis%2520of%2520Boron-Containing%2520Primary%2520Amines%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26issue%3D10%26spage%3D12346%26epage%3D12367%26doi%3D10.3390%2Fmolecules181012346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mosey, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floreancig, P. E.</span></span> <span> </span><span class="NLM_article-title">Versatile Approach to α-Alkoxy Carbamate Synthesis and Stimulus-Responsive Alcohol Release</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">7980</span>– <span class="NLM_lpage">7985</span>, <span class="refDoi"> DOI: 10.1039/c2ob26571k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1039%2Fc2ob26571k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=7980-7985&issue=39&author=R.+A.+Moseyauthor=P.+E.+Floreancig&title=Versatile+Approach+to+%CE%B1-Alkoxy+Carbamate+Synthesis+and+Stimulus-Responsive+Alcohol+Release&doi=10.1039%2Fc2ob26571k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1039%2Fc2ob26571k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob26571k%26sid%3Dliteratum%253Aachs%26aulast%3DMosey%26aufirst%3DR.%2BA.%26aulast%3DFloreancig%26aufirst%3DP.%2BE.%26atitle%3DVersatile%2520Approach%2520to%2520%25CE%25B1-Alkoxy%2520Carbamate%2520Synthesis%2520and%2520Stimulus-Responsive%2520Alcohol%2520Release%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26issue%3D39%26spage%3D7980%26epage%3D7985%26doi%3D10.1039%2Fc2ob26571k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temple, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J. A.</span></span> <span> </span><span class="NLM_article-title">Potential Folic Acid Antagonists. IV. Synthetic Approaches to Analogs of Aminopterin and Methotrexate. IV. Preparation of P-{[(2,4-Diamino-6-Pteridinyl)methyl]amino}benzoic Acids</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1680</span>, <span class="refDoi"> DOI: 10.1021/jo00830a093</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00830a093" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1970&pages=1676-1680&issue=5&author=R.+D.+Elliottauthor=C.+Templeauthor=J.+A.+Montgomery&title=Potential+Folic+Acid+Antagonists.+IV.+Synthetic+Approaches+to+Analogs+of+Aminopterin+and+Methotrexate.+IV.+Preparation+of+P-%7B%5B%282%2C4-Diamino-6-Pteridinyl%29methyl%5Damino%7Dbenzoic+Acids&doi=10.1021%2Fjo00830a093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjo00830a093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00830a093%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DR.%2BD.%26aulast%3DTemple%26aufirst%3DC.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26atitle%3DPotential%2520Folic%2520Acid%2520Antagonists.%2520IV.%2520Synthetic%2520Approaches%2520to%2520Analogs%2520of%2520Aminopterin%2520and%2520Methotrexate.%2520IV.%2520Preparation%2520of%2520P-%257B%255B%25282%252C4-Diamino-6-Pteridinyl%2529methyl%255Damino%257Dbenzoic%2520Acids%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1970%26volume%3D35%26issue%3D5%26spage%3D1676%26epage%3D1680%26doi%3D10.1021%2Fjo00830a093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zidar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupnik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovač, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras
Martel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller
Premru, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterlin
Mašič, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikelj, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel 5-Benzylidenerhodanine and 5-Benzylidenethiazolidine-2,4-Dione Inhibitors of MurD Ligase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">6584</span>– <span class="NLM_lpage">6594</span>, <span class="refDoi"> DOI: 10.1021/jm100285g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100285g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6584-6594&issue=18&author=N.+Zidarauthor=T.+Toma%C5%A1i%C4%87author=R.+%C5%A0inkauthor=V.+Rupnikauthor=A.+Kova%C4%8Dauthor=S.+Turkauthor=D.+Patinauthor=D.+Blanotauthor=C.+Contreras%0AMartelauthor=A.+Dessenauthor=M.+M%C3%BCller%0APremruauthor=A.+Zegaauthor=S.+Gobecauthor=L.+Peterlin%0AMa%C5%A1i%C4%8Dauthor=D.+Kikelj&title=Discovery+of+Novel+5-Benzylidenerhodanine+and+5-Benzylidenethiazolidine-2%2C4-Dione+Inhibitors+of+MurD+Ligase&doi=10.1021%2Fjm100285g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm100285g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100285g%26sid%3Dliteratum%253Aachs%26aulast%3DZidar%26aufirst%3DN.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DT.%26aulast%3D%25C5%25A0ink%26aufirst%3DR.%26aulast%3DRupnik%26aufirst%3DV.%26aulast%3DKova%25C4%258D%26aufirst%3DA.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DPatin%26aufirst%3DD.%26aulast%3DBlanot%26aufirst%3DD.%26aulast%3DContreras%2BMartel%26aufirst%3DC.%26aulast%3DDessen%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%2BPremru%26aufirst%3DM.%26aulast%3DZega%26aufirst%3DA.%26aulast%3DGobec%26aufirst%3DS.%26aulast%3DPeterlin%2BMa%25C5%25A1i%25C4%258D%26aufirst%3DL.%26aulast%3DKikelj%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520Novel%25205-Benzylidenerhodanine%2520and%25205-Benzylidenethiazolidine-2%252C4-Dione%2520Inhibitors%2520of%2520MurD%2520Ligase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D18%26spage%3D6584%26epage%3D6594%26doi%3D10.1021%2Fjm100285g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malavašič, Č.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grošelj, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golobič, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezenšek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanovnik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stare, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svete, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Structure of Novel (S)-1,6-Dialkylpiperazine-2,5-Diones and (3S,6S)-1,3,6-Trialkylpiperazine-2,5-Diones</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2011.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=10.1016%2Fj.tetasy.2011.03.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=629-640&issue=6&author=%C4%8C.+Malava%C5%A1i%C4%8Dauthor=U.+Gro%C5%A1eljauthor=A.+Golobi%C4%8Dauthor=J.+Bezen%C5%A1ekauthor=B.+Stanovnikauthor=K.+Stareauthor=J.+Waggerauthor=J.+Svete&title=Synthesis+and+Structure+of+Novel+%28S%29-1%2C6-Dialkylpiperazine-2%2C5-Diones+and+%283S%2C6S%29-1%2C3%2C6-Trialkylpiperazine-2%2C5-Diones&doi=10.1016%2Fj.tetasy.2011.03.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2011.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2011.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DMalava%25C5%25A1i%25C4%258D%26aufirst%3D%25C4%258C.%26aulast%3DGro%25C5%25A1elj%26aufirst%3DU.%26aulast%3DGolobi%25C4%258D%26aufirst%3DA.%26aulast%3DBezen%25C5%25A1ek%26aufirst%3DJ.%26aulast%3DStanovnik%26aufirst%3DB.%26aulast%3DStare%26aufirst%3DK.%26aulast%3DWagger%26aufirst%3DJ.%26aulast%3DSvete%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Structure%2520of%2520Novel%2520%2528S%2529-1%252C6-Dialkylpiperazine-2%252C5-Diones%2520and%2520%25283S%252C6S%2529-1%252C3%252C6-Trialkylpiperazine-2%252C5-Diones%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2011%26volume%3D22%26issue%3D6%26spage%3D629%26epage%3D640%26doi%3D10.1016%2Fj.tetasy.2011.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barclay, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantopoulos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrovsky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matisons, J. G.</span></span> <span> </span><span class="NLM_article-title">Chiral Self-Assembly of Designed Amphiphiles: Influences on Aggregate Morphology</span>. <i>Langmuir</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">32</span>),  <span class="NLM_fpage">10001</span>– <span class="NLM_lpage">10010</span>, <span class="refDoi"> DOI: 10.1021/la401987y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/la401987y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2013&pages=10001-10010&issue=32&author=T.+G.+Barclayauthor=K.+Constantopoulosauthor=W.+Zhangauthor=M.+Fujikiauthor=N.+Petrovskyauthor=J.+G.+Matisons&title=Chiral+Self-Assembly+of+Designed+Amphiphiles%3A+Influences+on+Aggregate+Morphology&doi=10.1021%2Fla401987y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fla401987y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fla401987y%26sid%3Dliteratum%253Aachs%26aulast%3DBarclay%26aufirst%3DT.%2BG.%26aulast%3DConstantopoulos%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DFujiki%26aufirst%3DM.%26aulast%3DPetrovsky%26aufirst%3DN.%26aulast%3DMatisons%26aufirst%3DJ.%2BG.%26atitle%3DChiral%2520Self-Assembly%2520of%2520Designed%2520Amphiphiles%253A%2520Influences%2520on%2520Aggregate%2520Morphology%26jtitle%3DLangmuir%26date%3D2013%26volume%3D29%26issue%3D32%26spage%3D10001%26epage%3D10010%26doi%3D10.1021%2Fla401987y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riebeseel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biedermann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Löser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breiter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanselmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mülhaupt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratz, F.</span></span> <span> </span><span class="NLM_article-title">Polyethylene Glycol Conjugates of Methotrexate Varying in Their Molecular Weight from MW 750 to MW 40000: Synthesis, Characterization, and Structure–Activity Relationships in Vitro and in Vivo</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">773</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1021/bc010098m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc010098m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1Krs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=773-785&issue=4&author=K.+Riebeseelauthor=E.+Biedermannauthor=R.+L%C3%B6serauthor=N.+Breiterauthor=R.+Hanselmannauthor=R.+M%C3%BClhauptauthor=C.+Ungerauthor=F.+Kratz&title=Polyethylene+Glycol+Conjugates+of+Methotrexate+Varying+in+Their+Molecular+Weight+from+MW+750+to+MW+40000%3A+Synthesis%2C+Characterization%2C+and+Structure%E2%80%93Activity+Relationships+in+Vitro+and+in+Vivo&doi=10.1021%2Fbc010098m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Polyethylene Glycol Conjugates of Methotrexate Varying in Their Molecular Weight from MW 750 to MW 40000: Synthesis, Characterization, and Structure-Activity Relationships in Vitro and in Vivo</span></div><div class="casAuthors">Riebeseel, Katja; Biedermann, Elfi; Loeser, Roland; Breiter, Norbert; Hanselmann, Ralf; Muelhaupt, Rolf; Unger, Clemens; Kratz, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">773-785</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Poly(ethylene glycol)s (PEGs) are potential drug carriers for improving the therapeutic index of anticancer agents.  In this study, the anticancer drug methotrexate (MTX) was activated with N,N'-dicyclohexylcarbodiimide (DCC) and coupled to amino group bearing PEGs of MW 750, 2000, 5000, 10,000, 20,000, and 40,000.  First, the activation process of MTX with DCC in the presence and absence of N-hydroxysuccinimide was analyzed by HPLC.  Preincubation of methotrexate with DCC alone at 0° was favorable with respect to the amt. of activated species and the formation of byproducts.  MTX-PEG conjugates were synthesized according to this procedure, isolated through size-exclusion chromatog., and characterized by anal. HPLC, MALDI-TOF spectrometry, and gel permeation chromatog.  In a cell-free assay, all of the drug polymer conjugates inhibited the target enzyme of MTX, dihydrofolate reductase (DHFR), to a similar extent, but were not as active as free MTX.  Addnl., incubation of the MTX-PEG 40,000 conjugate for 6 days at 37° in phosphate buffered saline (pH 7.4), in cell-conditioned medium, or in human serum revealed no significant release of methotrexate.  These results, taken together, indicate that release of MTX from polymer conjugates is not necessary for an effective interaction with the active site of dihydrofolate reductase.  Evaluation of the in vitro cytotoxicity of the MTX-PEG conjugates in 2 adherent and 3 suspension human tumor cell lines revealed that the IC50 values of the tested compds. increased with the size of the drug-polymer conjugates.  The most effective compd. tested in these assays was the free drug MTX itself (IC50 value ranging from ∼0.01 to 0.05 μM), while the IC50 values of the polymer conjugates were higher (IC50 value for MTX-PEG750, 2000 and 5000: 0.6-3 μM; for MTX-PEG 10,000 and 20,000: 2-7 μM; and for MTX-PEG 40,000: >6 μM).  Subsequently, MTX-PEG 5000, MTX-PEG 20,000, and MTX-PEG 40,000 were evaluated in a human mesothelioma MSTO-211H xenograft model, and their antitumor effects were compared with free methotrexate and the albumin conjugate MTX-HSA, a conjugate that is currently in phase II clin. trials.  In contrast to the in vitro results, the high mol. wt. MTX-PEG conjugates exhibited the highest in vivo antitumor activity: at a dose of 40 and 80 mg/kg MTX-PEG 5000 was less active than MTX at its optimal dose of 100 mg/kg; MTX-PEG 20,000 at a dose of 40 mg/kg showed antitumor efficacy comparable to MTX, but MTX-PEG 40,000 at a dose of 20 mg/kg was superior to MTX and demonstrated antitumor activity of the same order as MTX-HSA (20 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzrr8MsDP_f7Vg90H21EOLACvtfcHk0lhiPy-mKqeFzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1Krs7w%253D&md5=f0dbed23f7655e8ad3a3e731bc4ab585</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fbc010098m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc010098m%26sid%3Dliteratum%253Aachs%26aulast%3DRiebeseel%26aufirst%3DK.%26aulast%3DBiedermann%26aufirst%3DE.%26aulast%3DL%25C3%25B6ser%26aufirst%3DR.%26aulast%3DBreiter%26aufirst%3DN.%26aulast%3DHanselmann%26aufirst%3DR.%26aulast%3DM%25C3%25BClhaupt%26aufirst%3DR.%26aulast%3DUnger%26aufirst%3DC.%26aulast%3DKratz%26aufirst%3DF.%26atitle%3DPolyethylene%2520Glycol%2520Conjugates%2520of%2520Methotrexate%2520Varying%2520in%2520Their%2520Molecular%2520Weight%2520from%2520MW%2520750%2520to%2520MW%252040000%253A%2520Synthesis%252C%2520Characterization%252C%2520and%2520Structure%25E2%2580%2593Activity%2520Relationships%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DBioconjugate%2520Chem.%26date%3D2002%26volume%3D13%26issue%3D4%26spage%3D773%26epage%3D785%26doi%3D10.1021%2Fbc010098m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S.-C.</span></span> <span> </span><span class="NLM_article-title">J. Para-[N-Bis-(2-Chloroethyl)]-Aminobenzoylglutamic Acid</span>. <i>J. Med. Pharm. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1021/jm01236a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm01236a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1962&pages=33-41&issue=1&author=S.-C.+Fu&title=J.+Para-%5BN-Bis-%282-Chloroethyl%29%5D-Aminobenzoylglutamic+Acid&doi=10.1021%2Fjm01236a004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm01236a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm01236a004%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DS.-C.%26atitle%3DJ.%2520Para-%255BN-Bis-%25282-Chloroethyl%2529%255D-Aminobenzoylglutamic%2520Acid%26jtitle%3DJ.%2520Med.%2520Pharm.%2520Chem.%26date%3D1962%26volume%3D5%26issue%3D1%26spage%3D33%26epage%3D41%26doi%3D10.1021%2Fjm01236a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vernall, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briddon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellam, B.</span></span> <span> </span><span class="NLM_article-title">Highly Potent and Selective Fluorescent Antagonists of the Human Adenosine A3 Receptor Based on the 1,2,4-Triazolo[4,3-A]quinoxalin-1-One Scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1771</span>– <span class="NLM_lpage">1782</span>, <span class="refDoi"> DOI: 10.1021/jm201722y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201722y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1771-1782&issue=4&author=A.+J.+Vernallauthor=L.+A.+Stoddartauthor=S.+J.+Briddonauthor=S.+J.+Hillauthor=B.+Kellam&title=Highly+Potent+and+Selective+Fluorescent+Antagonists+of+the+Human+Adenosine+A3+Receptor+Based+on+the+1%2C2%2C4-Triazolo%5B4%2C3-A%5Dquinoxalin-1-One+Scaffold&doi=10.1021%2Fjm201722y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm201722y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201722y%26sid%3Dliteratum%253Aachs%26aulast%3DVernall%26aufirst%3DA.%2BJ.%26aulast%3DStoddart%26aufirst%3DL.%2BA.%26aulast%3DBriddon%26aufirst%3DS.%2BJ.%26aulast%3DHill%26aufirst%3DS.%2BJ.%26aulast%3DKellam%26aufirst%3DB.%26atitle%3DHighly%2520Potent%2520and%2520Selective%2520Fluorescent%2520Antagonists%2520of%2520the%2520Human%2520Adenosine%2520A3%2520Receptor%2520Based%2520on%2520the%25201%252C2%252C4-Triazolo%255B4%252C3-A%255Dquinoxalin-1-One%2520Scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D4%26spage%3D1771%26epage%3D1782%26doi%3D10.1021%2Fjm201722y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lellouche, J. P.</span>; <span class="NLM_string-name">Naddaka, M.</span>; <span class="NLM_string-name">Peled, A.</span>; <span class="NLM_string-name">Mondal, E.</span></span> <span> </span><span class="NLM_article-title">Surface-Modified Polymer Films</span>. <span class="NLM_patent">U.S. Patent 20110306722 A1</span>, December 15, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+P.+Lellouche&author=M.+Naddaka&author=A.+Peled&author=E.+Mondal&title=Surface-Modified+Polymer+Films"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLellouche%26aufirst%3DJ.%2BP.%26atitle%3DSurface-Modified%2520Polymer%2520Films%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuellar, R. A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazar, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suryanarayanan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurvich, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georg, G. I.</span></span> <span> </span><span class="NLM_article-title">Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9334</span>– <span class="NLM_lpage">9344</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01329</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01329" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9334-9344&issue=23&author=S.+Patilauthor=L.+G.+Lisauthor=R.+J.+Schumacherauthor=B.+J.+Norrisauthor=M.+L.+Morganauthor=R.+A.+D.+Cuellarauthor=B.+R.+Blazarauthor=R.+Suryanarayananauthor=V.+J.+Gurvichauthor=G.+I.+Georg&title=Phosphonooxymethyl+Prodrug+of+Triptolide%3A+Synthesis%2C+Physicochemical+Characterization%2C+and+Efficacy+in+Human+Colon+Adenocarcinoma+and+Ovarian+Cancer+Xenografts&doi=10.1021%2Facs.jmedchem.5b01329"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01329%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%26aulast%3DLis%26aufirst%3DL.%2BG.%26aulast%3DSchumacher%26aufirst%3DR.%2BJ.%26aulast%3DNorris%26aufirst%3DB.%2BJ.%26aulast%3DMorgan%26aufirst%3DM.%2BL.%26aulast%3DCuellar%26aufirst%3DR.%2BA.%2BD.%26aulast%3DBlazar%26aufirst%3DB.%2BR.%26aulast%3DSuryanarayanan%26aufirst%3DR.%26aulast%3DGurvich%26aufirst%3DV.%2BJ.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26atitle%3DPhosphonooxymethyl%2520Prodrug%2520of%2520Triptolide%253A%2520Synthesis%252C%2520Physicochemical%2520Characterization%252C%2520and%2520Efficacy%2520in%2520Human%2520Colon%2520Adenocarcinoma%2520and%2520Ovarian%2520Cancer%2520Xenografts%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D23%26spage%3D9334%26epage%3D9344%26doi%3D10.1021%2Facs.jmedchem.5b01329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i60"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01775">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82377"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01775">10.1021/acs.jmedchem.7b01775</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Hydrogen peroxide prodrug activation, cell viability, chemical, SGF, SIF, plasma, and metabolic stabilities assays, and assigned NMR spectra of synthesized compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_001.pdf">jm7b01775_si_001.pdf (2.04 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01775/suppl_file/jm7b01775_si_002.csv">jm7b01775_si_002.csv (2.23 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-8%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01775%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01775" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679947e8e9053d1e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
